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Although postpartum psychosis is a devastating and predictable disorder, it has 
received little attention in biological research. This is the first study assessing 
cognitive, emotional and neuroimaging correlates of women at risk of postpartum 
psychosis. We hypothesised that women “at risk” will show decreased brain 
activation in the dorsolateral prefrontal cortex in a working memory task and 
increased brain activation in the amygdala in a facial emotion processing task, 
compared to healthy controls, similar to that observed in bipolar disorder and 
psychoses unrelated to childbirth.   
Twenty-five women “at risk” (N=13 due to non-postpartum and N=12 due to 
postpartum episodes) were compared to 21 healthy women within the first year after 
delivery. Women took part in two study visits including clinical interviews and a 
magnetic resonance imaging (MRI) scan. We assessed working memory and 
emotional face processing using two functional MRI tasks and verbal memory using 
two behavioural tasks. 
Groups were matched on sociodemographic background and medical and obstetric 
history. Women “at risk” showed an activation increase of the midcingulate and 
temporal cortices compared to healthy controls, which was accompanied by deficits 
in working and verbal memory performance. Women with postpartum episodes, 
compared to healthy controls, showed a relative increase in activation to fearful faces 
in the left inferior frontal gyrus.  
This study provides preliminary evidence that women “at risk” of postpartum 
psychosis show cognitive impairments similar to those of patients with bipolar 
disorder and psychoses unrelated to childbirth. Women with postpartum episodes 
seem to differ in emotional processing from healthy controls, possibly indicating an 
increased emotional response to fear. These results represent a first step towards a 
better understanding of cognitive and emotional processes in postpartum psychosis. 
When validated in larger and longitudinal studies, they may help clinicians in 
developing individual management strategies and implementing targeted cognitive 
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1. Chapter: Introduction 
Postpartum psychosis is a rare, but severe postpartum disorder often occurring within 
the first days to weeks following childbirth (Heron, Robertson Blackmore, 
McGuinness, Craddock, & Jones, 2007; Sit, Rothschild, & Wisner, 2006). Symptoms 
typically include hallucinations, delusions, cognitive disorganisation and mood 
disturbances (Sit et al., 2006). Recovery is a long and difficult process and often 
takes up to a year (Heron et al., 2012). Frequently, women need to be hospitalised 
(Sharma, 2008). Postpartum psychosis is currently diagnosed under the mood 
disorder section or as a brief psychotic episode according to the Diagnostic and 
Statistical Manual of Mental Disorders (DSM)-IV (American Psychiatric 
Association, 1994). Women are often in their mid to late twenties when they 
experience postpartum psychosis, although it can occur at any age during the 
childbearing years with an incidence of 1-2/1000 women (Brockington, 1996; Sit et 
al., 2006). Postpartum psychosis has severe consequences for mother and child and 
needs to be treated as an emergency (Sit et al., 2006). Consequently, it is very 
important to investigate factors precipitating and accompanying postpartum 
psychosis.                                                                                                                                               
     One key issue concerning research in postpartum psychosis is the difficulty in 
terms of its nosology, which has led to a general paucity in research. In order to shed 
light onto neurobiological and neuropsychological processes implicated in 
postpartum psychosis, it is of great importance to investigate potential clinical, 
cognitive, emotional, and neuroimaging correlates of postpartum psychosis. The 
objective of this thesis is to assess these correlates in four experimental chapters. 
Before this, a theoretical background of postpartum psychosis is given, followed by a 
discussion of its relation to other mental disorders. This is important because having 
a psychiatric diagnosis is considered as a major risk factor. In addition, this section 
lies the theoretical background down for our selected “at risk” population. Then, 
biological, clinical and sociodemographic, and cognitive, emotional, and 
neuroimaging findings will be discussed. We propose that women with postpartum 
psychosis will show similar cognitive, emotional, and neuroimaging alterations as 




1.1 Postpartum psychosis 
In this chapter, the historical context and epidemiology will be reviewed. 
 
1.1.1 Historical context 
Early descriptions of postpartum psychosis (“postpartum mania or insanity, or 
puerperal psychosis”), found in general medical texts of the seventeenth century, 
describe it as severe mental illness which appears suddenly and unexpectedly after 
childbirth (Plater, 1602 and 1656; Schenk, 1609; in Brockington, 1996). The concept 
that a mental illness is triggered by childbirth seemed to have been established by the 
end of the eighteenth century, following which the first research data were collected 
(Osiander, 1797; Denman, 1801; Esquirol, 1818 and 1845; in Brockington, 1996). 
The first controlled studies assessing postpartum psychosis commenced in the 
twentieth century (Brockington, 1996; Paffenbarger, 1961, 1964; Paffenbarger & 
McCabe, 1966).    
     Postpartum psychosis is a serious disorder and given the severity of symptoms 
(e.g. hallucinations, confusion, or disorientation) and temporal proximity to 
childbirth, there is no dispute about its existence per se. However, the Kraepelinian 
classification of the “two entities principle” between schizophrenia and affective 
psychosis established in the nineteenth century made it difficult to classify 
postpartum psychosis in terms of its nosology (Brockington, 1996; Klompenhouwer 
& van Hulst, 1991; Loudon, 1988). This difficulty arises partly due to its often mixed 
presentation of psychotic and affective symptoms. Another reason is that having a 
diagnosis of bipolar or schizoaffective disorder, or to a lesser extent a history of 
psychosis unrelated to childbirth or schizophrenia, puts women at a higher risk of 
developing postpartum psychosis and vice versa (Boyce & Barriball, 2010; Harlow 
et al., 2007; Jones & Craddock, 2001; Nager, Szulkin, Johansson, Johansson, & 
Sundquist, 2012; Reich & Winokur, 1970; Sit et al., 2006). Until today, the 
nosological status of postpartum psychosis remains controversial (Benvenuti et al., 
1992; Jones & Craddock, 2007; Klompenhouwer & van Hulst, 1991). Whether 
postpartum psychosis forms its own entity (i.e. a condition triggered exclusively by 
childbirth) or is part of another mental disorder will be further explored in section 




This section includes the current classification of postpartum psychosis according to 
DSM-IV, followed by a description of symptoms, incidence, onset, treatment and 
risks following postpartum psychosis.  
 
1.1.2.1 Classification 
In the current version of the DSM-IV, postpartum psychosis is diagnosed as either a 
mood disorder (major depressive, manic, mixed episode of major depressive 
disorder, bipolar I disorder, or bipolar II disorder) or as a brief psychotic disorder 
(for symptoms see section 1.1.2.3). The specified time criterion requires that the 
onset of symptoms should be within four weeks following delivery (American 
Psychiatric Association, 1994; Brockington, 1996). This time-frame is shorter than 
the six weeks following delivery required by the International Classification of 
Diseases (ICD)-10. According to the ICD-10, postpartum psychosis can be included 
under mental disorders associated with the puerperium if no criteria for other 
disorders are met (World Health Organization, 1992). These two classification 
systems already highlight the inconsistencies regarding postpartum psychosis 
between existing diagnostic manuals. Far more in agreement are the findings 
concerning the incidence of postpartum psychosis. 
 
1.1.2.2 Incidence 
Postpartum psychosis is quite consistently estimated to occur after 1-2/1000 
deliveries (Brockington et al., 1981; Dean & Kendell, 1981; Kendell, Chalmers, & 
Platz, 1987; Klompenhouwer & van Hulst, 1991; R. Kumar, 1994; R. Kumar, Marks, 
Platz, & Yoshida, 1995; Meltzer & Kumar, 1985; Sit et al., 2006; Tschinkel, Harries, 
Le Noury, & Healy, 2007). The mean age of onset for postpartum psychosis has been 
reported to be in the mid to late twenties of an age range typically within the 
childbearing years of 20-40 years (P. Agrawal, Bhatia, & Malik, 1990; Dowlatshahi 
& Paykel, 1990; C. L. E. Katona, 1982; Reich & Winokur, 1970; Rohde & Marneros, 
1993). Some variability in the rates may be explained by differences in diagnostic 
tools and time of onset following delivery used across research studies (ranging from 




Symptom presentation is inconsistent across patients, which may contribute to 
difficulties in establishing clear and reliable classification criteria. Symptoms can be 
categorised as psychotic, affective, cognitive, and other symptoms (Table 1.1). 
Postpartum psychosis can present itself with symptoms frequently seen in psychoses 
unrelated to childbirth such as delusions and hallucinations (Engqvist, Ferszt, Åhlin, 
& Nilsson, 2009; Rohde & Marneros, 1993; Sit et al., 2006). These symptoms can be 
mood congruent and incongruent (Sit et al., 2006). In the case of postpartum 
psychosis, it has been reported that 53-78% of the delusional ideas are related to the 
infant (Chandra, Bhargavaraman, Raghunandan, & Shaligram, 2006).  
 
Table 1.1 Symptoms of postpartum psychosis 
Psychotic symptoms Affective symptoms  Cognitive symptoms Other symptoms 
Delusions Elation Disorganisation No Insight 
Hallucinations Dysphoria Confusion Insomnia 
Thought insertion Mood lability Perplexity Rambling in speech 
Thought broadcasting Odd affect  Excessive activity 
Experiences of alienation Agitation   
Echo phenomena Aggression   
Catatonic features Depression   
Disconnection    
 
 
Other rare symptoms have been reported, such as the Capgras and the Fregoli 
syndromes (Cohn, Rosenblatt, & Faillace, 1977; De Leo, Galligioni, & Magni, 1985; 
Nilsson & Perris, 1971; O'Sullivan & Dean, 1991). The Capgras syndrome is the 
delusion that someone who is well known to the patient has been replaced by an 
imposter. Patients suffering from the Fregoli syndrome identify a familiar person in 
various strangers, claiming that although those have no physical resemblance, they 
are psychologically identical (Cohn et al., 1977; De Leo et al., 1985; Nilsson & 
Perris, 1971; O'Sullivan & Dean, 1991). One key symptom of postpartum psychosis, 
however, is cognitive disorganisation (e.g. confusion or disconnected thinking) 
(Kisa, Aydemir, Kurt, Gülen, & Göka, 2007; Platz & Kendell, 1988; Wisner, Peindl, 
& Hanusa, 1994). In addition, postpartum psychosis often presents with mixed 
affective symptoms (e.g. feeling like a failure at the same time as having flight of 
ideas) (Brockington, 1996; Brockington et al., 1981; Brockington, Margison, 
Schofield, & Knight, 1988; Dean & Kendell, 1981; Hanson & Brown, 1973; Jones, 
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2008; Jones & Craddock, 2005; Kadrmas, Winokur, & Crowe, 1979; 
Klompenhouwer & van Hulst, 1991; Oosthuizen, Russouw, & Roberts, 1995; 
Sharma, Smith, & Khan, 2004; Sit et al., 2006; Vinogradov & Csernansky, 1990). 
Mild hypomanic symptoms have been reported within the first day after delivery 




The time of onset of postpartum psychosis following delivery has often been 
reported to be within the first two to four weeks after childbirth, with a supposed 
“symptom free period” lasting from 24 hours to up to a week (Heron et al., 2007; Sit 
et al., 2006). However, an onset of symptoms within 24 hours has been reported in 
one of the earlier studies of postpartum psychosis (Paffenbarger, 1961). This was 
supported by more studies showing that in fact prodromal symptoms (reported as 
subjectively experienced emotional and behavioural changes) can emerge within the 
first three days after delivery (Heron et al., 2008; Heron et al., 2007; Melges, 1968). 
Subjective recall of clinically significant symptoms was investigated retrospectively 
in a sample of women with a previous episode of postpartum psychosis. The results 
of this study showed that the majority of women had a symptom onset within the first 
week after delivery, with 22% of the symptoms occurring within the first day and 
50% within the first three days (Heron et al., 2007). These findings challenge the 
concept of a symptom free period after delivery in postpartum psychosis (Heron et 
al., 2008; Heron et al., 2007; Melges, 1968). It has been suggested that the concept of 
a symptom free period has emerged due to reporting the time of the women’s 
admission to hospital as the time of illness onset, which is logically later, rather than 
the actual symptom onset which may have been days before (Heron et al., 2007).  
     Early symptoms of postpartum psychosis include feeling excited, elated, or high 
(52%), not needing to sleep or not being able to sleep (48%), feeling active or 
energetic (37%), and talking more or feeling very chatty (31%) (Heron et al., 2008). 
These prodromal, often hypomanic, symptoms might have gone unnoticed by 
midwives, who instead may even have declared the mother as being highly 
functional (Heron et al., 2008). It has been proposed that a mild hypomanic state 
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could indeed be “adaptive”, leading to an improved general functioning of the 
mother and a better relationship between mother and infant. However, mild 
hypomanic symptoms found in healthy women following delivery were predictive of 
later depression as were high scores on scales quantifying depression, tears and 
lability (Glover, Liddle, Taylor, Adams, & Sandler, 1994; Heron, Craddock, & 
Jones, 2005; Heron, Haque, Oyebode, Craddock, & Jones, 2009; Kendell, McGuire, 
Connor, & Cox, 1981). It seems possible that any major emotional lability following 
delivery, with either a manic or depressed tendency, could be an early sign for the 
potential development of mood problems, leading potentially to postpartum 
psychosis and with that to serious adverse consequences for the mother and the child 
(P. Agrawal et al., 1990; Dowlatshahi & Paykel, 1990; C. L. E. Katona, 1982; Reich 
& Winokur, 1970; Rohde & Marneros, 1993). 
 
1.1.2.5 Adverse consequences  
Following an episode of postpartum psychosis, there is a high risk of a lack of 
emotional bonding or even separation between the mother and the child. There is the 
potential for impaired cognitive, physical, and psychological development of the 
child if the condition is not treated (Chandra et al., 2006; R. Kumar et al., 1995; Sit et 
al., 2006; Wisner et al., 1994). When given appropriate care, the impact on the child 
may be reduced (Murray, Cooper, & Hipwell, 2003). Identifying early symptoms and 
risk factors is therefore an important step to ensure appropriate care is given as early 
as possible. 
     Due to the severity of the symptoms, the risks of unsafe practices towards the 
baby, abusive incidents, or neglect can increase (Chandra et al., 2006). Although 
homicide rarely occurs, women do express more homicidal ideation than in other 
nonpsychotic childbirth onset illnesses such as postpartum depression (Sit et al., 
2006; Wisner et al., 1994). Approximately 4% of women who suffer from 
postpartum psychosis commit neonaticide, often related to a denial of pregnancy, 
depersonalisation, dissociative hallucinations, or intermitted amnesia (M.G.  Spinelli, 
2001; M.G. Spinelli, 2009). Suicidal ideation is also associated with infanticidal 
ideas (Babu, Subbakrishna, & Chandra, 2008). Compared to healthy women, in 
women with postpartum psychosis the risk of suicide is increased 70-fold in the first 
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year after delivery, with depressive symptoms being the most important risk factor 
for suicidal ideation and attempts (Appleby, Mortensen, & Faragher, 1998; Babu et 
al., 2008; Brockington, 1996; Rohde & Marneros, 1993). In fact, the majority of 
maternal deaths with a psychiatric cause are due to suicide (up to 80%) and suicide 
accounts for 28% of maternal death in general (Lewis, 2007; M. Oates, 2003a, 
2003b). Attempts are often aggressive and irreversible (e.g. jumping from heights, 
self-incineration) (Babu et al., 2008; M. Oates, 2003a, 2003b; Sit et al., 2006). In 
order to prevent these serious consequences it is important to identify and implement 
effective treatment to prevent or treat postpartum psychosis.  
 
1.1.2.6 Treatment 
As will be discussed in section 1.2.2, women with a diagnosis of bipolar disorder or 
schizoaffective disorder or those who have a history of psychoses unrelated to 
childbirth are at a high risk of developing postpartum psychosis. Pharmacological 
management does not only focus on the treatment of the condition but also on its 
prevention. If preventative treatment is started during pregnancy or breastfeeding it is 
important to balance benefits and possible side effects for mother and baby (Gentile, 
2006; Price, Turnbull, Gregory, & Stevens, 1989). Possible pharmacological side 
effects include foetal abnormalities or a neurodevelopmental delay in the infant 
(Gentile, 2011). Mothers may experience more specific adverse reactions to 
medication during pregnancy, such as nausea, vomiting, and excessive weight gain, 
indirectly contributing to the occurrence of complications during pregnancy (Gentile, 
2011). Currently, research results regarding treatment and prevention are 
inconclusive and many studies show limitations, such as small sample sizes, that 
make it difficult to draw conclusions about the effectiveness of the treatment and the 
severity of the side effects (Gentile, 2006, 2011). 
     In women at risk of postpartum psychosis due to a previous psychiatric diagnosis, 
lithium seems to be the first choice for prevention of postpartum psychosis starting 
during pregnancy (Doucet, Jones, Letourneau, Dennis, & Blackmore, 2011; Roy & 
Payne, 2009). Typical antipsychotics (e.g. haloperidol) have been shown to be 
relatively safe during pregnancy, as well as other psychotropic drugs including 
venlafaxine, bupropion, mirtazapine and tricyclic antidepressants (Roy & Payne, 
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2009). It has been found that lithium and other mood stabilisers, being used 
prophylactically, lead to significantly better outcomes in women at risk of 
postpartum psychosis, reducing the relapse rate enormously (ranging from 10% to 
70%) (Austin, 1992; V.  Bergink et al., 2012; Bilszta, Meyer, & Buist, 2010; L. S. 
Cohen, Sichel, Robertson, Heckscher, & Rosenbaum, 1995; Viguera et al., 2000).      
     The acute treatment of postpartum psychosis most commonly involves mood 
stabilisers, antipsychotics and benzodiazepines (L. S. Cohen et al., 1995; Sit et al., 
2006; M.G. Spinelli, 2009). Due to the fact that postpartum psychosis is such a 
severe disorder, hospitalisation in a specialist psychiatric setting is frequently 
required (Sharma, 2008). Electroconvulsive therapy (ECT) is typically used for 
women resistant to pharmacotherapy (M.G. Spinelli, 2009). It has been 
recommended that ECT should be the treatment of choice in postpartum psychosis as 
it does not involve the potential detrimental side effects of pharmacological treatment 
on mother and baby, although more research is needed to confirm this idea (Doucet 
et al., 2011; Focht & Kellner, 2012).  
     In addition to the pharmacological management, it is also important to consider 
clinical interventions, such as help with parenting skills in order to meet the women’s 
and children’s needs (Doucet et al., 2011; Doucet, Letourneau, & Blackmore, 2012). 
Recovery may take up to one year, during which the patient must be adequately 
supported (Heron et al., 2012). If treated appropriately women show good future 
employment and adjustment rates (Marks, Wieck, Checkley, & Kumar, 1992; 
Robling, Paykel, Dunn, Abbott, & Katona, 2000; Videbech & Gouliaev, 1995). The 
earlier postpartum psychosis or the risk of developing postpartum psychosis can be 
recognised and treated, the better the outcome is for the woman. Therefore, it is of 
great importance to identify potential risk factors as well as correlates contributing to 
postpartum psychosis.      
 
1.2 Relation to other mental disorders 
One of the most prominent risk factors for postpartum psychosis is mental health 
history, in particular a diagnosis of bipolar or schizoaffective disorder, a history of 
psychosis or schizophrenia, or a personal or family history of postpartum psychosis. 
Therefore, the clinical classification of postpartum psychosis remains controversial 
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and the precise relationship of postpartum psychosis to other postpartum mood 
disorders and other mental disorders is still a matter of debate. In the following 
section this relationship will be discussed.  
 
1.2.1 Relation to other postpartum mood disorders  
While a wide variety of disorders can develop during the postpartum period, such as 
post-traumatic stress disorder, obsessive-compulsive disorder, and anxiety (I. 
Brockington, 2004; I. F. Brockington, 2004), the focus of this paragraph will be on 
postpartum mood disorders under which postpartum psychosis is typically classified. 
Postpartum mood disorders are classified into three categories: postpartum blues, 
postpartum depression, and postpartum psychosis (M. R. Oates, 2009; G. E. 
Robinson & Stewart, 1986). Postpartum blues, considered as a rather benign form of 
a postpartum mood disorder, often lasts only a few days and presents with crying and 
emotional lability or irritability and is usually manageable with emotional 
reassurance. Although postpartum blues can be distressing at the time, it has not been 
associated with recognised serious negative consequences on mother or baby 
(Chaudron & Pies, 2003; M.W. O'Hara, 2009).  
     Postpartum depression and postpartum psychosis are both considered as serious 
disorders which can have a severe impact on the life of mother and baby, including 
suicide and infanticide (Appleby et al., 1998; Chaudron & Pies, 2003; Doucet, 
Dennis, Letourneau, & Blackmore, 2009; M.G.  Spinelli, 2001), although they differ 
in terms of their risk factors, presentation and management. Most experts agree that 
postpartum psychosis and postpartum depression are not distinct nosological entities 
(Doucet et al., 2009; Jones, 2010). Postpartum depression is diagnosed, similarly to 
postpartum psychosis, as a mood disorder with a postpartum onset specifier, in the 
DSM-IV with an onset within four weeks after childbirth and in the ICD-10 within 
six weeks after childbirth (American Psychiatric Association, 1994; World Health 
Organization, 1992). According to the DSM-IV, there must be a minimum of two 
weeks in which the patient presents with depressed mood or has a loss of interest or 
pleasure in daily activities that represents a change in the normal behaviour and 
causes impairment in everyday functioning. Additionally, at least five of these 
symptoms must also be present nearly every day: 1. depressed mood or irritable most 
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of the day; 2. decreased interest or pleasure in most activities, most of each day; 3. 
significant weight change or change in appetite; 4. insomnia or hypersomnia; 5. 
psychomotor agitation or retardation; 6. fatigue or loss of energy; 7. feelings of 
worthlessness or excessive or inappropriate guilt; 8. diminished ability to think or 
concentrate, or indecisiveness; 9. thoughts of death or suicide, or has suicide plan 
(American Psychiatric Association, 1994; Doucet et al., 2009). The new DSM-V 
criteria continue the use of four weeks into the postpartum period, however also 
cover the time during pregnancy (i.e. peripartum period), as episodes of depression 
commonly occur during pregnancy (Jones & Smith, 2009; M.W.  O'Hara & McCabe, 
2013).  
     Most studies report that postpartum depression is not distinctive to depression 
unrelated to childbirth in its symptomatology (Doucet et al., 2009; Jones, 2008, 
2010; G. E. Robinson & Stewart, 1986), although there is some inconsistency in the 
literature.  
     As shown in Table 1.2, postpartum depression is more common than postpartum 
psychosis and shows a different symptom profile. Women with postpartum psychosis 
can be mainly differentiated from those with major depression by the presence of 
cognitive disturbances, hallucinations, delusional beliefs, and disorganised 
behaviour. However, as discussed in paragraph 1.1.2.4 Onset, it has been found that 
mild hypomanic symptoms, which may be an early sign of the development of a 
postpartum psychotic episode (Heron et al., 2008), are also common among women 
who develop postpartum depression (Glover et al., 1994; Heron et al., 2005; Heron et 
al., 2009; Kendell, McGuire, et al., 1981). Because of the sudden onset, and the rapid 
deterioration that often follows, mothers presenting with postpartum psychosis tend 
to be admitted sooner following delivery than women with postpartum depression. It 
has been reported that as more time elapses after delivery, more women present with 
a non-psychotic form of illness (Lier, Kastrup, & Rafaelsen, 1989). In addition, 
postpartum depression has been reported to have a stronger association with stressful 
life events before symptom onset compared to postpartum psychosis (Brockington, 
Martin, Brown, Goldberg, & Margison, 1990; Doucet et al., 2009; R. Kumar et al., 
1993; Marks et al., 1992). However, results are inconsistent and some authors 
suggest that stressful life events or social stressors (e.g. marital or socioeconomic 
status) do equally play a role in postpartum psychosis (Cheetham, Rzadkowolsk, & 
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Rataemane, 1981; Kendell et al., 1987; Kendell, Rennie, Clarke, & Dean, 1981; 
Nager, Johansson, & Sundquist, 2006; Robertson Blackmore et al., 2006). One major 
risk factor for a postpartum depression is a personal history of depression (Doucet et 
al., 2009), while for postpartum psychosis, having a history of bipolar disorder is one 
of the main risk factors, which will be discussed in the next section.  
 
Table 1.2 Comparison of postpartum depression and psychosis 
Postpartum Depression  Postpartum Psychosis 
Prevalence    
13%-15%  0.1%-0.2% 
Risk factors    
Personal history of depression Personal/family history of postpartum psychosis 
Depression/anxiety during pregnancy Personal/family history of bipolar disorder 
Family psychiatric history Genetics 
Hormonal changes  Hormonal changes 
Life stress Primiparity 
Low social support Sleep loss 
Poor marital relationship   
Onset    
2 weeks to 1 year postpartum Sudden, usually within 2 weeks postpartum 
Symptoms    
Nonpsychotic depression Manic or affective psychosis 
Depressed mood Mania 
Loss of interest Mood lability 
Weight change Delusions 
Insomnia or hypersomnia Hallucinations 
Psychomotor agitation Bizarre behaviour 
Fatigue or loss of energy Severe depression 
Feelings of worthlessness or guilt Confusion 
Decreased concentration Perplexity 
Thoughts of death or suicide   
Management   
Nondirective counselling Hospitalisation 
Cognitive behavioural therapy Mood stabilisers 
Interpersonal psychotherapy Antipsychotics 
Psychodynamic therapy Hormones 
Telephone-based peer support ECT 
Antidepressants Antidepressants (with caution) 
Long-term outcomes   
25% have non-postpartum episodes 62% have non-postpartum episodes 
41% have postpartum episodes 57% have postpartum episodes 
Taken from Doucet et al., 2009 
 
1.2.2 Relation to bipolar disorder and psychosis spectrum 
Various studies have investigated the relationship between postpartum psychosis and 
other mental disorders in the bipolar disorder and psychosis spectrum and these are 
discussed in the following section. Confusion and disagreement over the clinical 
classification and the inadequacy of diagnostic tools have contributed to the 
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difficulties in studying this accurately (Chaudron & Pies, 2003). Therefore, the 
studies discussed here will be grouped according to the following three clusters: 
 
1) Studies focusing on women with a current or previous episode of postpartum 
psychosis, investigating whether affective diagnoses or diagnoses in the 
psychosis domain are prevailing. Follow-ups of these studies are indicative of 
whether having a postpartum psychotic episode leads to a higher risk of 
developing further illness, related and unrelated to the puerperium. Studies 
comprising women suffering from an undefined severe postpartum illness are 
included in this cluster, as they typically involve women presenting with 
postpartum psychosis (see Table 1.3). 
 
2) Studies focusing on women with a diagnosis of bipolar disorder. These studies 
are important in order to find out more about the risk of developing postpartum 
psychosis in the context of a diagnosis of bipolar disorder and vice versa (see 
Table 1.4). 
 
3) Studies investigating women with a diagnosis within the psychosis spectrum. 
These studies can help to find out more about the risk of developing postpartum 
psychosis in the context of a diagnosis within the psychosis spectrum (see Table 
1.5).  
 
In all three tables, the country of the study, whether the study was based on medical 
records or on interviews, the diagnostic criteria used, the length of follow-up and the 
time of delivery will be reported when stated in the original study. Further, the 
sample size including the diagnostic distributions and relapses will be presented, as 




Table 1.3 Studies assessing mothers with postpartum psychosis/severe postpartum disorders 
Authors/     
Year/ 
Country 




















91 mood disorder (19 mania,  
72 depression)               
37 schizophrenia             
6 organic psychosis 
None 121 deliveries, 14 women had 
18 postpartum episodes (PE) 
40 women had non-
postpartum episodes (NPE)        
5 women had PE and NPE 
Dean & 
Kendell, 1981  
UK 
Medical records 








58 mood disorder (9 mania,  
49 depression)                                     
4 schizoaffective                    
1 schizophrenia                                  
5 unspecified functional psychosis      
3 other 




1981          








39 mood disorder (17 mania,  
22 depression)       
12 schizoaffective                       
5 schizophrenia 
52 women with NPE 
23 mood disorder (10 mania, 13 
depression) 
13 schizoaffective        
16 schizophrenia 
NR 
Katona, 1982   
UK  
Medical records 
1970-1980   
NR 
DSM-III        
6 months         
N=84  
71 mood disorder (18 mania,  
53 depression)                                
Other diagnoses not applicable to 
DSM 




Douglass, 1984  
Canada 
Medical records and 
personal investigation 
1963-1975  





10 patients with schizophreniform 








Authors/     
Year/ 
Country 










Control Group Subsequent episodes 
Schoepf et al., 
1984  
Switzerland 
Medical records and 
interview  





43 mood disorder (20 depression, 
13 mania and  10 depression with 
psychotic symptoms)     
14  Psychoses 
None 32 deliveries, 11 women had 
PE 
37 had NPE                 
Davidson 
 & Robertson, 
1985 
UK  
Medical records and 
interview  
1946-1971                   
1-32 years 
NR   
3 months 
N=82  
58 mood disorder (15 bipolar,  
43 depression)                               
13 schizophrenia                            
11 other 
None 19 women had PE  
39 had NPE                                 
Meltzer & 
Kumar, 1985 
UK    
Medical records 





97 mood disorder (31 mania,  
3 bipolar, 63 depression)                    
8 schizoaffective              
9 schizophrenia                             
3 unspecified functional psychosis      
25 other 
None NR 
Platz & Kendell, 
1988        
UK 
Medical records and 
interview  
1971-1980            




66 mood disorder (12, mania,  
54 depression)                                     
6 schizoaffective 
Diagnosis matched controls with 
NPE 
40 deliveries (sample), 4  PE  
41 deliveries (controls), 4 PE  
Controls had more NPE 
Dean et al., 
1989       
UK 
Medical records and 
interview  




N=51  33 women with PE and NPE (mood)     
19 women with NPE (mood)  
36% and 50% of deliveries 
followed by PE in sample and 




Authors/     
Year/ 
Country 










Control Group Subsequent episodes 









36 mood disorders (4 mania,  
32 depression)     
8 schizoaffective            
32 schizophrenia           
68 unspecified functional psychosis 
Diagnosis matched controls with 
NPE 
12 women with past history of 
postpartum psychosis (8 
schizophrenia, 2 mania, 2 
schizomania) and 6 with 
schizophrenia         
Klompenhouwer 
& van Hulst, 
1991     
Netherlands 
Medical records 





71 mood disorder (29 mania ,  
2 bipolar, 40 depression)                   
63 schizoaffective          
12 schizophrenia                             
74 unspecified functional psychosis 
30 others                                             
None NR 
Benvenuti et al., 
1992  
Italy 
Medical records and 
interview 1973-1987          




25 mood disorder (14 bipolar,  
1 mania, 10 depression)                     
2 schizoaffective              
3 brief reactive psychosis 
None 8 deliveries, 4 women had  5 
PE  





1950-1979               
12-41 Years 
DSM- 
III & III-R    
6 weeks           
N=61  
8 affective disorder       
30 schizoaffective           
17 schizophrenia             
6 organic mental disorder 
None 46 deliveries, 8 women had  8 
PE  
39 women had  NPE                   




1988-1989     
NR 
RDC 
NR   
2 weeks 
N=100  
38 mood disorder (17 mania,  
15 bipolar, 7 depression 
(psychotic))                                       
18 schizoaffective          
20 schizophrenia                                 




Authors/     
Year/ 
Country 










Control Group Subsequent episodes 
Videbech & 
Gouliaev, 1995  
Denmark 
Medical records and 
interview (general 
practitioner) 





N=50 (first onset)                                
38 mood disorders (6 mania,  
3 mixed mania, 29 depression)           
6 schizophreniform psychosis  
5 schizophrenia                   
1 brief reactive psychosis 
Matched healthy controls 16 women with delivery, 4 
women had  PE  
30 women had  NPE                   
Kirpinar et al., 
1999  
Turkey 
Medical records and 
interview  
1973-1994              
2-23 years 
DSM-IV 
3 months   
N=64 (first onset)                            
25 mood disorder (11 mania,  
14 depression)    
19 schizophreniform       
20 brief psychotic disorder 
64 matched controls with NPE 
(psychosis) 
52 women had NPE           
11 bipolar                             
7 depressive                     
7 schizoaffective                     
27 schizophrenia  
Pfuhlmann et 
al., 1999  
Germany 
Medical records and 




classification   
6 months       
N=39 (first onset)                 
16 mood disorder (5 bipolar,  
11 depression)                                     
5 schizoaffective                            
5 schizophrenia                                 
8 acute polymorphous psychotic 
disorder                              
5 other  
None 22 deliveries, 9 women 
developed 11 PE 
20 women developed  NPE        
Robling et al., 
2000    
UK 
Medical records and 
interview (follow-up 
Katona, 1982)  





54 mood disorders (17 mania,  
2 bipolar, 35 depression)                    
2 schizoaffective                                  
3 schizophrenia                                   
2 other psychoses                              
3 other  
None 34 deliveries with 10 women 
(29%) developing  PE 
48 women had  NPE                   
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Authors/     
Year/ 
Country 










Control Group Subsequent episodes 
Garfield et al., 
2003  
UK 
Medical records and 
interview  





36 mood disorder (12 mania,  
24 depression)                                     
11 schizoaffective                               
13 schizophrenia                                 
2 unspecified functional psychosis      
7 other  
None 27 deliveries, 14 PE,  
Recurrence rate higher for 
psychoses than depression (80 
versus 27%) 
41 women had NPE (out of 47 
traced)                                         
Robertson et al., 
2005  
UK 





4 weeks           
N=103                                  
90 bipolar                                
13 schizoaffective  
None 54 women had another 
delivery, 31 women had PE  
64 experienced NPE (mood)       
 
Kisa et al., 2007 
Turkey   
Interview  
1998-2006    
min. 2 years 
DSM-IV 
6 months         
N=23  
5 bipolar                                 
4 schizoaffective                             
4 schizophreniform                     
6 schizophrenia               
4 brief psychotic disorder 
25 matched controls with first onset 
NPE 
11 women had another 
delivery, 7 women had  PE 
15 women had  NPE                   
Bergink et al., 
2011  
Netherlands 






N=51 (first onset)                             
32 with manic psychotic features        
4 with only psychotic features             
7 with depressed psychotic features    
8 with mixed features 
Population based control group of 
6969 women (2 months follow-up) 
NR 




1975-2004    
1-30 years 
ICD-8,-9,-10 
3 months         
N=1340  
130 mothers with schizophrenia         
260 with affective psychosis                
950 with unspecified psychosis 
None High lifelong NPE rate, 
Schizophrenia incidence 
(0.64)  
affective psychosis (0.42)           
unspecified psychosis (0.3)    
Table 1.3 Studies investigating the relationship between postpartum psychosis, bipolar disorder and psychoses unrelated to childbirth. NR=Not reported. RDC=Research 




Table 1.4 Studies assessing mothers with bipolar disorder  
Authors/     
Year/ 
Country 










Control Group Subsequent episodes 
Bratfos & Haug, 
1966     
Norway      
Medical records & 
personal investigation 




N=82  None 251 deliveries of 82 women, 
31 women developed 52 PE 
(all depressive polarity) 
Reich & 
Winokur, 1970      
US      
Interview 




N=20  None 46 deliveries, 8 women 
developed 14 PE (11 manic 
polarity) 








3 months       
N=33  22 mothers with schizophrenia              
79 mothers with depressive neurosis 
44 deliveries (sample), 7 PE  











N=23  None 42 deliveries, 22 PE  
Jones & 
Craddock, 2001  
UK 




DSM-IV    
6 weeks 
N=152 (also schizoaffective) None 313 deliveries, 58 women 
developed 81 PE  
39 women developed mood 
episodes in pregnancy or 6 
months postpartum   
Serretti et al., 
2006  
Italy 
Medical records & 
interview 1990-2000  
NR 
DSM-III-R 
& IV  
4 weeks 
N=22 (postpartum onset) 101 women with bipolar disorder 
non-postpartum onset 
Women with PE had fewer 





Medical records  
1973-2005  
NR 
ICD-8 & 10  
1 year 
N=208  878 mothers with schizophrenia-like 
disorders 
56  women (27%) developed 
PE (sample)                                 




Authors/     
Year/ 
Country 

















ICD-8 & 10   
1 year 
N=132 (postpartum onset) 2930 women with bipolar disorder 
non-postpartum onset 
19 (14%) women with 
postpartum and 119 (4%) 
women with non-postpartum 
onset developed bipolar 
disorder within 15 years  
Table 1.4. Studies investigating the relationship between postpartum psychosis, bipolar disorder and psychoses unrelated to childbirth. NR=Not reported. RDC=Research 
Diagnostic Criteria. ICD=International Classification of Diseases. DSM=Diagnostic and Statistical Manual of Mental Disorders. PE= Postpartum episodes. NPE=Non-
postpartum episodes. 
 
Table 1.5 Studies assessing women with previous psychoses 
Authors/     
Year/ 
Country 










Control Group Subsequent episodes 
McNeil, 1988a, 
1988b, 1986  
Sweden 
Interview  
1973-1977   




15 affective illness       
15 cycloid psychosis    
17 schizophrenia            
6 psychogenic psychosis                    
18 postpartum psychosis                     
17 other psychosis  
104 healthy controls 25 women had PE 







10     
3 months 
N=1348                            
276 schizophrenia                         
46 schizoaffective     
1026 non-affective psychotic 
disorder 
786 women with bipolar disorder Sample: 14.54% risk of 
developing PE (psychosis) and  
2.59% PE (mood) 
Controls: 1.35% risk of 
developing PE (psychosis) and 
8.46% PE (mood) 
Table 1.5. Studies investigating the relationship between postpartum psychosis, bipolar disorder and psychoses unrelated to childbirth. NR=Not reported. RDC=Research 




The studies reviewed in Tables 1.3, 1.4, and 1.5 show that the existing research on 
postpartum psychosis is limited and inconsistent. There are discrepancies concerning 
the diagnostic criteria used and there is no consensus on the time-frame within which 
women can be included in the study, ranging from two weeks to up to a year across 
studies. Many studies are exclusively based on medical records and lack verification 
by a structured clinical interview. This is a particular concern when the diagnosis in 
the records was obtained some decades ago, when the diagnostic criteria were likely 
to be different. This is an issue that will lead to inconsistencies in the data and reduce 
comparability across studies. The time-frame of follow-up also differed greatly, 
potentially contributing to different percentages of relapses within the follow-up 
period. Finally, many studies did not use a control group and only 11 of the 34 
studies published information on the psychiatric family history. This information is 
important in order to compare similarities between postpartum psychosis and mood 
disorders or psychoses unrelated to childbirth. It will be important for future studies 
to develop more agreement on the diagnostic criteria and onset time-frame in order to 
investigate specific questions regarding postpartum psychosis. Based on the literature 
there seem to at least three possible approaches to the classification of postpartum 
psychosis (McGorry & Connell, 1990): 
  
1. Postpartum psychosis as part of the bipolar spectrum. 
2. Postpartum psychosis as a separate diagnostic entity. 
3. Postpartum psychosis as part of the psychosis spectrum. 
 
1.2.2.1 Postpartum psychosis as part of the bipolar spectrum 
Many studies presented in this literature review support the view that postpartum 
psychosis fits best as part of the bipolar disorder spectrum. The key evidence 
supporting this position is that having a diagnosis of bipolar disorder puts a woman 
at higher risk of developing a postpartum psychotic episode after delivery (i.e. a 30-
50% higher risk compared to healthy controls)  (Jones & Craddock, 2001; Robertson, 
Jones, Haque, Holder, & Craddock, 2005). Some authors suggest, however, that 
pregnancy itself might have a protective effect for women with a bipolar disorder as 
there are typically fewer and shorter relapses during pregnancy than either before or 
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after (Grof et al., 2000). Women with bipolar disorder and a first-degree relative with 
postpartum psychosis have a 74% chance of developing postpartum psychosis 
compared to 30% chance when no history of postpartum psychosis is present in the 
family (Jones & Craddock, 2001). This demonstrates that hereditary factors are also 
implicated in susceptibility to puerperal psychosis in women with bipolar disorder 
(Jones & Craddock, 2001). Other studies support the finding that the risk of 
developing postpartum psychosis is higher in women with a first-degree relative with 
postpartum psychosis, suggesting that familial factors are indeed involved (Craddock 
et al., 1994; Kane, 1968; Reich & Winokur, 1970; Thuwe, 1974; Whalley, Roberts, 
Wentzel, & Wright, 1982). The morbidity risk for first-degree relatives of women 
with postpartum psychosis has been found to be high overall and similar to that of 
women with non-postpartum mood disorder or also schizophrenia, suggesting a close 
relationship between postpartum psychosis and other mental disorders (P. Agrawal et 
al., 1990; Benvenuti et al., 1992; Dean, Williams, & Brockington, 1989; Kirpinar, 
Coşkun, Cayköylü, Anaç, & Ozer, 1999; Platz & Kendell, 1988; Protheroe, 1969). A 
shorter time to non-postpartum relapses is also associated with a positive family 
history of mental illness (Robertson et al., 2005).  
     In addition, it was also found that a first episode of postpartum psychosis 
significantly predicted later conversion to bipolar disorder. Percentage of conversion 
has been reported to be 14% (compared to 4% of women with a non-postpartum 
onset) within 15 years and is even higher over the life-time (Brockington, 1996; 
Munk-Olsen, Laursen, Meltzer-Brody, Mortensen, & Jones, 2012; Sit et al., 2006). 
Some studies report that there are no noticeable differences concerning the 
symptomatology between postpartum and non-postpartum episodes (Brockington et 
al., 1981; Reich & Winokur, 1970). Others find differences in onset and symptoms 
between women with postpartum onset and women with previous bipolar disorder 
(see section 1.2.2.2) (V. Bergink, Lambregtse-van den Berg, Koorengevel, Kupka, & 
Kushner, 2011). Cases with exclusive postpartum psychosis are rare and affective 
symptoms seem to be more common than psychotic symptoms (Brockington et al., 
1981; Reich & Winokur, 1970; Videbech & Gouliaev, 1995). This points towards a 
close association between postpartum psychosis and bipolar disorder, indicating that 
postpartum psychosis likely presents as an episode of bipolar disorder triggered by 
childbirth or that it at least belongs to a possible heterogeneous bipolar disorder 
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group instead of representing a separate entity (Benvenuti et al., 1992; Bratfos & 
Haug, 1966; Brockington et al., 1981; Davidson & Robertson, 1985; Dean & 
Kendell, 1981; Hunt & Silverstone, 1995; Jones & Craddock, 2001; C. L. Katona, 
1982; Kendell et al., 1987; Meltzer & Kumar, 1985; Munk-Olsen et al., 2012; Munk-
Olsen et al., 2009; Platz & Kendell, 1988; Protheroe, 1969; Reich & Winokur, 1970; 
Robertson et al., 2005; Robling et al., 2000; Videbech & Gouliaev, 1995). 
 
1.2.2.2 Postpartum psychosis as a diagnostic entity 
An alternative approach is to consider postpartum psychosis as a separate diagnostic 
entity. Support for this view comes from studies assessing differences in symptoms, 
illness course and family background between women with a postpartum and non-
postpartum episode. Some studies find differences in symptoms and also in the 
progression of the disorder between women with postpartum and non-postpartum 
onset (Dean & Kendell, 1981; Hunt & Silverstone, 1995). Women with a postpartum 
onset appear to have more Schneiderian first rank symptoms (e.g. thought 
broadcasting, experience of alienation, experiences of influence, and auditory 
hallucinations) and fewer first-degree relatives with an affective disorder (Hays, 
1978; Hays & Douglass, 1984; Kadrmas et al., 1979), more cognitive 
disorganisation, bizarre behaviour, thought disorganisation, lack of insight, and 
delusions of reference or persecution related to childbirth (e.g. about the 
identification of the baby) compared to those with non-postpartum episodes (M.G. 
Spinelli, 2009; Wisner et al., 1994).  
    With one exception, a postpartum onset has been associated with better illness 
outcome than a non-postpartum onset (i.e. fewer non-postpartum recurrences than 
with a non-postpartum onset) (Davidson & Robertson, 1985; Hunt & Silverstone, 
1995; C. L. Katona, 1982; Platz & Kendell, 1988). In fact, women with postpartum 
psychosis seem to have a better prognosis in terms of number of relapses, time on 
medication, and employment and social functioning than women who had also or 
only non-postpartum episodes or schizophrenia (Davidson & Robertson, 1985; Dean 
et al., 1989; Doucet et al., 2009; Nager, Johansson, & Sundquist, 2005; Serretti, 
Olgiati, & Colombo, 2006). Before symptom onset, women have often attained 
higher functional levels compared to those with a chronic illness (Sit et al., 2006). 
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This evidence comes together to show that postpartum psychosis and psychoses 
unrelated to childbirth are not equivalent. However, none of these studies exclude the 
possibility that despite differences in symptomatology and progression, postpartum 
psychosis might be a separate entity within an affective or psychotic disorder 
spectrum, demonstrating the potential heterogeneity of these spectra.  
 
1.2.2.3 Postpartum psychosis as part of the psychosis spectrum 
A third approach suggests that postpartum psychosis could be part of the psychosis 
spectrum. A few studies have found a predominance of diagnoses within the 
psychoses rather than the affective spectrum among women suffering from 
postpartum psychosis (P. Agrawal et al., 1990; Garfield, Kent, Paykel, Creighton, & 
Jacobson, 2004; Harlow et al., 2007; Kirpinar et al., 1999; Kisa et al., 2007; 
Klompenhouwer & van Hulst, 1991; McNeil, 1986, 1988a, 1988b; Nager et al., 
2012; Pfuhlmann, Franzek, Beckmann, & Stöber, 1999; Schöpf, Bryois, Jonquière, & 
Le, 1984). As with bipolar disorder, it has been found that the risk of postpartum 
psychosis is higher in women with a personal or family history of psychoses 
unrelated to childbirth (Schöpf et al., 1984). However, childbirth may have a smaller 
effect on severe illness courses of schizophrenia, as benign forms of schizophrenia or 
other psychoses have been found to be more influenced by childbirth (Davies, 
McIvor, & Channi, 1995).  
 
1.2.2.3.1 Postpartum psychosis and schizoaffective disorder 
One nosological category that is particularly interesting in relation to the risk of 
postpartum psychosis is “schizoaffective disorder”. There has been in fact extensive 
debate as to whether this diagnosis simply reflects the co-occurrence of both 
schizophrenia and a mood disorder (bipolar disorder or major depressive disorder), 
or whether is a variant of schizophrenia in which mood symptoms like irritability, 
elation, sadness, are particularly prominent, or whether actually this condition 
reflects severe forms of affective disorders that do not completely remit between 
mood episodes. In any case, it is accepted that the phenomenology of this disorder is 
characterised by the presence of important affective symptoms. Considering the 
particularly strong relationship between risk of postpartum psychosis and bipolar 
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affective disorder described above, it is therefore important to consider the 
relationship with this diagnosis more closely. 
     According to the DSM-IV, schizoaffective Disorders are classified under 
schizophrenia and other psychotic disorders (American Psychiatric Association, 
1994). The DSM-IV criteria for schizoaffective disorder include: A. an uninterrupted 
period of illness during which, at some time, there is either a major depressive 
episode, a manic episode, or a mixed episode concurrent with symptoms that meet 
symptom criteria for schizophrenia; b. during the same period of illness, there have 
been delusions or hallucinations for at least two weeks in the absence of prominent 
mood symptoms; C. symptoms that meet criteria for a mood episode are present for a 
substantial portion of the total duration of the active and residual periods of the 
illness. The DSM-IV further differentiates two types of schizoaffective disorder. The 
bipolar type is diagnosed if the disturbance includes a manic or a mixed episode (or a 
manic or a mixed episode and major depressive episodes). The depressive type is 
diagnosed if the disturbance only includes major depressive episodes (American 
Psychiatric Association, 1994).  
     As discussed in the previous section, women diagnosed with schizophrenia and 
other psychoses are also considered at higher risk of developing psychosis after 
childbirth (Schöpf et al., 1984). However, the term postpartum psychosis often refers 
to the acute onset of an episode of severe affective psychosis, including manic, 
depressed and schizoaffective forms in a woman who has been well before delivery 
(independently of a previous psychiatric history) (Jones & Smith, 2009). In the 
literature, a high risk to develop postpartum psychosis due to a diagnosis of 
schizoaffective disorder bipolar type is typically rated similarly to the estimated risk 
due to having a previous bipolar disorder diagnosis and therefore higher than that 
conferred by a schizophrenia diagnosis (Brockington, 1996; Dean et al., 1989; Jones 
& Craddock, 2001; Robertson et al., 2005; Robling et al., 2000; Sit et al., 2006). 
Most research studies conducted by experts in field, thus, include women with 
bipolar disorder as well as schizoaffective disorder bipolar type among their 
recruitment criteria (Jones et al., 2007; Robertson Blackmore et al., 2006; Robertson, 
Jones, Middle, Moray, & Craddock, 2003). This may be particularly relevant in 
studies investigating the neurobehavioral dysfunctions present in these diagnostic 
categories, which would be better conceptualised as lying along a continuum rather 
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than boxed into separate nosological categories. For further discussion of the 
recruitment strategy in this study please see paragraph 1.2.4 Summary.  It is 
important to note that there are differences between Western and non-Western 
cultures concerning the rates of diagnosis of schizophrenia and other psychoses and 
mood disorders following postpartum psychosis (Sit et al., 2006).  
 
1.2.2.3.2 Cross cultural comparison 
Postpartum psychosis has a similar incidence worldwide (P. Agrawal et al., 1990; 
Cheetham et al., 1981; Ifabumuyi & Akindele, 1985; R. Kumar, 1994; Makanjuola, 
1982; Rahim & Al-Sabiae, 1991; Shoeb & Hassan, 1990). Studies conducted in India 
and Africa consistently find that more women with postpartum psychosis are 
diagnosed with schizophrenia compared to studies conducted in Western cultures (R. 
Kumar, 1994). This might imply a difference in the presentation of postpartum 
psychosis in other cultures, where women may show less affective and more 
psychotic symptoms, such as confusion (Kirpinar et al., 1999). Differences in 
diagnostic criteria are also a likely explanation, as a direct comparison between 
women hospitalised for postpartum psychosis in Saudi Arabia and the United 
Kingdom showed that women presented mainly with affective symptoms in both 
countries when the same criteria were used (Rahim & Al-Sabiae, 1991). This finding 
supports the view that postpartum psychosis is part of the bipolar disorder spectrum 
and that inconsistencies may be due to differences in the diagnostic criteria used in 
different settings.  
 
1.2.3 Comparison to other high risk approaches 
Investigating people at high risk of developing a specific disorder has become a 
common approach in both the bipolar disorder and psychosis research, as it offers the 
chance of early intervention, possibly postponing, ameliorating or preventing the 
onset of a disorder (McGuire, Selvaraj, & Howes, 2011; Yung et al., 2005). 
Furthermore, this approach provides the opportunity to study the illness from the 
very early stages, before other potential confounders, such as medication, 
institutionalisation, exposure to substance use, have altered the trajectory and the 




As discussed in the section 1.2.2 Relation to bipolar disorder and psychosis 
spectrum, women with a diagnosis of bipolar or schizoaffective disorder, and to a 
lesser degree psychosis unrelated to childbirth, are a group at a higher risk to develop 
postpartum psychosis compared to healthy controls (Jones & Craddock, 2001; 
Robertson et al., 2005; Sit et al., 2006). Therefore, investigating risk factors and 
correlates in this population differs from other high risk approaches in psychosis and 
bipolar disorder research. There, conceptually, the increased high risk is not 
conferred by a pre-existing diagnosis, but rather defined by the presence of a 
“genetic risk” or a “clinical risk” (Smieskova et al., 2013). For example, an 
individual at genetic high risk of bipolar disorder or psychosis would be someone 
who does not have these disorders but has a monozygotic twin or a first- or second-
degree relative suffering from bipolar disorder or psychosis, respectively (Baig et al., 
2010; Ettinger et al., 2012; Fusar-Poli, Howes, Bechdolf, & Borgwardt, 2012; 
Smieskova et al., 2013). Someone at clinical high risk of psychosis would be defined 
by the presence of a set of clinical -prodromal- symptoms, used to indicate a so 
called “at-risk mental state” (ARMS) (Aiello, Horowitz, Hepgul, Pariante, & 
Mondelli, 2012; Riecher-Rössler et al., 2007; Smieskova et al., 2013).  
     The at risk approach for postpartum psychosis is also different from other at risk 
approaches in that the conversion rate for the women at risk is very high, ranging 
from 30-50% after each delivery and even up to 75% if there is additionally a first-
degree family history (Jones & Craddock, 2001; Robertson et al., 2005). Conversion 
rates for people at genetic or clinical risk of bipolar disorder or psychosis are 
typically lower. Studies report that conversion rates range from 13% to 30% within 
one year of follow up in psychosis studies (R. E. Carrión, McLaughlin, Goldberg, & 
et al., 2013; Haroun, Dunn, Haroun, & Cadenhead, 2006; McGuire et al., 2011) and 
from 15% to 30% over a lifetime in people at risk of bipolar disorder (Fusar-Poli et 
al., 2012). Furthermore, postpartum psychosis is associated with a discrete biological 
event, childbirth. This disorder has been reported to develop suddenly within the first 
days after childbirth, with 50% of women having a symptom onset in the first three 
days postpartum (Brockington, 1996; Heron et al., 2007; Sit et al., 2006).  In 
contrast, people at genetic or clinical risk are often being followed up and monitored 
for years for the conversion to occur, and show a much slower conversion even when 
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this occurs (R. E. Carrión et al., 2013; Haroun et al., 2006; McGuire et al., 2011; 
Yung et al., 2005). Therefore, despite the nosological and practical difficulties in 
investigating postpartum psychosis, since the time of maximum risk in women at risk 
of postpartum psychosis is so well identifiable, research in this area also offers 
important advantages over other at risk approaches. 
  
1.2.4 Summary 
While some studies show that women with a diagnosis within the psychosis spectrum 
are at higher risk of developing postpartum psychosis and vice versa, postpartum 
psychosis seems to have a closer association with bipolar disorder (Jones & Smith, 
2009). The mixed findings across studies are likely to be explained by differences in 
diagnostic criteria, time-frame, source of data and other methodological details. 
Whether postpartum psychosis is a separate diagnostic category or an exacerbation of 
an affective or psychotic disorder remains a matter of debate in the psychiatric 
literature. Some authors propose that it would be better to create a separate 
nosological entity as this might aid research, help to define treatment, and reduce the 
stigma associated with bipolar disorder and psychoses unrelated to childbirth (Boyce 
& Barriball, 2010). Nonetheless, the evidence suggests that postpartum psychosis is 
part of a lifelong non-specific affective disorder (Garfield et al., 2004; Nager et al., 
2012; Pfuhlmann, Stoeber, & Beckmann, 2002; Rohde & Marneros, 1993).         
     In order to create a homogenous group, based on the literature, specifically on 
studies led by Ian Jones, the focus of the research in this PhD is on women with 
diagnoses of bipolar or schizoaffective disorder (bipolar type) or with a personal or 
family history of postpartum psychosis. In addition to existing psychiatric diagnoses, 
other risk factors are likely to contribute to the development of postpartum psychosis 
and these will be explored in the following section together with potential correlates 
of postpartum psychosis.  
 
1.3 Correlates  
In the following section, biological, clinical, cognitive, emotional and neuroimaging 
findings in postpartum psychosis will be reviewed. Given the lack of research on 
46 
 
postpartum psychosis, evidence for potential cognitive, emotional and neuroimaging 
alterations will be reviewed in the light of related mental disorders.  
 
1.3.1 Biological correlates 
Here, findings in the hormonal domain as well as on the role of neurotransmitter and 
genes will be discussed.  
 
1.3.1.1 Oestrogens 
Although evidence suggests that levels of circulating gonadal steroid hormones in 
women with postpartum psychosis are normal (Wisner & Stowe, 1997), one theory 
proposes that postpartum psychosis is triggered by abrupt changes in oestrogen levels 
following delivery in women with a pre-existing vulnerability (Brockington, 1996; 
Wieck, 2011). At the end of pregnancy, serum oestrogen levels are very high, but 
decline abruptly after delivery (Hendrick, Altshuler, & Suri, 1998). Therefore, 
postpartum oestrogen deficiency can be severe and prolonged and can impact on the 
mood of the mother (Hendrick et al., 1998). Oestrogens have been suggested to be a 
protective factor, delaying or preventing the onset of psychoses, while low oestrogen 
levels are thought to put women at higher risk of developing a psychotic disorder 
(Cyr, Calon, Morissette, & Di Paolo, 2002; Wieck, 2011). The effects of oestrogens 
are also of interest in the context of the menstrual cycle and menstrual cycle related 
mood disorders, which are further discussed in paragraph 1.3.1.3. Menstrual cycle 
effects as the onset of psychotic symptoms has been associated with the low levels of 
oestrogens (I. F. Brockington, 2004; Brockington, Kelly, Hall, & Deakin, 1988; 
Brockington & Meakin, 1994; Huber, Borsutzky, Schneider, & Emrich, 2004). 
     If oestrogens are implicated in postpartum psychosis, their administration could 
potentially be useful in the prevention or treatment of this disorder. A number of 
studies have been carried out to investigate this therapeutic potential of oestrogens in 
postpartum psychosis. In a pilot study, the effect of daily oestrogens administration 
immediately after delivery as a prophylactic agent was investigated (Sichel, Cohen, 
Robertson, Ruttenberg, & Rosenbaum, 1995). Seven women at risk of postpartum 
psychosis received oestrogens for four weeks. The study found that the 
administration prevented a relapse in all but one woman (Sichel et al., 1995). In two 
47 
 
studies, each using a sample size of two women with postpartum psychosis, 
oestradiol administered after more than eight weeks was also found to be effective in 
treating postpartum psychosis (Ahokas & Aito, 1999; Ahokas, Aito, & Turtiainen, 
2000). In these studies, women showed a low pre-treatment oestradiol concentration 
and the rise in serum oestradiol during treatment coincided with a decline in 
psychotic symptoms, while the discontinuation of treatment resulted in a rebound of 
florid psychotic symptoms (Ahokas & Aito, 1999; Ahokas, Aito, & Turtiainen, 
2000). Another study, assessing the effects of a 10 week course of sublingual 
oestradiol in 10 women who had developed postpartum psychosis, found that 
symptoms decreased as serum oestradiol levels increased (Ahokas, Aito, & Rimón, 
2000). In addition, one patient who discontinued the therapy experienced a relapse 
(Ahokas, Aito, & Rimón, 2000).  
     Despite the evidence from four studies with a total of 21 participants, other work 
has suggested that administration of oestrogen is not preventative for postpartum 
psychosis. One study with a larger sample size of 29 pregnant women with a history 
of bipolar or schizoaffective disorder showed that relapse could not be prevented by 
the administration of oestradiol within 48 hours after delivery (C. Kumar et al., 
2003). The fact that the study with the largest sample size shows no beneficial effect 
of oestrogens on the prevention of postpartum psychosis questions earlier results. 
Although it seems plausible that oestrogens are implicated in triggering postpartum 
psychosis, future studies will need to confirm the contribution of hormones to the 
development of postpartum psychosis. Another hormone that has been implicated in 
postpartum psychosis is cortisol.  
 
1.3.1.2 Cortisol 
Hypothalamic-pituitary-adrenal (HPA) axis activity is triggered by the release of 
corticotropin releasing hormone (CRH) and of vasopressin (AVP), synthesised in the 
hypothalamus, which in turn activates the secretion of the adrenocorticotrophic 
hormone (ACTH) from the pituitary (Borges, Gayer-Anderson, & Mondelli, 2013; 
Pariante & Lightman, 2008). ACTH then stimulates the secretion of glucocorticoids 
(i.e. cortisol in humans) from the adrenal cortex, which interacts with receptors in 
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multiple target tissues and is responsible for feedback inhibition to the hypothalamus 
and the pituitary (Borges et al., 2013; Pariante & Lightman, 2008).  
     High cortisol release is associated with stress (e.g. stressful life events such as 
childhood trauma) and has been documented in other mental health disorders such as 
depression and psychoses unrelated to childbirth (Aiello et al., 2012; Bennett & 
Maxwell, 2008; Schäfer & Fisher, 2011). Differences in cortisol levels have also 
been associated with the menstrual cycle and impaired neurocognitive functioning. A  
greater response to CRH stimulation linked to lower baseline cortisol levels was 
found in in women with menstrual cycle related disorders compared to healthy 
controls and the luteal phase has been associated with low cortisol levels and 
neurocognitive impairment (Rubinow & Schmidt, 1995; Symonds, Gallagher, 
Thompson, & Young, 2004). For further discussion see paragraph 1.3.1.3 Menstrual 
cycle effects.  
     High cortisol levels are also associated with delivery (Hendrick et al., 1998) and 
have been associated with postpartum psychosis (Paykel, del Campo, White, & 
Horton, 1991). Using the dexamethasone suppression test of cortisol (i.e. by 
providing negative feedback to the pituitary gland via the synthetic glucocorticoid 
dexamethasone), elevated post-dexamethasone cortisol levels were found in women 
with postpartum psychosis compared to healthy controls (Paykel et al., 1991). These 
results are similar to those found in depression and indicate hormonal abnormalities 
in postpartum psychosis (Paykel et al., 1991). This finding suggests that it could be 
of importance in future studies to investigate the influence of cortisol levels, both 
during pregnancy and after delivery, on the development of postpartum psychosis.  
 
1.3.1.3 Menstrual cycle effects 
A proposed hormonal aetiology of postpartum psychosis would be supported by 
findings in the context of menstrual cycle effects (Brockington, 1996; Brockington & 
Meakin, 1994; Rubinow & Schmidt, 1995). The onset of psychotic symptoms has 
been associated with the low oestrogen/high progesterone phase of the cycle, the 
time preceding menstruation (i.e. pre-menstrual or luteal phase) (I. F. Brockington, 
2004; I. F. Brockington et al., 1988; Brockington & Meakin, 1994). Women 
suffering from psychosis have also been found to be more likely to be admitted 
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during the luteal phase of their cycle (Huber et al., 2004). In addition, these women 
often show markedly reduced oestradiol levels and variability over the menstrual 
cycle compared to healthy controls and women suffering from other psychiatric 
disorders (Huber et al., 2004). 
     Rubinow and Schmidt (1995) reviewed the neuroendocrinological effects of the 
menstrual cycle on patients with menstrual cycle related disorders, referring to a 
group of disorders with a cyclic recurrence of mood and behavioural symptoms 
during the luteal phase of the menstrual cycle. According to their review, women 
with menstrual cycle related disorders, or the more general premenstrual syndrome, 
do not show abnormal circulating levels of gonatropins, gonadal steroids and their 
metabolites or hypothalamic-pituitary-ovarian axis function (Rubinow & Schmidt, 
1995). These findings are similar to the above cited evidence, that levels of 
circulating gonadal steroid hormones in women with postpartum psychosis also seem 
to be normal (Wisner & Stowe, 1997). Nevertheless, these authors found that cyclic 
mood disturbances could be prevented in patients with menstrual cycle related 
disorders by ovarian suppression, and again be precipitated by administering 
oestrogens and progesterone (Rubinow & Schmidt, 1995).  
     An abnormal thyroid function and menstrual-cycle-independent differences in 
response to thyroid-releasing hormones have been found in women with 
premenstrual syndrome compared to healthy controls (Rubinow & Schmidt, 1995). 
Although differences in cortisol levels related to the luteal phase have not been 
consistently observed in women with menstrual cycle related disorders, or the more 
general premenstrual syndrome, there seem to be menstrual-cycle-independent 
differences in response to CRH stimulation compared to healthy controls. A greater 
response to CRH stimulation was found in in women with menstrual cycle related 
disorders (Rubinow & Schmidt, 1995). These findings suggest that changes in non-
reproductive endocrine systems can also precipitate menstrual cycle related mood 
disorders (Rubinow & Schmidt, 1995).  
     Furthermore, it has been suggested that the menstrual cycle does not only impact 
on mood and symptoms but also affects cognitive functioning. A lower performance 
of women during the mid-luteal phase compared to the menstrual phase (low 
oestrogen/low progesterone) has been reported, with testosterone having a positive 
and oestradiol having a negative effect on spatial cognition (Hausmann, 
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Slabbekoorn, Van Goozen, Cohen-Kettenis, & Güntürkün, 2000). Working memory 
function has been found to be impaired in the luteal phase in healthy controls as well 
as in women with premenstrual dysphoric syndrome (Man, MacMillan, Scott, & 
Young, 1999). It has also been reported that oestradiol levels correlate positively 
with verbal fluency and negatively with mental rotations during the menstrual cycle 
(Maki, Rich, & Shayna Rosenbaum, 2002). In a study conducted by Symonds and 
colleagues (2004), it was found that changes in the menstrual cycle have an effect on 
neurocognitive functioning in healthy female volunteers (Symonds et al., 2004). 
Participants were assessed during the mid-follicular (high oestrogen/low 
progesterone) and the late-luteal phase on mood, neurocognitive function, basal 
cortisol and dehydroepiandrosterone (DHEA). Data showed that compared to the 
mid-follicular phase, women were impaired in verbal fluency and had faster reaction 
times on a continuous performance task during the late-luteal phase. Also mood, 
cortisol and DHEA were decreased in the luteal phase. These results indicate that 
HPA axis function is lower in the luteal phase in healthy female volunteers compared 
to the follicular phase of the cycle, which may in turn influence mood and 
neurocognitive function (Symonds et al., 2004). 
     Differences in the levels of oestrogens have been associated with verbal memory 
impairment and differences in prefrontal functioning in previous functional magnetic 
resonance imaging (fMRI) studies in healthy pre-menopausal women pre-, during, 
and post-acute ovarian hormone suppression using Gonadotropin Hormone 
Releasing Hormone agonists (GnRHa) (Craig et al., 2008; Craig et al., 2007). The 
impairment reversed following the resolution of ovarian hormone suppression. In a 
recent fMRI study conducted by Thimm, Hausmann and Sturm (2013), it was found 
that the menstrual cycle also influenced selective attention and its underlying 
functional cortical networks (Thimm, Weis, Hausmann, & Sturm, 2013). Healthy 
female volunteers were assessed during the menstrual, follicular and the luteal phase 
on a go/no-go task. The performance results suggested a functional cerebral 
asymmetry toward the left hemisphere in selective attention during the menstrual 
phase, which was however not associated with changes in the imaging data. Yet, a 
functional connectivity analysis of the data showed a weaker negative correlation 
during the luteal phase between the left hemispheric frontal areas and the left inferior 
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parietal region and the right middle frontal gyrus, possibly reflecting a reduction of 
inhibition of the left medial frontal cortex on the areas (Thimm et al., 2013). 
     Taken together, studies conducted to assess the effects of the menstrual cycle 
show the importance of taking the hormonal variations associated with it into 
account in studies assessing patients with mood disorder or psychoses, as well as in 
healthy women, as biological and neurocognitive measures can be heavily influenced 
by these variations. In addition to hormonal variations in women at risk of or 
suffering from postpartum psychosis, it is also likely that changes in neurotransmitter 
levels play an important role. Hormones may also interact with neurotransmitters to 
increase the risk of developing the disorder. A neurotransmitter that has been 




Dopamine dysfunction has been considered to alter the appraisal of stimuli, 
potentially resulting in the development of psychosis (Howes & Kapur, 2009). In 
addition, it has been proposed that oestrogens affect the neurotransmitter dopamine 
(Cyr et al., 2002; Gogos, Kwek, & Buuse, 2012; Howes & Kapur, 2009). Therefore, 
researchers have suggested that dopamine has an important role in postpartum 
psychosis (Cookson, 1982; Meakin, Brockington, Lynch, & Jones, 1995; Wieck et 
al., 1991). It is possible that the postpartum fall in oestrogens leads to an increased 
sensitivity to dopaminergic stimulation, which in turn triggers the onset of 
postpartum psychosis (Cookson, 1982; Meakin et al., 1995; Wieck et al., 1991).  
     Based on the assumption that oestrogens also modulate dopamine function, the 
response of growth hormone (GH) to the dopamine agonist apomorphine was 
assessed on the fourth day postpartum in women at high risk due to a history of 
bipolar or schizoaffective disorder. The GH response is indicative of the 
responsiveness of dopamine sensitive neurons in the brain (Wieck et al., 1991). 
Researchers showed that illness onset in eight of the 15 women was associated with 
an increased sensitivity, since their GH response was enhanced, compared to the 
other women at high risk who did not develop postpartum psychosis and 15 healthy 
controls (Wieck et al., 1991).  
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Although a promising start, these results were not confirmed by a replication study, 
which found no increase in sensitivity of dopamine neurons in three women who 
developed postpartum psychosis (Meakin et al., 1995). Another study assessing the 
sensitivity of dopamine neurons on the fourth day postpartum used apomorphine in a 
series of 25 women with bipolar or schizoaffective disorder, 15 depressed women 
and 15 healthy controls. They found that the women with bipolar or schizoaffective 
disorder had a significantly elevated GH response, with the highest response in those 
who developed depression (R. Kumar et al., 1997). Given the positive association 
found in the two studies with a larger number of participants, the current best 
evidence suggests that dopamine is important for the development of postpartum 
psychosis. 
     As well as the GH response, the prescription of bromocriptine, a dopamine 
agonist which inhibits prolactin, has been associated with postpartum psychosis 
(Brockington & Meakin, 1994; Canterbury, Haskins, Kahn, Saathoff, & Yazel, 1987; 
Iffy, Lindenthal, Szodi, & Griffin, 1989). Bromocriptine is often prescribed to stop 
lactation (i.e. preventing or reducing milk production). Similar to the results found in 
studies assessing hormones in postpartum psychosis, results from investigating 
dopamine changes in women with postpartum psychosis are inconsistent, with some 
studies showing an association (Wieck et al., 1991) while others do not (Meakin et 
al., 1995). This makes it difficult to draw any firm conclusions. However, based on 
the assumption that there are changes in hormone and neurotransmitter levels, some 
researchers investigated whether variations in genes associated with these hormones 
and neurotransmitters might be underlying these changes. 
 
1.3.1.5 Genes 
Since there has been some level of agreement over the role of oestrogen in 
postpartum psychosis, research has aimed to investigate whether alterations in genes 
known to be influenced by oestrogen levels are present in women with postpartum 
psychosis. Jones et al. (2000) proposed that a certain variation within the oestrogen 
receptor gene would be associated with susceptibility to bipolar disorder or 
postpartum psychosis (Jones et al., 2000). Their sample consisted of 219 bipolar 
women, including 26 women with a postpartum psychotic episode, and 219 controls. 
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They did not find that this genetic variation was associated with susceptibility to 
bipolar disorder or postpartum psychosis.  
     Oestrogens exert a wide range of actions on different neuronal systems (e.g. 
dopaminergic and serotoninergic pathways) (Cyr et al., 2002; Gentile, 2005; Gogos 
et al., 2012). Therefore, serotonergic genes are plausible candidates for assessing a 
possible association with postpartum psychosis. However, results have been mixed. 
It was found that certain variations of the serotonin transporter gene were associated 
with vulnerability to bipolar affective postpartum psychosis (Coyle, Jones, 
Robertson, Lendon, & Craddock, 2000; H. B. K. Kumar et al., 2007) while others 
were not (Robertson et al., 2003). In addition to investigating serotonergic genes, 
whether there are any chromosomal alterations associated with postpartum psychosis 
was also investigated. In a genetic linkage genome study investigating 54 women 
with a first-degree relative who suffered from postpartum psychosis, a strong linkage 
to chromosome 16p13 and 8q24 was found, possibly defining a genetically relevant 
subtype of bipolar disorder (Jones & Craddock, 2007; Jones et al., 2007).  
Given the link with increased cortisol levels found in postpartum psychosis, genetic 
variations of the glucocorticoid receptor were also investigated. The study did not 
find any differences between women suffering from postpartum psychosis, those 
suffering from psychoses unrelated to childbirth, and healthy controls (Feng et al., 
2000).  
     In summary, studies assessing variations in serotonergic genes have found some 
association with postpartum psychosis and bipolar disorder. Also, a strong linkage to 
chromosome 16p13 and 8q24 has been observed. No association was found in 
genetic variations in the oestrogen or glucocorticoid receptors. In the future, more 
specific studies will need to clarify the precise relationship and implications of these 
findings.  
 
1.3.2 Sleep loss  
Another risk factor that has been discussed in the literature is sleep loss and it has 
been suggested as the final common pathway in the development of postpartum 
psychosis in susceptible women (Sharma & Mazmanian, 2003). Sleep loss is seen as 
a major precipitant for postpartum psychosis (Sharma et al., 2004; Sit et al., 2006). 
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Pregnancy and the postpartum period are associated with significant changes in sleep 
patterns (e.g. more awakenings and sleep disruptions), often occurring in the first 
night postpartum (Karacan, Williams, Hursch, McCaulley, & Heine, 1969; Sharma & 
Mazmanian, 2003). In a study assessing loss of sleep as a result of length of labour 
and time of delivery, it was found that insomnia was the most frequent (experienced 
by 87%) and earliest symptom in women developing postpartum psychosis (Sharma 
et al., 2004). Sleep loss is also more pronounced in primipara women (i.e. women 
having their first child), who have been found to be at a higher risk of developing 
postpartum psychosis (P. Agrawal et al., 1990; V. Bergink et al., 2011; Kendell et al., 
1987; Kendell, Rennie, et al., 1981; Kirpinar et al., 1999; Kisa et al., 2007; Meltzer 
& Kumar, 1985; Schöpf et al., 1984; Videbech & Gouliaev, 1995).  
     Oestrogens play a role in the regulation of the circadian cycle and the huge drop 
of oestrogen levels that occurs following delivery has the potential of triggering 
insomnia (Hunter, Rychnovsky, & Yount, 2009; Sharma & Mazmanian, 2003). 
Nonetheless, findings are inconsistent. In a different study, changes in sleep and 
wake activity were compared during pregnancy and in the postpartum period in 
women with a history of bipolar disorder as well as postpartum psychosis and 
healthy controls and no significant differences were found between groups (Bilszta et 
al., 2010).  
     Results of studies assessing the role of sleep loss in postpartum psychosis are 
inconsistent and further research is needed to establish its precise role, as sleep loss 
might in turn be associated with the amount of stress the women experience (e.g. due 
to difficulties during the delivery or social stressors). Moreover, sleep loss might 
represent an early symptom of postpartum psychosis rather than being a risk factor in 
itself. Contrary to other areas such as sleep loss, clinical and sociodemographic 
correlates have received more attention in previous research.   
 
1.3.3 Clinical and sociodemographic correlates 
The common view has been that postpartum psychosis is not typically precipitated 
by stressful life events (Brockington et al., 1990; R. Kumar et al., 1993; McNeil, 
1988b; Paffenbarger & McCabe, 1966; Protheroe, 1969). Women with postpartum 
psychosis have been reported to have a similar amount or even less exposure to acute 
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stressful life events before symptom onset compared to women who did not develop 
symptoms in the postpartum period (Brockington et al., 1990; Dowlatshahi & 
Paykel, 1990). 
     However, findings are inconsistent across the literature. Some studies found that 
postpartum psychosis is associated with both stressful life events (e.g. caesarean 
section, having the first child)  (P. Agrawal et al., 1990; V. Bergink et al., 2011; 
Kendell et al., 1987; Kendell, Rennie, et al., 1981) as well as social stressors (e.g. 
being single, higher maternal age, living in a poor socioeconomic environment, or 
having a lower educational level) (Cheetham et al., 1981; Kendell et al., 1987; 
Kendell, Rennie, et al., 1981; Nager et al., 2006; Nager et al., 2012; Paffenbarger, 
1961; Paffenbarger & McCabe, 1966; Valdimarsdóttir, Hultman, Harlow, 
Cnattingius, & Sparén, 2009).  
     It seems plausible that given the importance of stressful life events and social 
stressors in triggering or exacerbating other mental disorders such as psychoses 
unrelated to childbirth (Aiello et al., 2012; Bennett & Maxwell, 2008; Schäfer & 
Fisher, 2011), both play an important role in postpartum psychosis. Although a lot of 
research has investigated stressful life events and social stressors in postpartum 
psychosis, results remain inconsistent. It will be important to determine more 
specifically in large epidemiological samples whether postpartum is indeed 
associated with stressful life events or social stressors. Other research areas that have 
received little attention in postpartum psychosis research are the potential cognitive, 
emotional, and neuroimaging correlates.  
 
1.3.4 Cognitive, emotional and neuroimaging correlates 
Given the close relationship between postpartum psychosis and bipolar disorder, as 
well as psychoses unrelated to childbirth, it could be expected that women with 
postpartum psychosis display similar cognitive, emotional or neuroimaging deficits 
as those found in these disorders (Bora, Yücel, & Pantelis, 2010; Bowie & Harvey, 
2005; Brüne, 2005; Y. Chen, Cataldo, Norton, & Ongur, 2012; Hoertnagl et al., 
2011; Kohler, Walker, Martin, Healey, & Moberg, 2010; Libby, Yonelinas, 
Ranganath, & Ragland, 2012; Malhi et al., 2007; Mur, Portella, Martínez-Arán, 
Pifarré, & Vieta, 2007; L. J. Robinson et al., 2006; Rocca, Heuvel, Caetano, & Lafer, 
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2009; Sachs, Steger-Wuchse, Kryspin-Exner, Gur, & Katschnig, 2004; J. B. Savitz, 
van der Merwe, Stein, Solms, & Ramesar, 2008; Valli, Tognin, Fusar-Poli, & 
Mechelli, 2012; Whittaker, Deakin, & Tomenson, 2001). Until today, these aspects 
have not been investigated in postpartum psychosis and only three preliminary 
studies have investigated cognition and potential brain changes. In one study 
assessing attention and working memory by using a serial subtraction and a digit 
span test, women with postpartum psychosis were not found to perform differently 
from healthy controls (Melges, 1968). Using computed tomography (CT), ventricular 
cerebrospinal fluid (CSF) spaces were investigated in women with postpartum 
psychosis and compared to women with psychoses or bipolar disorder unrelated to 
childbirth, as well as to healthy controls. It was found that the left ventricular area, 
planimetric ventricular-brain ratio and superior cerebellar cistern volume were larger 
in the first group than the other two (Lanczik et al., 1998). These widespread changes 
could indicate an unspecific structural vulnerability marker (Lanczik et al., 1998).  
     One fMRI case study conducted in a monozygotic pair of twins discordant for 
postpartum affective psychosis, investigated whether there was any differential 
activation in the orbitofrontal cortex (OFC; Brodmann area 47) between the two 
women while viewing emotional film excerpts. The study found less activation in the 
OFC in the woman with the history of postpartum psychosis (later diagnosed with 
schizoaffective disorder), indicating a disturbance in the integration of emotionally 
relevant information, which is a key characteristic in bipolar disorder and psychoses 
unrelated to childbirth (Drevets, 2007; Fahim, Stip, Mancini-Marïe, Potvin, & 
Malaspina, 2007; van der Schot, Kahn, Ramsey, Nolen, & Vink, 2010).  
     Given the lack of research on these aspects, no firm conclusions can be drawn. 
However, cognitive and emotional dysfunction are key impairments found in both 
bipolar disorder and psychoses unrelated to childbirth (Bora et al., 2010; Bowie & 
Harvey, 2005; Brüne, 2005; Y. Chen et al., 2012; Hoertnagl et al., 2011; Kohler et 
al., 2010; Libby et al., 2012; Malhi et al., 2007; Mur et al., 2007; L. J. Robinson et 
al., 2006; Rocca et al., 2009; J. B. Savitz et al., 2008; Valli et al., 2012). Impairments 
in cognitive functioning including working and verbal memory have been strongly 
associated with bipolar disorder and psychoses unrelated to childbirth (D.M. Barch & 
Ceaser, 2012; Bora et al., 2010; Brewer et al., 2006; R.E. Carrión et al., 2011; I.N. 
Ferrier, Stanton, Kelly, & Scott, 1999; Lee & Park, 2005; Libby et al., 2012; L. J. 
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Robinson et al., 2006; J. B. Savitz et al., 2008; Valli et al., 2012). These impairments 
do not seem to qualitatively differ between diagnostic groups (i.e. schizophrenia, 
schizoaffective disorder, bipolar disorder and major depressive disorder), although 
the schizophrenia group shows the most severe impairments (Reichenberg, 2010; 
Reichenberg et al., 2009; Stefanopoulou et al., 2009). In line with this result is the 
finding that cognitive deficits are more pronounced in bipolar patients with psychotic 
symptoms than in non-psychotic bipolar patients (Bora et al., 2010; Levy & Weiss, 
2010; J. Savitz, van der Merwe, Stein, Solms, & Ramesar, 2009). Still, the deficits in 
working memory and verbal memory persist - with less intensity - during euthymic 
phases in bipolar patients and can be found in their first-degree relatives (Arts, 
Jabben, Krabbendam, & van Os, 2008; I.N.  Ferrier, Chowdhury, Thompson, 
Watson, & Young, 2004; I.N. Ferrier et al., 1999; Reichenberg, 2010; L. J. Robinson 
et al., 2006; Zubieta, Huguelet, O'Neil, & Giordani, 2001). This suggests that the 
impairments are not only by-products of the symptoms, but are rather a trait 
characteristic of the illnesses (I.N. Ferrier et al., 1999; J. B. Savitz et al., 2008; 
Zubieta et al., 2001). In addition, impairments seem to start before symptom onset as 
they are present in high risk individuals (Brewer et al., 2006; R.E. Carrión et al., 
2011). Cognitive dysfunction found in patients at high risk or suffering from bipolar 
disorder or psychoses unrelated to childbirth is also reflected in abnormalities in 
brain activation assessed with fMRI (C. Chen, Suckling, Lennox, Ooi, & Bullmore, 
2011; Fusar-Poli et al., 2012; Glahn et al., 2005; Minzenberg, Laird, Thelen, Carter, 
& Glahn, 2009). Especially frontal, but also temporal, parietal and subcortical areas 
seem to be affected in working memory tasks (C. Chen et al., 2011; Fusar-Poli et al., 
2012; Glahn et al., 2005; Minzenberg et al., 2009).  
     Similarly, bipolar disorder and psychoses unrelated to childbirth are associated 
with deficits in emotional processing (Brüne, 2005; Y. Chen et al., 2012; Hoekert, 
Kahn, Pijnenborg, & Aleman, 2007; Hoertnagl et al., 2011; Kohler et al., 2010; 
Malhi et al., 2007; Rocca et al., 2009). Deficits seem to be mainly driven by an 
impairment in recognising and categorising facial emotion expressions (Hooker & 
Park, 2002; Kohler et al., 2010). The ability to recognise facial emotion expressions 
is of great importance and a fundamental skill for any social interaction, work 
functioning and independent living in order to be able to evaluate situations and 
respond in an appropriate manner (Hoertnagl et al., 2011; Kee, Green, Mintz, & 
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Brekke, 2003; Kohler et al., 2010). Impairment in recognising emotion has been 
found to be related to poorer social functioning in patients with psychoses unrelated 
to childbirth (Hooker & Park, 2002; Poole, Tobias, & Vinogradov, 2000). In line 
with the findings in cognitive functioning, patients with bipolar disorder and 
psychoses unrelated to childbirth do not show qualitative differences in facial 
emotion processing and share specific aspects of facial emotion processing deficits, 
such as mislabelling fear (Goghari & Sponheim, 2012). Patients with psychoses 
unrelated to childbirth and patients with more severe psychotic symptoms have been 
found to show a stronger impairment in recognising emotions than patients with 
bipolar disorder without psychotic symptoms (Aleman & Kahn, 2005; Goghari & 
Sponheim, 2012; Poole et al., 2000; Rocca et al., 2009). Furthermore, impairment in 
emotion processing has also been reported in individuals at risk of psychosis, with 
similar performance to patients diagnosed with a first episode (Addington, Penn, 
Woods, Addington, & Perkins, 2008; G. P. Amminger et al., 2012; G.P. Amminger 
et al., 2012; L. K. Phillips & Seidman, 2008).  
Deficits in emotional processing found in bipolar disorder as well as psychoses 
unrelated to childbirth have been accompanied by differential brain activation (i.e. 
increases as well as decreases) in cingulate, frontal, subcortical, temporal and parietal 
areas, when compared to healthy controls (Li et al., 2012; Liu et al., 2012; Malhi et 
al., 2007). These differences in brain activation have also been reported in people at 
risk of psychoses unrelated to childbirth, with activation levels intermediate to 
patients with psychoses unrelated to childbirth and healthy controls (Li et al., 2012).  
     In summary, there is consistent evidence for impairments in cognitive and 
emotional processing and accompanying differences in brain activation in bipolar 
disorder and psychoses unrelated to childbirth. Given the vital role of these processes 
in social interactions, work life and independent functioning, it is of great importance 
to investigate whether women at risk of or suffering from postpartum psychosis show 
similar impairments with accompanying differences in brain activation. 
 
1.3.5 Summary of research findings in postpartum psychosis 
Most research on postpartum psychosis has focused on clinical and 
sociodemographic correlates, including clinical presentation, prognosis, and 
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treatment. There are many studies which have assessed women’s clinical profile and 
background with a particular emphasis on stressful life events and social stressors. 
Most other results, such as those on hormonal, neurotransmitter and genetic 
influences and sleep in postpartum psychosis, are sparse and inconsistent. In 
addition, many studies suffer from important limitations such as small sample sizes 
or the lack of a control group, making it difficult to derive valid conclusions at this 
stage. However, the evidence collected so far suggests that genetic variations and 
hormones have an important role in postpartum psychosis, possibly affecting 
neurotransmitters and sleep. It will be important in the future to target these areas in 
order to investigate potential triggers and correlates of postpartum psychosis.  
     Other important areas have been almost completely neglected in postpartum 
psychosis research. These include cognitive, emotional, and neuroimaging markers. 
This is surprising, given that cognitive and emotional dysfunctions are considered 
key impairments in bipolar disorder and psychoses unrelated to childbirth. As a 
diagnosis of these disorders puts women at high risk of developing postpartum 
psychosis, it is of great significance to assess whether these processes are also 
impaired in women at risk of or suffering from postpartum psychosis.    
 
1.4 Rationale 
Despite its rare occurrence, postpartum psychosis is a severe disabling illness which 
is extremely important to investigate. There must be a focus on the possibility of 
preventing it and the potential of therefore preventing serious consequences for 
mother and child. Most studies investigating postpartum psychosis have focused on 
clinical presentation, prognosis, and treatment. Important questions about the 
potential cognitive, emotional, and neuroimaging correlates that are considered key 
impairments in bipolar disorder and psychoses unrelated to childbirth have not been 
addressed. Investigating whether there are potential verbal, working or facial 
emotion processing deficits in women with postpartum psychosis is essential in order 
to shed light on the pathophysiology of this disorder and to increase the knowledge 
and understanding of cognitive and emotional functioning in postpartum psychosis. 
Knowledge about these processes could potentially help in predicting future onset of 
postpartum psychosis and could also assist with treatment and recovery and a 
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profound understanding may help clinicians in developing individual management 
strategies and implementing targeted cognitive trainings or interventions.  
     Therefore, in the present study, the aim is to investigate for the first time whether 
women at risk of postpartum psychosis have cognitive, emotional, or neuroimaging 
impairments within one year postpartum that are typically associated with bipolar 
disorder and psychosis unrelated to childbirth. Women were included in the study 
when they were at risk of postpartum psychosis due to a history of bipolar or 
schizoaffective disorder, a previous diagnosis of postpartum psychosis according to 
the DSM-IV, or if they had a first-degree family history of postpartum psychosis. To 
keep the sample homogenous, we did not include women with other psychoses 
unrelated to childbirth.  
     As discussed in the section 1.2 Relation to other mental disorders, having a 
diagnosis of bipolar disorder puts women at the highest risk of developing an episode 
of postpartum psychosis. Therefore, we define our high risk group as including 
women with this diagnosis. It is well known that patients with bipolar disorder show 
impairments in verbal memory and working memory as well as facial emotion 
processing (for an overview see paragraph 1.3.4 Cognitive, emotional and 
neuroimaging correlates). However, our “at risk” group as a whole includes both 
women with and without a history of bipolar disorder, and therefore it is important to 
establish if, since postpartum psychosis episodes are considered part of an affective 
disorder spectrum, all women considered at risk show impairments similar to those 
seen in bipolar disorder, independently of whether they have such a diagnosis or not. 
This would allow us to establish whether there is a set of neurobehavioural 
alterations that is common to this population of “at risk” women. In addition, it will 
further advance knowledge on the bipolar disorder literature, since there has been no 
neuroimaging study that has, thus far, investigated women with a diagnosis of 
bipolar disorder in the postpartum period. This approach creates the context for the 
novel research question: whether women who do develop postpartum psychosis 
differ from women who, although at risk, do not develop postpartum psychosis. 
Furthermore, it will provide knowledge of the cognitive, emotional and 
neuroimaging correlates of these postpartum episodes as this may help, if validated, 
the identification of a set of predictors for the development of a postpartum episode 
among women at risk. 
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The two overarching research questions were: 1) whether working memory and 
verbal memory as well as emotional face processing – usually impaired in people 
with bipolar disorder or other psychoses unrelated to childbirth - are impaired in 
women at risk of postpartum psychosis and 2) whether women who have had 
postpartum episodes show a more pronounced impairment than women who have 
had non-postpartum episodes only. 
 
1.5 Hypotheses  
More detailed background on the literature on working memory, verbal memory and 
facial processing as well as the tasks will be presented in the individual chapter 
introduction.  
Primary hypotheses: 
1. Women at risk of postpartum psychosis will show, in comparison to healthy 
controls, decreased brain activation in the dorsolateral prefrontal cortex during a 
working memory task.  
2.  Women at risk of postpartum psychosis will show, in comparison to healthy 
controls, higher brain activation of the amygdala during a facial emotion processing 
task.  
In addition, I will test a set of exploratory, secondary hypotheses: 
1. Women at risk of postpartum psychosis will show, in comparison to healthy 
controls, differential brain activation during a working memory and facial emotion 
processing task as assessed with whole brain analysis.  
2. Women at risk of postpartum psychosis will show, in comparison to healthy 
controls, impaired working memory performance.  
3. Women at risk of postpartum psychosis will show, in comparison to healthy 
controls, impaired verbal memory performance.  
4. Impairments in verbal and working memory and differences in brain activation in 
working memory as well as in facial emotion processing will be more pronounced in 
women who had developed postpartum psychosis episodes, compared to women who 




In this thesis clinical, cognitive, emotional, and neuroimaging measures of women at 
risk of postpartum psychosis are investigated and described. In chapter 2, the 
methods used in the current study will be outlined. In chapter 3, the clinical and 
sociodemographic correlates of the sample, including the psychiatric diagnoses, 
sociodemographic information, medical and obstetric history, and history of 
substance use as well as clinical scales, are explored and compared to previous 
studies on postpartum psychosis. Chapter 4 – verbal memory - will describe the 
assessment and findings of the performance in two verbal memory tasks. In chapter 
5, the behavioural performance as well as the neuroimaging correlates of working 
memory will be presented. In chapter 6, neuroimaging correlates of facial emotion 
processing will be investigated. A specific introduction of previous literature and 
discussion of the results is given in each chapter. A general discussion of the findings 




2. Chapter: Methods 
In this chapter the methods used in the study will be discussed. A description of 
participants will be given, including recruitment procedures, inclusion criteria and 
reasons for exclusion. The study design as well as clinical and cognitive assessments 
will be presented. This will be followed by a detailed description of the 
neuroimaging technique used in this study, comprising the background of fMRI, and 
tasks and the image acquisition used. Then, the analysis methods will be outlined for 
the behavioural and neuroimaging data. Finally, the study procedure will be 
explained, covering both study visits and a statement on the personal contribution 
will be made. 
 
2.1 Participants 
A total of 51 women were recruited for the study according to the following 
inclusion criteria: women in the “at risk” group had a diagnosis of current or 
previous personal history of bipolar disorder, schizoaffective disorder, or postpartum 
psychosis and/or a family history of postpartum psychosis (N=27) (Jones & 
Craddock, 2001; Robertson et al., 2005). Healthy female controls had no current 
psychiatric disorder, no personal history of any of the above diagnoses, no family 
history of postpartum psychosis and did not take any medication (except nutritional 
supplements) at the time of recruitment (N=24). Healthy controls were matched to 
the “at risk” group according to IQ, ethnicity, education and the number of weeks 
after delivery.  
 
Inclusion criteria for both groups were: 
1) Pregnant or within the first year after delivery. 
2) Age 18-45 years inclusive. 
3) Able to communicate in English. 
4) No fMRI contraindications (e.g. metallic implants, claustrophobia). 
5) No severe obstetric complications. 




The study was approved by the Joint South London and Maudsley/Institute of 
Psychiatry Research Ethics Committee (10/H0807/14). Women at risk of postpartum 
psychosis were recruited through the perinatal psychiatry services of the South 
London and Maudsley and the Central and North West London National Health 
Service (NHS) Foundation Trusts. The perinatal services of the South London and 
Maudsley NHS Foundation Trust included the liaison perinatal psychiatry services 
based at King’s College Hospital, St Thomas Hospital, and Croydon University 
Hospital and the in-patient Mother and Baby Unit at the Bethlem Royal Hospital. 
The Central and North West London NHS Foundation Trust included the Coombe 
Wood Perinatal in-patient Mother and Baby Unit at the Park Royal Centre for Mental 
Health.  
     In the UK, women are routinely screened by midwives at their first antenatal 
appointment and are referred to perinatal services, if they may be at risk of or are 
experiencing mental health problems. Only women who agreed to be contacted by a 
member of the healthcare team in the perinatal services were approached (for the 
recruitment process see Figure 2.1A and Figure 2.2). Healthy female controls were 
recruited via the obstetric services at King’s College Hospital (for the recruitment 
process see Figure 2.1B). Eligible women were approached after being identified by 
a member of the healthcare team as being 32 weeks pregnant or over. An initial 
screening procedure close to the expected date of delivery took place on the phone. 
The number of women “at risk” and healthy controls that were not suitable 
(including the reasons of exclusion) is shown in Table 2.1 and 2.2. In total, three 
women withdrew from the study. Women gave written consent (see Appendix D) 













Figure 2.1 Recruitment process I 
 
Figure 2.1 shows the recruitment process of women “at risk” (column A) and healthy controls 
(column B).  
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Figure 2.2 Recruitment process II 
 
Figure 2.2 shows the recruitment process of women “at risk” for the five recruitment sites (King’s College Hospital and the two Mother and Baby Units (first column) St 
Thomas Hospital (second column) and Croydon University Hospital (third column). 
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Table 2.1 Reasons for exclusion of women “at risk” 
N=20 Follow-up diagnosis of schizophrenia/psychosis unrelated to childbirth 
N=16 Follow-up diagnosis of major depressive disorder  
N=6 Remained too unwell to be approached (within one year after delivery) 
N=4 Medical condition 
N=3 Baby was taken into foster care 
N=3 Pregnancy did not result in a live birth and it was considered too stressful to 
take part 
N=2 Not fluent in English 
N=2 Termination of pregnancy  
N=1 Learning difficulties (IQ < 80) 
N=1 MRI contraindications 
N=13 Other (e.g. not taken under the care of the perinatal psychiatry team) 
N=71 Total of excluded women 
 
Table 2.2 Reasons for exclusion of healthy controls 
N=9 MRI contraindications 
N=8 Current or past psychiatric diagnoses 
N=7 Not fluent in English 
N=1 Medical condition 
N=14 Other (e.g. did not give birth at King’s College Hospital) 
N=39 Total of excluded women 
 
2.2 Design 
This study consisted of two visits using a case-control design comprising two groups 
(women “at risk” versus healthy controls). Both assessments took place within the 
first year of delivery and were separated by no more than four months from each 
other.  
 
2.3 Clinical and cognitive assessments 
All women underwent a general assessment consisting of the evaluation of 
sociodemographic information, medical and obstetric history, smoking history, tea, 
coffee and alcohol consumption, and information on breastfeeding. All medication 
taken at the time of the MRI scan was recorded. This was followed by the Structured 
Clinical Interview for DSM-IV Axis I Disorders (Clinician Version) (SCID-I CV) 
(First, Spitzer, Gibbon, & Williams, 1996). Medical records and clinical notes were 
also reviewed. All assessments were carried out by a trained researcher (A. Pauls), 




For further clinical and cognitive evaluation participants completed the following 
scales and assessments (these were both interview-based and self-report; see 
Appendix A): 
 
2.3.1 Clinical assessments  
2.3.1.1 Life event scales and family history 
1) Brief Life Events (BLE) scale; a scale containing 12 questions investigating 
stressful life events over the past six months (Brugha & Cragg, 1990). 
2) Intrusive Life Events (ILE) scale; a 10 item self-report questionnaire in which 
participants had to indicate whether they have ever suffered from 
stressful/intrusive life events and they had to specify the year in which these 
events took place (Bebbington et al., 2004). 
3) Childhood Experience of Care and Abuse Questionnaire (CECA.Q); a 
questionnaire in order to assess adverse childhood experiences until the age of 17 
years (Bifulco, Bernazzani, Moran, & Jacobs, 2005). 
4) Family Interview for Genetic Studies (FIGS); an interview used to investigate 
diagnostic information about the relatives of participants (Maxwell, 1992). 
 
2.3.1.2 Assessment of functioning 
5) Global Assessment of Functioning (GAF); an assessment of the current overall 
(i.e. psychological, social and occupational) functioning of participants on a 
continuous scale; it is divided into 10 ranges of functioning (American 
Psychiatric Association, 1994).  
6) Clinical Global Impressions (CGI); a scale consisting of eight items, rating the 
current severity of the illness of the participants (Guy, 1976). 
 
2.3.1.3 Mood and symptom scales 
7) Hamilton Depression Rating Scale (HAM-D); a scale consisting of 17 items 
assessing depressive symptoms of participants over the past two weeks (M. 
Hamilton, 1960).  
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8) Beck Depression Inventory (BDI); a 21 item self-report questionnaire 
investigating the intensity of depression over the past few days (Beck, Ward, 
Mendelson, Mock, & Erbaugh, 1961). 
9) Young Mania Rating Scale (YMRS); a scale containing 11 items assessing the 
severity of manic symptoms over the past 48 hours (Young, Biggs, Ziegler, & 
Meyer, 1978) . 
10) Positive and Negative Syndrome Scale (PANSS); a scale consisting of 30 items 
measuring the prevalence of positive and negative psychotic symptoms over the 
last seven days (Kay, Fiszbein, & Opler, 1987). 
 
2.3.1.4 Stress, anxiety and sleep scales 
11) State-Trait Anxiety Inventory (STAI); a 40 item self-report questionnaire 
assessing anxiety in the specific situation and as a general trait (Spielberger, 
Gorssuch, Lushene, Vagg, & Jacobs, 1983). 
12) Perceived Stress Scale (PSS); a 11 item self-report questionnaire assessing the 
degree to which events during the last month have been perceived as stressful (S. 
Cohen, Kamarck, & Mermelstein, 1983). 
13) Athens Insomnia Scale (AIS); a self-report questionnaire quantifying sleep 
difficulty over the past two weeks based on the ICD-10 criteria, which consist of 
eight items (Soldatos, Dikeos, & Paparrigopoulos, 2000 ).  
 
2.3.2 Cognitive assessments  
1) Wechsler Test of Adult Reading (WTAR); a test in which participants have to 
read 50 English words with irregular pronunciations aloud, was used in order to 
estimate premorbid intellectual functioning (Wechsler, 2001). 
2) Verbal memory assessments. Participants completed the logical memory test I 
and II, part of the Wechsler Memory Scale (WMS-III), in order to assess 
auditory-linguistic immediate and delayed memory (Abikoff et al., 1987; 
Wechsler, 1997). Participants also completed and a remember-know paradigm 
(Tulving, 1985), administered on a laptop using E-prime (W.  Schneider, A. 
Eschman, & A.  Zuccolotto, 2002; W. Schneider, A. Eschman, & A. Zuccolotto, 
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2002). Further descriptions of the assessments can be found in chapter 4 – verbal 
memory. 
 
The WTAR and the logical memory were recorded on an Olympus WS-450S Digital 
Voice Recorder and rated by a trained native English speaking researcher.  
 
2.4 Neuroimaging 
All women underwent an MRI scan at the Centre for Neuroimaging Sciences, at 
King’s College London, in order to assess brain function and structure. The 
following section will give a short overview of the background of MR imaging, the 
image acquisition and parameters for the tasks used in the current study. 
 
2.4.1 Background of fMRI 
In this section, the physics underlying MR imaging will be introduced, followed by a 
brief description of the principles of functional MRI and an outline of the task 
designs used in the current study.  
 
2.4.1.1 Nuclear Spins 
Hydrogen nuclei are most commonly imaged using MRI (Brown, Perthen, Liu, & 
Buxton, 2007; Huettel, Song, & McCarthy, 2004). They consist of single protons 
spinning around their own axis (Huettel et al., 2004). This spinning (referred to as 
spin angular momentum) generates an electrical current due to the positive charge of 
the proton, which in turn produces a small magnetic dipole and torque when placed 
in a magnetic field. In the absence of a magnetic field, spins are distributed randomly 
because of thermal effects, and the sum of all magnetic moments from the spins in 
different orientations (i.e. the net magnetisation) is very small (Brown et al., 2007; 
Huettel et al., 2004). In order to align the spins and increase net magnetisation, they 





Figure 2.3 The random spin orientations of protons 
 
Figure 2.3 (taken from Huettel et al., 2004) shows protons having random spin orientations in the 
absence of a magnetic field (A) and protons aligned either parallel to or antiparallel to the main axis 
after being placed into a magnetic field (B) (Huettel et al., 2004). 
 
2.4.1.2 Spins in an external magnetic field 
In an external magnetic field, spins can be parallel to the magnetic field (i.e. in a low 
energy state) or antiparallel to the magnetic field (i.e. in a high energy state) (Huettel 
et al., 2004) (Figure 2.4). At equilibrium, there are more spins in the low energy state 
which creates a weak net magnetisation (Brown et al., 2007), the size of which is 
determined by the temperature and strength of magnetic field (Brown et al., 2007). 
To excite a spin from the lower to the higher energy state requires an electromagnetic 
wave at the Larmor frequency. This is the same frequency at which the spin 
precesses around the main magnetic field.  
 
2.4.1.3 Net magnetisation of a spin system 
The net magnetisation can be divided into two components: longitudinal (parallel to 
the external magnetic field) and transverse (perpendicular to the external magnetic 
field) (Huettel et al., 2004). The transverse components will cancel each other out, so 
that the net magnetisation is oriented along the longitudinal. The net magnetisation 








Figure 2.4 Protons in antiparallel and parallel states 
 
Figure 2.4 (taken from Huettel et al., 2004) shows protons in antiparallel/high energy (shown in blue) 
and parallel / low energy (shown in orange) states (Huettel et al., 2004). 
 
 
Figure 2.5 The net magnetisation 
 
Figure 2.5 (taken from Huettel et al., 2004) shows the net magnetisation, which is determined by the 





2.4.1.4 Excitation and reception 
By applying a radiofrequency pulse at the frequency matching the precession, spins 
can be tipped by a certain angle called a “flip angle” (Brown et al., 2007). Spins can 
be tipped into the transverse plane by a 90-degree excitation pulse. When the pulse is 
turned off again, the protons return to their low energy state while emitting energy 
equal to the difference between the two states (at the Larmor frequency). The 
resulting magnetic resonance signal can be measured by a receiver coil (i.e. a process 
known as reception; see Figure 2.6) (Huettel et al., 2004).  
 
 
Figure 2.6 Changes between states due to absorption or release of energy 
 
Figure 2.6 (taken from Huettel et al., 2004) shows the changes between states due to absorption or 
release of energy. (A) Spins in an external magnetic field, and more spins are in parallel (shown in 
orange) than antiparallel (shown in blue) states. In (B) due to a radiofrequency pulse (shown in black) 
spins will change from a parallel to an antiparallel state. In (C) after the radiofrequency pulse stops, 
spins will return to their normal state, emitting the absorbed energy (shown in black) (Huettel et al., 
2004). 
 
2.4.1.5 Relaxation  
There are three relaxation mechanisms by which the spin system recovers its 
equilibrium (Matthews & Jezzard, 2004). The first is longitudinal recovery in which 
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the magnetisation of the z direction returns to equilibrium. This is a relatively slow 
process and is described by the time constant T1. The second is transverse relaxation 
and is described by the time constant T2 (Huettel et al., 2004), which happens 
because the coherence of precessing spins reduces over time in the external magnetic 
field due to spin-spin interactions. Some spins precess at a higher and some at a 
lower frequency and so they get out of phase. Spatial inhomogeneities add to these 
differences in precession frequency which increases the rate of transverse decay and 
that effect is additive to T2 decay (Brown et al., 2007). The combination of spin-spin 
interactions and magnetic field inhomogeneities are described by the time constant 
T2* (Huettel et al., 2004).  
     T2* relaxation forms the basis of the Blood Oxygen Level Dependent (BOLD) 
contrast in fMRI as T2*-weighted images are sensitive to the amount of  
deoxygenated haemoglobin present, which changes according to metabolic demands 
of active neurons (Huettel et al., 2004; Logothetis, 2003; Ogawa, Lee, Kay, & Tank, 
1990). Although longitudinal and transverse relaxation take place simultaneously, 
they have different time constants and vary according to the tissue composition 
(Amaro & Barker, 2006; Huettel et al., 2004) (see Figure 2.7). Depending on the 
imaging parameters, different tissues (e.g. gray or white matter) have different signal 
intensities. An image is T1 weighted if the relative signal intensity of voxels depends 
on the T1 values of the tissue. An image is T2 weighted when the amount of signal 
loss depends on the echo time. 
 
Figure 2.7 T1and the T2 decay  
 
Figure 2.7 (taken from Huettel et al., 2004) shows the T1 or longitudinal recovery and the T2 or 




2.4.1.6 Image formation 
Introducing spatial gradient magnetic fields along the x, y, and z directions varies the 
strength of magnetic field systematically over space and causes spins to precess at 
different rates in different spatial locations (Brown et al., 2007; Huettel et al., 2004). 
A sequence of gradient field changes is applied in order to create MR images (see 
Figure 2.8). An electromagnetic pulse with a range of precession frequencies excites 
spins within only one slice. This is followed by two spatial gradients that provide 
more information about the distribution of nuclei within the slice (Huettel et al., 
2004). The first is frequency encoding, a gradient applied during data acquisition so 
that spin precession frequencies change over space; the second is phase encoding, a 
gradient applied before the data acquisition period so that spins can accumulate 
differential phase offsets over space (Huettel et al., 2004).  
     Often used in fMRI is echo-planar imaging (EPI), which is very rapid as the data 
from a complete slice are acquired after a single radiofrequency pulse. The returning 
MR signal is a combination of frequencies, each corresponding to a signal from a 
particular location (Brown et al., 2007). There are two important aspects that 
determine the time at which MR images are collected. The first is the time interval 
between successive excitation pulses (i.e. repetition time) and the second is “echo 
time”, the time interval between excitation and data acquisition (Huettel et al., 2004).  
 
Figure 2.8 Spatial distributions of the x-, y-, and z-gradient magnetic fields acquisition 
 
Figure 2.8 (taken from Huettel et al., 2004) shows a schematic illustration of the spatial distributions 




2.4.1.7 BOLD imaging 
The assumption behind using the BOLD contrast in fMRI is that the information 
processing activity of neurons increases their metabolic requirements and that the 
vascular system provides energy to meet these needs in the form of glucose and 
oxygen (bound to haemoglobin molecules) (Huettel et al., 2004). Under normal 
circumstances oxygenated haemoglobin is converted to deoxygenated haemoglobin 
at a constant rate within the capillary beds.  
     However, when neurons become active, the vascular system supplies more 
oxygenated haemoglobin than is needed by neurons. This is achieved through an 
overcompensatory increase in blood flow by changing both the volume of blood 
vessels and the velocity with which blood moves through those vessels (Huettel et 
al., 2004). This results in a decrease in the amount of paramagnetic deoxygenated 
haemoglobin (Ogawa et al., 1990). This reduces distortions of the surrounding 
magnetic field and therefore increases T2*. Consequently, MR pulse sequences 
sensitive to T2* should show more MR signal when blood is highly oxygenated, as 
seen in Figure 2.9 (Amaro & Barker, 2006; Brown et al., 2007). The BOLD contrast 





















Figure 2.9 The BOLD signal generation. 
 
Figure 2.9 (taken from Huettel et al., 2004) shows the BOLD signal generation. Oxygenated 
hemoglobin is converted to deoxygenated hemoglobin at a constant rate within the capillary beds (A). 
When neurons become active, the vascular system supplies more oxygenated hemoglobin than 
necessary, resulting in a decrease in the amount of deoxygenated hemoglobin (B) and a corresponding 
decrease in signal loss due to T2*effects. This leads to a brighter MR image (Huettel et al., 2004).  
 
 
The recorded MR signal triggered by this neuronal activity is known as the 
hemodynamic response (HDR), which occurs after the neuronal events that initiate it 
(Huettel et al., 2004). The exact form of the HDR can vary in width and length (see 
Figure 2.10) depending on stimuli amplitude and intensity. Sometimes the HDR 
starts with an initial dip (1-2 seconds) following a short stimulus, then shows a 
transient increase with a peak around 4-6 seconds and ends with a post-stimulus 
undershoot (i.e. a decrease in MR signal amplitude below baseline due to a 








Figure 2.10 The BOLD hemodynamic response 
 
Figure 2.10 (taken from Huettel et al., 2004) shows a schematic representation of the BOLD 
hemodynamic response. Panel A shows the hemodynamic response to a short stimulus. Panel B shows 
the hemodynamic response to a block of sequential events (Huettel et al., 2004).  
 
2.4.1.8 Designs  
In this study, two types of design were used: block and event-related. For the block 
design (N-back paradigm) the experimental and control conditions were presented in 
distinct periods, each for an extended time (seconds) or block. Control blocks (with 
no task requirements) were used to compare each condition. In the majority of cases, 
block designs are superior to other designs in the efficient detection of voxels with 
significant activation and can identify a wide range of task related changes regardless 
of any variations in the timing and shape of BOLD signal (Brown et al., 2007). 
Furthermore, certain tasks such as memory paradigms or tasks in which the level of 
difficulty is varied between conditions may require a block design.  
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The second type of design was an event-related design (Ekman faces paradigm) in 
which stimuli were presented as discrete, short-duration events - separated by an 
interstimulus interval - and where timing and order was randomised. The assumption 
behind event-related designs is that neural activity will occur for short and discrete 
intervals. High temporal resolution is important for event-related fMRI because 
transient changes in the brain are associated with discrete stimuli. Provided that 
events of interest are presented in a random order, short interstimulus intervals can 
be used. Estimations of the shape and timing of the HDR are better in event-related 
than in block designs, but their detection power is lower (Brown et al., 2007; Huettel 
et al., 2004).  
 
2.4.1.9 Tasks 
The N-back task was used in order to assess working memory (Gevins & Cutillo, 
1993; Kirchner, 1958; Owen, McMillan, Laird, & Bullmore, 2005). The Ekman faces 
paradigm was used in order to assess facial emotion processing (Ekman & Friesen, 
1976; M. L. Phillips et al., 1997). For further details of the tasks see chapter 5 which 
is on working memory and chapter 6 which is on facial emotion processing. 
 
2.4.2 Image acquisition 
MRI data were obtained using a 3T GE Signa HDx System (General Electric, 
Milwaukee, Wisconsin) with an eight-channel head coil. Stimulus images were 
projected onto a screen, clearly visible through a periscopic mirror placed in front of 
participants’ eyes.   
 
2.4.2.1 High-resolution image  
A high-resolution gradient-echo echo-planar image was obtained for accurate spatial 
normalisation, with a repetition time of three seconds and an echo time of 30ms. The 
flip angle was 90°. Forty three slices were acquired with a slice thickness of 3mm 




2.4.2.2 Functional imaging 
2.4.2.2.1 N-back 
One hundred and eighty-six T2*-weighted images were acquired using a gradient-
echo echo-planar imaging sequence. The repetition time was two seconds and the 
echo time was 30ms. The flip angle was 75°. Thirty nine slices were acquired 
interleaved from bottom to top with a slice thickness of 3.5mm and a gap of 0.5mm. 
The in-plane resolution was 3.75 mm2 and the field of view was 24cm.  
 
2.4.2.2.2 Ekman faces paradigm 
One hundred and eighty T2*-weighted images were acquired for the Ekman faces 
task using a gradient echo-planar imaging sequence. The repetition time was two 
seconds and the echo time was 30ms. The flip angle was 75°. Thirty nine slices were 
acquired sequentially descending from top to bottom with a slice thickness of 3.5mm 




2.5.1 Questionnaires and performance data analysis  
Questionnaires and behavioural data of the tasks were analysed using IBM SPSS 20 
for Windows. All continuous data were quality checked for outliers and non-
normality using the Shapiro-Wilk test. Non-parametric testing was used for all non-
normally distributed data. The non-parametric Mann-Whitney U test was reported 
when two groups were compared. When three groups were compared, the non-
parametric Kruskal-Wallis one-way analysis of variance was reported, with Mann-
Whitney U tests for post-hoc pairwise comparisons carried out when a significant 
difference was indicated by the Kruskal-Wallis test. For repeated measures, the non-
parametric Friedman’s test was used (akin to a one-way repeated-measures 
ANOVA).  
     Normally distributed variables were assessed with the Analysis of Variance 
(ANOVA) model when three groups were compared, and with independent t-tests for 
two groups or as post hoc comparison when the ANOVA indicated a significant 
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difference between the three groups. A repeated measures ANOVA was conducted 
for within group comparisons (with paired t-test as follow-up when a significant 
difference was indicated by the repeated measures ANOVA). For post-hoc pairwise 
comparisons statistical significance was calculated using Bonferroni correction based 
on the number of pairwise comparisons. Categorical variables were assessed using 
the chi-square test of independence. In order to account for small numbers, Fisher’s 
exact was calculated for the exact chi-square probability and was reported for all 
variables (Field, 2009). The chi-square test of independence was also reported for 
post-hoc pairwise comparisons of categorical variables when a significant group 
difference was indicated. Correlations were examined using bivariate correlation in 
SPSS 20.  
     The significant value was set at p=.05. However, in addition to the primary 
hypotheses, we also formulated exploratory secondary hypothesis for this study, 
concerning whole brain and performance analyses. Due to the high number of 
comparisons we had an increased risk of a Type I error. In order to account for 
multiple comparisons, an overall correction significance value was calculated based 
on the number of pairwise comparisons. Since there were over 50 pairwise 
comparisons, the overall significant value for the exploratory secondary hypothesis 
was set at p=.001. The impact of this overall significance value will be discussed 
separately in Chapter 7, General discussion, 7.5.3 Power and multiple comparison 
correction.      
 
For more detailed information on the analyses see chapter 3 Clinical and 
sociodemographic correlates, chapter 4 Verbal memory, chapter 5 Working memory, 
and chapter 6 Facial emotion processing.  
 
2.5.2 Neuroimaging data analysis 
In the following section, the basic pre-processing and analysis steps of the fMRI 
analysis will be given. More detail can be found in the individual chapters. 
Beforehand, a power calculation for the two primary hypotheses will be presented 
along with a discussion of issues with calculating power for fMRI designs. Image 
pre-processing and whole-brain analysis were carried out using Statistical Parametric 
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Mapping software developed by the Functional Imaging Laboratory, UCL, (SPM8, 
www.fil.ion.ucl.ac.uk/spm/), running in Matlab 7.0.1, on a UNIX platform.   
 
2.5.2.1 Issues with power calculations for fMRI studies 
Standard statistical computations of power of detection are difficult for neuroimaging 
studies as the statistical inference is made from the computation of thousands of 
voxels per participant and following multiple comparison corrections, the parameters 
of which are typically calculated from the distribution of the residuals of the data 
after model fitting. Previous investigations indicated that BOLD related signal 
changes as small as 1% at the individual level are reliably detectable with groups of 
10−12 participants (Brammer et al., 2004). However, up until recently, actual power 
calculations for fMRI designs have been lengthy and complicated and often 
inaccessible to non-statisticians (Mumford, 2012; Mumford & Nichols, 2008). Only 
lately, with the increasing demands for power calculations in neuroimaging studies, a 
power calculation guide has been published in order to make fMRI power 
calculations more accessible to all neuroimaging users (Mumford, 2012). We used 
these guidelines to calculate the power of the current study in detecting differences in 
regions of interest. According to Mumford (Mumford, 2012), if no pilot data or data 
from other research groups are available for a power calculation, the next option is to 
use results from published research. For this study it was possible to utilise previous 
research in bipolar disorder for the facial emotion processing task. For the working 
memory task previous research in schizophrenia was used as no study in patients 
with bipolar disorder assessing working memory with a N-back task fulfilled the 
minimum criteria required for power calculation according to the above mentioned 
guidelines (i.e. had a predefined ROI and reported the mean and the variance) 
(Cremaschi et al., 2013; Mumford, 2012). G*Power was used for the power 
calculation (Faul, Erdfelder, Lang, & Buchner, 2007).  
 
2.5.2.2 Power calculation for the study 
We calculated that an effect size of 0.72 would be needed in order to detect a 
statistical significant effect at an alpha of 0.05, a power of 0.80 and a sample size of 
24 participants for both primary hypotheses of this study (i.e. 1) women at risk of 
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postpartum psychosis will show, in comparison to healthy controls, decreased brain 
activation in the dorsolateral prefrontal cortex during a working memory task; 2) 
women at risk of postpartum psychosis will show, in comparison to healthy controls, 
higher brain activation of the amygdala during a facial emotion processing task). In 
order to compare the required effect size to previous studies, we used data reported 
by Bleich-Cohen and colleagues (2013) for the first primary hypothesis, investigating 
brain activation in an N-back task in patients with schizophrenia compared to healthy 
controls (Bleich-Cohen et al., 2013). In line with our calculation, they found a 
significant difference in their predefined ROI of the dorsolateral prefrontal cortex 
between healthy controls (Mean = 0.45, SD = 0.31) and patients with schizophrenia 
(Mean = 0.24, SD = 0.21) in the two back condition with an effect size of 0.79 (see 
Figure 1 in Bleich-Cohen and colleagues (2013). For the second primary hypothesis 
we used results of Kim and colleagues (2012). They reported a significant difference 
in amygdala activation between patients with bipolar disorder (Mean = 0.03, SD 
0.05) and healthy controls (Mean = 0.004, SD = 0.03) during the fearful faces 
condition in a facial emotion paradigm with an effect size of 0.68, see Figure 3 (P. 
Kim et al., 2012). This suggests that our study is well powered as the required effect 
size is not dissimilar to that detected in previous case-control studies with 
neuropsychiatric patients, although as the first functional imaging study in this group 
we are necessarily limited in knowing the precise expected effect size. We therefore 
took an approach to maximise the at risk group within the constraints of the study 
criteria and the referral rate. 
 
2.5.2.3 Pre-processing 
Data were pre-processed in order to account for variations in timing of acquisition of 
slices and head movement. Data were quality checked by visually inspecting the 
images. 
 
2.5.2.3.1 Slice-time correction 
The data were slice-time corrected (by temporal interpolation, which is the 
estimation of the value of a signal at a time point that was not originally collected 
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using data from nearby time points (Huettel et al., 2004)) to account for inter-slice 
differences in BOLD signal sampling. 
 
2.5.2.3.2 Realignment 
In order to correct for participants’ head movement each image in the time-series is 
realigned to a reference image. A two pass procedure was used whereby the images 
were initially realigned to the first image and then to the mean image (default 
procedure in SPM http://www.fil.ion.ucl.ac.uk/spm/doc/manual/). Six realignment 
parameters were applied in order to control for movement in the x-, y-, and z-axes 
and to control for rotation (pitch, roll and yaw).  
 
2.5.2.3.3 Co-registration and normalisation 
The high resolution gradient echo echo-planar was spatially normalised to a template 
image in order to get better normalisation accuracy due to improved anatomical 
contrast compared to the BOLD time-series images. In order to allow inter-subject 
comparisons, the data were spatially normalised into a standard anatomical space 
(Montreal Neurological Institute, MNI) (i.e. data were transformed so that they have 
the same image size, voxel size and shape as the template (Huettel et al., 2004)). 
 
2.5.2.3.4 Smoothing 
In order to improve statistical testing and maximise the signal-to-noise ratio and 
allow for inherent functional and gyral variability across participants, the resulting 
normalised volume time-series were spatially smoothed using a Gaussian kernel of 
8mm full-width at half-maximum. A Gaussian spatial filter spreads the intensity at 
each voxel in the image over nearby voxels. Combining data from many subjects 
distributes activation across a range of voxels; using a filter that matches the 
expected spatial correlation of the data can increase the signal-to-noise ratio. It also 
implicitly reduces the effective number of multiple comparisons, as due to spatial 
correlation there may be many fewer maxima that exhibit significant activation 




2.5.2.4 First-level analysis 
Data were analysed within the framework of the general linear model. A single-
subject (first-level) model was created for each session for each participant, 
including the following regressors of interest: 1) N-back task: correct responses to 
the control, and the 1-, 2-, and 3-back conditions as well as nuisance regressors 
(movement); 2) Ekman faces task: correct trials to neutral and fearful faces (with 
50% and 100% intensity) as well as movement regressors.  
 
2.5.2.5 Second-level analysis 
Weighted linear contrasts were used to create maps of activation for each session, 
which were used in a group (second-level) analysis. Statistical significance was 
defined following voxel wise correction across the whole brain for multiple 
comparisons on the basis of family wise error FWE (p < .05). Brodmann areas (BAs) 
and brain regions were defined using the templates from MRIcron 
(www.cabiatl.com/mricro/mricron). For the specific contrasts see chapter 5 on 
working memory and chapter 6 on facial emotion processing.  
 
2.5.3 Potential confounders and sources of variability 
As in most studies conducted in psychiatric patient populations, there are potential 
confounders and sources of variability, which may affect the results and therefore 
need to be considered in order to be able to interpret the results correctly. The 
following general and more specific confounders for this particular study will be 
discussed in chapter 7, General discussion: 
1) Medications 
2) Symptoms 
3) History of alcohol and substance abuse 
4) Hormones and menstrual cycle effects 




2.6 Procedure  
2.6.1 Visit 1 
Following the initial screening procedure over the phone a first study visit was 
arranged for as soon as possible after delivery. The first visit lasted approximately 
two hours and took place either at participants’ homes, at the Centre for 
Neuroimaging Sciences, Institute of Psychiatry, or, if the participant was an inpatient 
at a Mother and Baby Unit, at the hospital. The complete study procedure was 
explained to participants and they had the opportunity to read a leaflet and an 
information sheet and to ask detailed questions prior to providing informed consent 
(see Appendix D). Participants received two separate information sheets depending 
on whether they were in the healthy control (Information Sheet I) or “at risk" group 
(Information Sheet II). Participants were asked about their demographic background, 
medication, medical and obstetric history, smoking history, tea, coffee, and alcohol 
consumption, and information on breastfeeding was also collected. Subsequently, the 
following assessments were carried out: SCID-I CV, Intrusive Life Events Scale, 
Brief Life Events Scale, Childhood Experience of Care and Abuse Questionnaire, 
Family Interview for Genetic Studies, and the Wechsler Test of Adult Reading. At 
the end of the first visit an appointment for the MRI scan was arranged.  
 
2.6.2 Visit 2 
The second visit was arranged as soon as possible after the first visit (i.e. within four 
months) except for in the cases of seven controls who were seen at specific intervals 
after delivery (ranging from five to seven months) in order to match the postpartum 
period “weeks after delivery” to the “at risk” group. In these seven cases a short 
additional confirmation was carried out to ensure that no change had taken place 
concerning the women’s mental state since the first visit. For the second visit, 
participants were invited to the Centre for Neuroimaging Science at the Institute of 
Psychiatry. Women could bring their newborn and a family member/acquaintance or, 
if requested, a carer was provided to look after the newborn. Prior to scanning the 
following clinical questionnaires were completed: Positive and Negative Syndrome 
Scale, Hamilton Depression Rating Scale, Young Mania Rating Scale, Beck 
Depression Inventory, State-Trait Anxiety Inventory, Perceived Stress Scale, Athens 
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Insomnia Scale, Global assessment of Functioning, and Clinical Global Impressions. 
Following this, women received instructions and training on the functional imaging 
tasks and were familiarised with the scanner environment using a “mock” scanner. 
Before the scanning session started, participants completed the encoding part of the 
verbal memory task. Scanning lasted one and a half hours, after which women 
completed the retrieval part of the verbal memory task and were discharged. In total, 
the visit lasted approximately four and a half hours. Figures 2.11 and 2.12 provide an 





Figure 2.11 Overview of all study assessments 
 
Figure 2.11 shows an overview of all study assessments. Assessments marked by an asterisk (*) are not included in this thesis. SCID-I=Structured Clinical Interview for 
DSM-IV Axis I Disorders; BLE=Brief Life Events; ILE=Intrusive life events; CECA.Q=Childhood Experience of Care and Abuse Questionnaire; FIGS=Family Interview for 
Genetic Studies (FIGS); WTAR=Wechsler Test of Adult Reading; TMT=Trail Making Test (Army Individual Test Battery, 1944; Frangou, Hadjulis, & Vourdas, 2008; 
Reitan & Wolfson, 1985). Verbal Fluency (Lezak, 1995; E. M. Weiss et al., 2004); CGI=Clinical Global; GAF=Global assessment of Functioning; HAM-D=Hamilton 
Depression Rating Scale; YMRS=Young Mania Rating Scale; PANSS=Positive and Negative Syndrome Scale; BDI=Beck Depression Inventory; PSS=Perceived Stress 
Scale; STAI=State-Trait Anxiety Inventory; and AIS=Athens Insomnia Scale. Blood samples were taken for hormonal assessment. Saliva samples were taken in order to 
assess cortisol levels. 
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Figure 2.12 The protocol on the MRI scanning day 
 
Figure 2.12 shows the protocol on the MRI scanning day. Assessments marked by an asterisk (*) are not included in this thesis. H=hours. DTI=Diffusion Tensor Imaging, an 
established imaging method for the assessing microstructure and architecture of the brain (including aspects of neuronal fiber coherence, axonal density etc.) based on the 
measure of tissue water diffusion. SPGR=coronal spoiled echo gradient sequence, an imaging sequence used in order to obtain structural images of the brain. 
cASL=continuous Arterial Spin Labelling, a perfusion imaging technique that measures blood flow by labelling spins with excitation pulses (Huettel et al., 2004). And 
mcDESPOT, a novel method that provides a voxel-by-voxel estimate of myelin content throughout the brain (S. C. Deoni, Rutt, Arun, Pierpaoli, & Jones, 2008).  
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2.7 Hypotheses and tasks 
Primary hypotheses: 
1. Women at risk of postpartum psychosis will show, in comparison to healthy 
controls, decreased brain activation in the dorsolateral prefrontal cortex during a 
working memory task. For this the N-back task will be used (chapter 5). 
2.  Women at risk of postpartum psychosis will show, in comparison to healthy 
controls, higher brain activation of the amygdala during a facial emotion processing 
task. In order to test this hypothesis, the Ekman faces task will be employed (chapter 
6).  
  
In addition, I will test a set of exploratory, secondary hypotheses: 
1. Women at risk of postpartum psychosis will show, in comparison to healthy 
controls, differential brain activation during a working memory and facial emotion 
processing task as assessed with whole brain analysis. For this the N-back task 
(chapter 5) and the Ekman faces task will be employed (chapter 6).  
2. Women at risk of postpartum psychosis will show, in comparison to healthy 
controls, impaired working memory performance. For this the N-back task will be 
used (chapter 5). 
3. Women at risk of postpartum psychosis will show, in comparison to healthy 
controls, impaired verbal memory performance. In order to test this hypothesis, two 
verbal memory tasks will be used. A standardised verbal memory test (i.e. the logical 
memory I and II of the Wechsler Memory Scale-III) and the remember-know 
paradigm (chapter 4).  
4. Impairments in verbal and working memory and differences in brain activation in 
working memory as well as in facial emotion processing will be more pronounced in 
women who had developed postpartum psychosis episodes, compared to women who 




2.8 Personal contribution 
Together with my supervisors, I was responsible for the writing and set up of the 
study protocol (i.e. developing a standardised clinical, cognitive and imaging core 
assessment package for study participants) and the application for ethical and R&D 
approval, as well as for the contact with the perinatal psychiatry and obstetric 
services at each involved site and the collaborations with the Mental Health Research 
Network (MHRN). During the first year of my PhD I was trained in clinical 
interviews and scales and psychometric testing. I completed a phlebotomy course at 
the South London and Maudsley NHS Foundation Trust. Together with other 
members of the team, I attended the perinatal liaisons meetings at King’s College 
Hospital, St Thomas Hospital, and Croydon University Hospital during which new 
referrals were discussed, and I visited the Mother and Baby Units on a regular basis 
to identify potential participants.  
     I was responsible for the organisation and management of the study and recruited 
and conducted both study visits with all participants. Furthermore, under the 
supervision of Dr Mehta, I developed the verbal memory task, including the 
development of the word lists and the design. I was also responsible for data analysis 
and the write up. In addition, part of my role was the supervision of two placement 
BSc students and two medical doctors during their speciality training. I successfully 
applied under the supervision of Drs Dazzan and Mehta and Prof Williams for two 
grants centred on the hypotheses of the study: one was from the Psychiatry Research 
Trust (£46,000) as a young investigator and one was from the Central University 
Fund of the University of London (£2,110).  
 
2.9 Original research data 
For the frequency distributions of the performance and activation data of verbal 
memory, working memory, and facial emotion processing please see Appendix F. 
For information about medications please see Appendix B. For further questions 
concerning the original research data or about other matters related to the study 
please contact the principal investigator Dr Paola Dazzan, Institute of Psychiatry, 




3. Chapter: Clinical and sociodemographic 
correlates 
In this chapter an overview of the sociodemographic information and obstetric data 
that have been discussed in the postpartum psychosis literature will be presented. 
Then, results on the psychiatric diagnoses, sociodemographic information, medical 
and obstetric history, substance abuse, and the clinical scales that have been used in 




As discussed in the main introduction of this thesis, certain clinical and 
sociodemographic correlates have been associated with a higher risk of developing 
postpartum psychosis. In the following section, sociodemographic information as 
well as obstetric data, which may be considered as stressful life events and long-term 
stressors, will be discussed. 
 
3.1.1 Sociodemographic information 
Postpartum psychosis affects people from all social and occupational backgrounds 
(M. R. Oates, 2009). However, certain disadvantageous social factors in particular 
have been linked to the development of postpartum psychosis. Some studies have 
found that being unmarried (i.e. being single) puts women at an increased risk of 
developing postpartum psychosis (Cheetham et al., 1981; Kendell et al., 1987; 
Kendell, Rennie, et al., 1981; Paffenbarger, 1961; Paffenbarger & McCabe, 1966). 
Not having a partner and therefore potentially lacking social support may overwhelm 
and subsequently increase the stress experienced by a single mother. Indeed, it has 
been found that problems in the social support of women, such as poor partner 
relationship, emotional problems during the pregnancy, or not living with the baby’s 
father, were also associated with postpartum psychosis (Bilszta et al., 2010; Marks et 
al., 1992; Nager et al., 2005, 2006). There is no evidence to date that women who 
develop postpartum psychosis have had a particularly difficult childhood (Bratfos & 
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Haug, 1966; Valdimarsdóttir et al., 2009), although higher parental disapproval has 
been found in women who experienced this disorder (Cheetham et al., 1981).  
     Women with a poor socioeconomic background and who are living in a deprived 
area (also those living in rural areas) are at a higher risk of developing postpartum 
psychosis (Kirpinar et al., 1999; Nager et al., 2006). This may be because of 
exposure to stressors such as a higher likelihood of witnessing crime and violence 
and also through having less social support (Nager et al., 2006). Being an immigrant 
is also associated with a higher risk of developing postpartum psychosis (Kendell, 
Wainwright, Hailey, & Shannon, 1976; Paffenbarger, 1961), potentially because of 
social stressors such as inadequate housing and cultural isolation. A lower level of 
education, which again may be linked to having a poorer socioeconomic background 
or living in a poorer area, also puts women at a higher risk of developing postpartum 
psychosis and further non-postpartum relapses (Kirpinar et al., 1999; Nager et al., 
2012). Taken together, despite disagreement in the literature, certain 
sociodemographic factors have been found to increase the risk of postpartum 
psychosis for some women. A stronger association, however, has been found with 
certain obstetric risk factors (Sit et al., 2006).  
 
3.1.2 Obstetric data  
Certain obstetric factors have been reported consistently in the literature as putting 
women at a higher risk of postpartum psychosis. One factor is that women who are 
having their first child are at a higher risk of developing postpartum psychosis. 
Percentages of primiparity found among women with postpartum psychosis are high 
(typically more than 60%) (P. Agrawal et al., 1990; V. Bergink et al., 2011; 
Blackmore et al., 2006; Cheetham et al., 1981; Kendell et al., 1987; Kendell, Rennie, 
et al., 1981; Kirpinar et al., 1999; Kisa et al., 2007; Meltzer & Kumar, 1985; 
Paffenbarger, 1961; Paffenbarger & McCabe, 1966; Protheroe, 1969; Schöpf et al., 
1984; Videbech & Gouliaev, 1995). The idea that this high percentage is accounted 
for by the fact that women who suffered from postpartum psychosis may not have 
another child after an episode of this severe illness has been contradicted (Bratfos & 
Haug, 1966; Paffenbarger, 1961). No differences in the number of subsequent 
children has been found between women with postpartum psychosis and other 
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women (Bratfos & Haug, 1966; Paffenbarger, 1961). Although the precise 
mechanism is not clear, it seems likely that having a first child imposes a greater 
social stressor for women and potentially triggers or contributes to the development 
of an episode of postpartum psychosis (Blackmore et al., 2006).   
       Another common finding is that a caesarean section is linked to an increased risk 
of developing postpartum psychosis (Kendell et al., 1987; Kendell, Rennie, et al., 
1981; Nager, Sundquist, Ramírez-León, & Johansson, 2008; Robertson Blackmore et 
al., 2006). There is support for the idea that a caesarean section contributes to the 
development of postpartum psychosis due to being a stressful life event. It was 
reported that only emergency caesarean sections, indicating problems with the 
delivery, were associated with the development of postpartum psychosis when 
compared to planned caesarean sections (Nager et al., 2008).       
     Other complications during pregnancy or delivery, such as pregnancies that do not 
result in a live birth, have not been typically connected to a higher risk of postpartum 
psychosis, although this again has been disputed by some studies (V. Bergink et al., 
2011; Blackmore et al., 2006; Kendell et al., 1987; Kendell, Rennie, et al., 1981; 
Kendell et al., 1976; Paffenbarger, 1961; Rehman, St Clair, & Platz, 1990; 
Valdimarsdóttir et al., 2009; Videbech & Gouliaev, 1995). The development of 
postpartum psychosis has been associated with a lower birth weight of the babies in 
some studies (Brockington, 1996; Paffenbarger, 1961; Paffenbarger & McCabe, 
1966), although another study observed a higher birth weight (Valdimarsdóttir et al., 
2009). Additionally, a shorter gestation length and preterm delivery have been found 
in women with postpartum psychosis (Nager et al., 2008; Paffenbarger, 1961; 
Paffenbarger & McCabe, 1966; Videbech & Gouliaev, 1995). Some studies found 
that a higher maternal age increased the risk of developing postpartum psychosis 
(Nager et al., 2005; Valdimarsdóttir et al., 2009). Incidentally, a higher maternal age 
may also be related to experiencing more complications related to pregnancy and 
delivery (Luke & Brown, 2007). 
     In summary, certain sociodemographic and obstetric factors are associated with 
postpartum psychosis. The aim of this chapter is to explore the sociodemographic 
background information, medical and obstetric history, and the history of stressful 
life events and clinical measures in our sample in order to present a detailed 
description of the study population and a tentative comparison to previous 
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epidemiological studies. Furthermore, the results discussed in this chapter will be 
used to assess the influence of certain clinical measures as potential confounders on 
cognitive, emotional, and neuroimaging processes in the following chapters.   
 
3.2 Methods 
The methods are described in chapter 2. For the combined analyses participants were 
split into “at risk” (N=25) and healthy control (N=21) groups as defined in chapter 2. 
For subsequent analyses, the “at risk” group was split into two sub groups; see 
section 3.3 where the results are presented.   
 
3.3 Results  
In the following section, psychiatric diagnoses, sociodemographic information, 
medical and obstetric history, nicotine, caffeine, cannabis, alcohol and other drugs of 
abuse consumption and clinical scales will be reported.  
 
3.3.1 Psychiatric diagnoses and clinical outcome 
The complete “at risk” group included 25 women who had either a previous 
diagnosis of bipolar disorder (N=14), schizoaffective disorder (bipolar type) (N=2), 
postpartum psychotic episodes only (N=8), a family history of postpartum psychosis 
(N=1) and healthy controls (N=21) according to the SCID. In order to confirm the 
diagnoses, clinical notes were also reviewed. No woman in the healthy control group 
had a current psychiatric diagnosis. For an overview of diagnoses see Table 3.1.  
 
 
Table 3.1 Psychiatric diagnoses in the “at risk” group 
N=14 Bipolar disorder 
N=2  Schizoaffective disorder 
N=8 Postpartum psychosis 






As described in the section on the inclusion criteria in the methods chapter, women 
were identified when either pregnant or within the first year after delivery. However, 
all assessments took place after delivery, and in the case of women who had a 
postpartum episode after this (i.e. the most recent) delivery, assessments took place 
when the woman was well enough to be approached, as indicated by the responsible 
clinician. Assessments took place in a range of 3-43 weeks after the most recent 
delivery. 
     For further analyses, the “at risk” group was split into two sub groups (sub group 
analysis). The “NPE” group consisted of 12 women who had non-postpartum 
episodes only (10 diagnosed with bipolar disorder and two with schizoaffective) and 
were “at risk” but had never developed postpartum psychosis. No woman in this 
group had developed postpartum psychosis following this pregnancy, or developed 
any other form of mental or physical illness after this pregnancy. The woman with a 
family history of postpartum psychosis was excluded from further analyses as her 
diagnosis was not suitable for the sub group comparison.  
     The “PE” group consisted of 12 women who had experienced at least one 
postpartum psychotic episode in their life, either with a previous pregnancy or with 
this pregnancy. Of this group, four women had experienced postpartum and non-
postpartum episodes (all four had a history of bipolar disorder) and eight women had 
suffered postpartum episodes only. Out of the 12 women in this PE group, nine 
women had had postpartum psychosis following this delivery and three women have 
had postpartum psychosis with a previous delivery, but did not develop an episode 
after this pregnancy. Of the nine women who had developed postpartum psychosis 
following this delivery, five were diagnosed with a mood episode (two with 
depression with psychotic features and three with mania with psychotic features) and 
four with a brief psychotic episode. All women were diagnosed with postpartum 
psychosis according to the DSM-IV and this was cross-checked with the responsible 









Table 3.2 Diagnoses of the women according to sub groups 
N =12 Diagnoses of women with NPE  
N=10 Bipolar disorder 
N=2 Schizoaffective disorder 
N=12 Diagnoses of women with PE 
N=4 Bipolar disorder and postpartum psychosis 
N=8 Postpartum psychosis 
Table 3.2 NPE=Non-postpartum episodes, PE=Postpartum episodes 
 
3.3.2 Combined group analysis (CGA) 
In the following section the “at risk” group as a whole will be compared to healthy 
controls.  
 
3.3.2.1 Comorbidity (CGA) 
Two women in the “at risk” group were also diagnosed with current anxiety disorder 
and two had a past history of anxiety disorder. One woman had a life-time diagnosis 
of anxiety and somatoform disorder, one a past history of an eating disorder 
(bulimia) and the woman with the family history of postpartum psychosis had 
suffered a depressive episode in the past. Of the healthy controls, two had a past 
diagnosis of an eating disorder and one had suffered a depressive episode in the past. 
However, none of the healthy controls had ever received prescribed medication for 
any of these conditions.  
 
3.3.2.2 Sociodemographic Information (CGA) 
Please refer to Table 3.3 and Table 3.4 for all relevant statistics in this section. 
Women did not significantly differ in age (age range 22–41 years), although there 
was a trend towards the healthy control group being older. There were no significant 
group differences between women “at risk” and healthy controls in terms of place of 
birth and childhood (until age 17), first language, or ethnicity. In both groups, 
approximately two-thirds of the women were born or spent the majority of their 
childhood in the United Kingdom and approximately 80% of the women spoke 
English as their first language.  
     There were no significant differences in marital status or partnership longevity 
between groups. Women did not significantly differ in their level of qualification or 
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employment status. There were also no differences in handedness between women. 
Groups did not differ regarding women being in a relationship with the biological 
father of the baby. There was a significant difference in the paternal ethnicity 
between groups, with more Caucasian partners in the healthy control group 
compared to the “at risk” group. One father’s ethnicity was unknown. For an 
overview of all ethnicities included in the study see Table 3.5. Partners in both 
groups had a high employment rate.   
 
Table 3.3 Age and partnership longevity in years (CGA) 
Groups “at risk” M (SD) HC M (SD) Statistics
Age in years (N=46) 32.24 (4.68) 35 (4.53) z=-1.93, p=.053 
Partnership longevity in years (N=43)  7.05 (5.01) 8.05(4.19) z=-.87, p=.38 
Table 3.3 “at risk”=“at risk” group. HC=healthy control group. M=mean. SD=standard deviation. 
 
 
Table 3.4 Sociodemographic information (CGA) 
Category Subcategory “at risk” N (%) HC N (%) Statistics (df, N) 
Place of birth and 
childhood 
Either in UK 16 (64) 14 (67) χ2 (3,46)=.28, 
p=.96, pexact=1 Both outside UK 9 (36) 7 (33) 
First language English 20 (80) 17 (81) χ
2(1,46)<.01, 
p=.94, pexact=1 Other 5 (20) 4 (19) 
Ethnicity of mother Caucasian 13 (52) 16 (76) χ
2(1,46)=2.87, 
p=.09, pexact=.13 Other 12 (48) 5 (24) 
Marital status 
Married/cohabit. 19 (75) 18 (86) χ2(3,46)=2.71, 
p=.44, pexact=.51 
Single partner 3 (12) 3 (14) 
Single no partner 3 (12) 0 
Qualifications of 
mother 
Degree or diploma 17 (68) 18 (86) χ2(1,46)=1.97, 
p=.16, pexact =.19 Other 11 (44) 3 (14) 
Employment status 
of mother 
Employed 15 (60) 16 (76) χ2(1,46)=1.36, 
p=.24, pexact =.35 Other 10 (40) 5 (24) 
Handedness  Right 24 (96) 18 (86) χ
2(1,46)=1.52, 
p=.22, pexact=.32 Left 1 (4) 3 (14) 
Current partner 
biological father 
Yes 21 (84) 21 (100) χ2(1,46)=3.68, 
p=.06 pexact=.11 No 4 916) 0 
Ethnicity of father Caucasian 14 (58) 19 (91) χ
2(1,45)=5.92, 
p=.02, pexact=.02 Other 10 (42) 2 (9) 
Employment of 
father 
Employed 19 (86) 20 (95) χ2(1,43)=1.00, 
p=.32, pexact=.61 Other 3 (14) 1 (5) 





Table 3.5 Ethnicity (CGA)      
 White Asian / Asian British Black Chinese Other Total 
British Irish Other Pakistani Other Caribbean African Other 
Maternal             
“at risk” group 
N (% of group) 6 (24) 1 (4) 6 (24) 2 (8) 1 (4) 2 (8) 3 (12) 1 (4) 1 (4) 3 (12) 25 (100) 
healthy controls 
N (%  of group) 12 (57) 0 4 (19) 0 0 2 (10) 0 0 1 (5) 2 (10) 21 (100) 
Total 
N (%  of  total) 18 (39) 1 (2) 10 (22) 2 (4) 1 (2) 4 (9) 3(7) 1 (2) 2 (4) 5 (11) 46 (100) 
 
Paternal            
“at risk”  group 
N (%  of group) 6 (25) 2 (8) 6 (25) 1 (4) 1 (4) 4 (16) 1 (4) 1 (4) 1 (4) 1 (4) 24 (100) 
healthy controls 
N (%  of group) 15 (71) 0 4 (19) 0 0 1 (5) 1 (5) 0 0 0 21 (100) 
Total 




3.3.2.3 Medication (CGA) 
As defined in the inclusion criteria, none of the healthy controls took any prescribed 
medication. Eighteen women in the “at risk” group took prescribed medication at the 
time of the MRI scan. Among these, five had started treatment before pregnancy and 
10 women after delivery. For three women the exposure in days was unknown. Of 
the “at risk” women taking antipsychotic medication (N=14), eight women were 
taking olanzapine, four were taking quetiapine, one was taking risperidone and one 
was taking haloperidol. Three women were taking antidepressants and one woman 
was taking benzodiazepines. For 12 women we were able to calculate the mean dose 
in chlorpromazine equivalents, which was 304mg per day (SD=252) based on Woods 
(2003). For 15 women we calculated the mean number of days of exposure, which 
was 246 days (SD=265). Two women were additionally taking mood stabilisers (one 
lithium valproate and one valproate semisodium). For an overview see Table 1 in 
Appendix B. There was no significant group difference between the “at risk” group 
and healthy controls in taking over-the-counter medication (e.g. multivitamins, fish 
oil, nicotine gum, contraceptive pill or paracetamol) at the time of the MRI scan 
(χ2(1,46)=.64, p=.43, pexact=.55). In the “at risk” group 36% and in the healthy 
control group 48% were taking over-the-counter medication. 
 
3.3.2.4 Medical and obstetric history (CGA) 
Please refer to Table 3.6 and Table 3.7 for all relevant statistics in this section. 
Women were matched for the number of weeks after delivery. There was a trend for 
women at risk of postpartum psychosis to experience more problems during 
pregnancy/delivery (such as infection from a caesarean section or postpartum 
haemorrhage) and breastfeeding (e.g. not latching on) than healthy controls. There 
was a significant difference between groups in term of breastfeeding as women in the 
“at risk” group used formula more often than healthy controls. There was no 
significant difference in maternal parity between the “at risk” group and the healthy 
controls. There was also no difference in the number of previous pregnancies that did 
not result in a live birth, due to either termination of pregnancy or miscarriage. Both 
groups had a similar first onset of menarche. Nineteen women had already had their 
first menstrual cycle after their recent delivery by the time of the MRI scan and there 
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was no significant difference between groups. There was a strong tendency for more 
women in the “at risk” group to be classified as obese compared to healthy controls; 
this was according to the Body Mass Index classification (World Health 
Organisation).  
 
Table 3.6 Weeks after delivery and onset of menarche (CGA) 
Groups “at risk” M (SD) HC M (SD) Statistics
Weeks after delivery (N=46) 16.76 (11.05) 14.43 (10.59) z=-1.08, p=.27 
Onset of menarche (N=46) 12.48 1.72 12.72 1.95 z=-1.01, p=.32 
Table 3.6 “at risk”=“at risk” group. HC=healthy control group. M=mean. SD=standard deviation. 
 
 
Table 3.7 Medical and obstetric history (CGA) 
Category Subcategory “at risk” N (%) HC N (%) Statistics (df, N) 
Problems during 
pregnancy/delivery 
Yes 10 (40) 3 (14) χ2(1,46)=3.72, 
p=.05, pexact=.09 No 15 (60) 18 (86) 
Problems during 
breastfeeding 
Yes 9 (36) 3 (14) χ2(1,46)=2.79, 
p=.10, pexact=.18 No 16 (64) 18 (86) 
Feeding 
Breast only 7 (28) 11 (52) χ2(2,46)=8.03, 
p=.02, pexact=.02 
Formula 12 (48) 2 (10) 
Mixed 6 (24) 8 (38) 
Parity 
1 child 14 (56) 14 (67) χ2(2,46)=.99, 
p=.61, pexact=.69 
2 children 8 (32) 4 (19) 
=>3 children 3 (12) 3 (14) 
Termination / 
miscarriage 
Yes 15 (62) 11 (52) χ2(1,45)=.47, 
p=.49, pexact=.56 No 9 (38) 10 (48) 
Menstrual cycle 
after recent delivery 
Yes 11 (44) 8 (38) χ2(1,46)=.16, 
p=.68, pexact=.77 No 14 (56) 13 (62) 
BMI classification 
Normal: 18-25 8 (33) 7 (35) χ2(2,44)=5.99, 
p=.05, pexact=.05 
Overweight: 25-30 8 (33) 12 (60) 
Obese:>30 8 (33) 1 (5) 




3.3.2.5 Nicotine, caffeine, cannabis, alcohol and other drugs of abuse (CGA) 
Please refer to Table 3.8 and Table 3.9 for all relevant statistics for this section. 
There were no significant differences between the “at risk” group and healthy 
controls in smoking history before pregnancy or current smoking (including during 
pregnancy and breastfeeding) or in coffee, tea or alcohol consumption at the time of 
the MRI scan. 
     There were also no significant differences between the two groups regarding the 
previous use of cannabis (i.e. whether women had ever tried cannabis and the mean 
duration of smoking cannabis). However, there was a significant difference between 
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the two groups in terms of frequency of cannabis use during the time of their highest 
use in the past, with the “at risk” women smoking cannabis more frequently than 
healthy controls. There was also a strong trend towards a group difference 
concerning the amount of cannabis used during their time of highest use with the “at 
risk” group using a higher amount than healthy controls. There was no significant 
difference between groups concerning the types of cannabis (hash, herbal cannabis or 
skunk) used (χ2(3,32)=2.69, p=.44, pexact=.53). Only two women in the “at risk” 
group were still smoking cannabis at the time of the study.   
     Groups differed significantly concerning past alcohol and substance abuse. None 
of the healthy controls had a history of alcohol or substance abuse, but 32% of the “at 
risk” group did. Three women in the “at risk” group suffered from past alcohol abuse 
disorder, three women from past alcohol and substance abuse disorder and two 
women had a history of substance abuse only.  
 
Table 3.8 Nicotine, caffeine, cannabis, alcohol and other drugs of abuse (CGA) 
Category Subcategory “at risk” N (%) HC N (%) Statistics (df, N) 
Smoking history 
before pregnancy 
Yes 15 (60) 14 (67) χ2(1,46)=.22, 
p=.64, pexact=.76 No 10 (40) 7 (33) 
Current smoking Yes 6 (24) 1 (5) χ
2(1,46)=3.27, p 
=.07, pexact=.11 No 19 (76) 20 (5) 
Current alcohol use 
Never 12 (48) 5 (24) 
χ2(3,46)=4.64, 
p=.20, pexact=.21 
Monthly or less 5 (20) 3 (14) 
2-4 times per 
month 6 (24) 8 (38) 
2-3 times per 
week 2 (8) 5 (23) 
Cannabis use during 
life-time 
Yes  16 (67) 16 (76) χ2(1,45)=.49, p 




On a daily basis 9 (56) 3 (19) χ2(4,32)=10.81, 
p=.03, pexact=.02 Less than daily 7 (44) 13 (81) 
Amount of cannabis 
used/highest use 
1 joint 6 (37) 12 (75) χ2(2,32)=5.71, 
p=.06, pexact=.06 2 or more joints 10 (63) 4 (25) 
Past alcohol or 
substance abuse 
Yes 8 (32) 0 χ2(3,46)=8.14, 
p<.04, pexact=.02 No 17 (68) 21 (100) 
Table 3.8 “at risk”=“at risk” group. HC=healthy control group. %=percentage of group. Df=degrees 
of freedom. 
 
Table 3.9 Past smoking, cannabis, coffee and tea consumption (CGA) 
Groups “at risk” M (SD) HC M (SD) Statistics
Number of cigarettes per day during 
highest use (N=29) 10.35 (6.31) 6.17 (6.98) z=-1.63, p=.11 
Past duration smoking cannabis (years) 
(N=28) 8.46 (5.77) 6.53 (5.23) z=-1.04, p=.30 
Coffee (cups per week) (N=46) 5.04 (8.21) 3.48 (4.08) z=-.89, p=.37 
Tea (cups per week) (N=46) 10.68 (10.89) 12.57 (13.76) z=-.22, p=.82 
Table 3.9 “at risk”=“at risk” group. HC=healthy control group. M=mean. SD=standard deviation. 
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3.3.2.6  Clinical assessments   (CGA) 
3.3.2.6.1 Life event scales and family history (CGA) 
Please refer to Table 3.10 for all relevant statistics in this section. More women in the 
“at risk” group had experienced stressful life events (e.g. financial loss or being a 
victim of violence) during the previous six months compared to healthy controls. 
Similarly, more women in the “at risk” group had experienced intrusive life events 
(e.g. abuse or being a victim of violence) during their life-time compared to the 
healthy control group. 
     There was no significant difference between the “at risk” and the healthy control 
group concerning the severity of family arrangements (i.e. having had more than 
three family arrangements up until the age of 17 years) according the CECA- Q. 
However, there was a significant difference between the two groups concerning 
sexual and physical abuse. Women “at risk” reported more sexual and physical abuse 
than healthy controls. There was also a significant difference between the “at risk” 
group and healthy controls concerning the number of first-degree relatives that were 
diagnosed with a psychiatric illness. More women in the “at risk” group had a first-
degree relative affected by a psychiatric illness than women in the healthy control 
group (also see Table 3 in Appendix C). 
 
Table 3.10 Life event scales and family history (CGA) 
Category Subcategory “at risk” N (%) HC N (%) Statistics (df, N) 
Stressful life events/ 
past 6 months 
Yes 13 (52) 4 (19) χ2(1,46)=5.32, 
p=.02, pexact=.03 No 12 (48) 17 (81) 
Intrusive life events  
/life-time 
Yes 19 (76) 9 (43) 2(1,46)=5.26, 
p=.02, pexact=.03 No 6 (24) 12 (57) 
Family 
arrangements 
Less than 3 17 (68) 17 (81) χ2(1,46)=.99, 
p=.32, pexact=.50 More than 3 8 (32) 4 (19) 
Physical and sexual 
abuse experiences 
No experiences 14 (58) 20 (95) 
χ2(3,45)=8.47, 
p=.04, pexact=.02 
Physical abuse 6 (25) 1 (5) 
Sexual abuse 1 (4) 0 




Yes 15 (63) 3 (15) (χ2(1,44)=10.18, 
p<.01, pexact<.01) No 9 (37) 17 (85) 







3.3.2.6.2 Assessment of functioning (CGA) 
Please refer to Table 3.11 for all relevant statistics in this section. The GAF scores of 
the “at risk” group were significantly lower than those of the healthy controls both at 
the time of the MRI scan and during the previous year. Women were also evaluated 
at the time of the MRI scan according to the CGI. For an overview see Table 3.12.  
 
Table 3.11 Assessment of functioning (CGA) 
Groups “at risk” M (SD) HC M (SD) Statistics
GAF scores (current) (N=46) 76.64 (17.06) 99.57 (1.96) z=-5.57, p<.01 
Highest GAF score during previous 
year (N=46) 88.52 (16.40) 99.76 (1.09) z=-3.51, p<.01 
Table 3.11 “At risk”=“at risk” group. HC=healthy control group. M=mean. SD=standard deviation. 
 
 
3.3.2.6.3 Mood and symptom scales (CGA) 
Please refer to Table 3.13 for all relevant statistics in this section. In comparison to 
healthy controls, the “at risk” group scored significantly higher on all mood and 
symptom scales including the Ham-D, BDI, YMRS, and PANSS.  
 
Table 3.13 Mood and symptom scales (CGA) 
Groups “at risk” M (SD) HC M (SD) Statistics
Ham-D 6.56 (3.03) 2.05 (3.0) z=-3.32, p<.01 
BDI 9.28 (8.67) 3.05 (4.07) z=-2.84, p<.01 
YMRS 1.80 (2.11) .52 (.82) z=-2.51, p=.01 
PANSS (positive) 8.44 (2.45) 7.05 (.22) z=-3.05, p<.01 
PANSS (negative) 8.56 (3.54) 7 (0) z=-2.81, p<.01 
PANSS (GPS) 21.32 (5.24) 16.90 (1.95) z=-3.87, p<.01 
PANSS (total) 38.32 (7.29) 30.95 (2.01) z=-4.31, p<.01 
Table 3.13 “at risk”=“at risk” group. HC=healthy control group. M=mean. SD=standard deviation. 
 
Table 3.12 Clinical Global Impression (CGA) 
Groups “At risk” N (%) HC N (%) Total N (%) 
Normal, not at all ill 1 (4) 21 (100) 22 (48) 
Borderline mentally ill 5 (20) NA 5 (11) 
Mildly ill 7 (28) NA 7 (15) 
Moderately ill 11 (44) NA 11 (24) 
Markedly ill 1 (4) NA 1 (2) 
Total 25 (100) 21 (100) 46 (100) 
Table 3.12 “at risk”=“at risk” group. HC=healthy control group. %=percentage of group. 
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3.3.2.6.4 Stress, anxiety and sleep scales (CGA) 
Please refer to Table 3.14 for all relevant statistics in this section. Women in the “at 
risk” group scored higher on all scales assessing state and trait anxiety, perceived 
stress, and sleep. 
 
Table 3.14 Stress, anxiety and sleep scales (CGA) 
Groups “at risk” M (SD) HC M (SD) Statistics
SAI 34.64 (12.39) 26.19 (6.79) z=-2.43, p=.01 
TAI 42.52 (13.32) 30.3 (8.91) z=-3.12, p<.01 
PSS 17.36 (7.46) 8.48 (7.32) t(44)=-4.06, p<.01
AIS 5.60 (4.59) 3.33 (4.71) z=-2.26, p=.02 
Table 3.14 “at risk”=“at risk” group. HC=healthy control group. M=mean. SD=standard deviation. 
 
3.3.2.7 Cognitive assessments 
Women did not differ in their full scale IQ as predicted by the WTAR (women “at 
risk”, Mean (M)=101.75, SD=11.44; healthy controls, M=109.44, SD=13.36 z=-
1.22, p=.22). 
 
3.3.3 Sub group analysis (SGA) 
In the following section women with non-postpartum episodes and postpartum 
episodes are compared to each other and healthy controls.  
 
3.3.3.1 Comorbidity (SGA) 
Two women in the NPE group were diagnosed with a current anxiety disorder; two 
women had a past history of anxiety disorder and one a past history of an eating 
disorder (bulimia). One woman in the PE group had a life-time diagnosis of anxiety 
and somatoform disorder. 
 
3.3.3.2 Number of episodes, age of onset and length of illness (SGA) 
Please refer to Table 3.15 and Table 3.16 for all relevant statistics in this section. 
Length of illness was determined based on the interviews. Women were asked when 
they had experienced their first episode (year and age), when they had seen a 
psychologist or psychiatrist for the first time, and when they had received medication 
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for the first time. This information was cross-checked with the clinical notes for 
validation and if possible with the responsible psychiatrist. Length of illness was 
calculated in years. When we compared the length of illness for women who had 
experienced more than one episode, we did not find any significant difference 
between women in the NPE and PE groups. There was a significant difference in the 
number of mood or psychotic episodes between the NPE and PE groups, as more 
women in the NPE group had a higher number of episodes than in the PE group. 
Women suffering from non-postpartum episodes only also had an earlier onset of 
illness than women with a postpartum onset. 
 
Table 3.15 Age of onset and length of illness (SGA) 
Groups NPE M (SD) PE M (SD)  Statistics
Age of onset in years (N=22) 21.42 (4.75) 27 (6.28) z=-2.54, p=.01 
Length of illness in years (N=18) 9.50 (6.61) 8.88 (7.16) z=-.46, p=.64 
Table 3.15 NPE=group with non-postpartum episodes. PE=group with postpartum episodes. 
M=mean. SD=standard deviation. 
 
Table 3.16 Number of Episodes (SGA) 
Groups NPE N (%) PE N (%) Total N (%) Statistics (df, N) 




2 episodes  2 (17) 4 (33) 6 (25) 
3 episodes 1 (8) 1 (8) 2 (8) 
4 episodes 0 1 (8) 1 (4) 
>5 episodes 9 (75) 2 (17) 11 (46) 
Total 12 (100) 12 (100) 24 (100) 
Table 3.16 NPE=group with non-postpartum episodes. PE=group with postpartum episodes. 
%=percentage of group. Df=degrees of freedom. 
 
3.3.3.3 Sociodemographic Information (SGA)  
Please refer to Table 3.17 and Table 3.18 for all relevant statistics in this section. 
Women did not significantly differ in age. There were also no significant group 
differences between the NPE, PE, and healthy control groups for place of birth, first 
language, or ethnicity. Groups did not differ in handedness. There were no 
significant differences in marital status or partnership longevity between groups. 
There were no significant differences between groups in level of qualifications or 
employment status. However, fewer women in the NPE group were in a romantic 
relationship with the biological father of the baby compared to healthy controls 
(χ2(1,33)=5.78, p=.02, pexact=.04). This was not significant following Bonferroni 
correction of α=.016. 
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There was also a significant difference between the NPE and healthy control groups 
concerning the paternal ethnicity following pairwise comparison with Bonferroni 
correction as more women in the healthy control group were with a Caucasian 
partner (χ2(1,32)=7.80, p<.01 pexact=.01). There was a significant difference between 
groups concerning partners’ employment rates as fewer partners in the NPE group 
were employed compared to both the PE and healthy control groups (χ2(1,21)=4.67, 
p=.03 pexact=.06; χ2(1,30)=4.45, p=.04 pexact=.07, respectively). These pairwise 
comparisons were not significant following Bonferroni correction of α=.016. All 
other pairwise comparisons were p>.05 without Bonferroni correction.      
 
Table 3.17 Age and partnership longevity in years (SGA) 
Groups NPE M (SD) PE M (SD)  HC M (SD) Statistics (df, N)




in years  4.89 (3.62) 8.92 (5.47) 8.05(4.19) 
χ2(2,42)=4.09, 
p=.13 
Table 3.17 NPE=group with non-postpartum episodes. PE=group with postpartum episodes. M=mean.
SD=standard deviation. Df=degrees of freedom. 
 
Table 3.18 Sociodemographic information (SGA)  
Category Subcategory NPE N (%) PE N (%) HC N (%) Statistics (df, N) 
Place of birth and 
childhood 
Either in UK 9 (75) 6 (50) 14 (67) χ2(6,45)=4.88, 
p=.56, pexact =.66 Both outside UK 3(25) 6 (50) 7 (33) 
First language English 11 (92) 8 (67) 17 (81) χ
2(2,45)=2.37, 
p=.31, pexact =.32 Other 1 (8) 4 (33) 4 (19) 
Ethnicity of 
mother 
Caucasian 5 (42)  7 (58) 16 (76) χ2(2,45)=3.98, 
p=.14, pexact=.15 Other 7 (58) 5 (42) 5 (24) 
Marital status 
Married/Cohabit. 7 (58) 11 (92) 18 (86) χ2(6,45)=9.69, 
p=.14, pexact=.28 
Single partner 2 (17) 1 (8) 3 (14) 
Single no partner 3 (25) 0 0 
Qualifications of 
mother 
Degree or diploma 6 (50) 10 (83) 18 (86) χ2(2,45)=5.81, 
p=.06, pexact=.09 Other 6 (50) 2 (17) 3 (14) 
Employment status 
of mother 
Employed 6 (50) 8 (67) 16 (76) χ2(2,45)=2.36, 
p=.31, pexact=.29 Other 6 (50) 4 (33) 5 (24) 
Handedness  Right 12 (100) 11 (92) 18 (86) χ
2(2,45)=1.93, 
p=.38, pexact=.57 Left 0 1 (8) 3 (24) 
Current partner 
biological father 
Yes 9 (75) 11 (92) 21 (100) χ2(2,45)=5.89, 
p=.05 pexact=.04 No 3 (25) 1 (8) 0 
Ethnicity of father Caucasian 5 (46) 8 (67) 19 (91) χ
2(2,44)=7.68, 
p=.02, pexact=.02 Other 6 (54) 4 (33) 2 (9) 
Employment of 
father 
Employed 6 (67) 12 (100) 20 (95) χ2(2,42)=7.73, 
p=.02, pexact=.03 Other 3 (33) 0 1 (5) 
Table 3.18 “NPE=group with non-postpartum episodes. PE=group with postpartum episodes. 




3.3.3.4 Medication (SGA) 
Please refer to Table 3.19 and Table 3.20 for all relevant statistics for this section. 
There was no significant difference between the NPE and PE groups in terms of how 
many women used prescribed medication at the time of the MRI scan. Four women 
in the NPE group had started treatment before pregnancy and one after delivery. One 
woman in the PE group started treatment before delivery and nine after pregnancy. 
For three women the exposure in days was unknown. Of the women in the NPE 
group taking antipsychotic mediation (N=5), two women took olanzapine, two 
quetiapine and one haloperidol. Of the women in the PE group taking antipsychotic 
medication (N=9), six women took olanzapine, two women took quetiapine and one 
woman took risperidone. One woman in the NPE group and one woman in the PE 
group were additionally taking mood stabilisers. For an overview see Table 2 in 
Appendix B. There was a significant difference between the NPE group and the PE 
group in terms of exposure in days, with women in the NPE group taking 
antipsychotic medication longer on average than the PE group. There was no 
significant difference between the NPE and PE groups in terms of mean dose in 
chlorpromazine equivalents at the time of the MRI scan (Woods, 2003). 
 
Table 3.19 Prescribed medication at the time of the MRI scan I (SGA) 
Groups NPE N (%) PE N (%) Statistics (df, N)
Yes 7 (58) 11 (92) χ2(1,24)=3,56, 
p=.06, pexact=.16 No 5 (42) 1 (8) 
Table 3.19 NPE=group with non-postpartum episodes. PE=group with postpartum episodes.
%=percentage of group. Df=degrees of freedom. 
 
Table 3.20 Prescribed medication at the time of the MRI scan II (SGA) 
Groups  NPE M (SD) PE M (SD) Statistics
Exposure in days (N=15) 484 (212) 127 (205) z=-2.45, p=.01 
Mean dose in chlorpromazine 
equivalents (mg per day) (N=12) 342 (225) 285 (276) z=-.43, p=.67 
Table 3.20 NPE=group with non-postpartum episodes. PE=group with postpartum episodes. 
M=mean. SD=standard deviation. 
 
There was no significant group difference between women taking over-the-counter 
medication (e.g. multivitamins, fish oil, nicotine gum, contraceptive pill or 
paracetamol) at the time of the MRI scan (χ2(2,45)=.64, p=.73, pexact=.80). In the 
NPE group 33%, in the PE group 42% and in the healthy control group 48% were 
taking over-the-counter medication.  
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3.3.3.5 Medical and Obstetric History (SGA)    
Please refer to Table 3.21 and Table 3.22 for all relevant statistics for this section. 
There was no significant difference between groups for weeks after delivery. Women 
did not differ concerning problems during pregnancy/delivery or with breastfeeding. 
However, there was a significant difference between groups concerning the current 
feeding of the baby. Fewer women in the PE group were breastfeeding compared to 
healthy controls following Bonferroni correction (χ2(2,33)=9.54, p<.01, pexact=.01). 
All other pairwise comparisons were p>.05 without Bonferroni correction.      
     All three groups had a similar onset of menarche and there were no differences 
between groups in women having had a first menstrual cycle after the recent delivery 
by the time of the MRI scan or in maternal parity. There were also no group 
differences in the number of previous pregnancies that did not result in a live birth, 
due to either a termination of pregnancy or miscarriage. Finally, there was no 
significant difference between groups according the Body Mass Index classification 
(World Health Organisation). 
 
Table 3.21 Weeks after delivery and onset of menarche (SGA) 
Groups NPE M (SD) PE M (SD)  HC M (SD) Statistics (df, N)
Weeks after delivery 13 (6.28) 21 (13.75) 4.43 (10.59) χ
2(2,45)=2.31, 
p=.31 
Onset of menarche 13 (1.54) 12.33 (2.3) 12.48 (1.7) χ
2(2,45)=.98, 
p=.61 
Table 3.21 NPE=group with non-postpartum episodes. PE=group with postpartum episodes. M=mean. 












Table 3.22 Medical and obstetric history (SGA)  
Category Subcategory NPE N (%) PE N (%) HC N (%) Statistics (df, N) 
Problems during 
pregnancy/delivery 
Yes 6 (50) 4 (33) 3 (14) χ2(2,45)=4.89, 
p=.09, pexact=.09 No 6 (50) 8 (67) 18 (86) 
Problems during 
breastfeeding 
Yes 4 (33) 5 (42) 3 (14) χ2(2,45)=3.30, 
p=.19, pexact=.20 No 8 (67) 7 (58) 18 (86) 
Feeding 
Breast only 4 (33) 2 (17) 11 (52) χ2(4,45)=9.72, 
p=.05, pexact=.04 
Formula 5 (42) 7 (58) 2 (10) 
Mixed 3 (25) 3 (25) 8 (38) 
Parity 
1 child 7 (58) 6 (50) 14 (67) χ2(4,45)=1.56, 
p=.82, pexact =.80 
2 children 4 (33) 4 (33) 4 (19) 
=>3 children 1 (8) 2 (25) 3 (14) 
Termination / 
miscarriage 
Yes 7 (58) 7 (6) 11 (52) χ2=(2,44).39, 




Yes 5 (42) 6 (50) 8 (38) χ2(2,45)=.45, 
p=.80, pexact=.92 No 7 (58) 6 (50) 13 (62) 
BMI classification 
Normal: 18-25 5 (42) 3 (27) 7 (35) χ2=(4,43)7.18, 
p=.13, pexact =.10 
Overweight: 25-30 3 (25) 4 (36) 12 (60) 
Obese:>30 4 (33) 4 (36) 1 (5) 
Table 3.22 NPE=group with non-postpartum episodes. PE=group with postpartum episodes. 
%=percentage of group. Df=degrees of freedom. 
 
3.3.3.6 Nicotine, caffeine, cannabis, alcohol and other drugs of abuse (SGA)  
Please refer to Table 3.23 and Table 3.24 for all relevant statistics in this section. 
There was no difference between the NPE, PE and healthy control groups in smoking 
history before pregnancy. However, women differed in the number of cigarettes 
smoked during the period of highest use. Women in the NPE group had smoked on 
average more cigarettes than healthy controls (z=-2.06, p=.04) and the PE group (z=-
2.04, p=.04). However these pairwise comparisons were not significant following 
Bonferroni correction (α=.016). There was no difference between groups in terms of 
current smoking (i.e. including during pregnancy and breastfeeding). There were also 
no significant group differences in coffee, tea or alcohol consumption at the time of 
the MRI scan. 
     There was a significant group difference regarding previous use of cannabis. 
More women in the NPE group had tried cannabis in their life-time compared to the 
PE group (χ2(1,23)=6.14, p=.01, pexact=.03); however, this did not remain significant 
following Bonferroni correction of α=.016. There was no significant difference 
between groups concerning the mean duration of smoking cannabis in years, the 
frequency or amount of cannabis used during the period of highest use, or the type of 
cannabis (hash, herbal cannabis or skunk) used (χ2(6,31)=5.19, p=.52, pexact=.49). 
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Only two women in the NPE group were still smoking cannabis at the time of the 
MRI scan.   
     There was a significant difference between groups concerning past alcohol and 
substance abuse, as none of the healthy controls, but 33% of the women in the NPE 
and PE groups had a history of alcohol or substance abuse (χ2(2,33)=7.96, p=.02, 
pexact=.01; (χ2(3,33)=7.96, p=.05, pexact=.01). This remained significant following 
Bonferroni correction (α=.016). Of the NPE group two women had a history of 
alcohol abuse and two women had a history of alcohol and substance abuse. In the 
PE group one woman had a history of alcohol abuse, two of substance abuse and one 
of alcohol and substance abuse. All other pairwise comparisons were p>.05 without 
Bonferroni correction.      
 
Table 3.23 Nicotine, caffeine, cannabis, alcohol and other drugs of abuse (SGA) 
Category Subcategory NPE N (%) PE N (%) HC N (%) Statistics (df, N) 
Smoking history 
before pregnancy 
Yes 9 (75) 5 (42) 14 (67) χ2(2,45)=3.17, 
p=.21, pexact=.28 No 3 (25) 7 (58) 7 (33) 
Current smoking Yes 3 (25) 2 (17) 1 (5) χ
2(2,45)=2.86, 
p=.24, pexact=.29 No 9 (75) 10 (83) 20 (5) 
Current alcohol 
use 
Never 5 (42) 6 (50) 5 (24) 
χ2(6,45)=7.71, 
p=.26, pexact =.22 
Monthly or less 2 (17) 3 (25) 3 (14) 
2-4 times per 
month 5 (42) 1 (8) 8 (38) 
2-3 times per week 0 2 (17) 5 (23) 
Cannabis use 
during life-time 
Yes  10 (91) 5 (42) 16 (76) χ2(2,44)=7.32, 




On a daily basis 6 (60) 2 (40) 3 (19) χ 2(8,31)=11.94, 




1 joint 4 (40) 2 (40) 12 (75) χ2(4,31)=6.06, 
p=.19, pexact=.16 2 or more joints 6 (60) 3 (60) 4 (25) 
Past alcohol or 
substance abuse 
Yes 4 (33) 4 (33) 0 χ2(6,45)=13.51, 
p=.04, pexact<.01 No 8 (67) 8 (67) 21 (100) 
Table 3.23 NPE=group with non-postpartum episodes. PE=group with postpartum episodes. 









Table 3.24 Past smoking, cannabis, coffee and tea consumption (SGA) 
Groups NPE M (SD) PE M (SD)  HC M (SD) Statistics (df, N)
Number of cigarettes 
per day during 
highest use  
13.37 (6.54) 6 (1.58) 6.17 (6.98) 
χ2(2,28)=6.716, 
p=.04 
Past duration of 
smoking cannabis 
(years) 
8.07 (6.3) 9 (5.61) 6.53 (5.23) 
χ2(2,28)=1.29, 
p=.52 
Coffee (cups per 
week) 5.42 (7.65) 5.08 (9.29) 3.48 (4.08) 
χ2(2,45)=.74, 
p=.69 
Tea (cups per week) 11.67 (12.18) 9.42 (10.34) 12.57 (13.76) χ
2(2,45)=.12, 
p=.94 
Table 3.24 NPE=group with non-postpartum episodes. PE=group with postpartum episodes. M=mean.
SD=standard deviation. Df=degrees of freedom. 
 
3.3.3.7 Clinical assessments (SGA) 
3.3.3.7.1 Life event scales and family history (SGA) 
Please refer to Table 3.25 for all relevant statistics in this section. There was a trend 
level difference concerning the experience of stressful life events during the previous 
six months and intrusive life events over a life-time between groups, with more 
women in the NPE group having experienced stressful and intrusive life events. 
There was no significant difference between the NPE, PE, and the healthy control 
groups concerning the severity of family arrangements (i.e. having had more than 
three family arrangements up until the age of 17 years) according the CECA- Q.       
However, there were significant differences between the three groups concerning 
sexual and physical abuse before the age 17, with the NPE group having higher rates 
of physical and sexual abuse than healthy controls (χ2(3,33)=12.26, p<.01, 
pexact<.01). This remained significant following Bonferroni correction (α=.016).  
There was also a significant difference between the NPE, PE and healthy control 
groups concerning the number of first-degree relatives that were diagnosed with a 
psychiatric illness. More women in the NPE group had first-degree relatives with a 
psychiatric illness compared to the PE group and healthy controls (χ2(1,23)=7.99, 
p=.01, pexact=.01; χ2(1,31)=16.79, p<.01, pexact<.01, respectively). These pairwise 
comparisons remained significant following Bonferroni correction (α=.016). Also see 
Table 4 in Appendix C. All other pairwise comparisons were p>.05 without 





Table 3.25 Life event scales and family history (SGA) 
Category Subcategory NPE N (%) PE N (%) HC N (%) Statistics (df, N) 
Stressful life events 
/ past 6 months 
Yes 7 (58) 6 (50) 4 (19) χ2(2,45)=6.28, 
p=.05, pexact=.06 No 5 (42) 6 (50) 17 (81) 
Intrusive life events 
/ life-time 
Yes 10 (83) 8 (67) 9 (43) χ2(2,45)=5.52, 
p=.06, pexact=.07 No 2 (17) 4 (33) 12 (57) 
Family 
arrangements 
Less than 3 7 (58) 10 (83) 17 (81) χ2(2,45)=2.65, 




No experiences 5 (42) 9 (82) 20 (95) 
χ2(6,44)=13.56, 
p=.04, pexact<.01 
Physical abuse 4 (33) 1 (9) 1 (5) 
Sexual abuse 1 (8) 0 0 




Yes 10 (91) 4 (33) 3 (15) χ2(2,43)=17.37, 
p<.01, pexact<.01 No 1 (9) 8 (67) 17 (85) 
Table 3.25 NPE=group with non-postpartum episodes. PE=group with postpartum episodes. 
%=percentage of group. Df=degrees of freedom. 
 
3.3.3.7.2 Assessment of functioning (SGA) 
Please refer to Table 3.26 and Table 3.27 for all relevant statistics in this section. 
There was a significant difference between the GAF scores of the NPE, PE and 
healthy control groups, with both the NPE and PE group having lower scores than 
healthy controls following Bonferroni correction (z=-5.31, p<.01; z=-4.59, p<.01, 
respectively). This was similar for the highest mean GAF score during the previous 
year (z=-3.91, p<.01; z=-2.67, p<.01, respectively). Women were also evaluated at 
the time of the MRI scan according to the CGI and there was no significant 
difference between the NPE and PE groups. All other pairwise comparisons were 
p>.05 without Bonferroni correction.      
 
Table 3.26 Assessment of functioning (SGA) 
Groups NPE M (SD) PE M (SD)  HC M (SD) Statistics (df, N)
GAF scores (current) 76.50 (15.23) 75.58 (19.57) 99.57 (1.96) χ
2(2,45)=30.69, 
p<.01 
Highest GAF score / 
previous year 86.08 (15.01) 90 (18.46) 99.76 (1.09) 
χ2(2,45)=14.76, 
p<.01 
Table 3.26 NPE=group with non-postpartum episodes. PE=group with postpartum episodes. M=mean. 





Table 3.27 Clinical Global Impression (SGA) 
Groups NPE N (%) PE N (%) HC N (%) Total N (%) Statistics (df, N) 
Normal, not at 







mentally ill 2 (17) 2 (17) NA 4 (9) 
Mildly ill 5 (42) 2 (17) NA 7 (16) 
Moderately ill 4 (33) 7 (58) NA 11 (24) 
Markedly ill 0 1 (8) NA 1 (2) 
Total 12 (100) 12 (100) 21 (100) 45 (100) 
Table 3.27 NPE=group with non-postpartum episodes. PE=group with postpartum episodes. 
%=percentage of group. Df=degrees of freedom. 
 
3.3.3.7.3 Mood and symptom scales (SGA) 
Please refer to Table 3.28 for all relevant statistics in this section. The NPE and the 
PE groups scored significantly higher than healthy controls following Bonferroni 
correction on the Ham-D (z=-2.69, p<.01; z=-2.63, p<.01, respectively), the positive 
symptom scale (z=-3.05, p<.01; z=- 2.73, p<.01, respectively), the negative symptom 
scale (z=-2.36, p=.02; z=-3.15, p<.01, respectively), the general pathology scale (z=-
2.68, p<.01; z=-3.87, p<.01, respectively), the total score of the PANSS (z=-3.16, 
p<.01; z=-4.19, p<.01, respectively), and the BDI (z=-2.33, p=.02; z=-2.16, p=.03, 
respectively), although the difference on the BDI was not significant following 
Bonferroni correction (α=.016). There was also a significant difference between the 
NPE, PE and healthy control groups on the YMRS, with the PE group having a 
higher score than healthy controls following Bonferroni correction (z=-3.10, p<.01). 
All other pairwise comparisons were p>.05 without Bonferroni correction.      
 
Table 3.28 Mood and symptom scales (SGA) 
Groups NPE M (SD) PE M (SD)  HC M (SD) Statistics (df, N)
Ham-D 6.50 (5.94) 6.33 (5.94) 2.05 (3.0) χ
2(2,45)=10.32, 
p=.01 
BDI 9.00 (8.07) 9.25 (9.87) 3.05 (4.07) χ
2(2,45)=7.41, 
p=.03 
YMRS 1.67 (2.64) 2.08 (1.51) .52 (.82) χ
2(2,45)=9.39, 
p=.01 
PANSS (positive) 8.08 (1.78) 8.92 (3.06) 7.05 (.22) χ
2(2,45)=9.81, 
p<.01 
PANSS (negative) 7.58 (1.08) 9.67 (4.85) 7 (0) χ
2(2,45)=9.48, 
p<.01 
PANSS (GPS) 20.75 (5.31) 22.08 (5.50) 16.90 (1.95) χ
2(2,45)=15.76, 
p<.01 
PANSS (total) 36.42 (5.96) 40.67 (8.24) 30.95 (2.01) χ
2(2,45)=19.87, 
p<.01 
Table 3.28 NPE=group with non-postpartum episodes. PE=group with postpartum episodes. M=mean. 
SD=standard deviation. Df=degrees of freedom 
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3.3.3.7.4 Stress, anxiety and sleep scales (SGA) 
Please refer to Table 3.29 for all relevant statistics in this section. The NPE and the 
PE groups had significantly higher scores than healthy controls on the TAI (z=-2.14, 
p=.03; z=-2.81, p<.01, respectively), although only the latter remained significant 
following Bonferroni correction (α=.016). The NPE and the PE groups also had 
significantly higher scores than healthy controls on the PSS (z=-2.4, p=.02; z=-3.25, 
p<.01, respectively) although only the former remained significant following 
Bonferroni correction (α=.016). Women in the PE group had a higher score than 
healthy controls on the SAI after Bonferroni correction (α=.016) (z=-2.55, p=.01). 
The three groups did not differ on the Athens Insomnia Scale. All other pairwise 
comparisons were p>.05 without Bonferroni correction.      
 
Table 3.29 Stress, anxiety and sleep scales (SGA) 
Groups NPE M (SD) PE M (SD)  HC M (SD) Statistics (df, N)
SAI 31 (10.07) 37.83 (14.33) 26.19 (6.79) χ
2(2,45)=6.98, 
p=.03 
TAI 41 (14.55) 43.17 (12.96) 30.3 (8.91) χ
2(2,45)=9.30, 
p=.01 
PSS 15.75 (8.60) 19 (6.45) 8.48 (7.32) χ
2(2,45)=13.50, 
p<.01 
AIS 5.92 (5.29) 5.17 (4.15) 3.33 (4.71) χ
2(2,45)=4.77, 
p=.09 
Table 3.29 NPE=group with non-postpartum episodes. PE=group with postpartum episodes. M=mean.
SD=standard deviation. Df=degrees of freedom 
 
3.3.3.8 Cognitive assessments (SGA) 
Women did not differ in their full scale IQ as predicted by the WTAR (NPE group 
M=104.20, SD=8.92; PE group M=98.44, SD=14.09; healthy controls M=109.44, 
SD=13.36; χ2(2,37)=1.82, p=.40).  
 
3.4 Discussion 
This chapter describes the psychiatric diagnoses, sociodemographic characteristics, 
medical and obstetric history, nicotine, caffeine, cannabis and alcohol and drugs of 
abuse consumption of the participants as well as the clinical scales used in the 
current study. The main aims were to assess the clinical and sociodemographic 
characteristics of the participants and investigate in our study population the rates of 
certain features across groups such as primiparity, problems with delivery, low social 
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support or poor socioeconomic status that have been previously associated with 
postpartum psychosis. In the following section the results will be summarised and 
interpreted in the context of the existing literature. It is important to bear in mind that 
this chapter provides a series of exploratory analyses and that we -due to the low 
sample size in our study- did not specify any epidemiological hypotheses, but simply 
report on the clinical and sociodemographic characteristics of the women in this 
study. In order to assess a meaningful epidemiological sample, a much larger sample 
size would be required. Nevertheless, this chapter may give an insight into what the 
potential confounders for this study may be, and point to what factors may need to be 
taken into account in future investigations.   
 
3.4.1 Clinical characteristics of the groups  
It has been reported that women with postpartum psychosis seem to have a better 
prognosis in terms of number of relapses and time on medication than women who 
had additional or only non-postpartum episodes (Davidson & Robertson, 1985; Dean 
et al., 1989; Doucet et al., 2009; Nager et al., 2005; Serretti et al., 2006). The 
findings in our study that women in the NPE group had a higher number of mood or 
psychotic episodes compared to the PE group and an earlier age of onset seems to be 
in line with this finding. In addition, it has been found previously that women with 
postpartum psychosis have often attained higher functional levels before symptom 
onset compared to chronic illness (Sit et al., 2006). One possible reason for this may 
be a later illness onset, as also suggested by our data.  
     However, since episodes in this study have been assessed retrospectively, the 
possibility cannot be excluded that the women who have suffered recently from their 
first or second postpartum episode will develop more postpartum or non-postpartum 
relapses in the future. It is important to carry out prospective follow-up studies in 
order to address this issue. Two women in the NPE group had a current comorbidity 
of anxiety disorder and one woman in the PE group had a life-time diagnosis of 
anxiety and somatoform disorder. None of the healthy controls had ever received 
prescribed medication. Therefore, current or past psychiatric comorbidities were 
considered unlikely to be significant and were not included in further analysis. In the 
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current study the focus is on the evaluation of the medical and obstetric history and 
socioeconomic background of the participants.  
 
3.4.2 Socioeconomic background  
The groups did not significantly differ in age, although there was a non-significant 
trend that women in the healthy control group were older than women in the “at risk” 
group. This finding is not in line with other research studies, which showed that there 
is a higher risk for women with a higher maternal age to develop postpartum 
psychosis (Nager et al., 2005; Valdimarsdóttir et al., 2009). Our finding may simply 
reflect a greater willingness of more mature healthy mothers to take part in research 
compared to younger and maybe less experienced mothers. However, the actual 
mean age difference between the groups was small and the age range for all women 
was restricted to the years from 22 to 41. Therefore, we do not expect this difference 
to represent a confounder in the analyses.    
     There were no differences between groups for place of birth, first language, or 
ethnicity in the main or sub group analyses. In all groups, the majority of the women 
were born or spent the majority of their childhood (until the age of 17) in the United 
Kingdom and spoke English as their first language. There was a significant 
difference between groups concerning the paternal ethnicity, as there were more 
Caucasian partners in the control group than in the “at risk” group, specifically in the 
NPE group. It is possible that the difference in the partners’ ethnicity may be 
associated with a difference in socioeconomic status (Kendell et al., 1976; 
Paffenbarger, 1961). However, as the difference was found for the NPE group, it 
does not confirm that a lower socioeconomic status is associated with the 
development of postpartum psychosis, as has previously been suggested (Kirpinar et 
al., 1999; Nager et al., 2006; Nager et al., 2012). In addition, our population as a 
whole was recruited from a relatively deprived area and is therefore likely to be 
matched on the socioeconomic background.  
     In addition, the groups did not differ in their marital status or the stability of their 
relationships. The majority of women were married or cohabiting. Even though a 
small amount of the women were not living with the father of the baby, most women 
in all the groups were in a stable relationship with a partner taking on the father role. 
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This finding is different to previous suggestions that postpartum psychosis is 
associated with “being single” or lacking social support due to a poor partner 
relationship (Bilszta et al., 2010; Cheetham et al., 1981; Kendell et al., 1987; 
Kendell, Rennie, et al., 1981; Marks et al., 1992; Nager et al., 2005, 2006; 
Paffenbarger, 1961; Paffenbarger & McCabe, 1966). Nonetheless, due to the small 
sample size it is difficult to draw general conclusions. It would be interesting to 
further investigate this aspect in future studies. Women did not differ in their level of 
qualifications or employment statuses. The majority of women in all groups had a 
degree and were employed, although numerically the percentages were lower in the 
NPE group. Women also did not differ in their full scale IQ as predicted by the 
WTAR.  
     Taken together, this indicates that the women who developed postpartum 
psychosis in our sample were well matched in terms of common socioeconomic 
characteristics previously associated with this illness. Next, we investigated whether 
our participants share medical and obstetric characteristics that have been found to 
put women at risk of developing postpartum psychosis.   
 
3.4.3 Medication 
There was no difference between groups on the use of over-the-counter medication. 
The NPE and PE groups also did not significantly differ in the number of women 
taking prescribed medication at the time of the MRI scan or the mean dose of 
antipsychotic medication in chlorpromazine equivalents. However, women in the 
NPE group had a longer duration in days of exposure compared to the PE group, 
which concurs with the finding that women in the NPE group reported more previous 
episodes and had an earlier illness onset. 
     Although lithium has been suggested as first choice treatment for postpartum 
psychosis (Doucet et al., 2011; Roy & Payne, 2009), only one woman was receiving 
it at the time of the MRI scan. In line with previous studies, treatment of women in 
our study involved antipsychotics and benzodiazepines (L. S. Cohen et al., 1995; 
Roy & Payne, 2009; Sit et al., 2006; M.G. Spinelli, 2009). Unfortunately, it was not 
possible to collect the exact data concerning the length and dose of medication use 
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for all participants in order to calculate chlorpromazine equivalence scores. None of 
the women had received ECT.      
 
3.4.4 Medical and obstetric history 
Problems in pregnancy have not typically been connected to a higher risk of 
postpartum psychosis (V. Bergink et al., 2011; Blackmore et al., 2006; Kendell et al., 
1987; Kendell, Rennie, et al., 1981; Kendell et al., 1976; Paffenbarger, 1961; 
Rehman et al., 1990; Valdimarsdóttir et al., 2009; Videbech & Gouliaev, 1995). 
However, some studies (Nager et al., 2008) suggest that women with postpartum 
psychosis experience more problems during pregnancy or delivery (e.g. infection 
from a caesarean section) or during breastfeeding (e.g. not latching on). In line with 
the latter study, we found a trend showing that women at risk of postpartum 
psychosis had experienced more problems during their most recent pregnancy, 
although this trend was mainly driven by the NPE group. However, there was no 
difference in the number of previous pregnancies that did not result in a live birth. 
Across all groups, the majority of women had had a previous miscarriage or 
termination. Fewer women in the PE group breastfed their child compared to healthy 
controls. This could also be as a result of the episode of severe illness after their 
recent delivery, making the women in the PE group too unwell or unwilling to 
breastfeed; it could also possibly be due to a higher use of medication. 
     There was no significant difference in maternal parity across groups. This differs 
to previous results which highlighted that primiparity is associated with a higher risk 
of developing postpartum psychosis (P. Agrawal et al., 1990; V. Bergink et al., 2011; 
Blackmore et al., 2006; Cheetham et al., 1981; Kendell et al., 1987; Kendell, Rennie, 
et al., 1981; Kirpinar et al., 1999; Kisa et al., 2007; Meltzer & Kumar, 1985; 
Paffenbarger, 1961; Paffenbarger & McCabe, 1966; Protheroe, 1969; Schöpf et al., 
1984; Videbech & Gouliaev, 1995). Yet, since the sample size in our study is small, 
this may not be a representative finding for the population.  
As reported previously, age of onset of menarche was not associated with postpartum 
psychosis (Paffenbarger, 1961). Groups were also matched according to the number 
of weeks after delivery and, by the time of the MRI scan, a similar number of women 
in each of the groups had already had their first period following their most recent 
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delivery. To conclude, women in our study did not differ in terms of their medical or 
obstetric history. Nonetheless, since this is not a large epidemiological sample, future 
studies have to further investigate a potential link between postpartum psychosis and 
medical and obstetric characteristics. Another important aspect of mental illness is 
the potential use of legal or illicit drugs.  
 
3.4.5 Nicotine, caffeine, cannabis, alcohol and other drugs of abuse 
There were no group differences in coffee, tea or alcohol consumption at the time of 
the MRI scan. Groups also did not differ in smoking history or current smoking, 
although women in the NPE group had previously smoked more cigarettes than 
women in the PE or healthy control groups. These findings are in line with previous 
results showing no association between postpartum psychosis and smoking 
(Valdimarsdóttir et al., 2009). There are no studies investigating the use of cannabis 
in postpartum psychosis. Still, it has been found that people diagnosed with bipolar 
disorder are more prone to using cannabis than healthy controls (A. Agrawal, 
Nurnberger, & Lynskey, 2011). In our study, women in both the NPE and PE groups 
had smoked cannabis more frequently during the period of highest use and used more 
cannabis on average during each use compared to healthy controls. However, more 
women in the NPE group had previously smoked cannabis than women in the PE 
group. Similarly to cannabis use, there are no studies on alcohol and substance abuse 
in postpartum psychosis. Nonetheless, bipolar disorder has been strongly linked to a 
higher risk of alcohol and substance abuse (Krishnan, 2005). None of the healthy 
controls, but one-third of the women in both the NPE and PE groups had a history of 
alcohol or substance abuse. Taken together, these results suggest that there is an 
association between illicit drug use and mental illness, as defined in our study, but 
not specifically for postpartum psychosis.  
 
3.4.6 Clinical assessments 
More women in the NPE and PE groups had experienced stressful life events during 
the previous six months and intrusive life events during their life-time compared to 
healthy controls. This suggests that in the PE group stress may be an important 
trigger of a postpartum psychotic episode. However, since the NPE group showed 
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similar rates of stressful and intrusive life events, the specific association with 
postpartum psychosis has to be established by future studies. The groups did not 
differ in the number of family arrangements, but women in the NPE and PE groups 
had experienced more physical and sexual abuse than the healthy controls. This is in 
line with the finding that postpartum psychosis is not specifically associated with a 
problematic childhood (Bratfos & Haug, 1966; Valdimarsdóttir et al., 2009). 
However, bipolar disorder or psychoses unrelated to childbirth have been associated 
with childhood trauma (J. Savitz et al., 2009; Schäfer & Fisher, 2011). Therefore, the 
abuse reported in this study may be more generally linked to the development of 
mental illness in the women in our study. Since the sample size in these sub-analyses 
is very small it is difficult to generalise these findings.   
     Taken together, these findings support, to some extent, the view that acute 
stressful life events do not specifically contribute to postpartum psychosis 
(Brockington et al., 1990; R. Kumar et al., 1993; McNeil, 1988b; Paffenbarger & 
McCabe, 1966; Protheroe, 1969). Nevertheless, consistent with a large body of 
literature (J. Savitz et al., 2009; Schäfer & Fisher, 2011), having experienced acute 
stressful life events seems to be associated with a higher risk of developing mental 
illness, including the development of episodes of postpartum psychosis. The 
preliminary findings of higher rates of severe childhood trauma are also interesting 
considering the lack of evidence in this area in relation to postpartum psychosis; the 
topic deserves further investigation using larger sample sizes.  
     Women in the NPE group had a higher number of first-degree relatives who were 
diagnosed with a psychiatric illness compared to the PE group and healthy controls, 
which differs from previous findings which suggest a similar familial risk in 
postpartum psychosis and bipolar disorder unrelated to childbirth (P. Agrawal et al., 
1990; Benvenuti et al., 1992; Dean et al., 1989; Kirpinar et al., 1999; Platz & 
Kendell, 1988; Protheroe, 1969). 
Women in the NPE and PE groups scored lower on scales assessing general, current 
and past year functioning when compared to healthy controls and, not surprisingly, 
higher on mood, positive, and negative symptoms, as well as on perceived stress and 
anxiety scales at the time of the MRI scan. The NPE and PE groups did not 
significantly differ from each other on any scales, although most women in the PE 
group had experienced a recent episode of postpartum psychosis. These findings 
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seem to have two implications. Firstly, the scores of women on the mood as well as 
positive and negative symptom scales were quite low, indicating that all the women 
were relatively well by the time of the MRI scan. Secondly, women with non-
postpartum episodes showed higher mood, anxiety and stress scores compared to 
healthy controls, although they had not suffered a recent episode. This suggests that, 
if validated in larger sample sizes, women with a psychiatric diagnosis may also need 
additional support within the first year after childbirth independently of the 
development of an acute mood or psychotic episode.  
 
3.4.7 Representativeness of the “at risk” group and healthy controls 
In order to assess whether women in the “at risk” group, recruited into this study, 
were representative of the patient population under the care of the perinatal services 
of the South London and Maudsley NHS Foundation Trust, we compared 
sociodemographic characteristics of our population with those that were available 
from two other studies conducted with in-patients at the Mother and Baby Unit at the 
Bethlem Royal Hospital (Kenny, Conroy, Pariante, Seneviratne, & Pawlby, 2013; R. 
Kumar et al., 1995). Kumar and colleagues (1995) reported a mean age of 29 years 
of women admitted to the Bethlem mother and baby unit with an affective psychosis 
diagnosed following childbirth. In a newer study conducted by Kenny and colleagues 
(2013), a mean age of 31 years was reported for new mothers that had been admitted 
to mother and baby unit. In comparison to these studies, the mean age of our “at risk” 
group was very similar, being 32 years.  
     In both previous studies, approximately 80% of women were either married or 
cohabiting, showing that this rate is also comparable to what we have found in our 
sample, where 75% of our women were either married or cohabiting. Approximately 
60% of women were Caucasian in the studies conducted by Kumar and Kenny. Here, 
our sample had a slightly lower proportion with 52% of women being Caucasian in 
the “at risk” group. The proportion of primiparous women was similar in our study 
(i.e. 56%) to the women with affective psychosis in the study of Kumar (i.e. 57%), 
while in Kenny’s study a lower proportion of only 42% of women being primiparous 
was reported. Finally, of the women who took part in the study of Kumar, 50% were 
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employed in comparison to 60% in our study. No information was given on 
employment in the study of Kenny et al. (2013).  
     The “at risk” group matches previous reports of in-patients of the mother and 
baby unit on important characteristics including age, marital status, primiparity, 
ethnicity, and employment rate. Unfortunately, there were no further data available 
from these studies on type of employment or IQ, which would have allowed a more 
detailed comparison. However, based on these sociodemographic characteristics, it 
can be concluded that our “at risk” group was a representative sample of women at 
risk of postpartum psychosis who have taken part in previous research. 
     In order to match the healthy controls recruited for this study on socioeconomic 
background, women were recruited in the same hospital and the population as a 
whole was recruited from the same, relatively deprived, area in London. The results 
of this chapter suggest that women were well matched regarding their socioeconomic 
background, medical and obstetric history, especially given that there were no 
significant differences even without using multiple comparisons correction in this 
exploratory chapter. However, although there were no statistically significant 
differences reported in the current chapter between the “at risk” group and healthy 
controls, healthy controls still had numerically a higher IQ, a higher employment rate 
and a higher rate of women had a degree or diploma. There was also a tendency of 
healthy controls to have a higher age than the “at risk” group. As discussed in the 
paragraph 3.4.2 Sociodemographic background, this may simply reflect a greater 
willingness of more mature healthy mothers to take part in research compared to 
younger and maybe less experienced mothers. Also, differences in these factors 
(employment, IQ, education) are most commonly reported in case-control studies of 
affective and non-affective psychosis, and it has been argued that attempting to 
match for characteristics that may actually be a corollary of the disorder itself may 
add other, unknown, biases. Nevertheless, these differences are important to consider 
in order to interpret the results and to exclude the possibility that significant 
differences in the experimental paradigms are due to high functioning controls. This 
limitation of the study will be further discussed in chapter 7. General discussion, 7.5 





In this exploratory chapter, women with non-postpartum episodes and women with 
postpartum episodes were well matched regarding their socioeconomic background, 
medical and obstetric history and medication use in the current study. There was no 
specific association between postpartum psychosis and life events, previous alcohol 
or illicit drug use or family history. However, there was a general association 
between these variables and both “at risk” groups, in line with existing evidence that 
they are important contributors to the development of mood and psychotic disorders.  
     Both “at risk” groups showed similar scores on scales assessing general 
functioning, mood, positive and negative symptoms, anxiety, and stress. These 
results indicate that women in the PE group were relatively well at the time of the 
MRI scan, although clinical scores suggest that both groups may need additional 
support within the first year after childbirth. Finally, these results suggest that 
women with postpartum psychosis show a similar clinical profile compared to 






4. Chapter: Verbal memory  
In this chapter, an overview of the relevant literature on verbal memory will be 
presented. Then, the logical memory paradigm of the WMS-III and a recognition 
paradigm, including the development and validation of the paradigm, will be 
described. This will be followed by the presentation of the results and their 
discussion with regard to the existing literature. 
 
4.1 Introduction 
As stated in the main introduction, while there are no studies assessing verbal 
memory in postpartum psychosis, verbal memory impairment seems to be one of the 
key deficits in bipolar disorder and in psychoses unrelated to childbirth (Aleman, 
Hijman, de Haan, & Kahn, 1999; Arts et al., 2008; Libby et al., 2012; Reichenberg, 
2010; Reichenberg et al., 2009; L. J. Robinson et al., 2006). Deficits have been found 
in standardised cognitive test batteries assessing verbal memory, such as story recall 
of the WMS-III as well as in recognition tasks assessed with remember-know 
paradigms (Glahn et al., 2007; Libby et al., 2012; L. J. Robinson et al., 2006; 
Tulving, 1985; Wechsler, 1997; Wood et al., 2007). 
 
4.1.1 Standardised tests of verbal memory  
Conducting a meta-analysis, Robinson and colleagues (2006) showed that an 
impairment in immediate and delayed verbal memory is present in bipolar patients 
even after long symptom free periods (I.N. Ferrier et al., 1999; Kieseppa et al., 2005; 
L. J. Robinson & Ferrier, 2006; L. J. Robinson et al., 2006). This impairment seems 
to be independent of the patient’s current clinical symptom profile and severity (i.e. 
manic, hypomanic, depressed or euthymic) (Martínez-Arán et al., 2004). However, 
verbal memory performance has been found to be more impaired in bipolar patients 
with any or a mix of the following: a history of psychosis, a longer illness, a higher 
number of manic episodes, frequent hospitalisations, suicide attempts (Bora et al., 
2007; Martinez-Aran et al., 2008; Martínez-Arán et al., 2004; L. J. Robinson & 
Ferrier, 2006; J. Savitz et al., 2009). The impairment also appears to be more 
pronounced in the bipolar I than in the bipolar II type disorder (Martínez-Arán et al., 
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2004; J. B. Savitz et al., 2008). Verbal memory deficits in bipolar disorder have also 
been found to remain when alcohol abuse, childhood trauma or medication effects 
were taken into account in the analyses (Bora et al., 2007; Martinez-Aran et al., 
2008; J. B. Savitz et al., 2008). In fact, it has been suggested that the effects of 
medication (predominantly mood stabilisers) are small as medication free euthymic 
bipolar patients perform at a similar level in verbal memory tasks when compared to 
medicated bipolar patients (Goswami et al., 2009).  
     Verbal memory dysfunction has also been demonstrated in patients suffering from 
psychoses unrelated to childbirth (Wood et al., 2007). Deficits have been consistently 
reported in schizophrenia in immediate and delayed recall (Reichenberg, 2010). 
Dysfunction has been found to be present already at the time of illness onset and 
even before onset in high risk individuals (Brewer et al., 2006; R.E. Carrión et al., 
2011; Wood et al., 2007). This is different to findings on bipolar disorder, as the 
deficit seems to be independent of chronicity (i.e. non-progressive) (Brewer et al., 
2006; R.E. Carrión et al., 2011; Wood et al., 2007). In fact, a stable association 
between verbal memory impairment and psychoses unrelated to childbirth has been 
suggested; it seems to be little influenced by age, medication use, duration of illness, 
severity of psychopathology or positive symptoms (Aleman et al., 1999; 
Reichenberg, 2010). However, another study has reported an association between of 
length illness and other forms of memory (Pelletier, Achim, Montoya, Lal, & 
Lepage, 2005). An association with negative symptoms has been reported repeatedly 
(Aleman et al., 1999; Reichenberg, 2010). In addition, verbal memory impairment 
has been found to negatively correlate with emotional discomfort (Lysaker, Bell, 
Greig, & Bryson, 2000). Deficits have also been confirmed using a different 
assessment of verbal memory, in the form of remember-know paradigms.  
 
4.1.2 Remember-know paradigms 
It has been proposed that recognition is supported by two independent processes: 
“recollection” and “familiarity” (Jacoby, 1991; Mandler, 1980; Rajaram & Roediger, 
1997; Yonelinas, 1999, 2001, 2002). Recollection and familiarity can be assessed 
with remember-know paradigms, which were first introduced by Tulving (1985) in 
order to assess retrieval that is accompanied by conscious experiences (Tulving, 
127 
 
1985). Although it was first used to explore the difference between episodic and 
semantic memory (Tulving, 1985), the remember-know paradigm is now widely 
used to investigate recollection and familiarity. Recollection and familiarity can be 
thought of as the memory processes and “remember” and “know” responses as the 
test format (Migo, Mayes, & Montaldi, 2012). This procedure is the most commonly 
used method to investigate dual process theories of recognition memory (Migo et al., 
2012). Specifically, during these paradigms participants indicate that they either 
remember or know a previously presented test-stimulus (e.g. words). With a 
remember judgement, a participant indicates that the stimulus evokes recollection of 
a specific episode in which it was presented previously (e.g. memory for 
spatiotemporal context). With a know judgement, a participant indicates that the 
stimulus does not evoke the recollection of a specific episode but instead a sense of 
familiarity (no retrieval of contextual information; for example recognising a face, 
but not remembering to whom it belongs) (R. N. A. Henson, Rugg, Shallice, Josephs, 
& Dolan, 1999; Tulving, 1985). It has been suggested that different neural substrates 
underlie remember and know judgements (R. N. A. Henson et al., 1999; Libby et al., 
2012; Yonelinas, 2002). In particular, recollection is said to be supported within the 
medial temporal lobe by the hippocampus, while familiarity is not associated with 
hippocampal involvement but rather by the perirhinal and prefrontal cortices (Aly, 
Yonelinas, Kishiyama, & Knight, 2011; Eichenbaum, Yonelinas, & Ranganath, 
2007; R. Henson, 2005; R. N. A. Henson et al., 1999; Libby et al., 2012; Yonelinas, 
2002). However, not all studies have found a functional division (R. Henson, 2005). 
     While there appears to be a paucity of research investigating remember-know 
paradigms in bipolar disorder, there is plenty of research into this area in regards to 
psychoses unrelated to childbirth. Some studies report an overall deficit in 
recognition (Pelletier et al., 2005; van Erp et al., 2008), although commonly a deficit 
in recollection performance is reported in these patients, while familiarity seems to 
be intact (Brébion, Gorman, Malaspina, Sharif, & Amador, 2001; Huron et al., 1995; 
Martin et al., 2011; Thoma, Zoppelt, Wiebel, & Daum, 2006; van Erp et al., 2008). 
The recollection deficit has been further associated with severity of depressive and 
negative symptoms, length of illness, as well as slowing of processing speed, but not 
with positive psychotic symptoms (Brébion et al., 2001; Pelletier et al., 2005; Thoma 
et al., 2006). Is has been speculated that a recollection deficit might be caused by 
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differences in encoding between patients and healthy controls and also by an increase 
in the false alarm rates (Brébion et al., 2001; Thoma et al., 2006). Some studies also 
report an impairment in familiarity (Caza, Doré, Gingras, & Rouleau, 2011; A. P. 
Weiss, Goff, Duff, Roffman, & Schacter, 2008). Moreover, in a recent quantitative 
review a more consistent deficit in familiarity was revealed, although still less 
pronounced than in recollection (Libby et al., 2012). 
     In summary, verbal memory dysfunction has consistently been found in bipolar 
disorder and psychoses unrelated to childbirth independently of the task employed. 
Therefore, we expected that women at risk of postpartum psychosis would show, in 
comparison to healthy controls, impaired verbal memory performance. Furthermore, 
we proposed that impairments in verbal memory would be more pronounced in 
women who had developed postpartum psychosis episodes, compared to women who 
had not developed postpartum psychotic episodes, and to healthy controls. These 
hypotheses belong to the group of secondary hypotheses of this thesis. In order to test 
these hypotheses, the two most commonly used verbal memory tasks will be used. A 
standardised verbal memory test (i.e. the logical memory I and II of the Wechsler 
Memory Scale-III) and the remember-know paradigm. 
 
4.2 Methods 
4.2.1 Participants, design, analyses and procedures 
Methods are described in chapter 2. For information on the combined group analyses 
and sub group analyses please see chapter 2 and chapter 3. 
 
4.2.2 Tasks 
4.2.2.1 Logical memory I and II 
In order to assess immediate and delayed verbal memory performance, logical 
memory I and II of the WMS-III were carried out according to a standardised 
procedure (Wechsler, 1997). For the immediate memory (logical memory I), two 
stories were orally presented. The second story was presented twice. The participants 
were asked to retell the stories from memory. For the delayed logical memory test 
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(logical memory II), participants were asked to retell both stories from the immediate 
condition after a 25-30 minute delay. 
 
4.2.2.2 Remember-know paradigm 
In order to assess immediate and delayed verbal memory performance in terms of 
recognition, participants completed a remember-know paradigm, consisting of two 
stages: encoding and retrieval. In the following section the development and 
validation of the task will be discussed.  
 
4.2.2.2.1 Development and validation of the remember-know paradigm 
A new verbal memory task was designed for this study based on previous tasks used 
(Craig et al., 2008; Craig et al., 2007). Three word lists (three encoding and three 
retrieval playlists) were developed and tested in a pilot. Words were chosen out of 
the British National Corpus (BNC) word collection 
(http://ucrel.lancs.ac.uk/bncfreq/). Nouns (2578 in total) were chosen based on the 
Medical Research Council Psycholinguistic Database (Wilson, 1988) 
(http://www.psych.rl.ac.uk) according to the following inclusion criteria: 
 
1) Frequency between 10 and 100 (per million words). 
2) Words with more than four and less than eight letters. 
3) Concreteness above 400. 
 
Subsequently, words lists were categorised into natural and “man made”, leaving two 
word lists with 255 words (man made) and 234 words (natural). Out of these two 
lists, three encoding playlists, each with 35 natural and 35 man made words, were 
created (words were randomly selected). For each encoding playlist (encoding 1, 2, 
3) a matching retrieval playlist was created (retrieval 1, 2, 3), each consisting of 70 
“old” (i.e. previously presented) and 35 “new” (i.e. not previously presented) words 





Using the MRC Psycholinguistic Database, word lists were matched according to: 
1. Frequency. 
2. Concreteness (Range 400-700). 
3. Imageability (Range 400-700). 
4. Number of letters (length). 
5. Number of syllables. 
 
Word lists were analysed and compared using one-way ANOVA within SPSS 20. 
Following the matching of the playlists, nine healthy volunteers (male and female 
and aged similarly to participants) were tested on each playlist in order to test if they 
were matched in terms of performance using repeated measures ANOVA. For 
simplicity of the task validation we checked only for overall recognition 
performance, adjusting for any floor and ceiling effects systematically (Snodgrass & 
Corwin, 1988). 
 
Variables of interest for validation of the encoding playlists included:  
1) Reaction time (RT). 
2) Percentage of correctly identified words.  
 
Variables of interest for the validation of the retrieval playlists included:  
1) RT. 
2) Hit	rate ൌ ୦୧୲ୱା଴.ହ୭୪ୢ	୧୲ୣ୫ୱାଵ 
3)	False	alarm	rate ൌ ୤ୟ୪ୱୣ	ୟ୪ୟ୰୫ୱ	ା଴.ହ୬ୣ୵	୧୲ୣ୫ୱାଵ  




No significant differences between playlists were found on 1) frequency 2) 
concreteness 3) imageability 4) number of letters (length) and 5) number of syllables 
(see Table 4.1).  
 
 
Further, no significant differences between the playlists were found based on the 
behavioural performance of participants. Also, the retrieval playlists significantly 
correlated with each other (smallest r(9)=.66, largest p=.05), validating the similarity 
of the playlists (see Table 4.2). 
 
Table 4.2 Performance results word lists verbal memory task 
Encoding (N=9) List 1 List 2 List 3 F(2, 7) p  
RT 1415(151) 1409(145) 1388(184) 0.06 0.94 
Percentage of correct 
words 93.49(3) 94.29(2) 93.96(3) 0.68 0.54 
Retrieval (N=9) List 1 List 2 List 3 F(2, 7) p  
RT 1328(237) 1362(179) 1340(228) 0.15 0.86 
Hit rate     0.89(0.06) 0.87(0.09) 0.85(0.11) 1.44 0.29 
False alarm rate 0.08(0.11) 0.06(0.06) 0.06(0.05) 0.23 0.80 
d’ 3.01(0.98) 2.91(0.61) 2.88(0.85) 0.25 0.78 
Table 4.2 shows the mean values of participants’ responses (standard deviation in brackets). 
RT=reaction times (shown in milliseconds). Also shown are the F-value (degrees of freedom) and 
corresponding p-value. d’ sensitivity index.  
 
4.2.2.2.2 Procedure 
During encoding, a sequence of words was presented on a computer screen to the 
participants, who had to decide whether the words presented to them represented 
natural (e.g. tree) or man made (e.g. house) objects by pressing “1” or “0” on the 
keyboard, respectively (see Figure 4.1). The encoding task included 70 words (35 
Table 4.1 Word lists verbal memory task 
Encoding (N=70) List 1 List 2 List 3 F(2, 207) p  
Frequency 31.10(20) 33.96(22) 33.24(23) 0.31 0.73 
Concreteness 585.3(25) 581.74(38) 581.53(30) 0.31 0.74 
Imageability 584.04(33) 581.19(33) 581.73(35) 0.14 0.87 
Length 5.01(1) 5.26(1) 5.14(1) 0.88 0.42 
Syllables  1.47(.58) 1.51(.65) 1.41(.58) 0.51 0.61 
Retrieval (N=105) List 1 List 2 List 3 F(2, 312) p  
Frequency 32.81(20) 31.86(22) 31.42(23) 0.11 0.89 
Concreteness 585.62(27) 583.01(35) 585.45(30) 0.26 0.79 
Imageability 583.12(34) 579.89(36) 581.41(34) 0.62 0.54 
Length 5.05(1) 5.20(1) 5.12(1) 0.49 0.61 
Syllables  1.44(.55) 1.50(.66) 1.45(.58) 0.37 0.69 
Table 4.1 shows the mean values of the variables (standard deviation in brackets), the F-value 
(degrees of freedom) and corresponding p-value. 
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natural and 35 man made objects) presented to participants for 3.5 seconds each 
(independent of participants’ responses).  
 
Figure 4.1 Encoding part of the verbal memory task 
 
Figure 4.1 shows the encoding part of the verbal memory task. Participants had to decide whether a 
word was natural or man made by pressing either the 1 or 0 on a keyboard, respectively.   
 
Recognition took place after a period of 90 minutes; after this time participants were 
shown a stream of words again and had to decide whether the words presented were 
old words (i.e. presented in the previous playlist). In order to assess recollection and 
familiarity, participants had to decide whether they remembered – (R) the item (i.e. 
whether they recollected that actual presentation of the word in the playlist and 
linked it with any context) or whether they just “knew – (K)” that the item was old 
(i.e. whether the item seemed familiar to them but they did not recall any associated 
details from the prior exposure) by pressing 9 or 0 on the keyboard, respectively. 
New words (i.e. not previously presented in the encoding playlist) had to be 











Figure 4.2 Retrieval part of the verbal memory task 
 
Figure 4.2 shows the retrieval part of the verbal memory task. Participants had to decide whether they 
remembered, knew or did not recognise a word by pressing 9, 0 or 1 on the keyboard, respectively.    
 
 
The recognition task consisted of 105 words (70 old words and 35 new words). 
Length of presentation was determined by participants’ reaction time. The possible 
response options of the task are shown in Table 4.3. Instructions were given verbally 
shortly before the encoding and retrieval part and were based on Rajaram (1993) 
(Rajaram, 1993). Then, it was confirmed that participants had understood and 
followed the instructions by giving them a test trial (Migo et al., 2012).  
 
Table 4.3 Response outcomes 
 Response options 
    old (remembered) old (know) new 
Word 
old hit (R) hit (K) miss 
new false alarm (R) false alarm (K) correct rejection 
Table 4.3 shows the response options for the retrieval part of the verbal memory task. Participants 




4.2.3.1 Logical memory 
The raw score scale of logical memory I ranges from 0 to75 points and for logical 
memory II from 0 to 50 points. Scores were converted using age adjusted standard 
scores of the WMS-III, which range from 1 to 19, with 10 representing the 
population average and with every three point increment or decrement representing 
one standard deviation (Wechsler, 1997). Variables of interest were logical memory I 
and II standard scale scores.  
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4.2.3.2  Remember-know paradigm 
For the encoding, the following variables of interest were calculated: 
1) RT. 
2) Percentage of correctly identified words. 
 
For the recognition analysis, the hit rate and the false alarm rate were calculated 
separately for recollection and familiarity according to the statistical independence 
assumption (Yonelinas, 1999, 2001, 2002). This most widely used method for the 
calculation assumes that the familiarity reported in a know response is the same as 
the familiarity that can accompany a remember response in terms of accuracy and 
frequency (Migo et al., 2012). Again, hit and false alarm rates were systematically 
corrected for ceiling and floor effects (Snodgrass & Corwin, 1988).  
 
In the following section the calculation of variables is presented by equations: 
 
The remember hit rate was calculated by  
ܪ݅ݐ	ݎܽݐ݁ሺݎܾ݁݉݁݉݁ݎሻ ൌ ݄݅ݐݏ	ሺܴሻ ൅ 0.5݋݈݀	݅ݐ݁݉ݏ ൅ 1 
 
The remember false alarm rate was calculated by  
ܨ݈ܽݏ݁	݈ܽܽݎ݉	ݎܽݐ݁	ሺݎܾ݁݉݁݉݁ݎሻ ൌ ݂݈ܽݏ݁	݈ܽܽݎ݉ݏ	ሺܴሻ ൅ 0.5݊݁ݓ	݅ݐ݁݉ݏ ൅ 1  
 
The know hit rate was calculated by  
ܪ݅ݐ	ݎܽݐ݁ሺ݇݊݋ݓሻ ൌ ݄݅ݐݏ	ሺܭሻ ൅ 0.5ሺ݋݈݀	݅ݐ݁݉ݏ ൅ 1ሻ െ ݄݅ݐݏ	ሺܴሻ 
 
The know false alarm rate was calculated by 
ܨ݈ܽݏ݁	݈ܽܽݎ݉	ݎܽݐ݁	ሺ݇݊݋ݓሻ ൌ ݂݈ܽݏ݁	݈ܽܽݎ݉ݏ	ሺܭሻ ൅ 0.5ሺ݊݁ݓ	݅ݐ݁݉ݏ ൅ 1ሻ െ ݂݈ܽݏ݁	݈ܽܽݎ݉ݏ	ሺܴሻ 
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In order to provide sensitivity measures (i.e. ability to discriminate signal from noise) 
of participants, the sensitivity index d’ was calculated. The higher the score of d’, the 
higher the sensitivity, with typical values below 4 and around 2 (Stanislaw & 
Todorov, 1999). 
 
The remember d’ was calculated by   
݀′	ሺܴሻ ൌ ܼ	ሺ݄݅ݐ	ݎܽݐ݁	ሺܴሻሻ 	െ 	ܼ	ሺܨܣ	ݎܽݐ݁	ሺܴሻሻ 
 
The know d’ was calculated by   
݀ᇱሺܭሻ ൌ ܼ	ሺ݄݅ݐ	ݎܽݐ݁	ሺܭሻሻ െ 	ܼ	ሺܨܣ	ݎܽݐ݁	ሺܭሻሻ 
 
In addition, we reported the remember and know response biases, indicating the 
position of the participants’ decision criterion with respect to the neutral point c=0, 
where there is no response bias (Stanislaw & Todorov, 1999). Values are ranging 
from -1 to +1. Values less than 0 indicate a bias towards the “yes” response (i.e. here 
a “remember “or know response) and values greater than 0 indicate a bias toward the 
“no” response (i.e. here a new response).  
 
The remember response bias was calculated by 
ܿ	ሺܴሻ ൌ െܼ	ሺ݄݅ݐ	ݎܽݐ݁	ሺܴሻሻ ൅ 	ܼ	ሺܨܣ	ݎܽݐ݁	ሺܴሻሻ2  
 
The know response bias was calculated by 
ܿ	ሺܭሻ ൌ െܼ	ሺ݄݅ݐ	ݎܽݐ݁	ሺܭሻሻ ൅ 	ܼ	ሺܨܣ	ݎܽݐ݁	ሺܭሻሻ2  
 
In summary, variables of interest were: 
1) Overall recognition. 
2) Remember performance as indicated by d’ (R). 
3) Know performance as indicated by d’ (K). 
4) Response bias for the remember performance as indicated by c (R). 




Group was the between subjects factor and memory performance as indicated by d’ 
(R) versus d’ (K) and response bias as indicated by c (R) versus c (K) the within-
subjects factors.  
 
4.3 Results 
4.3.1 Logical memory I and II 
Due to a problem with the recording of the task, only the data of 33 women could be 
analysed (NPE=10, PE=9, healthy controls=14).  
 
4.3.1.1 Combined group analysis (CGA) 
In the following section the “at risk” group as a whole will be compared to healthy 
controls. As shown in Figure 4.3, there was a significant difference between the “at 
risk” group and healthy controls on the immediate memory performance (t(31)=2.19, 
p=.04), with the “at risk” group performing worse than the healthy controls. There 
was, however, no significant group difference for the delayed memory performance 
(t(31)=1.59, p=.12); see Figure 4.4 and for scores see Table 4.4.  
 
Figure 4.3 Logical memory I (CGA) 
 
Figure 4.3 shows the mean performance of the “at risk” group and healthy controls on immediate 




Figure 4.4 Logical memory II (CGA) 
 
Figure 4.4 shows the mean performance of the “at risk” group and healthy controls on delayed 




Table 4.4 Logical memory scores (CGA) 
Groups “at risk” M (SD) healthy controls M (SD) 
LM I standard scores 9.82 (2.65) 11.71 (2.05) 
LM I raw scores 39.68 (10.26) 46.14 (8.10) 
LM II standard scores 10.74 (2.75) 12.29 (2.81) 
LM II raw scores 26.00 (7.88) 30.14 (8.05) 
Table 4.4 shows the raw and standard scores of the “at risk” group and healthy controls on immediate 
(LM I) and delayed (LM II) memory. M=mean. SD=standard deviation.  
 
 
4.3.1.2 Sub group analysis (SGA) 
As shown in Figures 4.5 and 4.6, there were no significant differences between the 
NPE, PE and healthy controls on the immediate or delayed memory performance 










Figure 4.5 Logical memory I (SGA) 
 
Figure 4.5 shows the mean performance of the NPE, PE and healthy control groups on immediate 
(LM I) memory. The y-axis shows the mean performance. The error bars show the standard error of 
mean (SEM).  
 
Figure 4.6 Logical memory II (SGA) 
 
Figure 4.6 shows the mean performance of the NPE, PE and healthy control groups on delayed (LM 







Table 4.5 Logical memory scores (SGA) 
Groups NPE M (SD) PE M (SD) healthy controls M (SD) 
LM I standard scores 10.22 (3.19) 9.67 (2.24) 11.71 (.59) 
LM I raw scores 41.33 (12.14) 39.00 (8.75) 46.14 (8.10) 
LM II standard scores 11.44 (3.21) 10.00 (2.35) 12.29 (2.81) 
LM II raw scores 28.00 (9.21) 23.89 (6.74) 30.14 (8.05) 
Table 4.5 shows the raw and standard scores of the NPE, PE and healthy control groups on immediate 
(LM I) and delayed (LM II) memory. M=mean. SD=standard deviation. 
 
4.3.1.3 Additional analysis 
There were no significant correlations between the HAM-D, PANSS, or length of 
illness and logical memory performance (largest r(19)=.39, smallest p=.14). There 
were also no significant effects of antipsychotic medication or having had a 
menstrual period after delivery when the two variables were included into the model 
as fixed factors (yes/no) (smallest p=.23). 
    As a further additional analysis we compared all women who were at risk of 
postpartum psychosis due to a diagnosis of bipolar disorder (N=11) or other 
diagnoses (i.e. schizoaffective disorder, postpartum psychosis or family history) 
(N=8) and healthy controls (N=14). However, there were no significant differences 
between groups in either the immediate (F(2,30)=2.44, p=.10) or delayed recall 
(F(2,30)=1.27, p=.30). 
 
4.3.2  Remember-know paradigm 
Three women could not complete the verbal memory task due to time reasons (i.e. 
the gap between encoding and retrieval was too long due to a delay in the MRI scan), 
leaving a total of 43 women for analysis (NPE=12, PE=11, and healthy controls=20). 
One healthy control was excluded for floor performance suggesting no engagement 
with the task. 
 
4.3.2.1 Encoding 
There were no significant differences between groups in the percentage of words 
correctly identified as natural or man made or RT (smallest p=.26). In each group the 
percentage of correctly identified words was above 89%. The mean RT for each 
group was between 1154ms and 1287ms.  
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4.3.2.2 Combined group analysis (CGA) 
In the following section the “at risk” group will be compared to healthy controls. As 
shown in Figure 4.7, a repeated measures ANOVA showed no interaction effect 
between group (“at risk” versus healthy controls) and memory performance as 
indexed by d’ (remember versus know) (F(1,40)=.82, p=.37). However, there was a 
significant main effect of group with the “at risk” group having a lower overall 
memory performance than healthy controls (F(1,40)=5.72, p=.02). This effect 
remained significant when we excluded the women that could not be analysed for the 
logical memory task (F(1,30)=4.88, p=.04). This group difference was also 
significant when overall recognition performance as indicated by d’ was compared 
(F(1,40)=9.17, p=.01). There was also a significant main effect of memory 
performance (F(1,40)=16.75, p=.01) as both groups showed a higher remember than 
know performance. We also investigated the response bias. There was no interaction 
effect between group and response bias as indexed by c (R versus K) (F(1, 40)=.02, 
p=.90) and no main effects of group or response bias (F(1, 40)=.02, p=.76; F(1, 
40)=2.28, p=.14, respectively). The RT did not differ between groups (t (40)=-.05, 
p=.96). For scores see Table 4.6.  
 
Figure 4.7 Memory performance (CGA) 
 
Figure 4.7 shows the mean performance of the “at risk” and healthy control groups on memory 
performance as indexed by d’ (remember and know). The y-axis shows the mean performance. The 





Table 4.6 Remember and know responses (CGA) 
Groups “at risk” M (SD) healthy controls M (SD) 
Remember   
   d’  1.85 (.59) 2.07 (.81) 
   c  .55 (.55) .56 (.52) 
   Hit rate  .63 (.24) .65 (.24) 
   False alarm rate  .09 (.08) .08 (.07) 
Know   
   d’ .98 (.58) 1.51 (1.02 
   c .77 (.78) .82 (.58) 
   Hit rate  .42 (.26) .48 (.28) 
   False alarm rate  .16 (.21) .08 (.07) 
RT 1406 (266) 1402 (193) 
Overall d’ 1.76 (.55) 2.39 (.81) 
Table 4.6 shows the scores of the “at risk” and healthy control groups on memory performance. 
M=mean. SD=standard deviation.
 
4.3.2.3 Sub group analysis (SGA) 
In the following section the NPE and PE groups will be compared to each other and 
healthy controls. As can be seen on the graph in Figure 4.8, a repeated measures 
between subjects ANOVA did not show an interaction effect between group (NPE, 
PE and healthy controls) and memory performance as indexed by d’ (R versus K) 
(F(2, 38)=1.67, p=.20). There was a strong trend towards a significant main effect of 
group (F(1,38)=2.91, p=.07). This trend remained when we excluded the women that 
could not be analysed for the logical memory task (F(2,28)=2.26, p=.09). Groups 
differed significantly when we compared overall recognition as indicated by d’ 
(F(1,38)=4.41, p=.02). Post-hoc t-tests with Bonferroni correction showed a 
significant difference between the NPE group and healthy controls (p=.04) and a 
trend between the PE group and healthy controls (p=.07). There was no difference 
between the NPE and PE group following Bonferrroni correction (p=.84). Again, 
there was a significant main effect of memory performance as all groups had a better 
remember than know performance (F(1,38)=18.35, p=.01).  We also investigated 
response bias. There was no significant interaction effect between group and 
response bias as indexed by c (R versus K) (F(2,38)=.50, p=.95). There were also no 
significant main effects for group or response bias (F(2, 38)=1.05, p=.36; 
F(2,38)=2.27, p=.14, respectively) or significant group differences in RT 






Figure 4.8 Memory performance (SGA) 
 
Figure 4.8 shows the mean performance of the NPE, PE and healthy control groups on memory 
performance as indexed by d’ (remember and know). The y-axis shows the mean performance. The 
error bars show the standard error of mean (SEM). 
 
Table 4.7 Remember and know responses (SGA) 
Groups NPE M (SD) PE M (SD) healthy controls M (SD) 
Remember    
   d’ 2.01 (.48) 1.68 (.68) 2.07 (.81) 
   c .38 (.39) .65 (.65) .56 (.52) 
   Hit rate  .71 (.15) .57 (.30) .66 (.25) 
   False alarm rate  .10 (.08) .09 (.08) .08 (.07) 
Know    
   d’ .75 (.60) 1.17 (.54) 1.51 (1.02) 
   c  .70 (.98) .83 (.62) .82 (.58) 
   Hit rate  .41 (.30) .42 (.28) .48 (.29) 
   False alarm rate  .21 (.29) .12 (.11) .08 (.07) 
RT 1363 (267) 1405 (246) 1402 (193) 
Overall d’ 1.71 (.72) 1.79 (.39) 2.39 (.81) 
Table 4.7 shows the scores of the NPE, PE and healthy control groups on memory performance. 
M=mean. SD=standard deviation.
 
4.3.2.4 Additional analysis 
There were no significant correlations between age, HAM-D, PANSS, or length of 
illness and overall recognition (largest r(43)=.14, smallest p=.38). There were further 
no significant effects found of antipsychotic medication or having had a period after 
delivery when the two variables were taken into the model as fixed factors (yes/no) 
on overall recognition (smallest p=.19).  
    As a further additional analysis we compared all women who were at risk of 
postpartum psychosis due to a diagnosis of bipolar disorder (N=12) or other 
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diagnoses (i.e. schizoaffective disorder, postpartum psychosis or family history) 
(N=11) and healthy controls (N=19). There was a significant group difference 
(F(2,39)=3.26, p.05) with the bipolar patients performing worse compared to healthy 
controls following pairwise comparisons with Bonferroni correction (p=.05). Women 
who were “at risk” due to other diagnoses also performed numerically worse; 
however, this difference was not significant following Bonferroni correction (p=.48). 
There was no difference between women diagnosed with bipolar disorder and other 
“at risk” women on memory performance (P=1). 
 
4.4 Discussion 
In this chapter, the verbal memory performance of women at risk of postpartum 
psychosis was investigated with the logical memory paradigm of the WMS-III 
assessing recall and a recognition paradigm assessing recollection and familiarity.  
We expected that women who are at risk of postpartum psychosis would show 
deficits in both paradigms compared to healthy controls. Furthermore, we proposed 
that women who developed postpartum psychotic episodes would perform worse 
than women who had non-postpartum episodes and healthy controls. The results of 
this chapter belong to the secondary hypotheses of this thesis and therefore, it is 
important to note that the tasks to assess verbal memory may be underpowered.  
 
4.4.1 Logical Memory 
As expected in our first hypothesis, women “at risk” showed an impaired verbal 
memory performance compared to healthy controls as shown in a worse immediate 
recall (Aleman et al., 1999; Arts et al., 2008; Libby et al., 2012; Reichenberg, 2010; 
Reichenberg et al., 2009; L. J. Robinson et al., 2006). The performance of the healthy 
controls was similar to previous studies in psychiatric populations (Bell, 2006; 
Kieseppa et al., 2005). Therefore, it is unlikely that the difference was due to a 
superior performance of the healthy controls. Women did not differ significantly on 
the delayed recall of the stories. One potential explanation for this result could be 
that we did not have sufficient power to detect a statistically significant delayed 
memory effect. Indeed, “at risk” women did still perform lower than healthy controls 
numerically. Contrary to our second hypothesis, there were no significant differences 
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between women with non-postpartum and postpartum episodes on either the 
immediate or delayed memory recall of the stories. Our findings show that women 
“at risk”, including women with non-postpartum and postpartum episodes, share 
common cognitive impairments in verbal memory with bipolar disorder and 
psychoses unrelated to childbirth (I.N. Ferrier et al., 1999; Kieseppa et al., 2005; L. J. 
Robinson & Ferrier, 2006; L. J. Robinson et al., 2006; Wood et al., 2007). 
 
4.4.2 Remember-know paradigm 
In line with our first hypothesis, women “at risk” showed an overall impaired 
memory performance on the remember-know paradigm compared to healthy 
controls. Somewhat surprising was the finding that the remember performance of “at 
risk” women was better than the know performance, given that previous reports often 
highlighted a more impaired recollection process in psychoses unrelated to childbirth 
(Brébion et al., 2001; Huron et al., 1995; Martin et al., 2011; Thoma et al., 2006; van 
Erp et al., 2008). However, as highlighted in a recent review, familiarity deficits have 
been found in psychoses unrelated to childbirth, even though they seem less strongly 
associated with the illness than recollection impairment (Libby et al., 2012). 
Furthermore, the fact that the remember scores were higher than the know scores in 
general fits previous results, stating that remember judgements are more common 
than know judgements (R. N. A. Henson et al., 1999). Not in line with our second 
hypothesis and similarly to the logical memory results, there were no significant 
differences between women with non-postpartum and postpartum episodes in terms 
of  recollection and familiarity. Both groups differed, however, from healthy control 
in overall recognition performance. Again, these findings further support the idea 
that women with postpartum psychosis do not show a different cognitive profile to 
patients that have non-postpartum mood or psychotic episodes and have a similar 
cognitive dysfunction as seen in bipolar disorder and psychosis unrelated to 
childbirth (Aleman et al., 1999; Arts et al., 2008; Libby et al., 2012; Reichenberg, 
2010; Reichenberg et al., 2009; L. J. Robinson et al., 2006). Differences between the 
“at risk” group and healthy controls were not explained by differences in encoding or 
in false alarm rates per se as previously suggested (Brébion et al., 2001; Thoma et 
al., 2006), as all women showed a similar performance on these variables. Also, 
women did not differ in their reaction time during encoding or retrieval and there 
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was no difference in response bias between groups, suggesting no differences in the 
strategic approach to the task. In general, all groups showed a positive response bias 
for both remember and know responses, typically indicating a conservative criterion 
leading to fewer false alarm rates (Stanislaw & Todorov, 1999). 
 
4.4.3 Additional analysis 
Verbal memory dysfunction was not associated with higher scores on depression or 
positive or negative psychotic symptoms. This is not in line with previous studies, 
which have reported lower verbal memory performance for patients who report more 
depressive or negative symptoms in bipolar disorder (Aleman et al., 1999; Brébion et 
al., 2001; Pelletier et al., 2005; Thoma et al., 2006). A lack of association with 
positive symptoms has been shown before (Lysaker et al., 2000). No association was 
found with length of illness (or age for the remember-know paradigm). It has been 
reported that chronicity is associated with verbal memory impairment in bipolar 
disorder and with recognition memory in schizophrenia (Pelletier et al., 2005; L. J. 
Robinson & Ferrier, 2006). Consequently, our finding that verbal memory 
performance was not related to length of illness differs to literature in bipolar 
disorder. Nonetheless, one important difference is that many women in our sample 
had just suffered one illness episode and, therefore, it may not be possible to draw 
valid conclusions on the basis of this single evaluation. 
     Antipsychotic medication did not have a significant effect on performance in 
either task when taken into the model as a dichotomous variable, which further 
supports the notion that verbal memory impairment in bipolar disorder and psychoses 
unrelated to childbirth is not an artefact of psychotropic medications and typically 
remains even once medications are taken into account (Goswami et al., 2009; L. J. 
Robinson et al., 2006; J. B. Savitz et al., 2008). In addition, we assessed whether 
there was a performance difference between women who had already recovered their 
regular menstrual cycle after delivery and those who had not. This was in order to 
find out whether there might have been an influence of oestrogens on verbal memory 
performance (Craig et al., 2008; Craig et al., 2007). Although having had a menstrual 
period did not have a direct significant effect on the results, we are aware that this is 
a very primary hormonal measure from which no firm conclusion can be drawn. 
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Unfortunately, it was not possible for us to recruit all women at exactly the same 
time point after delivery and some women were already using contraception. 
Therefore, for this sample we were unable to investigate hormonal levels with more 
sophisticated measures.       
 
4.4.3.1 Impact of bipolar disorder 
Women who were diagnosed with bipolar disorder did not show impaired 
performance compared to healthy controls on the logical memory task, but were 
impaired for recognition memory. Since there is a paucity of research on recognition 
deficits in bipolar disorder, this is one of the first studies to report an impairment. 
Given that women who were at risk of postpartum psychosis due to “other” 
diagnoses also performed numerically lower on the recognition paradigm compared 
to the healthy controls, as well as the apparent performance differences between 
women “at risk” due to bipolar disorder and women “at risk” due to “other” 
diagnoses on the two tasks, it is difficult to draw a firm conclusion about the 
influence of bipolar disorder per se on our results.  However, based on these findings 
it seems reasonable to assume that women who have suffered from postpartum 
psychosis show similar deficits in their cognitive profile to those found in bipolar 
disorder.   
 
4.4.4 Conclusion 
This is the first study investigating verbal memory performance in women at risk of 
postpartum psychosis. As expected, we have found a significant impairment in verbal 
memory performance, including deficits in recall and recognition (i.e. recollection 
and familiarity) for women at risk of postpartum psychosis. Both groups of women 
(those with non-postpartum episodes and those with postpartum episodes) showed a 
similar impaired performance compared to healthy controls, indicating that women 
with postpartum psychosis show a similar cognitive profile to bipolar disorder and 
psychoses unrelated to childbirth. It is important to acknowledge, that if the overall 
multiple comparison correction is applied (P< 0.001) none of the results is still 
significant. However, the fact that this deficit emerged in two different tasks in a 
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relatively small sample of women suggests that this is a robust finding and should be 




5. Chapter: Working memory 
In this chapter, an overview of the relevant fMRI literature on working memory will 
be presented. Then, the N-back working memory task, used in the current study, and 
additional details of the analysis will be described. This will be followed by the 
presentation of the behavioural and imaging results and their discussion in the 
context of the existing literature. 
 
5.1 Introduction 
Similar to other domains of cognitive functioning, no studies on working memory 
function have been conducted in women at risk of, or suffering from, postpartum 
psychosis. However, working memory dysfunction is considered one of the main 
impairments in bipolar disorder and psychoses unrelated to childbirth and is therefore 
of potential relevance to psychosis related to childbirth (Bora et al., 2010; I.N. Ferrier 
et al., 1999; Libby et al., 2012; Mur et al., 2007; L. J. Robinson et al., 2006; J. B. 
Savitz et al., 2008; Torres, Boudreau, & Yatham, 2007; Valli et al., 2012). Working 
memory is the ability to temporarily maintain and manipulate information for future 
action and is important for many complex cognitive processes (Baddeley, 2000; 
D.M. Barch & Ceaser, 2012). Often used for the assessment of working memory are 
tasks requiring storage and maintenance or maintenance and manipulation of task-
relevant information (e.g. keeping a sequence of numbers in mind that is needed later 
on in the task) (Reichenberg, 2010).  
     In fMRI, the N-back task is most commonly used in order to assess working 
memory and was therefore chosen in this study, although its reliability and construct 
validity has been criticised in the past (Gevins & Cutillo, 1993; Jaeggi, Buschkuehl, 
Perrig, & Meier, 2010; Kirchner, 1958; Owen et al., 2005). The N-back task requires 
on-line monitoring, updating, and manipulation of remembered information by 
asking participants to remember sequences of letters. This continuous performance 
task is said to place great demands on working memory (Glahn et al., 2005; Owen et 
al., 2005). As shown in a meta-analysis of N-back fMRI tasks in healthy volunteers, 
typically activated regions in the brain during task performance compared to a 
visuomotor control are the frontal and parietal cortices including the lateral premotor, 
dorsal cingulate and medial premotor cortex, dorsolateral and ventro-lateral 
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prefrontal cortex, frontal poles, and medial and lateral posterior parietal cortex 
(Owen et al., 2005). However, certain deviations from this activation pattern during 
task performance have been repeatedly linked to bipolar disorder and psychoses 
unrelated to childbirth when compared to healthy controls (C. Chen et al., 2011; 
Fusar-Poli et al., 2012; Glahn et al., 2005; Minzenberg et al., 2009).   
 
5.1.1 Working memory dysfunction in bipolar disorder 
In patients with bipolar disorder, both hyper- and hypoactivations have been reported 
compared to healthy controls, which were sometimes accompanied by poorer and 
sometimes by similar task performance. Increases in brain activation, accompanied 
by poorer task performance when compared to healthy volunteers, have been 
reported in areas including the frontal cortex (e.g. dorsolateral prefrontal cortex, 
insula and anterior cingulate cortex), temporal and parietal cortices and subcortical 
structures (e.g. thalamus and caudate nucleus) (Adler, Holland, Schmithorst, 
Tuchfarber, & Strakowski, 2004; Drapier et al., 2008). Increases in activation within 
similar regions have also been reported in people at genetic risk of bipolar disorder 
(i.e. specifically in frontal and parietal cortices as well as in subcortical structures) 
(Drapier et al., 2008; Fusar-Poli et al., 2012; Thermenos et al., 2010; Thermenos et 
al., 2011). The activation seems to further increase with higher working memory load 
(Frangou, Kington, Raymont, & Shergill, 2008).  
       Other studies report that bipolar disorder patients show both decreases and 
increases in activations in certain brain areas compared to healthy volunteers; these 
are not necessarily accompanied by differences in performance (C. Chen et al., 2011; 
Jogia, Dima, & Frangou, 2012; Jogia, Dima, Kumari, & Frangou, 2012; Monks et al., 
2004). Reduced activation has been reported in frontal regions (e.g. inferior frontal 
gyrus and insula), temporal and parietal cortices, and subcortical structure, while 
increases were shown in cingulate cortices and also in frontal and parietal areas (C. 
Chen et al., 2011; Jogia, Dima, & Frangou, 2012; Jogia, Dima, Kumari, et al., 2012; 
Monks et al., 2004).  
     Modulation of activation reported in bipolar disorder compared to healthy 
controls appears to be independent of mood state (Townsend, Bookheimer, Foland-
Ross, Sugar, & Altshuler, 2010). Furthermore, modulation of activation seems to be 
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independent of gender, as no working memory related differences have been reported 
in either healthy individuals (Schmidt et al., 2009) or patients with bipolar disorder 
(Jogia, Dima, & Frangou, 2012; Jogia, Dima, Kumari, et al., 2012). In line with other 
findings in the cognitive domain it has been shown that when compared to patients 
with psychoses unrelated to childbirth, euthymic bipolar patients demonstrate 
activation differences intermediate between healthy controls and people with 
psychoses (L. S. Hamilton et al., 2009; Reichenberg, 2010; Reichenberg et al., 2009; 
Stefanopoulou et al., 2009).  
 
5.1.2 Working memory dysfunction in psychoses unrelated to childbirth 
As described earlier, working memory is severely impaired in psychoses unrelated to 
childbirth (Forbes, Carrick, McIntosh, & Lawrie, 2009; Reichenberg, 2010) and in 
the last decade considerable evidence has been collected to demonstrate that this is 
accompanied by aberrant brain activation (Glahn et al., 2005; Minzenberg et al., 
2009). Similar to patients with bipolar disorder, hyper- and hypoactivations have 
been reported in the literature. A typical finding is that in N-back working memory 
paradigms, patients with psychoses unrelated to childbirth show, compared to 
healthy controls, reductions in the activation of certain frontal regions (e.g. 
dorsolateral and ventro-lateral prefrontal cortex, anterior cingulate cortex), but also 
in temporal, parietal and occipital cortices as well as subcortical areas (e.g. 
hippocampus, thalamus and putamen) (Glahn et al., 2005; Henseler, Falkai, & 
Gruber, 2009; Minzenberg et al., 2009).  
     However, decreases in activation have often been accompanied by increases in 
certain areas, including frontal areas (e.g. prefrontal cortex, anterior cingulate, 
insula), temporal and parietal cortices, and subcortical structures (D.M.  Barch & 
Csernansky, 2007; Glahn et al., 2005; Minzenberg et al., 2009; Thormodsen et al., 
2011). Differences in brain activation in frontal areas, including the dorsolateral 
prefrontal cortex, and in parietal areas have also been reported in people at high risk 
of developing psychoses unrelated to childbirth, with activation being intermediate 
between patients and healthy controls (Broome et al., 2009; Smieskova et al., 2012). 
Several authors have tried to find explanations for the apparent inconsistencies of 
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hyper- and hypoactivation found in bipolar disorder and psychoses unrelated to 
childbirth.  
 
5.1.3 The effect of working memory load 
Several attempts have been made to explain the hyper- and hypoactivation patterns 
of bipolar disorder and psychoses unrelated to childbirth when compared to healthy 
controls. For example, it has been proposed that some regions show a compensatory 
response (i.e. hyperactivation) to the hypoactivation in other regions (Minzenberg et 
al., 2009). However, the most accepted hypothesis is the “inefficiency hypothesis” 
(Callicott et al., 2003; Karlsgodt et al., 2009; M. A. Kim et al., 2010). According to 
this hypothesis, increasing task load correlates with increasing activation, but 
patients with psychoses unrelated to childbirth use greater prefrontal activation in 
order to achieve the same task performance as healthy controls (Callicott et al., 2003; 
Karlsgodt et al., 2009; M. A. Kim et al., 2010). It is also possible that at a higher 
working memory load, patients fail to sustain prefrontal activation (i.e. showing 
reductions compared to healthy controls following a u-shaped curve) with a 
subsequent decline in performance (Callicott et al., 2003; Karlsgodt et al., 2009; M. 
A. Kim et al., 2010). This hypothesis is supported by the fact that hypoactivation, 
especially in the dorsolateral prefrontal cortex, has been linked to worse performance 
in participants with psychoses unrelated to childbirth (D.M. Barch & Ceaser, 2012; 
Glahn et al., 2005; Perlstein, Carter, Noll, & Cohen, 2001). Nonetheless, in bipolar 
disorder increases in activation have been typically linked to poorer task 
performance, thus questioning the proposed hypothesis (Adler et al., 2004; Drapier et 
al., 2008).  
     In summary, working memory deficits that have been consistently reported in 
patients with bipolar disorder and psychoses unrelated to childbirth have been 
associated with differential brain activation compared to healthy controls, most 
significantly in the frontal cortex when assessed with the N-back task. Therefore, we 
expected to find a similar performance deficit and activation pattern in women at risk 
of postpartum psychosis. Specifically, we hypothesised that 1) women at risk of 
postpartum psychosis will show, in comparison to healthy controls, decreased brain 
activation in the dorsolateral prefrontal cortex during a working memory task 
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(primary hypothesis); 2) women at risk of postpartum psychosis will show, in 
comparison to healthy controls, differential brain activation as assessed with whole 
brain analysis (secondary hypothesis); 3) women at risk of postpartum psychosis will 
show, in comparison to healthy controls, impaired working memory performance 
(secondary hypothesis); 4) impairments in working memory and differences in brain 
activation in working memory will be more pronounced in women who had 
developed postpartum psychosis episodes, compared to women who had not 
developed postpartum psychotic episodes, and to healthy controls (secondary 
hypothesis). For these hypothesis the N-back task will be used. 
 
5.2 Methods 
5.2.1 Participants, design, analyses and procedures 
The methods have been described in chapter 2. For information on the combined 
group analyses and sub group analyses please see chapter 2 and chapter 3. 
 
5.2.2 N-back paradigm 
This task comprised a stream of letters presented to the participant while lying in the 
MRI scanner. In the easiest level of difficulty, the participant had to respond if any 
letter was followed by the same letter (e.g. A-B-C-C). In this case the condition 
began with the instruction “one back”. In the next level of difficulty (i.e. two back), 
the participant had to respond if a letter was followed by the same letter with one 
distractor in between (e.g. A-B-C-B). Finally, in the three back condition (the 
highest level of difficulty) the participant had to respond if a letter was followed by 
the same letter with two distractors in between (e.g. A-B-C-A); see Figure 5.1.  
     During a control condition, the participant was asked to respond to the letter “X’. 
The task was presented in the form of a block design consisting of varying levels of 
difficulty. It included 12 blocks, each lasting 30 seconds and containing one 
instruction and 14 letters. Altogether the task lasted six minutes and 20 seconds with 





Figure 5.1 The N-back task 
 
Figure 5.1 shows all three levels of difficulty of the N-back task with the easiest in the first column 
(one back), followed by the next level of difficulty in the middle column (two back) and the most 
difficult condition in the last column (three back). 
 
5.2.3 Analysis 
For a further description of the performance and imaging analyses please see chapter 
2. The dependent variables for the behavioural analysis were the number of correct 
responses for the one-, two-, three back and the control condition and the reaction 
times of each condition. Specific contrasts of interest for the second-level model of 
the imaging analysis were the one, two and three back versus the control condition. 
Based on our hypotheses, we conducted a region of interest (ROI) analysis limited to 
the dorsolateral prefrontal cortex. This region was defined by commonly used 
anatomical landmarks of the right dorsolateral prefrontal cortex using the WFU 
PickAtlas tool in SPM (Bleich-Cohen et al., 2013; Glahn et al., 2005). We also 
conducted a whole brain analysis. In order to investigate possible correlations 
between activation and performance, we also examined the contrast between the 
three back and the two back condition with a ROI analysis. Regions were selected 
based on our results of this contrast and included the left midcingulum (MNI 
coordinates x=-16, y=-24, z=38), the right superior temporal gyrus (MNI coordinates 
x=52, y=-4, z=-10), and the left superior temporal gyrus (MNI coordinates x=-48, 
y=-38, z=10). Spherical masks with a radius of 10mm were created around the 
coordinates using the SPM toolbox MarsBaR. Regions of interest were further 
analysed using SPSS 20 for Windows.  
 
5.3 Results 
One healthy control was excluded from the analysis as her overall accuracy across all 
N-back conditions was only 50%, suggesting that she did not engage in the task. In 
154 
 
total 45 women were analysed (NPE=13, PE=12, healthy controls=20). Two 
participants had movement values greater than two mm/degrees (i.e. movement 
greater than one voxel). However, following inspection of the performance and 
imaging results, these participants did not show any significant differences in 
performance or activation and were therefore included in the analysis. 
 
5.3.1 Performance results 
There were no significant differences between groups (CGA and SGA) in accuracy 
or RT of the control condition (smallest p=.34).  
 
5.3.1.1 Combined group analysis 
There was no difference between groups (“at risk” versus healthy controls) on 
accuracy in the one back and two back conditions (z=-.09, p=.92; z=-.44, p=.66; 
respectively). However, there was a strong trend for a difference between groups on 
accuracy in the three back condition, with the “at risk” group performing worse than 
healthy controls (z=-1.91, p=.06). There was no significant difference between the 
“at risk” and healthy control group on false positives in the one, two, or three back 
conditions (smallest p=.22); see Figure 5.2 and Table 5.1.   
 
Table 5.1 N-back performance (CGA) 
Groups “at risk” M (SD) healthy controls M (SD) 
Accuracy (%)   
Control 99 (2) 98 (7) 
One back 97 (6) 97 (7) 
Two back 85 (22) 91 (11) 
Three back 69 (21) 82 (15) 
False positives (%)   
One back <1 (3) <1 (4) 
Two back 4 (6) 2 (5) 
Three back 8 (10) 7 (10) 
RT   
Control 515 (82) 490 (88) 
One back 626 (130) 587 (135) 
Two back 725 (142) 648 (122) 
Three back 718 (144) 715 (161) 
Table 5.1 shows the N-back scores of the “at risk” group and healthy controls on accuracy, false 




5.3.1.2 Sub group analysis 
There was no difference between groups (NPE, PE and healthy controls) on accuracy 
in the one back and two back conditions (χ2(2,44)=.13, p=.94; χ2(2,44)=.55, p=.76). 
Again, there was a trend for a difference between groups in accuracy in the three 
back condition (χ2(2,44)=5.41, p=.07), with the NPE group performing worse than 
healthy controls following Bonferroni correction (z=-2.44, p=.05). There was no 
significant difference between the NPE, PE and healthy control groups on false 
positives in the one, two, or three back conditions (smallest p=.25); see Figure 5.3 
and Table 5.2.  
 
Table 5.2 N-back performance (SGA) 
Groups NPE M (SD) PE M (SD) healthy controls M (SD) 
Accuracy (%) 
Control 97 (9) 100 (0) 99 (32) 
One back 97 (7) 97 (5) 97 (7) 
Two back 80 (28) 87 (15) 91 (11) 
Three back 65 (19) 72 (25) 82 (15) 
False positives (%)  
One back <1 (0) <1 (3) <1 (4) 
Two back 2 (4) 5 (8) 2 (5) 
Three back 9 (11) 6 (8) 7 (10) 
RT  
Control 504 (75) 525 (91) 490 (88) 
One back 644 (139) 619 (122) 587 (135) 
Two back 731 (155) 730 (135) 648 (122) 
Three back 670 (157) 772 (119) 715 (161) 
Table 5.2 shows the N-back scores of the NPE, PE and healthy control groups on accuracy, false 
positive and reaction time. RT=reaction time. M=mean. SD=standard deviation. 
 
5.3.1.3 Working memory load 
The performance measure accuracy was analysed using Friedmans ANOVA. As 
shown in the graphs (Figures 5.2 and 5.3), there was a significant effect of working 
memory load across all groups (χ2(2,45)=46.66, p<.01) between both the one and two 
back, and the two and three back conditions, with the task getting increasingly more 







Figure 5.2 Working memory load (CGA) 
 
Figure 5.2 shows the mean N-back task performance of the “at risk” group and healthy controls on 
accuracy. The y-axis shows the mean performance. The error bars show the standard error of mean 
(SEM).  
 
Figure 5.3 Working memory load (SGA) 
 
Figure 5.3 shows the mean N-back task performance of the NPE, PE, and healthy control groups on 
accuracy. The y-axis shows the mean performance. The error bars show the standard error of mean 
(SEM). 
 
There was also a significant linear trend of false positives across all groups 
(χ2(2,45)=29.95, p<.01) between both the one and two back, and the two and three 
back conditions, with all women making increasingly more errors (z=-2.35, p=.02; 




Figure 5.4 False positives (CGA) 
 
Figure 5.4 shows the mean N-back task performance of the “at risk” group and healthy controls on 




Figure 5.5 False positive (SGA) 
 
Figure 5.5 shows the mean N-back task performance of the NPE, PE and healthy control groups on 
false positives. The y-axis shows the mean performance. The error bars show the standard error of 
mean (SEM). 
 
5.3.1.4 Reaction time 
Reaction time was assessed using parametric tests. Using a repeated measures 
between groups ANOVA, there was no significant interaction effect in the combined 
analysis between group (“at risk” versus healthy controls) and RT (one, two, and 
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three back) (F(2,42)=1.76, p=.18) and no significant main effect between the “at 
risk” and healthy control groups (F(1,43)=1.25, p=.27). There was a linear effect of 
RT (F(2,42)=17.61, p=<.01). However, when split into sub groups, there was a trend 
towards an interaction between group (NPE, PE and healthy controls) and RT (one, 
two, and three back) (F(4,82)=2.51, p=.06) with the NPE group having numerically a 
lower RT in the three back condition compared to the two back condition; see 
Figures 5.6 and 5.7. This indicates that women in the NPE group showed a relative 
faster response during the three back condition compared to the PE and healthy 
control groups.  
 
Figure 5.6 Reaction time (CGA) 
 
Figure 5.6 shows the mean reaction time of the “at risk” group and healthy controls during the one, 
two and three back conditions. The y-axis shows the mean reaction time. The error bars show the 











Figure 5.7 Reaction time (SGA) 
 
Figure 5.7 shows the mean reaction time of the NPE, PE, and healthy control groups during the one, 
two and three back conditions. The y-axis shows the mean reaction time. The error bars show the 
standard error of mean (SEM). 
 
5.3.1.5 Additional analyses  
There were no significant correlations between age, YMRS, HAM-D, PANSS, or 
length of illness and any of the performance measures within the “at risk” group 
(largest r(25)=-34, smallest p=.10). There was also no significant effect of 
antipsychotic medication on performance when included into the models for the 
combined or sub group analysis as fixed factors (yes/no) (smallest p=.24). 
As a further additional analysis we compared all women who were at risk of 
postpartum psychosis due to a diagnosis of bipolar disorder (N=14) or other 
diagnoses (i.e. schizoaffective disorder, postpartum psychosis or family history) 
(N=11) and healthy controls (N=20). There were no significant group differences in 
accuracy or false positives (smallest p=.10). There was a trend towards an interaction 
between group (bipolar, “other” and healthy controls) and RT (one, two, and three 
back) (F(4,84)=2.12, p=.09) with women in the bipolar group having numerically a 
lower RT in the three back condition compared to the two back condition. This 
indicates that women in the bipolar group showed a relative faster response during 





5.3.2 Imaging results 
Two ROI analyses of the dorsolateral prefrontal cortex and two full-factorial 
ANOVA models were conducted with 1) group (“at risk” versus healthy controls) as 
between subject factor and load (one-, two-, and three-back) as within subject factor 
for the combined group analysis (2x3) and 2) group (NPE, PE and healthy controls) 
as between subject factor and load (one-, two-, and three-back) as within subject 
factor for the sub group analysis (3x3). 
 
5.3.2.1 N-back working memory network 
As a first analysis, we confirmed that the task robustly elicited the established 
network of regions reported in the literature in our participants, including the frontal 
and parietal areas (Minzenberg et al., 2009; Owen et al., 2005). For this, we 
performed an analysis looking at brain regions activated by the one-, two-, and three-
back conditions across groups in the 2x3 model (CGA); see Table 5.3 and Figure 5.8.   
 
Table 5.3 The N-back task network for one-, two-, and three-back conditions across all groups 
Area x Y z BA Voxels Z Pcor 
R Mid Frontal 34 2 60 6 2932 7.27 <.001 
L Mid Frontal -40 50 12 46 345 6.30 <.001 
L Precentral -44 0 30 6 2145 7.54 <.001 
R Insula 32 24 -4 47 301 6.83 <.001 
L Insula -32 22 0 47 179 5.56 <.001 
R Inf Temporal 52 -52 -14 20 50 4.97 =.005 
R Angular 30 -64 44 7 3753 >7.54 <.001 
L Parietal Sup -24 -68 46 7 2748 >7.54 <.001 
L Inf Occipital -46 -62 -14 37 34 4.69 =.009 
L Thalamus -14 -22 18 27 6 4.49 =.029 
Table 5.3 shows the brain regions activated during the contrast “all back>control”. X, y, and z refer to 
the MNI coordinates. BA refers to the Brodmann area and Z and Pcor give the Z value and the 
significant p-value (corrected for multiple comparisons on the basis of family wise error (FWE)). L 











Figure 5.8 The N-back task network for one-, two-, and three-back conditions across groups 
 
Figure 5.8 shows the brain regions activated during the contrast “all back>control” overlaid on a high 
resolution T1-weighted template image in Montreal Neurological Institute space. Numbers refer to z 
coordinates. Voxels are corrected for multiple comparisons on the basis of family wise error (FWE). 
Left is the left and right the right side of the brain.  
 
5.3.2.2 Working memory load 
As a next step, we investigated the linear effect of increasing working memory load 
across groups and found modulations in areas depicted in Table 5.4 with increasing 
task demands in the 2x3 model (CGA); see Figures 5.9, 5.10, and 5.11.   
 
Table 5.4 The effect of increasing working memory load across groups 
Area (>10 voxels) x Y z BA Voxels Z Pcor 
L Tri Inf Frontal -44 14 28 48 3312 7.02 <.001 
R Mid Frontal 40 36 22 45 3832 6.55 <.001 
L Mid Frontal -32 46 8 10 336 5.62 <.001 
R Ant Cingulate 14 28 22 32 61 5.41 =.001 
R Insula 38 -16 18 48 96 5.24 =.002 
R Caudate 16 0 14 NA 118 5.27 =.001 
L Caudate -18 -2 14 NA 65 4.99 =.005 
L Heschl -54 -12 8 48 99 5.50 <.001 
R Sup Temporal 60 -8 6 22 180 5.68 <.001 
L Inf Parietal -40 -58 50 39 2266 6.52 <.001 
R Lingual 20 -58 0 19 23 4.57 =.030 
R Fusiform 24 -40 -12 30 31 4.74 =.014 
R Precuenus 4 -56 28 23 120 5.04 =.004 
R Precuneus 16 -70 50 7 2612 6.48 <.001 
R Cuneus 10 -94 28 18 47 5.13 =.002 
Table 5.4 shows the brain regions modulated during the contrast three-back>two-back>one-back. X, 
y, and z refer to the MNI coordinates. BA refers to the Brodmann area and Z and Pcor give the Z 
value and the significant p-value (corrected for multiple comparisons on the basis of family wise error 




Figure 5.9 The effect of increasing working memory load across all groups 
 
Figure 5.9 shows the brain regions activated during the contrast three-back>two-back>one-back 
overlaid on a high resolution T1-weighted template image in Montreal Neurological Institute space. 
Numbers refer to z coordinates. Voxels are corrected for multiple comparisons on the basis of family 
wise error (FWE). Left is the left and right the right side of the brain. 
 
 
Figure 5.10 The effect of increasing working memory load (CGA) 
 
Figure 5.10 shows the mean BOLD increase in activation in the “at risk” group and healthy controls 
for the three-back>two-back>one-back contrast in the left inferior frontal cortex (MNI coordinates: 
x=-44, y=14, z=28). The y-axis shows the mean BOLD response. The error bars show the standard 







Figure 5.11 The effect of increasing working memory load (SGA) 
 
Figure 5.11 shows the mean BOLD increase in activation in the NPE, PE and healthy control groups 
for the three-back>two-back>one-back contrast in the left inferior frontal cortex (MNI coordinates: 
x=-44, y=14, z=28). The y-axis shows the mean BOLD response. The error bars show the standard 
error of mean (SEM). 
 
5.3.2.3 Group versus load interactions 
There were no significant group differences in our ROI analyses. Furthermore, there 
were no supra-threshold clusters when we looked at an overall interaction between 
group and load for either the combined or sub group analyses. There were also no 
supra-threshold clusters for the main effect of group for the combined or sub group 
analyses. However, when we compared the group versus load separately for the 
“one- versus two-back” and “two- versus three-back” conditions in order to assess 
increased working memory load, with a special importance of the “two- versus three-
back”, we found a significant interaction in the latter comparison between the “at 
risk” and healthy control groups, with the “at risk” group showing a lower activation 
during the two back, but higher activation during the three back condition. This 
pattern also emerged when we performed the sub group analysis, as the NPE and PE 
groups showed a similar activation profile. However, results only were statistically 






Table 5.5 Group versus load (two- and three-back) interaction (CGA) 
Area x Y z BA Voxels Z Pcor 
L Mid Cingulum -16 -24 38 23 669 4.42 =.007 
R Sup Temporal 52 -4 -10 21 667 4.26 =.008 
L Sup Temporal -48 -38 10 42 695 3.84 =.066 
Table 5.5 shows the brain regions activated during the contrast two-back versus three-back in the “at 
risk” group versus healthy controls. X, y, and z refer to the MNI coordinates. BA refers to the 
Brodmann area and Z and Pcor give the Z value and the significant p-value (corrected for multiple 
comparisons on the basis of cluster extent (p<.001)). L refers to left and R to right side of the brain. 
The activation in the left mid cingulum remained significant after FWE correction (Z=.42, p=.04).  
 
Figure 5.12 Group versus load (two- and three-back) interaction (CGA I) 
 
Figure 5.12 shows the brain regions activated during the contrast two-back versus three-back in the 
“at risk” group versus healthy controls overlaid on a high resolution T1-weighted template image in 
Montreal Neurological Institute space. Numbers refer to z coordinates. Voxels are corrected for 

















Figure 5.13 Group versus load (two- and three-back) interaction (CGA II) 
  
Figure 5.13 shows the interaction between the mean BOLD response of the “at risk” and the healthy 
control groups, with the “at risk” group shows a lower activation during the two back, but higher 
activation during the three back condition compared to healthy controls in the left mid cingulum (MNI 
coordinates: x=-16, y=-24, z=38). The y-axis shows the mean BOLD response. The error bars show 
the standard error of mean (SEM). 
 
 
Figure 5.14 Group versus load (two- and three-back) interaction (SGA) 
 
Figure 5.14 shows the interaction between the mean BOLD response of the NPE, PE and healthy 
control groups, with the NPE and PE groups shows a lower activation during the two back, but higher 
activation during the three back condition compared to healthy controls in the left mid cingulum (MNI 
coordinates: x=-16, y=-24, z=38). The y-axis shows the mean BOLD response. The error bars show 






Table 5.6 Group versus load (two- and three-back) interaction (SGA) 
Area x Y z BA Voxels Z Pcor 
NPE group        
L Mid Cingulum -18 -26 40 23 353 4.07 =.072 
L Sup Temporal -48 -40 12 42 631 4.01 =.013 
PE group        
R Precuneus 4 -48 16  368 4.06 =.006 
Table 5.6 shows the brain regions activated during the contrast two-back versus three-back in the NPE 
and PE group versus healthy controls. X, y, and z refer to the MNI coordinates. BA refers to the 
Brodmann area and Z and Pcor give the Z value and the significant p-value (corrected for multiple 
comparisons on the basis of cluster extent (p<.001)). L refers to left and R to right side of the brain.  
 
The significant interaction was driven by a deactivation in the three areas in the 
healthy control group as assessed with a one sample t-test; see Table 5.7. 
 
Table 5.7 Deactivations in the healthy control group for the contrast three-back>two-back 
Area x Y z BA Voxels Z Pcor 
L Mid Cingulum -10 0 36 24 147 4.16 =.252 
R Sup Temporal 54 -4 -10 22 795 4.38 =.001 
L Sup Temporal -48 -10 8 48 553 4.53 =.004 
Table 5.7 shows the brain regions deactivated during the contrast three-back>two-back in the healthy 
controls group. X, y, and z refer to the MNI coordinates. BA refers to the Brodmann area and Z and 
Pcor give the Z value and the significant p-value (corrected for multiple comparisons on the basis of 
cluster extent (p<.001)). L refers to left and R to right side of the brain.   
 
5.3.2.4 Additional analyses 
We did not find any supra-threshold group differences in frontal regions using the 
SPM WFU PickAtlas ROI approach. We further investigated whether the differences 
in activation found in the left midcingulate cortex and the right and left superior 
temporal gyrus correlated with the task performance. For that, we conducted a ROI 
analysis of these three regions for the contrast “three back” greater “two back” and 
correlated the activations with the behavioural difference scores of the three and two 
back, the three back and overall performance within the “at risk” group. There were 
no significant correlations of the activation in the left midcingulate cortex or the right 
and left superior temporal gyrus with any of behavioural performance measures 
(largest r(25)=-.26, smallest p=.21). There were also no correlations of activation in 
the left midcingulate cortex or the right or left superior temporal gyrus with age, 
YMRS, HAM-D, PANSS, or length of illness (largest r(25)=.33, smallest p=.11). 
Antipsychotic medication (yes/no), age, scores of the YMRS, HAM-D, PANSS, or 
length of illness did not have significant effects on the imaging results when included 
as covariates in the full-factorial models.  
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As a further additional analysis we compared all women who were at risk of 
postpartum psychosis due to a diagnosis of bipolar disorder or other diagnoses (i.e. 
schizoaffective disorder, postpartum psychosis or family history) and healthy 
controls. When we compared the group versus load for the “two- versus three-back” 
conditions, we found a significant interaction between the bipolar and healthy control 
groups, with the bipolar group showing a relative lower activation during the two 
back, but relative higher activation during the three back condition in the right mid 
cingulum (BA=23, x=10, y=-30, z=36, voxels=2626, Z=4.48, Pcor<.001) and the left 
superior temporal gyrus (BA=48, x=-54, y=-16, z=8, voxels=869, Z=4.06, 
Pcor=.003). When we compared the other “at risk” diagnoses to healthy controls we 
also found a similar modulation of the left mid cingulum (BA=23, x=-18, y=-20, 
z=36, voxels=140, Z=4.21, Pcor=.32) and the left postcentral gyrus (BA=2, x=-40, 
y=-38, z=60, voxels=118, Z=3.71, Pcor=.39). However, results were only 
statistically significant for the bipolar group. 
 
5.4 Discussion 
In this chapter, the working memory performance and accompanying brain activation 
were investigated in women at risk of postpartum psychosis using an N-back fMRI 
working memory paradigm. We expected that 1) women at risk of postpartum 
psychosis will show, in comparison to healthy controls, decreased brain activation in 
the dorsolateral prefrontal cortex during a working memory task (primary 
hypothesis); 2) women at risk of postpartum psychosis will show, in comparison to 
healthy controls, differential brain activation as assessed with whole brain analysis 
(secondary hypothesis); 3) women at risk of postpartum psychosis will show, in 
comparison to healthy controls, impaired working memory performance (secondary 
hypothesis); 4) impairments in working memory and differences in brain activation 
in working memory will be more pronounced in women who had developed 
postpartum psychosis episodes, compared to women who had not developed 




5.4.1 Summary of findings 
In all groups there was an effect of working memory load on performance, showing 
decreasing task accuracy and increasing rate of false positives and reaction time with 
increasing task difficulty. As expected in our secondary hypothesis, women at risk of 
postpartum psychosis showed a trend towards an impaired task performance in the 
most difficult condition of the N-back task placing the highest working memory load 
demands on participants. Differently from our prediction, however, was that the NPE 
group performed the worst, showing a faster reaction time than healthy controls with 
the PE group performing on an intermediate level. We could not confirm our primary 
hypothesis, as there was no decreased brain activation in the dorsolateral prefrontal 
cortex of the “at risk” group compared to healthy controls. However, we found a 
relative increase in activation as evidenced by a significant interaction between the 
“at risk” and healthy control groups in the left midcingulate cortex and the bilateral 
superior temporal cortex following the whole brain analysis. The “at risk” group 
showed a lower activation during the two back, but higher activation during the three 
back condition compared to healthy controls. The PE group showed a similar 
activation profile as the NPE group, but with intermediate activation levels compared 
to the NPE and healthy control groups. While we had a large enough sample size in 
order to assess the primary hypothesis, we would like to acknowledge that for the 
secondary hypotheses, including the whole brain and the performance analyses, the 
study may have been underpowered. 
 
5.4.2 Performance 
The effect of working memory load on task accuracy, false positives and reaction 
time found across all groups is in agreement with the N-back task literature (Jogia, 
Dima, & Frangou, 2012; Jogia, Dima, Kumari, et al., 2012; Schmidt et al., 2009). In 
addition, the strong trend of an impairment in task performance in the “at risk” group 
is consistent with previous results demonstrating an impairment in working memory 
performance in bipolar disorder (Adler et al., 2004; Drapier et al., 2008). There are 
studies that do not report performance deficits using a two-back design (Broome et 
al., 2009; Monks et al., 2004; Thermenos et al., 2011). One difference to these 
studies is that in our study a three-back task design, adding a higher level of 
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difficulty, was employed (Broome et al., 2009; Monks et al., 2004; Thermenos et al., 
2011). It is possible that the performance difference was only evident at this level of 
task difficulty. This suggestion is supported by the fact that our two back 
performance results were similar to earlier studies (Broome et al., 2009; Monks et al., 
2004; Thermenos et al., 2011). 
     In contrast to our prediction, it was the PE group that showed intermediate levels 
of accuracy between healthy controls and the NPE group. Additionally, the decrease 
in accuracy was accompanied by a decrease in reaction time only in the NPE group, 
suggesting that women in this group may have used a different response strategy, 
such as a greater speed-accuracy trade-off for the most difficult task condition, 
compared to women in both the healthy control and PE groups. A more rapid 
response to the task under greater loads has been previously found in a working 
memory study on schizophrenia (M. A. Kim et al., 2010). Alternatively, women in 
the NPE group may have been less engaged in the task during the three back 
condition due to higher task demands. However, accuracy was still above chance 
level, suggesting that, on average, women in the NPE group were following task 
instructions.  
     In summary, women at risk of postpartum psychosis seem to have performance 
deficits in verbal working memory. Similarly to our findings in the verbal memory 
domain, this result seems mainly driven by women with previous non-postpartum 
episodes, while women with postpartum episodes show intermediate performance 
levels. Furthermore, it is possible that women in the non-postpartum group employed 
a different strategy during the three back condition, possibly due to a deficit in 
coping with the task demands. This is an interesting hypothesis, which should be 
validated in larger sample sizes in the future.   
 
5.4.3 Imaging results 
We evaluated a general N-back memory network across all groups as a previous 
meta-analysis found that controls and people with psychosis activate a qualitatively 
similar network during cognitive task performance (Minzenberg et al., 2009; Owen 
et al., 2005). The task elicited the typical N-back working memory network and 
activation for increasing load in our participants, including the frontal and parietal 
170 
 
areas (Minzenberg et al., 2009; Owen et al., 2005), confirming that the task 
manipulation worked. We did not find evidence to confirm our primary hypothesis. 
Based on our power calculation, the study should have had enough power to detect 
an effect in this sample. Yet, the sample size was still relatively small and therefore 
our study may have been underpowered. A better prediction of an accurate power 
would have been possible with pilot data (Mumford, 2012). As this current study is 
the first one conducted in women at risk of postpartum psychosis, these findings can 
be taken as preliminary and used as pilot data on which a power calculation for 
future investigations can be based. Therefore it contributes important knowledge and 
data to research in postpartum psychosis.  
It could also be that there is no significant difference in dorsolateral prefrontal cortex 
functioning in women at risk of postpartum psychosis compared to healthy controls 
and therefore, we could not detect an effect. Another explanation for the lack of 
finding of a significant difference in the dorsolateral prefrontal cortex may be that in 
our study only women took part. According to our knowledge, only one study has 
reviewed gender effects in bipolar disorder, stating that there is an absence of fMRI 
studies reporting on sex differences (Jogia, Dima, & Frangou, 2012). It is possible 
that differences in frontal brain activation during working memory assessments are 
more pronounced in males diagnosed with bipolar disorder. In line with a recent 
review on working memory dysfunction in bipolar disorder assessed by the N-back 
task, our whole brain analysis showed significant activation differences in regions, 
which have been found to be implicated in working memory (Cremaschi et al., 
2013). There was a relative increase in activation in the left midcingulate cortex and 
the bilateral temporal cortex in the “at risk” group compared to healthy controls 
between the two and three back conditions, as evidenced by a significant interaction. 
This relative change in activation in the midcingulate cortex and the bilateral 
temporal cortex may reflect an increase in task demands, possibly proving more 
challenging for the “at risk” group than healthy controls due to dysfunction in 
promoting task efficiency and resulting in a strategy change in this group. In the 
following sections the potential roles of the midcingulate cortex and the bilateral 




5.4.3.1 Potential role of the midcingulate cortex 
The midcingulate cortex has been found to be involved in motor response selection, 
producing different combinations of actions and outcome (Vogt, Berger, & 
Derbyshire, 2003), especially in tasks involving cues which may cause conflict such 
as divided attention and stroop tasks (Derbyshire, Vogt, & Jones, 1998; van Veen & 
Carter, 2002). It could be that a relative increase in activation in the midcingulate 
activation of the “at risk” group reflects an increase in the difficulty of linking the 
cognitive demands of the more challenging task condition with the appropriate motor 
response. It has been reported previously that midcingulate cortex activity increases 
with task difficulty (Vogt, 2009). However, the actual motor response required 
during the three back condition is not different to the other task conditions, 
suggesting that the increase was not related to the difficulty of linking the cognitive 
demands with the motor response. Furthermore, this hypothesis would also predict an 
increase in activation with difficulty in healthy controls and they showed a decrease 
in our study. 
     It is also possible that the increase in activation, specifically driven by the NPE 
group, is linked to a change in strategy use during the three back condition. It has 
been reported that the midcingulate cortex is activated during changes in responses 
and the reorganisation of behaviour for changing rewards (Bush et al., 2002; Vogt, 
2009; Vogt et al., 2003). In addition, lesions in the anterior and midcingulate cortex 
and an increase in activation in these areas have been associated with task switching 
(Rushworth, Hadland, Gaffan, & Passingham, 2003; Rushworth, Hadland, Paus, & 
Sipila, 2002). Given that we see a change in reaction time combined with a trend 
towards a worse performance, this possibility should be further investigated. In order 
to further assess possible changes in strategy use in postpartum psychosis under 
difficult task conditions, future studies should manipulate difference components of 
the task or employ paradigms which directly assess task switching (Rushworth et al., 
2003; Rushworth et al., 2002).    
     Finally, it has been reported that the dorsal anterior cingulate cortex bordering on 
the midcingulate cortex promotes task efficiency by speeding up responses (Sheth et 
al., 2012). Yet, in situations with changing conditions responses are slowed down in 
order to ensure accuracy (Sheth et al., 2012). It may be that this process in women at 
risk of postpartum psychosis is dysfunctional, and that they respond with a decrease 
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in reaction time to more difficult task conditions. This dysfunction could be 
accompanied by an increase in midcingulate activation in the NPE group. Taken 
together, our data suggest that the aberrant activation in the midcingulate cortex in 
the “at risk” group is most likely linked to a change in strategy use or a deficit in 
promoting task efficiency in this group.  
 
5.4.3.2 Potential role of the bilateral temporal cortex 
An increased activation in the right superior and middle temporal gyri has been 
reported in other fMRI N-back working memory studies in bipolar disorder and 
psychoses unrelated to childbirth compared to healthy controls (Adler et al., 2004; 
Jogia, Dima, & Frangou, 2012; M. A. Kim et al., 2010). This greater activation has 
been associated with increases in task demands in studies using other verbal tasks 
(Ragland et al., 2008). The view that an increased activation may be linked to higher 
task demands, possibly more challenging for the “at risk” group, is supported by the 
lower task performance of the “at risk” group in the current study. However, again, 
this hypothesis would also predict an increase in activation with difficulty in healthy 
controls and they showed a decrease in our study. 
     Alternatively, the faster reaction time of the NPE group in the three back 
condition could be an indication of a strategy change in this group for the more 
difficult task condition, resulting in the relative increase of activation in the temporal 
lobes. An increased activation in the bilateral temporal cortex during a working 
memory task correlated previously with a faster reaction time in patients with 
psychosis compared to healthy controls (M. A. Kim et al., 2010). This increased 
activation was further proposed to be associated with an attempt of patients to 
maintain high accuracy during the more demanding task conditions (M. A. Kim et 
al., 2010). Similarly, in our study, the increased activation in the “at risk” group was 
also accompanied by a decrease in reaction time, indicating that the temporal cortex 
may have been used for a more rapid response to the task in order to compensate for 
performance deficits. However, given that there was a trend for the “at risk” group to 
show a lower task performance in the three back condition and the lack of a 
correlation between imaging and behavioural performance measures, this explanation 
seems less plausible.      
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Another possibility is that the “at risk” group showed a functional compensation for 
potential structural abnormalities as temporal lobes volumetric grey matter 
reductions have been reported in first episode as well as chronic schizophrenia 
(Kuroki et al., 2006; Onitsuka et al., 2004). In order to prove this hypothesis, future 
analysis should look at the association between the functional data of the task and 
volumetric measures. Nonetheless, lesion studies have found that language 
comprehension is impaired in people with lesions in the temporal cortex (Dronkers, 
Wilkins, Van Valin, Redfern, & Jaeger, 2004), potentially influencing verbal 
working memory activation and performance.  
     Finally, the temporal cortex has previously been reported to be employed for 
maintenance of phonological information during a working memory task (Strand, 
Forssberg, Klingberg, & Norrelgen, 2008). Therefore, the relative increase in 
activation in the bilateral temporal lobe could be associated with the increasing 
maintenance demands due to the longer delay between targets in the three back 
condition. This may have been more challenging for the “at risk” group than the 
healthy controls due to a working memory dysfunction. However, the task used by 
Strand and colleagues was a phonological working memory paradigm and therefore 
it is not clear to what extent the results are generalisable to other working memory 
paradigms. In summary, the bilateral temporal lobes show an increase in activation 
as task demands increase during the three back condition. This may indicate that this 
condition was more challenging for the “at risk” group than the healthy control 
group, resulting in a faster reaction time and an increase in temporal lobe activation. 
Future studies should assess the precise role of the temporal cortex in working 
memory paradigms.  
 
5.4.4 Additional analysis 
There were no correlations between age or clinical measures and performance or 
imaging results. Furthermore, taking antipsychotic medication did not seem to 
influence performance or imaging results. There were also no correlations between in 




5.4.4.1 Impact of bipolar disorder 
We also assessed the influence of a bipolar disorder diagnosis on performance and 
imaging results. Women with bipolar disorder did not perform worse compared to 
healthy controls or women who were “at risk” due to other diagnoses. Nonetheless, 
we did find a trend towards a faster reaction time during the three back condition. 
Women with bipolar disorder also showed a significant lower activation during the 
two back, but higher activation during the three back conditions in the right mid 
cingulum and the left superior temporal gyrus compared to healthy controls. This 
indicates that the findings in the NPE group were mainly driven by women with a 
bipolar disorder diagnosis. However, women with “other at risk diagnoses” also 
showed a non-significant modulation of the left mid cingulum and the left postcentral 
gyrus compared to healthy controls. These results suggest that women with bipolar 
disorder show a strategy change or difficulty in promoting task efficiency during the 
most difficult task condition, which is accompanied by an increase in activation in 
the midcingulate and the temporal cortices. Nonetheless, there is an indication that 
women who are at risk of postpartum psychosis due to other diagnoses, with a 
majority of women in the group who have suffered from a postpartum episode, show 
aberrant activation in similar areas. The more subtle modulation in the other “at risk” 
group may have been affected by a reduced statistical power. Unfortunately, we did 
not have a separate group with bipolar disorder unrelated to childbirth, which would 
have been important for an independent confirmation of the bipolar hypothesis. 
Taken together, our results suggest that women who have suffered from postpartum 
psychosis show similar working memory deficits in their cognitive profile to those 
with bipolar disorder.  
 
5.4.5 Conclusion 
Women at risk of postpartum psychosis show indications of a performance deficit in 
verbal working memory as predicted by our secondary hypothesis. This was 
accompanied by an increase in activation in the midcingulate cortex and the bilateral 
temporal lobe compared to healthy controls. As the differences we have found in the 
midcingulate cortex and the bilateral temporal lobe were part of the whole brain 
analyses, they will need to be validated in larger sample sizes in the future as they 
175 
 
would not survive overall multiple comparison corrections (P<0.001) of this study. 
Nonetheless, this increased activation likely reflects an increase in the task demands, 
which may have been more challenging for the “at risk” group due to dysfunction in 
promoting task efficiency, resulting in a strategy change in this group. Furthermore, 
results indicate that women who have suffered from postpartum episodes show a 




6. Chapter: Facial emotion processing 
In this chapter, an overview of the relevant fMRI literature on facial emotion 
processing will be presented. Then, the Ekman faces task, used in the current study, 
and additional details of the analysis will be described. This will be followed by the 
presentation of the performance and imaging results and their discussion in the 
context of the existing literature. 
 
6.1 Introduction 
With the exception of one case study on a monozygotic twin pair discordant for 
postpartum psychosis, no studies have been conducted in postpartum psychosis 
assessing emotional processing (Fahim et al., 2007). In this specific study a 
decreased activation in the orbital frontal gyrus was found in the sibling with history 
of postpartum psychosis compared to her sister, indicating a disturbance in the 
integration of emotionally relevant information (Fahim et al., 2007). Dysfunctional 
emotional processing is one of the key impairments in bipolar disorder and 
psychoses unrelated to childbirth (Bediou et al., 2005; Brüne, 2005; Y. Chen et al., 
2012; Hoertnagl et al., 2011; Kohler et al., 2010; Malhi et al., 2007; Rocca et al., 
2009). While the impairment in emotional processing seems to be task and modality 
independent, most studies concentrated on a deficit in facial emotion processing 
(Aleman & Kahn, 2005; V. Bozikas et al., 2007; Chan, Li, Cheung, & Gong, 2010; 
C. Chen et al., 2011; Edwards, Jackson, & Pattison, 2002; Hooker & Park, 2002; 
Kohler et al., 2010).  
     The Ekman faces paradigm is the most often used paradigm in the fMRI literature 
to assess facial emotion processing (Fusar-Poli et al., 2009) and was therefore chosen 
in this study. It typically depicts 60 faces portraying specific emotions (e.g. happy, 
fear, anger, sadness). Brain regions involved in facial processing independent of 
emotional valence are visual areas (e.g. fusiform gyrus), limbic and subcortical areas 
(e.g. the amygdala), and prefrontal and temporoparietal areas, as reported by a recent 
meta-analysis of 105 studies in healthy volunteers (Fusar-Poli et al., 2009). During 
conditions portraying specific emotions, such as fearful, happy or sad faces, a 
specific involvement of the amygdala has been found, while during angry and 
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disgusted faces the insula seems to play a more important role (Fusar-Poli et al., 
2009; Moriguchi et al., 2005; M. L. Phillips et al., 1997).  
     Facial emotion paradigms including the Ekman faces task can be presented 
explicitly or implicitly (C. Chen et al., 2006; Gorno-Tempini et al., 2001). During 
explicit recognition, participants usually have to guess a specific facial emotion 
shown and potentially also give a rating of the emotional intensity (Goghari & 
Sponheim, 2012; Hoertnagl et al., 2011; Li et al., 2012). The explicit paradigm is 
frequently used during studies aiming to measure differences in performances of 
emotion recognition between certain groups, while implicit facial emotion processing 
designs are used in order to ensure an identical task response across all conditions 
(M. L. Phillips et al., 1997). Participants can be asked to concentrate on a different 
aspect of the faces presented (e.g. to make a judgment about the gender or age) (Liu 
et al., 2012; M. L. Phillips et al., 1997). Especially in fMRI studies, the implicit 
design is often used to keep performances similar between groups (M. L. Phillips et 
al., 1997). Both designs have been reported to be associated with activation of the 
prefrontal cortex in healthy volunteers (Fusar-Poli et al., 2009). Explicit processing 
has shown a stronger association with activation in the amygdala, while implicit 
processing was stronger associated with activation in the inferior prefrontal cortex 
and insula (Fusar-Poli et al., 2009; Gorno-Tempini et al., 2001).  
     Patients with bipolar disorder and psychoses unrelated to childbirth have been 
found to show both deficits in facial emotion recognition performance and associated 
differences in brain activation as well as differential brain activation during implicit 
tasks (Bediou et al., 2005; Hoertnagl et al., 2011; Kohler et al., 2010; Li et al., 2012; 
Malhi et al., 2007). However, bipolar patients appear to be more accurate than 
patients with psychoses unrelated to childbirth in recognising emotions (Rocca et al., 
2009). In the following paragraphs, research findings will be discussed for both 
disorders separately.  
 
6.1.1 Facial emotion processing in bipolar disorder 
It is an established finding that patients with bipolar disorder show performance 
deficits in emotion recognition compared to healthy controls (V. Bozikas et al., 2007; 
Schaefer, Baumann, Rich, Luckenbaugh, & Zarate, 2010). It has been found that 
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processing negative facial expression such as fear seems to be associated with an 
underestimation of the intensity of the facial expression but with a more intense 
experience of the negative emotion (Hoertnagl et al., 2011; Rocca et al., 2009). 
Similarly to deficits in executive functioning found in bipolar disorder, facial 
emotion processing deficits seem to remain during euthymic phases (Hoertnagl et al., 
2011). Some studies did not find evidence for trait like deficits in facial emotion 
processing in bipolar disorder and suggest that altered perception may rather indicate 
a mood-congruent bias (Gray et al., 2006; Venn et al., 2004).  
     Indeed, it has been reported that the extent of emotion recognition deficits varies 
according to the mood state, for example patients may display an enhanced 
recognition of fear during an acute manic state (Rocca et al., 2009), although a 
general trend towards an impairment in fear processing in bipolar disorder has also 
been highlighted by several authors (Lembke & Ketter, 2002; Rocca et al., 2009; 
Venn et al., 2004). Deficits in facial emotion processing seem to be independent of 
deficits in facial processing in bipolar disorder (V. P. Bozikas, Tonia, Fokas, 
Karavatos, & Kosmidis, 2006). Furthermore, there seems to be no association with 
gender, medication or symptom severity (Derntl, Seidel, Kryspin-Exner, Hasmann, 
& Dobmeier, 2009).  
     Impairments in facial emotion processing have been found to be accompanied by 
differences in brain activation in frontal, subcortical (specifically amygdala) and 
parietal activation compared to healthy controls (Lawrence et al., 2004; Lennox, 
Jacob, Calder, Lupson, & Bullmore, 2004; Malhi et al., 2007; Yurgelun-Todd et al., 
2000). However, while the regions that show aberrant activation are quite consistent 
between studies, it has not yet been established, whether some regions are associated 
with a general decrease or increase of activation during facial emotion processing. 
Some studies reported reduced prefrontal, subcortical and parietal activation in 
bipolar patients compared to healthy controls (Malhi et al., 2007; van der Schot et al., 
2010), while others demonstrated a limbic overactivation accompanied by a 
decreased prefrontal engagement (Delvecchio et al., 2012; Yurgelun-Todd et al., 
2000). A reduced functional connectivity between the ventrolateral prefrontal cortex 
and the amygdala during an emotional task in bipolar disorder compared to healthy 
controls has also been reported (Foland et al., 2008). One explanation for the 
discrepancies in findings might be differences in task design such as the use of 
179 
 
implicit and explicit processing which have been associated with over- and 
underactivation in bipolar patients, respectively (C. Chen et al., 2006). 
     Due to the specific link to impaired recognition of fear, fMRI studies have often 
focused on the functional processing of fearful faces (Yurgelun-Todd et al., 2000). 
Typically reported are functional abnormalities in sub-cortical (i.e. amygdala) and 
ventral prefrontal regions for bipolar patients compared to healthy controls 
(Delvecchio et al., 2012; Lawrence et al., 2004; Yurgelun-Todd et al., 2000). This 
specific association has also been reported for psychoses unrelated to childbirth (Li 
et al., 2012; R. W. Morris, Weickert, & Loughland, 2009; Mukherjee et al., 2012). 
 
6.1.2 Facial emotion processing in psychoses unrelated to childbirth 
Patients with psychoses unrelated to childbirth show impaired performance in facial 
and other emotion recognition paradigms (Edwards et al., 2002; Schneider et al., 
2006; Trémeau, 2006; Tsoi et al., 2008). There has been a claim that the deficit in 
facial emotion processing rather reflects a general deficit in facial processing linked 
to a reduced volume of the fusiform gyrus in psychoses unrelated to childbirth 
(Hooker & Park, 2002; Kohler, Bilker, Hagendoorn, Gur, & Gur, 2000; Onitsuka et 
al., 2006). Some studies also find overattribution of (negative) emotions to neutral 
faces (Eack et al., 2010; Habel et al., 2010). However, other studies do find a specific 
impairment in emotional processing, which seems to be most pronounced for 
negative emotions (Chan et al., 2010; Leppänen et al., 2006; Schneider et al., 2006). 
Furthermore, only facial emotion processing deficits seem to be correlated with 
positive and negative symptomatology and lead to problems in social interaction 
(Chan et al., 2010; Hooker & Park, 2002; Kohler et al., 2000; Poole et al., 2000). No 
correlations with length of illness or level of education have been reported 
(Leppänen et al., 2006). Facial emotion processing impairment has also been found 
in people at risk of psychosis (due to genetic risk or attenuated symptoms) and 
patients diagnosed with schizoaffective disorder, whereby “at risk” individuals and 
those diagnosed with schizoaffective disorder show intermediate levels to patients 
with psychoses unrelated to childbirth and healthy controls (Addington et al., 2008; 
G. P. Amminger et al., 2012; G.P. Amminger et al., 2012; Y. Chen et al., 2012; 
Leppänen et al., 2008; L. K. Phillips & Seidman, 2008). 
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Deficits in facial processing and facial emotion processing in psychoses unrelated to 
childbirth have been accompanied by aberrant brain activation (Habel et al., 2010; Li 
et al., 2012; Marwick & Hall, 2008; Reske et al., 2009). Similarly to bipolar disorder, 
there are some inconsistencies about whether specific areas can be associated with 
general decreases or increases in activation. Abnormal activation when processing 
emotional stimuli has been found in widely distributed areas such as the fusiform 
gyrus, amygdala, anterior cingulate, frontal areas, precentral and postcentral gyri, and 
temporal and parietal areas (Habel et al., 2010; Li et al., 2012; Marwick & Hall, 
2008; Reske et al., 2009).  
     However, the frontal regions such the prefrontal cortex, the insula, anterior 
cingulate and orbitofrontal cortex and the amygdala seem to be of particular 
importance as these areas have been most consistently associated with dysfunctional 
emotional processing in psychoses unrelated to childbirth (Gur et al., 2002; Hempel, 
Hempel, Schönknecht, Stippich, & Schröder, 2003; Li, Chan, McAlonan, & Gong, 
2010). This differential activation seems to be stable over time and not affected by 
symptomatology or length of illness (Li et al., 2010; Reske et al., 2007). According 
to the general consensus, patients with psychoses unrelated to childbirth are 
particularly impaired in recognising fear (Li et al., 2012; R. W. Morris et al., 2009; 
Mukherjee et al., 2012). The amygdala in particular has been ascribed an important 
role in fear processing, also in healthy individuals, and has been associated with 
reduced volume in psychoses unrelated to childbirth (Adolphs, 2008; Adolphs, 
Tranel, Damasio, & Damasio, 1995; Aleman & Kahn, 2005; J. S. Morris et al., 1996; 
Whalen et al., 1998). In several studies, aberrant amygdala activity to fearful faces 
has been reported in psychoses unrelated to childbirth alongside abnormalities in 
other areas including the frontal cortex (Das et al., 2007; Li et al., 2012; R. W. 
Morris et al., 2009). This was also reported for people at risk of psychosis with an 
intermediate activation between patients and healthy controls (Li et al., 2012). 
Furthermore, a reduced effective connectivity has been demonstrated between the 
amygdala and a large cluster of regions including the precuneus and parietal lobe in 
patients with psychoses unrelated to childbirth compared to healthy controls 
(Mukherjee et al., 2012). Also, there has been a report of no habituation of activation 
in the amygdala-hippocampal complex for fearful faces in patients with psychoses 
unrelated to childbirth compared to healthy controls, indicating that stimuli remain 
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salient (Holt et al., 2005). This suggests that the amygdala has a key role in 
understanding dysfunctional facial fear processing and we predict that it may also be 
dysfunctional in postpartum psychosis due to the close relationship to psychoses 
unrelated to childbirth.  
     In summary, facial emotion processing deficits are consistently reported in bipolar 
disorder and psychoses unrelated to childbirth with a pronounced impairment in fear 
processing. These deficits are associated with differential activity, most significantly 
in the amygdala when compared to healthy controls. Therefore, we expected to find a 
similar activation pattern in women at risk of postpartum psychosis when processing 
fearful faces. Specifically, we hypothesised that 1) women at risk of postpartum 
psychosis will show, in comparison to healthy controls, higher brain activation of the 
amygdala during a facial emotion processing task (primary hypothesis); 2) women at 
risk of postpartum psychosis will also show, in comparison to healthy controls, 
differential brain activation during the facial emotion processing task as assessed 
with whole brain analysis (secondary hypothesis); 3) differences in brain activation 
in facial emotion processing will be more pronounced in women who had developed 
postpartum psychosis episodes, compared to women who had not developed 
postpartum psychotic episodes, and to healthy controls (secondary hypothesis). In 
order to test this hypothesis, the Ekman faces task will be employed (chapter 6).  
 
6.2 Methods 
6.2.1 Participants, design, analyses and procedures 
The methods have been described in chapter 2. For information on the combined 
group analyses and sub group analyses please see chapter 2 and chapter 3. 
 
6.2.2 Ekman faces paradigm  
An implicit Ekman faces paradigm was used, portraying fearful faces in order to 
assess emotional face processing while keeping performance levels similar across the 
groups (M. L. Phillips et al., 1997). Participants had to indicate the gender of 60 
grey-scale images of five women and five men from the Pictures of Facial Affect 
series (Ekman & Friesen, 1976; M. L. Phillips et al., 1997) by pressing on either a 
182 
 
left (for female) or right (for male) button using a two button response box in the 
MRI scanner. Participants were not informed that the aim of the study was to 
investigate responses to emotional expression. Each face was presented six times, 
twice with a lower expression intensity of fear (50%) and twice with a standard 
expression of fear (100%) and two times with neutral expressions; see Figure 6.1. All 
participants received a training session prior to the MRI scan. During the training 
sessions neutral, lower, and standard expressions of happy were presented. The MRI 
task was presented in the form of an event-related design as 72 stimuli were 
randomly presented to participants, including 12 blank trials (i.e. a fixation cross). 
Images were displayed for two seconds followed by a fixation cross in the middle of 
the screen. The inter-trial interval was jittered (i.e. intervals were randomised 
between successive stimulus events) over a range between 3.33 and 8.64 seconds, 
with an average of 4.99 seconds. Paradigms were programmed using Visual Basic 






















Figure 6.1 The Ekman faces task 
Figure 6.1 shows the female (first panel) and male (second panel) Ekman faces with ascending fear 
intensity. The first column shows neutral facial expression, the second column the lower intensity 
facial expression of fear and the last column the standard facial expression intensity of fear.  
 
6.2.3 Analysis 
For a further description of the behavioural and imaging analysis please see chapter 
2. The dependent variables for the behavioural analysis were the number of correct 
responses (i.e. accuracy) for the neutral, lower and standard fear faces condition and 
the reaction times to all conditions. Specific contrasts of interest for the second-level 
model of the imaging analysis were the neutral, lower and standard fear faces versus 
an implicit baseline and the lower and standard fear faces (combined and separately) 
against neutral faces. We conducted a ROI analysis limited to the amygdala using the 
WFU PickAtlas tool in SPM. We also conducted a whole brain analysis. For a 
secondary analysis, in order to assess correlations with clinical variables, we also 
examined the contrast between lower and standard fear against neutral with a ROI 
analysis. The left inferior frontal gyrus was selected based on our results (MNI 
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coordinates x=-34, y=16, z=28). Spherical masks with a radius of 10mm were 
created around the coordinates using MARSBAR. Regions of interest were further 
analysed using SPSS 20 for Windows. 
 
6.3 Results 
Two healthy controls were excluded based on their behavioural performance. Both 
women had an error rate of more than 30% suggesting that they were not able to 
discriminate the gender of the faces. Another two women were excluded from the 
analysis because they had movement values greater than five mm/degrees. In total 42 
women (NPE=12, PE=12, healthy controls=18) were analysed.  
 
6.3.1 Performance results 
No woman had a higher miss rate than 8% (i.e. four out of 60 faces) indicating that 
all remaining participants engaged in the task. The highest error rate of all three faces 
conditions combined was 23% (i.e. seven faces out of 60) after exclusion of the two 
outliers.   
 
6.3.1.1 Combined group analysis 
There were no significant accuracy differences between groups (“at risk” versus 
healthy controls) in the neutral, or standard fear faces condition (z=-.05, p=.34; z=-
.98, p=.33). There was a significant difference between groups in the lower fear faces 
condition (z=-2.03, p=.04), with healthy controls performing better (M=89, 
SD=4.16) than the “at risk” group (M=87, 5.28). However, this represents a small 
difference of about 0.54 more faces recognised in the healthy controls, questioning 
the (clinical) relevance of this finding. Using a repeated measures between subject 
ANOVA, we found no significant interaction between group and reaction time 
(neutral, lower fear, standard fear) (F(2,39)=.55, p=.58) and no significant main 






Table 6.1 Faces performance (CGA) 
Groups “at risk” M (SD) healthy controls M (SD) 
Accuracy (%)   
Neutral 86 (5.89) 88 (4.53) 
Lower fear 87 (5.28) 89 (4.16) 
Standard fear 88 (4.42) 89 (2.14) 
RT   
Neutral 943 (176) 868 (128) 
Lower fear 941 (167) 877 (147) 
Standard fear 965 (161) 909 (141) 
Table 6.1 shows the faces performance scores of the “at risk” group and healthy controls on accuracy 
and reaction time. RT=reaction time. M=mean. SD=standard deviation. 
 
 
Figure 6.2 Faces performance - accuracy (CGA) 
 
Figure 6.2 shows the mean faces task performance of the “at risk” group and healthy controls on 
accuracy. The y-axis shows the mean performance. The error bars show the standard error of mean 
(SEM). 
 
6.3.1.2 Sub group analysis 
There were no significant accuracy differences between groups (NPE, PE and 
healthy controls) in the neutral, lower or standard fear faces condition 
(χ2(2,41)=1.49, p=.47; χ2(2,41)=5.01, p=.08; χ2(2,41)=1.16, p=.56). There was also 
no significant interaction between group and reaction time (neutral, lower fear, 
standard fear) (F(42,76)=1.12, p=.35) using a repeated measures between subject 
ANOVA and no significant main effect of group on reaction time (F(2,38)=1.59, 




Table 6.2 Faces performance (SGA) 
Groups NPE M (SD) PE M (SD) healthy controls M (SD) 
Accuracy (%) 
Neutral 85 (5.82) 86 (6.36) 88 (4.53) 
Lower fear 87 (5.82) 86 (5.05) 89 (4.16) 
Standard fear 88 (3.99) 87 (5.18) 89 (2.14) 
RT  
Neutral 928 (175) 983 (160) 868 (128) 
Lower fear 931 (174) 975 (144) 877 (147) 
Standard fear 969 (180) 982 (137) 909 (141) 
Table 6.2 shows the faces performance scores of the NPE, PE and healthy control group on accuracy 
and reaction time. RT=reaction time. M=mean. SD=standard deviation. 
 
Figure 6.3 Faces performance - accuracy (SGA) 
 
Figure 6.3 shows the mean faces task performance of the NPE, PE and healthy control groups on 




There was no linear effect of accuracy across groups for the neutral, lower and 
standard fear faces condition (χ2(2,42)=2.96, p=.23). There was a significant linear 
main effect of RT with all participants responding slower to the standard fear faces 
conditions (F(1,39)=6.28, p=.004), with a significant difference between the lower 
and standard fear faces condition (t(41)=-2.37, p=.02) but not between the neutral 






Figure 6.4 Faces performance – reaction time (CGA) 
 
Figure 6.4 shows the mean reaction time of the “at risk” group and healthy controls during the three 
conditions of the Ekman faces task. The y-axis shows the mean reaction time. The error bars show the 
standard error of mean (SEM). 
 
 
Figure 6.5 Faces performance - reaction time (SGA) 
 
Figure 6.5 shows the mean reaction time of the NPE, PE and healthy control groups during the three 
conditions of the Ekman faces task. The y-axis shows the mean reaction time. The error bars show the 
standard error of mean (SEM). 
 
6.3.1.4 Additional analyses  
Based on the assumption, which was confirmed by our results, that the task is 
designed to produce equal performances across groups, we did not further investigate 
correlations between performances and clinical variables. As a further additional 
analysis we compared all women who were at risk of postpartum psychosis due to a 
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diagnosis of bipolar disorder (N=13) or other diagnoses (i.e. schizoaffective disorder, 
postpartum psychosis or family history) (N=11) and healthy controls (N=18). There 
was a non-significant difference between groups in the lower fear faces condition 
(χ2(2,42)=5.98, p=.05), with healthy controls performing better than the bipolar 
group (z=-2.29, p=.06, without Bonferroni correction). However, this represents a 
small difference of about 0.74 more faces recognised in the healthy controls, 
questioning the (clinical) relevance of this finding. There were no other performance 
differences between groups in accuracy or reaction time (smallest p=.18). 
 
6.3.2 Imaging results 
Two ROI analyses and two full-factorial models were conducted with 1) group (“at 
risk” versus healthy controls) as between subject factor and intensity (lower and 
standard fear against neutral) as within subject factor for the combined group 
analysis (2x2) 2) group (NPE, PE, and healthy controls) as between subject factor 
and intensity (lower and standard fear against neutral) as within subject factor for the 
sub group analysis (3x2). As a first analysis, we confirmed that the task robustly 
elicited the established faces task network in our participants including the fusiform 
gyrus, amygdala, frontal and temporal areas (Fusar-Poli et al., 2009). For that, we 
performed an analysis looking at brain regions activated by the neutral, lower, and 
standard fear conditions against the implicit baseline across all groups (CGA); see 
Table 6.3 and Figure 6.6.   
 
Table 6.3 The faces task network for all faces conditions across groups 
Area x y z BA Voxels Z Pcor 
R Inf Frontal 56 14 32 44 2685 >7.06 <.001 
L Sup Medial Frontal 0  32 44 8 3 4.54 =.036 
R Fusiform/Cerebellum  36 -38 -30 37 29915 >7.06 <.001 
R Hippocampus/Amygdala 22 -22 -8 NA 3191 7.06 <.001 
L Paracentral Lobule -16 -24 78 4 1 4.69 =.043 
R Supra Marginal 62 -16 22 48 113 5.33 =.001 
L Mid Temporal -48 -50 8 21 3 4.47 =.036 
Table 6.3 shows the brain regions activated during the contrast “neutral, lower and standard 
fear>baseline”. X, y, and z refer to the MNI coordinates. BA refers to the Brodmann area and Z 
and Pcor give the Z value and the significant p-value (corrected for multiple comparisons on 






Figure 6.6 The faces task network for all faces conditions across groups 
Figure 6.6 shows the brain regions activated during the contrast “neutral, lower and standard 
fear>baseline” overlaid on a high resolution T1-weighted template image in Montreal Neurological 
Institute space. Numbers refer to z coordinates. Voxels are corrected for multiple comparisons on the 
basis of family wise error (FWE). Left is the left and right the right side of the brain.  
 
6.3.2.1 Fear intensity 
We also investigated the effect of fear intensity across groups and found significantly 
higher activations in the frontal cortex, the fusiform gyrus, the postcentral gyrus and 
subcortical areas with increasing fear intensity in the 2x2 full-factorial model (CGA); 
see Table 6.4 and Figure 6.7.   
 
Table 6.4 The faces task network for fear intensity across groups 
Area x y z BA Voxels Z Pcor 
R Inf Frontal 42 8 26 44 363 6.39 <.001 
L Inf Frontal -38 6 26 48 36 4.85 =.009 
R Inf Occipital/Fusiform 36 -68 -10 19 2963 6.89 <.001 
L Mid Occipital/Fusiform -38 -82 -2 19 2422 6.49 <.001 
L Postcentral -32 -30 54 3 61 6.17 =.004 
R Thalamus 4 -6 -8 NA 52 4.69 =.005 
L Thalamus -8 -18 -10 NA 8 4.55 =.027 
R Hippocampus 20 -20 -10 NA 6 4.51 =.030 
Table 6.4 shows the brain regions activated during the contrast “standard fear>lower fear 
against neutral”. X, y, and z refer to the MNI coordinates. BA refers to the Brodmann area and 
Z and Pcor give the Z value and the significant p-value (corrected for multiple comparisons on 







Figure 6.7 Increase in fear intensity across groups 
 
Figure 6.7 shows the brain regions activated during the contrast “standard fear>lower fear against 
neutral” overlaid on a high resolution T1-weighted template image in Montreal Neurological Institute 
space. Numbers refer to z coordinates. Voxels are corrected for multiple comparisons on the basis of 
family wise error (FWE). Left is the left and right the right side of the brain. 
 
6.3.2.2 Group effects 
There was no difference between groups following our ROI analyses. There were no 
interaction effects found between group (“at risk” versus healthy controls for the 
combined group analysis (2x2 factorial model) or NPE, PE and healthy controls for 
the sub group analysis (3x2 factorial model)) and fear intensity (standard fear>lower 
fear against neutral). There was also no significant group effect in the combined 
group analysis. However, we found a significant increase in the left inferior frontal 
gyrus in the PE group compared to healthy controls for the contrast of both fear 
conditions averaged against neutral; see Table 6.5 and Figures 6.8 and 6.9. There 
were no further significant differences in the sub group analysis.  
 
Table 6.5 Group effect in the left inferior frontal gyrus, PE>healthy controls (SGA) 
Area x y z BA Voxels Z Pcor 
L Inf Frontal -34 16 28 48 390 4.01 =.050 
Table 6.5 shows the brain regions activated during the contrast “standard fear and lower fear 
against neutral in PE>healthy controls”. X, y, and z refer to the MNI coordinates. BA refers to 
the Brodmann area and Z and Pcor give the Z value and the significant p-value (corrected for 






Figure 6.8 Group effect in the left inferior frontal gyrus, PE>healthy controls 
Figure 6.8 shows the brain regions activated during the contrast “standard fear and lower fear against 
neutral in PE>healthy controls” overlaid on a high resolution T1-weighted template image in Montreal 
Neurological Institute space. Numbers refer to z coordinates. Cluster are corrected for multiple 




Figure 6.9 Group effect in the left inferior frontal gyrus (SGA) 
 
Figure 6.9 shows the significant increase of the PE group compared to healthy controls during the 
contrast “standard fear and lower fear against neutral” in the left inferior frontal gyrus (MNI 
coordinates: x=-34, y=16, z=28). The y-axis shows the mean BOLD response. The error bars show the 




The group effect was driven by a non-significant activation in the left inferior frontal 
gyrus areas by the PE group as assessed with a one sample t-test for the contrast 
standard fear>neutral (see Table 6.6). 
 
Table 6.6 Activation in the PE group for the contrast all fear>neutral 
Area x y z BA Voxels Z Pcor 
L Inf Frontal -34 16 28 48 95 3.20 =.964 
Table 6.6 shows the brain regions activated during the contrast “standard fear and lower fear against 
neutral” in the PE group. X, y, and z refer to the MNI coordinates. BA refers to the Brodmann area 
and Z and Pcor give the Z value and the significant p-value (corrected for multiple comparisons on the 
basis of cluster extent .005). L refers to left and R to right side of the brain.  
 
6.3.2.3 Additional analyses 
We did not find any supra-threshold clusters indicating group differences in the 
amygdala using the SPM WFU PickAtlas ROI approach. There were no significant 
correlations of the activation in the left inferior frontal gyrus with age, YMRS, 
HAM-D, PANSS, or length of illness (largest r(23)=.29, smallest p=.17). 
Antipsychotic medication (yes/no), age, scores of the YMRS, HAM-D, PANSS, or 
length of illness did not have significant effects on the imaging results when included 
as covariates in the full-factorial models. As a further additional analysis we 
compared all women who were at risk of postpartum psychosis due to a diagnosis of 
bipolar disorder (N=13) or other diagnoses (i.e. schizoaffective disorder, postpartum 
psychosis or family history) (N=11) and healthy controls (N=18). There were no 
significant group differences in activation when we compared all women diagnosed 
with bipolar disorder to healthy controls. However, when we compared women who 
were “at risk” due to other diagnoses, we found a significant increase in the left 
inferior frontal gyrus activation in this group compared to healthy controls, 
indicating that the previous result was mainly driven by women who were at risk of 
postpartum psychosis due to other diagnosis and women who have suffered a 








Table 6.7 Activation in the other “at risk” group for the contrast all fear>neutral 
Area x y z BA Voxels Z Pcor 
L Inf Frontal -34 16 28 48 1040 4.82 =.002 
Table 6.7 shows the brain regions activated during the contrast “standard fear and lower fear against 
neutral” in the other “at risk” group compared to healthy controls. X, y, and z refer to the MNI 
coordinates. BA refers to the Brodmann area and Z and Pcor give the Z value and the significant p-
value (corrected for multiple comparisons on the basis of cluster extent .001). L refers to left and R to 
right side of the brain.  
 
6.4 Discussion 
In this chapter, brain activation was investigated in women at risk of postpartum 
psychosis using the Ekman facial emotion paradigm portraying fearful faces. We 
expected that 1) women at risk of postpartum psychosis will show, in comparison to 
healthy controls, higher brain activation of the amygdala during a facial emotion 
processing task (primary hypothesis); 2) women at risk of postpartum psychosis will 
also show, in comparison to healthy controls, differential brain activation during the 
facial emotion processing task as assessed with whole brain analysis (secondary 
hypothesis); 3) differences in brain activation in facial emotion processing will be 
more pronounced in women who had developed postpartum psychosis episodes, 
compared to women who had not developed postpartum psychotic episodes, and to 
healthy controls (secondary hypothesis).  
 
6.4.1 Summary of findings 
As expected with an implicit facial emotion paradigm, there were no significant 
group performance differences in the combined or sub group analysis in accuracy or 
reaction times for the gender task. Contrary to our primary hypothesis, we did not 
find any increased activation in the amygdala of women at risk of postpartum 
psychosis. Still, we found a differential modulation in the form of a relative increase 
in activation in the left inferior frontal gyrus in the PE group compared to healthy 
controls when both fear conditions where compared to the neutral condition 
following the whole brain analysis. There were no significant correlations between 
activations and other variables such as clinical questionnaires, length of illness, age 
or medication. As the whole brain analysis was part of our secondary hypotheses, it 




6.4.2 Performance  
As expected according to the implicit task paradigm used in this study, there were no 
significant group differences in the combined or sub group analysis in accuracy or 
reaction times for the gender task. All groups were slower in responding to fearful 
faces, which is in line with previous studies showing that responses to fearful faces 
or negative stimuli are slower than to happy faces or neutral stimuli (Blair et al., 
2007; C. Chen et al., 2006). This further confirms that healthy controls and women 
“at risk” showed the expected behavioural variation with emotional faces and that the 
task worked in our population. Although the overall task accuracy was good (close to 
90%), it was slightly lower than expected given that this study used a gender 
discrimination design (implicit emotion recognition). One reason for this could be 
the fact that women from various ethnic backgrounds took part in this study and may 
potentially have found it harder to rate some of the Caucasian faces used in the 
Ekman faces task. However, given that there were no differences between groups in 
ethnicity we do not expect this finding to have confounded the results. In addition, 
until now there are no consistent data on race effects for facial emotion paradigms 
(Kohler et al., 2010), suggesting that lower scores may have been caused by other 
factors such as the challenge of being in a scanner environment during the 
postpartum period while performing the task. 
 
6.4.3 Imaging  
We assessed the general facial emotion processing network across all groups, as in a 
previous meta-analysis it was found that controls and people with psychosis activate 
a qualitatively similar network during facial emotion task performance (Li et al., 
2010). Our task elicited the expected network involved in facial and facial emotional 
processing including the inferior and superior frontal gyrus, fusiform gyrus, 
hippocampus and amygdala, paracentral lobule, and temporal areas (Fusar-Poli et al., 
2009), indicating that the task manipulation worked. We furthermore found that there 
was an effect of fear intensity (i.e. standard fear>lower fear) across groups in the 
inferior frontal gyrus, fusiform gyrus, postcentral gyrus, and subcortical structures. 
This suggests that the groups responded as expected to the fear manipulation.  
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We did not find evidence to confirm our primary hypothesis. One reason for not 
finding differential activation within the amygdala as expected could be the use of an 
implicit task design. While both explicit and implicit task designs have been 
associated with frontal activation, the implicit task design showed a stronger 
modulation with the inferior frontal cortex and insula compared to a stronger 
amygdala modulation by explicit designs (Fusar-Poli et al., 2009; Gorno-Tempini et 
al., 2001). However, there are also other studies which do not find an aberrant 
activation in the amygdala in patients with psychoses unrelated to childbirth when 
compared to healthy controls (Holt et al., 2005; Li et al., 2012; Sachs et al., 2012; 
Surguladze et al., 2006). One possible explanation for this might be that our study 
and these other studies used neutral faces as a baseline which may reduce the 
capacity to detect abnormal amygdala activation (for a discussion see Li and 
colleagues (2012)) (Holt et al., 2005; Li et al., 2012). Alternatively, it has been 
suggested previously that altered emotion processing varies according to the mood 
state (Rocca et al., 2009) and may rather represent a mood-congruent bias than a trait 
like deficit (Gray et al., 2006; Venn et al., 2004). It could be that our group with non-
postpartum episodes, which was euthymic at the time of the MRI scan, was not 
showing a current impairment in facial emotion processing, which may well become 
apparent during a potential relapse. Another explanation may be that our results show 
a gender effect, since it has been reported that males activate the amygdala more 
strongly during emotional processing (Fusar-Poli et al., 2009). However, others have 
reported that there is no effect of gender on facial emotion processing (Derntl et al., 
2009). Finally, it may be that our study was not able to detect a difference between 
groups in amygdala activation due to fact that the effect size may was too small for 
the power of this study. Further studies and ultimately meta-analysis will be required 
to understand if this is the issue.    
     However, we found a relative increase in the frontal cortex, specifically in the left 
inferior frontal gyrus in the PE group compared to healthy controls for the contrast of 
both fear conditions averaged against neutral faces. The inferior frontal gyrus has 
previously been found to be implicated in emotional processing as well as in 
cognitive tasks in bipolar disorder and psychoses unrelated to childbirth (C. Chen et 
al., 2011; Gorno-Tempini et al., 2001; Li et al., 2012). Moreover, increased 
activation in the inferior frontal gyrus to fearful faces has been reported previously in 
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bipolar disorder compared to controls (Lawrence et al., 2004). While typically 
associated with response inhibition (Aron, Behrens, Smith, Frank, & Poldrack, 2007; 
Aron, Robbins, & Poldrack, 2004; Rubia, Smith, Brammer, & Taylor, 2003), the 
increased activation may reflect a higher impulsivity or distractibility associated with 
bipolar disorder in the emotion regulation of women who had developed postpartum 
psychosis (C. Chen et al., 2011; Green, Cahill, & Malhi, 2007; Strakowski et al., 
2010). However, we did not find any differences in reaction times, which would 
support this hypothesis.  
     The inferior frontal gyrus has also been found to show increased activation during 
fear processing in patients with panic disorder, which was reduced following 
cognitive behavioural therapy (Kircher et al., 2013). This suggests that women with 
postpartum psychosis may have had higher levels of fear (i.e. increased emotional 
responses) regulated by the inferior frontal gyrus while performing the task. In 
addition, the inferior frontal gyrus has also been involved in observation and 
imitation of facial expression, with an increase in activation during imitation when 
compared to observation only (Carr, Iacoboni, Dubeau, Mazziotta, & Lenzi, 2003). 
Taken together, if validated in larger studies, these results suggest that women who 
had developed postpartum psychosis showed a greater emotional response regulated 
by the inferior frontal gyrus, possibly due to feeling more empathetic and affected by 
the fearful faces. 
 
6.4.4 Additional analyses 
There were no correlations with other variables for the imaging results. This is in line 
with other studies of emotion processing as no association with length of illness, 
medication or symptom severity have been reported in bipolar disorder (Derntl et al., 
2009; Leppänen et al., 2006). Only one study found a correlation between positive 
and negative symptomology and facial emotion processing deficits in psychoses 
unrelated to childbirth (Kohler et al., 2000).  
 
6.4.4.1 Impact of bipolar disorder 
We conducted an additional analysis in which women with a diagnosis of bipolar 
disorder were compared to women who were at risk of postpartum psychosis due to 
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other diagnoses and healthy controls. There were no significant performance or 
activation differences between the bipolar women and healthy controls or women “at 
risk” due to other diagnoses. However, women who were “at risk” due to other 
diagnoses showed a similar relative increase in activation in the left inferior frontal 
gyrus compared to healthy controls, as were found for the PE group. This suggests 
that the current results are mainly driven by the women who have suffered recently 
from postpartum psychosis and women who are at risk of postpartum psychosis due 
to other diagnoses rather than by a bipolar diagnosis. This possibly indicates a 
difference in emotional fear processing between euthymic women with a bipolar 
disorder diagnosis and women who have suffered from postpartum episodes and who 
are “at risk” due to other diagnoses.  
 
6.4.5 Conclusion 
In summary, women who had developed postpartum psychosis showed a relative 
increase in activation in the left inferior frontal gyrus compared to healthy controls 
which was not found in the non-postpartum group, suggesting an increased 
emotional response to the facial fear processing regulated by the inferior frontal 
gyrus. As the difference in the inferior frontal gyrus was part of the whole brain 
analyses, it will need to be validated in larger sample sizes in the future as it would 
not survive overall multiple comparison corrections (P<0.001) of this study. In order 
to confirm our finding further support this hypothesis, future studies should also look 
at the physiological and reported fear response of women during and shortly after 
performing the task. It will also be of further interest to investigate functional 
connections of the inferior frontal gyrus and other regions during emotional fear 
processing in order to confirm a potential emotion regulation by the left inferior 




7. Chapter: General discussion 
In this chapter, an overview of the aims and hypotheses of this study will be given. 
This will be followed by a brief summary of the relevant findings and conclusions of 
each chapter. Then, a general discussion of the results and how they might relate to 
each other will be presented, followed by a discussion of the difficulties and 
limitations of this study. Finally, a potential future outlook and an overall conclusion 
will be given. 
 
7.1 Overview of aims and hypotheses of the study 
In the present study, one aim was to investigate potential clinical and 
sociodemographic correlates of postpartum psychosis and to make a tentative 
comparison to previous epidemiological studies. Furthermore, for the first time, it 
was assessed whether women at risk of postpartum psychosis have cognitive, 
emotional, or neuroimaging impairments similar to those reported in bipolar disorder 
and psychoses unrelated to childbirth. Specifically, we investigated whether: 
 
Primary hypotheses: 
1. Women at risk of postpartum psychosis will show, in comparison to healthy 
controls, decreased brain activation in the dorsolateral prefrontal cortex during a 
working memory task.  
2.  Women at risk of postpartum psychosis will show, in comparison to healthy 
controls, higher brain activation of the amygdala during a facial emotion processing 
task.  
 
In addition, I will test a set of exploratory, secondary hypotheses: 
1. Women at risk of postpartum psychosis will show, in comparison to healthy 
controls, differential brain activation during a working memory and facial emotion 
processing task as assessed with whole brain analysis.  
2. Women at risk of postpartum psychosis will show, in comparison to healthy 
controls, impaired working memory performance.  
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3. Women at risk of postpartum psychosis will show, in comparison to healthy 
controls, impaired verbal memory performance.  
4. Impairments in verbal and working memory and differences in brain activation in 
working memory as well as in facial emotion processing will be more pronounced in 
women who had developed postpartum psychosis episodes, compared to women who 
had not developed postpartum psychotic episodes, and to healthy controls. 
 
7.2 Summary of findings 
In the following section a general overview of the relevant findings and conclusions 
of each chapter will be presented, as the specific results have already been discussed 
in detail in the chapters. The multiple comparison issue will be discussed in section 
7.5 Limitations, under 7.5.3 Power and multiple comparison correction.       
 
7.2.1 Clinical and sociodemographic correlates 
In the chapter assessing clinical and demographic correlates (chapter 3), we assessed 
whether women in the NPE, PE and healthy controls groups differed in their 
socioeconomic background, medical and obstetric history, medication or drug of 
abuse, or in life events, family history or clinical scales. Women were well matched 
for their socioeconomic background and medical and obstetric history. Medication 
use was also very similar between the postpartum and non-postpartum group in terms 
of type of medication and dose. There was no specific association between 
postpartum psychosis and life events, previous alcohol or illicit drug use or family 
history. However, there was an association between these variables and both “at risk” 
groups, suggesting that stressful life events, alcohol or illicit drug use, or a first-
degree family history of psychiatric illness are important contributors to the 
development of mood and psychotic disorders in general (J. Savitz et al., 2009; 
Schäfer & Fisher, 2011). 
     There was no difference between the postpartum and non-postpartum group on 
scales assessing general functioning, mood, positive and negative symptoms, anxiety 
and stress. In addition, scores for positive and negative psychotic symptoms were 
low in both groups. This indicates that women in the PE group were relatively well at 
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the time of the MRI scan, although most of them had suffered a recent episode of 
postpartum psychosis. However, the mood, anxiety and stress scores still suggest that 
both groups may need additional support within the first year after childbirth 
independently of having suffered from a postpartum episode or not. In conclusion, 
the results of the clinical and sociodemographic correlates chapter suggest that 
women with postpartum psychosis presented similarly in their clinical profile to 
women with a diagnosis of an affective illness unrelated to childbirth. This is in line 
with previous studies suggesting no noticeable differences concerning the 
symptomatology between postpartum and non-postpartum episodes (Brockington et 
al., 1981; Reich & Winokur, 1970). 
 
7.2.2 Verbal memory 
To the best of our knowledge, this is the first time that verbal memory function has 
been assessed in women at risk of postpartum psychosis (chapter 4). We used a 
standardised assessment of verbal memory (i.e. logical memory I and II of the WMS-
III) and an experimental verbal memory test using a remember-know paradigm. 
Significant impairments in the immediate recall as well as in recollection and 
familiarity were found in women at risk of postpartum psychosis in line with our 
secondary hypotheses. Women with postpartum and non-postpartum episodes 
showed a similar impaired performance compared to healthy controls, indicating that 
women with postpartum psychosis have a comparable verbal memory dysfunction to 
that observed in bipolar disorder and psychoses unrelated to childbirth (Aleman et 
al., 1999; Arts et al., 2008; Libby et al., 2012; Reichenberg, 2010; Reichenberg et al., 
2009; L. J. Robinson et al., 2006). In addition, this difference emerged in two 
different tasks in a relatively small sample of women, suggesting that this is a robust 
finding and should be a key area in future research.     
 
7.2.3 Working memory 
As a second assessment of cognitive functioning in women at risk of postpartum 
psychosis, an fMRI working memory paradigm was employed (chapter 5). As 
expected in our secondary hypothesis, women at risk of postpartum psychosis 
showed a trend towards impaired task performance during the most challenging task 
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condition. The most pronounced difference in performance was observed in the non-
postpartum group suggesting that women in this group employed a different strategy 
compared to healthy controls and women with postpartum episodes. Although our 
primary hypothesis was not confirmed, this difference in performance was also 
accompanied by a relative increase in activation in the non-postpartum group in the 
left midcingulate cortex and the bilateral superior temporal cortex following whole 
brain analysis. However, women who had suffered from postpartum psychosis 
showed a non-significant relative increase in activation in similar brain areas with 
intermediate activation levels compared to the NPE and healthy control groups. This 
differential activation possibly reflects an increase in the task demands, which may 
have been more challenging for the “at risk” groups due to a dysfunction in 
promoting task efficiency, resulting in a strategy change in this group. Furthermore, 
the activation profiles in both “at risk” groups indicate that women who have 
suffered from postpartum episodes show similar working memory deficits compared 
to women with non-postpartum episodes, bipolar disorder and psychoses unrelated to 
childbirth in general (Bora et al., 2010; I.N. Ferrier et al., 1999; Libby et al., 2012; 
Mur et al., 2007; L. J. Robinson et al., 2006; J. B. Savitz et al., 2008; Torres et al., 
2007; Valli et al., 2012). 
 
7.2.4 Facial emotion processing 
In addition to assessing cognitive functioning in women at risk of postpartum 
psychosis, facial emotional processing was also investigated (chapter 6), as it is 
proposed to be one of the key impairments in bipolar disorder and psychoses 
unrelated to childbirth (Bediou et al., 2005; Brüne, 2005; Y. Chen et al., 2012; 
Hoertnagl et al., 2011; Kohler et al., 2010; Malhi et al., 2007; Rocca et al., 2009). 
Our primary hypothesis was not confirmed. However, we found a differential 
modulation for fearful faces in the form of a relative increase in activation in the left 
inferior frontal gyrus in women with postpartum episodes compared to healthy 
controls. This finding suggests an increased emotional response to facial fear 
processing regulated by the inferior frontal gyrus. This modulation was not found 
between women suffering from non-postpartum episodes and healthy controls.   
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7.3 Overall discussion and implications of findings 
Postpartum psychosis is a severe incapacitating illness with serious consequences for 
the mother and baby, such as a higher risk of suicide of the mother (Appleby et al., 
1998; Babu et al., 2008; Brockington, 1996; Rohde & Marneros, 1993), risks of 
unsafe practices towards the baby (Chandra et al., 2006), and a high risk of a lack of 
emotional bonding or even separation between the mother and the child (Sit et al., 
2006). However, evidence has shown that, when given appropriate care, the impact 
of postpartum psychosis on a child’s development can be reduced (Murray et al., 
2003). Therefore, it is of great importance to further develop our understanding of 
postpartum psychosis in terms of its cognitive and emotional correlates. These 
represent not only key aspects of normal daily functioning (e.g. independent living, 
work functioning and social interactions), but also central impairments reported in 
bipolar disorder and psychoses unrelated to childbirth and therefore are potentially of 
relevance in postpartum psychosis (Bediou et al., 2005; Bora et al., 2010; Bowie & 
Harvey, 2005; Brüne, 2005; Y. Chen et al., 2012; Hoertnagl et al., 2011; Kohler et 
al., 2010; Libby et al., 2012; Malhi et al., 2007; Mur et al., 2007; L. J. Robinson et 
al., 2006; Rocca et al., 2009; J. B. Savitz et al., 2008; Valli et al., 2012). Most studies 
conducted in women at risk of or suffering from postpartum psychosis have 
concentrated on clinical presentation, prognosis, and treatment of the disorder. 
Therefore, this thesis has helped to add data to an under researched area.  
     This is the first study to show that women at risk of postpartum psychosis present 
with deficits in verbal and working memory and facial emotional processing 
accompanied by differential brain activation compared to healthy controls, while 
being matched for sociodemographic, medical and obstetric and clinical variables. 
Although this pilot study may have been -considering a strict multiple comparison 
correction- underpowered, it may lead towards important implications. Women who 
have suffered from postpartum psychosis also show, in addition to a similar clinical 
profile, similarities in their cognitive profile to women with non-postpartum 
episodes, bipolar disorder and psychoses unrelated to childbirth in general (Bediou et 
al., 2005; Bora et al., 2010; Bowie & Harvey, 2005; Brüne, 2005; Y. Chen et al., 
2012; Hoertnagl et al., 2011; Kohler et al., 2010; Libby et al., 2012; Malhi et al., 
2007; Mur et al., 2007; L. J. Robinson et al., 2006; Rocca et al., 2009; J. B. Savitz et 
al., 2008; Valli et al., 2012). This finding is of significance, as, if extended in to 
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larger groups, it indicates that women with postpartum psychosis might be rightly 
placed into the diagnostic category of mood disorders representing a sub group of 
this nosological group. Furthermore, this may be especially interesting considering 
the recent debate on the new diagnostic criteria for postpartum mood disorders in the 
DSM-V, for which leading experts in the field (Jones & Smith, 2009) have 
recommended that postpartum psychosis is part of the usual categories and does not 
form a separate specific nosological entity. Considering our results, this conclusion 
can be supported.  
     Adding assessments of cognitive functioning, including tests of verbal memory 
and working memory, and neuroimaging measures to the clinical diagnostic criteria 
may help to provide a better understanding of the pathophysiology of this disorder. 
This may also lead towards better diagnostic tools for clinicians in recognising and 
diagnosing the disorder. Moreover, a more precise knowledge of potential underlying 
cognitive impairments may also be beneficial to the mothers, as targeted training 
programmes can be developed focusing on the cognitive recovery needs of patients. 
     Women who have suffered from postpartum psychosis show abnormalities in the 
emotional processing of fear, which is not found in women with non-postpartum 
episodes only. This indicates that there is potentially a difference between women 
presenting with postpartum and non-postpartum episodes, although this difference 
was not found in a direct contrast but in comparison to healthy controls. Nonetheless, 
differences in the facial emotional processing of fear may present an important 
characteristic associated with postpartum episodes. Facial emotional processing is 
important for social interactions, especially when the mother is interacting with an 
infant that is unable to express herself/himself. This should therefore be further 
explored in future studies with larger sample sizes.  
         
7.4 Original study design and difficulties of the study 
One contributing factor to the lack of research in postpartum psychosis is represented 
by the practical difficulties of conducting rigorous research in this group. This was 
also the case in this study, in which a difficult aspect was the practical set up, 
including the recruitment and data collection. As no previous study had looked at 
cognitive, emotional and neuroimaging correlates of women at risk of postpartum 
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psychosis around the time of delivery, a proposal was originally developed for an 
ambitious study with a prospective design. This protocol initially envisaged six study 
visits, including two antenatal visits around the 25th week of pregnancy and four 
postnatal assessments (two within the first week after delivery, also comprising the 
MRI scan), one eight weeks after delivery and a final one, one year after delivery. 
During these study visits the aim was to conduct clinical, cognitive and hormonal 
assessments of the mother, and of the mother and the baby after delivery. For an 
overview of the original study design up until eight weeks after delivery see 
Appendix E.  
     However, since it was anticipated that the original study protocol could be very 
challenging for women at the end of a pregnancy and after a delivery, we also 
planned for an alternate, less intensive protocol (described in chapter 2, Methods in 
the paragraphs 2.2 Design and 2.6 Procedure. For an overview see also Figure 2.11 
Overview of all study assessments). Following several pilot runs conducted over the 
first 10 months of the study, it became clear that indeed the original study design was 
not feasible with the current study team. The reasons for this were:  
1. Most women were physically too unwell after labour and delivery to travel to 
the Centre for Neuroimaging Sciences within one week after delivery.  
2. Healthy controls and patients found it too challenging to undergo a study visit 
lasting approximately five hours, which included a 90 minute MRI scan, 
when they had a newly born baby.  
3. Women who developed postpartum psychosis were also often mentally too 
unwell to be able to complete the assessments so close to delivery.  
4. Many women who were first time mothers were reluctant to participate in the 
study as they felt they were not able to commit to the time it would take up in 
general.  
5. During the first year of the study we recruited from only two sites including 
the King’s College Hospital and the Royal Bethlem Mother and Baby Unit. 
This led to the identification of a relatively low number of potential 
participants that could be approached in the first place, given that postpartum 




These reasons also contributed to difficulties in assessing all women at around the 
same time point after delivery. This was especially true for the women who 
experienced a postpartum episode during the time of the study, since they often 
remained unwell for several months and could not be approached. As we had 
expected that certain changes had to be made to the protocol, a plan for review was 
in place 12 months into the study. Therefore, the study protocol was changed in the 
second year of the study without the need for ethics amendments.  
The following changes were made to the protocol in December 2010: 
1. The number of visits was reduced to two visits within the first year after 
delivery, in order to decrease the time commitment of the women taking part 
and increase the flexibility for assessments. 
2. The time gap for the assessments after delivery was increased to up to one 
year, so that we could include women who had been severely ill after delivery 
and we could give all women more flexibility in terms of their time 
commitment.  
3. Three additional study sites were added for recruitment, expanding the pool 
of potential participants.  
4. The MRI scanning protocol was changed so that women could stop the scan 
after 60 minutes or 90 minutes depending on their well-being.  
For an overview of the protocol see also chapter 2, Methods, paragraphs 2.2 Design 
and 2.6 Procedure and Figure 2.11 Overview of all study assessments. After these 
changes had been implemented, a sufficient number of participants were willing to 
take part and to complete the study. Given the rarity of the condition, the difficulties 
in identifying patients, and the problems in recruiting them into the study, future 
work in this area should build on these difficulties and be better designed in the 
context of multisite collaborations, which would result in well powered studies.  
 
7.5 Limitations 
As in other studies investigating disorders or diseases with low prevalence rates, 
several aspects need to be mentioned when interpreting the results of this study. 
These will be discussed in the following section.  
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7.5.1 Heterogeneity and the impact of bipolar disorder 
A limitation of this study is the relatively small sample size of the sub groups. Our 
sample was quite heterogeneous, making it difficult to match the sub groups on 
different aspects such as diagnosis and postpartum episodes. For example, it was not 
possible to separate out women who had experienced both postpartum and non-
postpartum episodes in order to create three sub groups. This would have been an 
interesting independent comparison to assess the effects of bipolarity on postpartum 
psychosis. However, based on the postpartum psychosis literature, categorising 
women into women with non-postpartum and women with postpartum episodes is 
considered a valid approach for analysis (P. Agrawal et al., 1990; Dean & Kendell, 
1981; Dean et al., 1989; C. L. Katona, 1982; Kirpinar et al., 1999; Kisa et al., 2007; 
Platz & Kendell, 1988).  
     To try and disentangle the possible role of diagnosis, we repeated most 
comparisons with women categorised into those “at risk” due to a bipolar disorder 
diagnosis and those “at risk” because of other diagnoses, including most women with 
a recent postpartum episode. Results of these comparisons show that while women 
with bipolar disorder show the most severe cognitive impairments and differences in 
brain activation in working memory, women who are “at risk” because of diagnoses 
other than bipolar show an intermediate performance and activation profile. While 
these results may add little to the existing literature on bipolar disorder, they advance 
existing knowledge by indicating that women “at risk” of postpartum psychosis for 
other diagnoses still show impairments similar to those of patients diagnosed with 
bipolar disorder. More importantly, they suggest that women who have suffered from 
postpartum psychosis show similar cognitive impairments to patients with bipolar 
disorder unrelated to childbirth. Interestingly, facial emotion processing dysfunction 
was only reported in the postpartum episodes group and not in the bipolar group, 
indicating a possible difference between euthymic women with bipolar disorder and 
women who are “at risk” due to a previous episode or other diagnoses. If future 
studies have access to a larger pool of participants, the homogeneity of the sample 
for potential sub group comparisons would allow further clarification of these 
differences.  
Another possibility would be to only look at risk factors for postpartum psychosis 
different from a history of bipolar disorder. However, as bipolar disorder is so highly 
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predictive of postpartum psychosis, it does not seem sensible to not take the most 
important risk factor into account. Some of the neurobehavioural correlates of this 
disorder may well be the very factors that are associated with the development of 
postpartum episodes. This is an aspect that deserves further clarification since not all 
women with bipolar disorder go on to develop postpartum psychosis after delivery. 
In order to be able to separate out the contributions of bipolar disorder in the future, 
it will be important to use a longitudinal approach and also look into more detail into 
the genetic contributions to postpartum psychosis.    
 
7.5.2 Healthy controls 
Healthy controls recruited into the study were matched to the “at risk” group on the 
following criteria: IQ, ethnicity, education and the number of weeks after delivery. In 
order to ensure that healthy controls did not differ on important socioeconomic 
variables, healthy women were recruited in the same hospital and from the same, 
relatively deprived, area in London as were women in the “at risk” group. In addition 
to that, we also applied the same inclusion/exclusion criteria to patients and controls, 
to limit the possibility that we included “well controls”, an approach which has been 
recently criticised in the literature (Schwartz & Susser, 2011). Only healthy controls 
with a current psychiatric diagnosis or one that was applicable to our “at risk” group 
were excluded.  
     Statistically, there were no significant or even trend differences in any of the 
above variables between the healthy control and the “at risk” group, implying that 
women were well matched regarding their socioeconomic background, medical and 
obstetric history in the current study. Still, as described in chapter 3, paragraph 3.4.7 
Representativeness of the “at risk” group and healthy controls, healthy controls still 
had numerically a higher IQ, a higher employment rate and a higher rate of women 
with a degree or diploma. Importantly, there was also a tendency of healthy controls 
to have a higher age than the “at risk” group. Therefore, we cannot exclude that 
healthy controls and women in the “at risk” group differed on other important 
variables in addition to the ones we have assessed in the experimental chapters. For 
example, we cannot exclude that healthy controls showed a -better than normal-
performance on the cognitive tasks and therefore that these could explain some of the 
differences we observed between groups. However, it is of note that our patients 
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group had a higher proportion of women in employment, especially in comparison to 
the local area (86%), and that these women were slightly above what is considered an 
average IQ (101.7), and therefore we have no reason to assume that their 
performance would be below the normal range. Furthermore, a comparison with 
other studies also suggests that the performance of the healthy women included in 
our study was within the normal range (Bell, 2006; Kieseppa et al., 2005).  
     Still we cannot exclude that this limitation may have, nonetheless, impacted on 
our results and it is of utmost importance in the future, to ensure that an healthy 
control group is even better matched on socioeconomic background and medical and 
obstetric history, so that a stringent comparison can be made between the “at risk” 
and the healthy control groups. Also for this reason a multisite collaboration would 
be preferable for the future of this study. 
   
7.5.3  Power and multiple comparison correction      
Important limitations in this study are the issues of power and multiple comparison 
correction. According to our calculations we had sufficient power for our primary 
hypotheses. However, the sample size was still relatively small. Especially for the 
second primary hypothesis, there was a lower predicted power. It is important to 
keep this limitation in mind when interpreting our study results. These will need to 
be confirmed by larger, better-powered studies in the future, in order to draw valid 
conclusions.  
     After delineating the primary hypotheses of the study, an overall multiple 
comparison correction was applied to the analyses of the explorative secondary 
hypotheses. We have calculated more than 50 comparisons, leading to a significance 
value set at p=.001 according to the Bonferroni correction. To adjust for such a high 
significance value, while formally controlling for Type I errors, potentially increases 
the likelihood of a Type II error. The power of the study becomes also more 
problematic when considering the issue of multiple comparisons as with a higher set 
significance value at p<.001, as more participants are needed in order to achieve the 
same statistical power. Due to the novelty of this work we cannot necessarily 
conclude that the groups do not differ in cognitive and emotional processing and 
differences found in this study may also identify potential important confounders, 
which can be taken into account in future studies. Furthermore, the conclusions 
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drawn from this pilot study are of great benefit for future studies in women at risk of 
or suffering from postpartum psychosis. This study has many practical implications 
for the setup and also suggests that women at risk of postpartum psychosis, including 
women with postpartum and non-postpartum episodes, show verbal and working 
memory and facial emotion processing impairments, which are important to be 
further investigated.   
 
7.5.4 Limitations of fMRI 
Since it is non-invasive, fMRI has become a very popular method in assessing brain 
function and the neurobiological correlates of neurocognitive and other 
psychological processes. As any other non-direct method, fMRI faces limitations that 
need to be considered when results of an imaging study are interpreted. For example, 
there are certain issues as to what deactivations or increases in brain activation 
actually mean in relation to cognitive processes (Logothetis, 2008). One of the main 
points that has been criticised in the literature is that fMRI does not measure 
neuronal activity directly (Huettel et al., 2004; Logothetis, 2008). (For an overview 
of the physics behind fMRI please see chapter 2, 2.4 Neuroimaging, 2.4.1 
Background of fMRI). Although the fact that the BOLD contrast reflects neuronal 
activity evoked by a stimulus has been established in previous research (Logothetis, 
2002, 2003), it remains possible that differences found between groups may relate to 
differences in neurovascular coupling in psychiatric disorders (D'Esposito, Deouell, 
& Gazzaley, 2003). Furthermore, the fMRI signal can also be confounded by other 
factors, such as medication or alcohol and substance abuse, which could be either 
only or to a larger extent, consumed by participants of one group and not the other 
(D'Esposito et al., 2003). As our study may be limited by these confounding effects, 
there is a more detailed discussion about possible effects of medication, symptoms, 
alcohol and substance abuse, hormones and menstrual cycle effects, and time after 
delivery on our results in the next section.  
 
7.5.5 Confounding variables and sources of variability 
As shortly discussed in chapter 2: Methods, paragraph 2.5.3 Potential confounders 
and sources of variability, in order to interpret the results of this study, it is also 
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important to look at the potential implications of confounding variables. In the 
following section, the effect of medications, symptoms, history of alcohol and 




As discussed in the individual chapters of this thesis, the role of medications on brain 
activation and performance was considered. However, we found no significant 
difference in dose or type of medication used in the two patient groups. However, as 
in many other studies in bipolar disorder and psychoses unrelated to childbirth, it is 
difficult to assess and control well for the potential effects of medications, because of 
the variable length of exposure, the variability in dose or the heterogeneity of 
exposure (C. Chen et al., 2011). For example, in this study it was not possible to get 
the exact information on length of exposure and dose of medication for all women. 
This was due to the fact that not all medical notes were accessible or complete, and 
that the women could not reliably remember when they had started their medication 
and the different dosages. Therefore, we could not calculate chlorpromazine 
equivalents for all women and this prevented the possibility of a direct quantitative 
comparison. Still, in order to account for medication effects, antipsychotic 
medication was taken into account in additional analyses as a dichotomous variable 
(yes/no). It is important to note the conversion to chlorpromazine equivalents has in 
itself been criticised (Rijcken, Monster, Brouwers, & de Jong-van den Berg, 2003). 
The two main criticisms of using chlorpromazine equivalents are that, firstly, the 
newer atypical antipsychotic have a different mode of action and affect several 
neurotransmitters compared to the mainly dopaminergic action of typical 
antipsychotics, questioning the comparability of the medications (Rijcken et al., 
2003; Stahl, 2008). The second criticism concerns the fact that there are no well 
controlled studies regarding dosage and potency on which a standardised use of 
chlorpromazine equivalents could be based (Rijcken et al., 2003), questioning the 




Taking medications into account has been problematic for all studies in patients 
treated with psychotropic drugs, as it makes it difficult to separate disorder effects 
from medication effects. However, it is important to note that previous studies show 
that medications do not seem to play a significant role in cognitive dysfunction in 
bipolar disorder or psychoses unrelated to childbirth (C. Chen et al., 2011; Goswami 
et al., 2009; Manoach, 2003; M. L. Phillips, Travis, Fagiolini, & Kupfer, 2008; L. J. 
Robinson et al., 2006; J. B. Savitz et al., 2008; Scheuerecker et al., 2008). It has been 
shown that unmedicated bipolar patients display the same cognitive deficits as 
medicated bipolar patients (Goswami et al., 2009). Furthermore, literature reviews 
have shown that antipsychotics may have a limited impact on fMRI findings and 
often seem to have rather normalising effects on brain function, (Hafeman, Chang, 
Garrett, Sanders, & Phillips, 2012; M. L. Phillips et al., 2008). However, some 
studies have also found that certain antipsychotics and lithium may be associated 
with increased volume in specific subcortical brain areas (Hafeman et al., 2012; 
Navari & Dazzan, 2009). Of specific importance to this study is the evidence that 
both antipsychotics and lithium increase prefrontal cortical activity during cognitive 
tasks and reduce limbic activity during emotion processing in bipolar adults, making 
activity more similar to that observed in healthy individuals (M. L. Phillips et al., 
2008). This implies that the effect of medication may obscure between-group 
differences, possibly leading to Type II errors (Hafeman et al., 2012; M. L. Phillips 
et al., 2008) 
     This suggests that our findings of cognitive and emotional processing 
impairments in women at risk of postpartum psychosis are not easily explained by 
medication differences. Nevertheless, we are aware that subtle differences in 
activation and performance potentially due to medication could not be fully 
controlled for with our assessment of medication exposure. Therefore, it is of great 
importance in the future of this study to develop a more sophisticated and detailed 
assessment of medication.   
 
7.5.5.2 Symptoms 
As discussed in the section 7.4. Original study design and difficulties of the study, it 
was not possible to assess women who developed postpartum psychosis while they 
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were unwell, as they were often not able to give informed consent. Also, women had 
to be well enough to follow the instructions of the task and sustain attention for a 
relatively a long time. Nevertheless, a higher symptom score on mood and psychotic 
symptoms scales was still found in the “at risk” group compared to healthy controls, 
and the potential role of these symptoms on the findings should be considered. It has 
been suggested that certain symptoms (e.g. persistent mood symptoms such as 
depression) are associated with more pronounced cognitive impairments in bipolar 
disorder as well as in psychoses unrelated to childbirth (Iosifescu, 2012). 
Specifically, verbal memory has been associated with both depressive and negative 
symptoms (Aleman et al., 1999; Brébion et al., 2001; Pelletier et al., 2005; 
Reichenberg, 2010; Thoma et al., 2006). Also, emotion recognition deficits have 
been found to vary with mood state, with depressed bipolar patients showing a mood 
congruent bias (a decreased sensitivity to happy faces and an increased sensitivity to 
sad faces) (Gray et al., 2006). In addition, facial emotion processing deficits seem to 
correlate with positive and negative symptomatology (Chan et al., 2010; Hooker & 
Park, 2002; Kohler et al., 2000; Poole et al., 2000). Still, it is also known in the 
literature that cognitive and facial emotion processing deficits persist during 
euthymic phases of patients with bipolar disorder (Hoertnagl et al., 2011; Townsend 
et al., 2010). 
     To control for the potential confounding effects of mood and psychotic symptoms 
is difficult, as they are so intrinsically linked to psychiatric disorders that controlling 
for symptoms actually may take away the “group effect” (Miller & Chapman, 2001). 
Nonetheless, in order to assess the effect of symptoms on the dependent variables in 
our study, we conducted correlations between the performance scores and activation 
and manic symptoms as assessed by the YMRS, depressive symptoms as assessed by 
the HAM-D, and positive or negative symptoms as assessed by the PANSS for each 
task. We did not find any correlations between clinical scales and performance or 
brain activation.  
     There were also no significant differences between the postpartum and the non-
postpartum group on any symptom scales. There was a significant difference with 
healthy controls, but the results on the YMRS, the HAMD-D and the PANSS suggest 
that the “at risk” group as a whole had very low scores on the clinical scales. This 
indicates that women in both groups (postpartum and non-postpartum) were virtually 
euthymic at the time of the scan, as the low scores were below the least stringent 
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criteria for euthymia proposed in a review on cognitive deficits in euthymic patients 
with bipolar disorder (L. J. Robinson et al., 2006). These low scores on the clinical 
scales, as well as the lack of correlations between such scores in our study, suggests 
that mood and psychotic symptoms were not heavily confounding the results of this 
study. Still, as symptoms have been associated with cognitive impairment and facial 
emotion processing deficits in previous studies, it will be important to further 
investigate their potential influence in the future.  
 
7.5.5.3 Alcohol and substance abuse 
Alcohol and substance abuse can have a profound impact on brain structure as well 
as on brain functioning (Leshner & Koob, 1999; Oscar-Berman & Marinkovic, 2003; 
Schulte et al., 2012). It is established that heavy and chronic alcohol and other drug 
abuse can lead to lasting changes in the brain affecting cognition and emotional 
functioning (Benningfield & Cowan, 2013; Büttner, Mall, Penning, Sachs, & Weis, 
2003; Schulte et al., 2012). Therefore, it is important in research studies to control 
for potential acute, but also lifetime, alcohol or drug abuse. Unfortunately, in 
psychiatric populations it is often difficult to recruit participants with no history of 
alcohol or substance abuse. Often rates of abuse are higher in psychiatric populations 
than in the control population, and bipolar disorder has been commonly associated 
with alcohol abuse (McDonald & Meyer, 2011). 
     None of the women in our sample reported any use of alcohol or other drugs of 
abuse during or after the pregnancy. However, 32% of women in the “at risk” group 
had a history of alcohol or substance abuse, while in the healthy control group none 
of the women reported any history of abuse. This result presents a potential 
confounder for the analysis. Due to the fact that we did not have a detailed 
assessment on history of abuse in addition to the SCID-I CV, we were not able to 
take history of alcohol or substance abuse into account in the analysis. Furthermore, 
the resulting low numbers would have made a statistical comparison difficult. 
However, as this was the first study conducted in women at risk of postpartum 
psychosis, it also has the purpose to identify potential confounders that are important 
to be controlled for in future research in this population. It will be important to 
adequately assess and control for acute and past alcohol and drug abuse by using 
214 
 
appropriate assessment tools, recruiting sufficient numbers of participants and also 
matching the healthy control group on this variable.  
 
7.5.5.4 Hormones and menstrual cycle effects  
One major limitation of this study is related to the difficulty to reliably assess 
differences in hormonal levels between women. The main reason for this was the 
large variation between women in the time of assessments after delivery. Although 
blood samples were taken in order to assess hormone levels, a comparison would 
have been difficult since some women had not had a first menstrual cycle after 
delivery while others did, and a few women were already on contraceptives. In the 
future, it will be of importance to streamline the assessments concerning the time 
after delivery as also discussed in paragraph 7.5.5.5 Time after delivery. This will 
help clarify whether hormonal changes that occur after delivery differ between 
groups and whether they affect the measures of interest (e.g. verbal memory, 
working memory).  
      As discussed in the introduction under paragraph 1.3.1.3 Menstrual cycle effects, 
assessing the current point in the menstrual cycle is also of great importance, as it 
may influence other biological parameters (e.g. cortisol levels, thyroid function) 
(Rubinow & Schmidt, 1995) as well as neurocognitive functions such as spatial 
working memory, selective attention and verbal memory (Craig et al., 2008; Craig et 
al., 2007; Hausmann et al., 2000; Maki et al., 2002; Man et al., 1999; Symonds et al., 
2004; Thimm et al., 2013). We only considered “having had a menstrual cycle after 
the most recent delivery” as a dichotomous variable into the additional analyses, 
specifically of the verbal memory task and found that it did not affect the results. 
This of course does not replace a detailed assessment of menstrual cycle phase and of 
subtle differences in hormonal levels. Unfortunately, since most women did not have 
a regular cycle yet after delivery, it was not possible to assess the effect of cycle 
phase. Therefore, we cannot exclude that hormonal variations represent a confounder 
in the current analysis and possibly influence the performance as well as the 
neuroimaging parameters. It is essential in future studies to pay special attention to 
this issue in order to make meaningful and valid comparisons between groups and to 
explore the possible interaction between hormone levels and an underlying brain 
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vulnerability. One valuable approach to assess menstrual cycle history has been 
presented by Symonds and colleagues (2004), using the Calendar of Premenstrual 
Experience (CoPE) along with recording the length of menstruation, abnormal mid-
cycle bleeding and length of cycle (Mortola, Girton, Beck, & Yen, 1990; Symonds et 
al., 2004). In summary, follow ups of this study, or future studies would hugely 
benefit from streamlining the time points of assessments after delivery as well as 
assessing the phase of the menstrual cycle.   
 
7.5.5.5 Time after delivery 
One of the most important reasons behind a change in the original study design was 
that women were not able, shortly after delivery, to undergo the MRI research visit. 
This applied to the healthy controls, but even more so to the women who developed a 
postpartum psychotic episode, as they often remained unwell for several months and 
could not be approached for research purposes. For this reason, the time period for 
recruitment was extended to up to one year after delivery. Unfortunately, this 
increased the variability in the number of weeks after delivery between participants. 
Although we controlled for weeks after delivery between groups, we cannot exclude 
that this variability had an impact on our results. For example, there could be a 
“carry-over” effect of pregnancy. Many women report a cognitive deterioration 
during pregnancy and early postpartum period and this is also partly supported by 
evidence from studies assessing cognitive function during pregnancy and early 
motherhood (De Groot, Vuurman, Hornstra, & Jolles, 2006; Henry & Rendell, 2007; 
Rendell & Henry, 2008). This would imply that women who have been assessed 
closer to the delivery may have performed worse than women who had more time to 
recover.  
     However, we believe this is unlikely. Firstly, weeks after delivery was taken into 
account in the cognitive tasks analyses and did not influence the results. Secondly, a 
recent study, and the first one done prospectively, highlights that, contrary to popular 
opinion, cognitive functioning does not seem to deteriorate during pregnancy, but 
may have been a result of sampling bias (Christensen, Leach, & Mackinnon, 2010). 
In addition, time after delivery was matched between groups and the time range was 
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restricted to one year after delivery, with the longest time interval being 43 weeks. 
This is a relatively short time-frame considering the complexity of the assessments.  
     Nonetheless, as discussed in the previous paragraph 7.5.5.4 Hormones and 
menstrual cycle effects, the variability in time after delivery made it impossible to 
assess the hormone levels in a structured way as some women had not had a first 
menstrual cycle after delivery while others did, and a few women were already on 
contraceptives. Also the differences in time after delivery led inevitably to some 
women having already stopped breastfeeding while other still did. This again is a 
factor that has a huge impact on hormonal levels and therefore also the potential to 
impact on brain functioning. Therefore, future studies may need to streamline the 
time points of assessments as much as practically possible.  
 
7.6 Future outlook 
The findings in this thesis represent a first important step towards a better 
understanding of cognitive, emotional and neuroimaging processes in women at risk 
of or suffering from postpartum psychosis. In order to further develop this 
knowledge, future analyses should implicate other biological correlates. Two 
interesting correlates are oestrogen and cortisol levels, the importance of which has 
been described in the main introduction of this thesis.   
 
7.6.1 Cortisol 
As discussed before, high cortisol levels are associated with stress and childbirth. In 
addition, higher cortisol has been found in patients suffering from mental health 
disorders such as depression and psychoses unrelated to childbirth (Aiello et al., 
2012; Bennett & Maxwell, 2008; Hendrick et al., 1998; Schäfer & Fisher, 2011). 
One pilot study also reported higher cortisol levels in women who developed 
postpartum psychosis (Paykel et al., 1991). Therefore, it would be interesting to 
investigate possible differences in cortisol levels between women with non-
postpartum and postpartum episodes and healthy controls. This would be particularly 
interesting considering that a higher percentage of women at risk of postpartum 
psychosis have a history of stressful or intrusive life events and report more physical 
and sexual childhood abuse compared to healthy controls. Furthermore, women in 
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both “at risk” groups experienced more subjective stress and higher anxiety at the 
time of the MRI scan and women who had suffered from postpartum psychosis 
showed differential brain activation to fearful faces. These results are indicative that 
a higher cortisol response may be present in women at risk of postpartum psychosis. 
 
7.6.2 Structural imaging 
Based on the results in this study, showing differences in functional brain activation 
in a working memory and a facial emotion processing task, it would be of further 
interest to investigate potential structural differences in both “at risk” groups. It has 
been previously reported that certain brain areas show an increased activation as a 
functional compensation for structural abnormalities (i.e. volumetric grey matter 
reductions) in first episode as well as chronic schizophrenia (Kuroki et al., 2006; 
Onitsuka et al., 2004). Therefore, investigating potential volumetric differences in 
our women at risk of postpartum psychosis may shed more light on the functional 
activation differences that were found.  
     In addition, an enlarged volume of the pituitary has been associated with being in 
a high-risk state of developing bipolar disorder and psychoses unrelated to childbirth 
(Aiello et al., 2012; Mondelli et al., 2008). This increase in the pituitary has 
furthermore been associated with higher cortisol levels and stress reactivity (Aiello et 
al., 2012). It would be interesting to assess cortisol levels and their potential 
association with an increased volumetric volume of the pituitary and higher levels of 
reported stress and anxiety.  
     Finally, another structural measure of interest would be the assessment of the 
white matter in women at risk of postpartum psychosis, as differences in white 
matter have been also associated with stress and childhood trauma (Daniels, Lamke, 
Gaebler, Walter, & Scheel, 2013). Intact myelin content is important for functional 
white matter connections (S. C. Deoni et al., 2008), which are in turn responsible for 
a good processing speed needed for cognitive functioning (S. C. L. Deoni, Dean Iii, 
O'Muircheartaigh, Dirks, & Jerskey, 2012). Therefore, it would be important to 
investigate potential alterations of myelin content and a possible association with 




7.6.3 Follow-up studies 
Women were assessed retrospectively in this study in terms of number of episodes 
and length of illness. For this reason we cannot exclude that women in the non-
postpartum group may develop postpartum episodes at a later time point. Likewise, 
women who experienced a first or second postpartum episode may develop non-
postpartum episodes later on. It would be of great interest to follow these women up 
at a later time point in order to assess whether they have suffered from new episodes. 
A later follow-up visit including a second MRI scan may also clarify whether the 
impairments we found are stable over time or whether women show a decline in 
verbal or working memory function or in facial emotion processing. In addition, it 
would be also of interest for future studies to assess women already during the 
pregnancy and follow them up postpartum in order to assess potential risk factors 
predictive of postpartum psychosis.   
     Of further interest would be, in addition to the assessment of the mothers, the 
evaluation of the effects of a postpartum psychotic episode on the child in terms of 
their cognitive and emotional development. Another possibility would be to measure 
stress levels of the child using biological measures. Furthermore, recent advances in 
imaging research show that babies as young as several months can undergo MRI 
scanning in order to assess myelin content (S. C. L. Deoni et al., 2012). Since this 
seems a potentially important measure in the mother, it would be useful to see 
whether alterations can also be found in their offspring. 
 
7.7 Final conclusion 
The results of this study represent an important first step towards a better 
understanding of cognitive and emotional processes and associated brain activation 
patterns in women at risk of or suffering from postpartum psychosis. Identifying 
correlates in women “at risk” may represent an important aid for clinicians. For 
example, the presence of some of these factors may in the future help to identify the 
subset of women who are at a particularly high risk of developing a postpartum 
episode and therefore help in guiding preventative pharmacological interventions. In 
addition, more in-depth knowledge and understanding of these processes may help 
clinicians to develop targeted cognitive training and therapies in addition to the 
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pharmacological treatment available, potentially speeding up the recovery process in 

















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































10.  Decorate 
11.  Fierce 
12.  Knead 
13.  Aisle 
14.  Vengeance 
15.  Prestigious 
16.  Wreathe 
17.  Gnat 
18.  Amphitheatre 
19.  Lieu 
20.  Grotesque 
21.  Iridescent 
22.  Ballet 
23.  Equestrian 
24.  Porpoise 
25.  Aesthetic 
 
26.  Conscientious 
27.  Homily  
28.  Malady 
29.  Subtle 
30.  Fecund 
31.  Palatable 
32.  Menagerie 
33.  Obfuscate 
34.  Liaison 
35.  Exigency 
36.  Xenophobia 
37.  Ogre 
38.  Scurrilous 
39.  Ethereal 
40.  Paradigm 
41.  Perspicuity 
42.  Plethora 
43.  Lugubrious 
44.  Treatise 
45.  Dilettante 
46.  Vertiginous 
47.  Ubiquitous  
48.  Hyperbole 
49.  Insouciant 




Brief life events questionnaire (BLE) 
The following questions are about events or problems which may have happened to 
you during the past 6 months which might have caused you distress and to seek help. 
 
1. In the last 6 months, did you suffer from a serious illness, injury or an assault?  
If yes, at that time, how bad was that for you?      
 
2. In the last 6 months, did a serious illness, injury or assault happen to a close 
relative?                   
If yes, at that time, how bad was that for you?       
 
3. In the last 6 months, did a parent, spouse (or partner), child, brother or sister of 
yours die?                 
If yes, at that time, how bad was that for you?       
 
4. In the last 6 months, did a close family friend or other relative die, such as an aunt, 
cousin or grandparent?             
If yes, at that time, how bad was that for you?     
   
5. In the last 6 months, did you have a separation due to marital difficulties or break 
off a steady relationship?            
If yes, at that time, how bad was that for you?      
  
6. In the last 6 months, did you have serious problems with a close friend, neighbour 
or relatives?                     
If yes, at that time, how bad was that for you 
 
7. In the last 6 months, were you made redundant or sacked from your job?  
If yes, at that time, how bad was that for you?       
 
8. In the last 6 months, were you seeking work without success for more than 1 
month?    
If yes, at that time, how bad was that for you 
 
9. In the last 6 months, did you have a major financial crisis such as losing the 
equivalent of three months’ income?                
If yes, at that time, how bad was that for you?       
 
10. In the last 6 months, did you have problem with the police involving a court 
appearance?                 
If yes, at that time, how bad was that for you?       
 
11. In the last 6 months, was something you valued lost or stolen?                
If yes, at that time, how bad was that for you? 
 
12. In the last 6 months, have you had any major pregnancy-related problems?                    






Intrusive life events (ILE) 
Instructions to researcher: Please ask participant the following - I would now like to 
ask you about things that may have happened to you or problems you may have 
faced throughout your life. Looking at the list above, can you tell me if you have 
ever suffered from any of the problems or events shown on the card, at any time in 
your life?  
        
a) Serious injury or assault to yourself:           
  
b) Bullying:                       
 
c) Violence at work:       
 
d) Violence in the home      
 
e) Sexual abuse                       
 
f) Being expelled from school     
 
g) Running away from home      
 
h) Being homeless  
      
i) Taken into local authority care     
 
j) Time in children’s institution     




Childhood experience of care and abuse questionnaire (Ceca-Q) 
I’m going to ask you some questions about your childhood experiences.  If you 
prefer not to answer any of the questions, that’s fine – just say you’d rather not 
answer. 
 
Who brought you up before age 17? 
 
Family Arrangements (all) 
   
Were you ever in a children’s home or institution prior to age 17? 
     If yes, type of institution: 
 
Parental Loss and Separation 
Did either parent die before you were aged 17? 
Have you ever been separated from either parent for 6 months or more before 17? 
 
Physical Punishment before the Age of 17 by a Parent Figure or Other 
Household   Member 
 
When you were a child or a teenager were you ever hit repeatedly with an implement 
(such as a belt or stick) or punched, kicked or burnt by someone in the household? 
 
b) How old were you when it began? 
c) Did the hitting happen on more than one occasion?  
d) How were you hit?  
f) Were you ever injured, e.g. bruises, black eyes, broken limbs? 
g) Was this person ever so angry they seemed out of control?  
Please describe your experience (not for data entry) 
 
h) Did you experience this from anyone else in the household?  
Please describe your experience (not for data entry) 
 
Unwanted Sexual Experiences before Age 17 
 
When you were a child or teenager did you ever have any unwanted sexual 
experience  
        
Did anyone force you or persuade you to have sexual intercourse against your wishes 
before age 17? 
 
Can you think of any upsetting sexual experiences before age 17 with a related adult 
or someone in authority, e.g. teacher? 
 
How old were you when it began? 
ii)  Was the other person someone you knew? 
iii)  Was the other person a relative? 
iv)  Did this person do it on more than one occasion? 
v)  Did it involve touching private parts of your body? 
vi)  Did it involve sexual intercourse? 
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Family interview for genetic studies (FIGS)  
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Now I am asking you to keep in mind all those in your family as I go through this list 




Feel very low for a couple of weeks or more, or have a diagnosis of depression? 
 
Attempt or complete suicide? 
 
Seem overexcited (or manic) day and night, or have a diagnosis of mania? 
 
Have visions, hear voices, or have beliefs that seem strange or unreal? 
 
Have unusual or bizarre behaviour, or have a diagnosis of schizophrenia? 
 


















Hamilton depression rating scale (HAM-D) 
 
(To be administered by a health care professional). The HAM-D is designed to rate 
the severity of depression in patients. Although it contains 21 areas, calculate the 
patient’s score on the first 17 answers. Rate symptoms over the past two weeks 
 
1.  DEPRESSED MOOD (Sadness, hopeless, helpless, worthless 
0 = Absent 
1 = These feeling states indicated only on questioning. 
2 = These feeling states spontaneously reported verbally 
3 = Communicates feeling states non-verbally – i.e. through facial expression,   
      posture, voice, and tendency to weep. 
4 = Patient reports VIRTUALLY ONLY these feeling states in her spontaneous  
      verbal and non-verbal communication.             
 
2. FEELINGS OF GUILT                        
0 = Absent 
1 = Self-reproach, feels she has let people down 
2 = Ideas of guilt or rumination over past errors or sinful deeds 
3 = Present illness is a punishment; delusions of guilt 
4 = Hears accusatory or denunciatory voices and/or experiences threatening visual  
      hallucinations  
 
3. SUICIDE                                              
0 = Absent 
1 = Feels life is not worth living 
2 = Wishes she were dead or any thoughts of possible death to self 
3 = Suicidal ideas or gestures 
4 = Attempts at suicide (any serious attempt rates 4) 
 
4. INSOMNIA EARLY                              
0 = No difficulty falling asleep 
1 = Complains of occasional difficulty falling asleep – i.e. more than ½ hour 
2 = Complains of nightly difficulty falling asleep 
 
5. INSOMNIA MIDDLE                          
0 = No difficulty 
1 = Patient complains of being restless and disturbed during the night 
2 = Waking during the night – any getting out of bed rates 2 (except for purposes of  
      voiding) 
 
6. INSOMNIA LATE                           
0 = No difficulty 
1 = Waking in early hours of the morning but goes back to sleep 





7. WORK AND INTERESTS                   
0 = No difficulty 
1 = Thoughts and feelings of incapacity, fatigue or weakness related to activities,  
      work or hobbies 
2 = Loss of interest in activity, hobbies, or work – either directly reported by patient  
      or indirect in listlessness, indecision and vacillation (feels she has to push self to  
      work or activities) 
3 = Decrease in actual time spent in activities or decrease in productivity  
4 = Stopped working because of present illness 
 
8. RETARDATION: PSYCHOMOTOR    (Slowness of thought and speech; 
impaired ability to concentrate; decreased motor activity)                         
0 = Normal speech and thought 
1 = Slight retardation at interview 
2 = Obvious retardation at interview 
3 = Interview difficult 
4 = Complete stupor 
 
9. AGITATION                                         
0 = None 
1 = Fidgetiness 
2 = Playing with hands, hair, etc. 
3 = Moving about, can’t sit still 
4 = Hand wringing, nail biting, hair-pulling, biting of lips 
 
10. ANXIETY  (PSYCHOLOGICAL)                     
0 = No difficulty 
1 = Subjective tension and irritability 
2 = Worrying about minor matters 
3 = Apprehensive attitude apparent in face or speech 
4 = Fears expressed without questioning 
 
11. ANXIETY SOMATIC    Physiological concomitants of anxiety, (i.e. effects of 
autonomic overactivity, “butterflies”, indigestion, stomach cramps, belching, 
diarrhoea, palpitations, hyperventilation, paraesthesia, sweating, flushing, tremor, 
headache, urinary frequency).  
Avoid asking about possible medication side effects (i.e dry mouth, constipation) 
0 = Absent 
1 = Mild 
2 = Moderate 
3 = Severe 
4 = Incapacitating 
 
12. SOMATIC SYMPTOMS (GASTROINTESTINAL)                          
0 = None 
1 = Loss of appetite but eating without encouragement from others. Food intake  
      about normal 
2 = Difficulty eating without urging from others. Marked reduction of appetite and  




13. SOMATIC SYMPTOMS GENERAL  
0 = Absent                                            
1 = Heaviness in limbs, back or head. Backache, headache, muscle aches. Loss of  
       energy and fatiguability 
2 = Any clear cut symptom rates 2 
 
14. GENITAL SYMPTOMS (Symptoms such as: loss of libido, impaired sexual 
performance;  menstrual disturbances) 
0 = Absent 
1 = Mild 
2 = Severe 
 
15. HYPOCHONDRIASIS                      
0 = Not present 
1 = Self-absorption (bodily) 
2 = Preoccupation with health 
3 = Frequent complaints, requests for help, etc. 
4 = Hypochondriacal delusions 
 
16. LOSS OF WEIGHT  (N.B. rate N/A [-88] for data entry)                               
A. When rating by history 
0 = No weight loss 
1 = Probable weight loss associated with present illness 
2 = Definite (according to patient) weight loss 
3 = Not assessed 
 
17. INSIGHT      (N.B. rate N/A [-88] for participants who do not have a diagnosis of 
MDD)                                          
0 = Acknowledges being depressed and ill 
1 = Acknowledges illness but attributes cause to bad food, climate, overwork, virus,  
      need for rest, etc. 
2 = Denies being ill at all 
 
18. DIURNAL VARIATION                     
A. Note whether symptoms are worse in morning or evening. If NO diurnal 
variation, mark none 
0 = No variation 
1 = Worse in AM  
2 = Worse in P.M. 
B. When present, mark severity of the variation. Mark “None” if NO variation. 
0 = None 
1 = Mild 




19. DEPERSONALIZATION AND DEREALIZATION (Such as:  Feelings of 
unreality, nihilistic ideas) 
0 = Absent 
1 = Mild 
2 = Moderate 
3 = Severe 
4 = Incapacitating 
 
20. PARANOID SYMPTOMS                  
0 = None 
1 = Suspicious 
2 = Ideas of reference 
3 = Delusions of reference and persecution 
 
21. OBSESSIONAL AND COMPULSIVE SYMPTOMS           
0 = Absent 
1 = Mild 




Young mania rating scale (YMRS) 
Instructions to researcher: Mainly rated from general observation and interview, 
rather than from asking direct questions. It may be necessary to ask directly about 
some subjects, to ensure all areas of the tool are covered.  A severity rating is 
assigned to each of the eleven items, based on the patient’s subjective report of her 
condition over the previous 48 hours and the clinician’s behavioural observations 
during assessment, with the emphasis on the latter. 
 
1. Elevated mood: How might you describe your mood in the last couple of days? 
 0 = Absent. 
 1 = Mildly or possibly increased on questioning. 
 2 = Definite subjective elevation; optimistic, self-confident; cheerful and  
   appropriate to content. 
 3 = Elevated, inappropriate to content and humorous 
 4 = Euphoric; inappropriate laughter, singing 
 
2. Increase motor activity/energy: In the last 2 or so days how restless would you say 
you’ve been? 
 0 = Absent. 
 1 = Subjectively increased. 
 2 = Animated, gestures increased. 
 3 = Excessive energy; hyperactive at times; restless (can be calmed). 
 4 = Motor excitement; continuous hyperactivity.  
 
3. Sexual interest: What about your interest in sex in the last couple of days? 
 0 = Normal; not increased. 
 1 = Mildly or possibly increased. 
 2 = Definite subjective increase on questioning. 
 3 = Spontaneous sexual content; elaborates on sexual matters; hypersexual by  
    self-report. 
 4 = Overt sexual acts (towards others). 
 
4. Sleep: How have you been sleeping in the last couple of days? 
 0 = Reports no decrease in sleep. 
 1 = Sleeping less than normal amount by up to one hour. 
 2 = Sleeping less than normal amount by more than one hour. 
 3 = Reports decreased need for sleep. 
 4 = Denies need for sleep. 
 
5. Irritability: Have you been more irritable recently? 
 0 = Absent. 
 1 = Subjectively increased. 
 2 = Irritable at times during interview; recent episodes of anger or annoyance  
                 on ward. 
 3 = Frequently irritable during interview; short, curt throughout. 







6.  Speech (rate and amount): Rate on basis of interview 
 0 = No increase. 
 1 = Feels talkative. 
 2 = Increased rate or amount at times, verbose at times. 
 3 = Push; consistently increased rate and amount; difficult to interrupt. 
 4 = Pressured; uninterruptible, continuous speech 
 
7. Language – thought disorder: Rate on basis of interview 
 0 = Absent. 
 1 = Circumstantial; mild distractibility; quick thoughts. 
 2 = Distractible; loses goal of thought; change topics frequently; racing  
                 thoughts. 
 3 = Flight of ideas; tangentiality; difficult to follow; rhyming, echolalia. 
 4 = Incoherent; communication impossible. 
 
8. Content: Rate on basis of interview 
 0 = Normal. 
 1 = Questionable plans, new interests. 
 2 = Special project(s); hyper-religious. 
 3 = Grandiose or paranoid ideas; ideas of reference. 
 4 = Delusions; hallucinations. 
 
9. Disruptive – aggressive behaviour: Rate on basis of interview 
 0 = Absent, cooperative. 
 1 = Sarcastic; loud at times, guarded. 
 2 = Demanding; threats on ward. 
 3 = Threatens interviewer; shouting; interview difficult. 
 4 = Assaultive; destructive; interview impossible.  
 
10. Appearance: Rate on basis of interview 
 0 = Appropriate dress and grooming. 
 1 =  Minimally unkempt. 
 2 = Poorly groomed; moderately dishevelled; overdressed. 
 3 = Dishevelled; partly clothed; garish make-up. 
 4 = Completely unkempt; decorated; bizarre garb. 
 
11.  Insight: Do you think you’ve been unwell in recent days? 
 0 = Present; admits illness and agrees with need for treatment. 
 1 = Possibly ill. 
 2 = Admits behaviour change, but denies illness. 
 3 = Admits possible change in behaviour, but denies illness. 
 4 = any behaviour change. 
     -88 = Not unwell  
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Positive and negative syndrome scale (PANSS) 
 
Instructions to researcher: Tick the box for each symptom which best describes the participant’s condition over the last 7 days and not relative to 











1. Delusions  
 
2. Conceptual disorganisation 
 
3. Hallucinatory behaviour  
 
4. Excitement  
 
5. Grandiosity  
 
6. Suspiciousness /persecution  
 
7. Hostility  
Absent    Minimal      Mild    Moderate  Mod. severe  Severe     Extreme 
 
1            2          3           4           5            6        7     
 
1            2          3           4           5            6        7 
 
1            2          3           4           5            6        7     
 
1            2          3           4           5            6        7 
 
1            2          3           4           5            6        7     
 
1            2          3           4           5            6        7 
 







8. Blunted affect  
 
9. Emotional withdrawal  
 
10. Poor rapport  
 
11. Passive/apathetic social withdrawal 
 
12. Difficulty in abstract thinking  
 
13. Lack of spontaneity and flow of conversation 
 
14. Stereotyped thinking 
 
Absent    Minimal      Mild    Moderate  Mod. severe  Severe    Extreme 
 
 
1            2          3           4           5            6        7     
 
1            2          3           4           5            6        7 
 
1            2          3           4           5            6        7     
 
1            2          3           4           5            6        7 
 
1            2          3           4           5            6        7     
 
1            2          3           4           5            6        7 
 









15. Somatic concern  
16. Anxiety  
17. Guilt feelings  
18. Tension  
19. Mannerisms and posturing  
20. Depression  
21. Motor retardation  
22. Uncooperativeness  
23. Unusual thought content  
24. Disorientation  
25. Poor attention  
26. Lack of judgement and insight  
27. Disturbance of volition  
28. Poor impulse control  
29. Preoccupation  
30. Active social avoidance  
  
Absent    Minimal     Mild    Moderate  Mod. severe   Severe    Extreme 
                                                                   
 
1            2          3           4           5            6        7     
1            2          3           4           5            6        7 
1            2          3           4           5            6        7     
1            2          3           4           5            6        7 
1            2          3           4           5            6        7     
1            2          3           4           5            6        7 
1            2          3           4           5            6        7 
1            2          3           4           5            6        7     
1            2          3           4           5            6        7 
1            2          3           4           5            6        7     
1            2          3           4           5            6        7 
1            2          3           4           5            6        7     
1            2          3           4           5            6        7 
1            2          3           4           5            6        7 
1            2          3           4           5            6        7 

















CODE    (Note: Use intermediate level when appropriate, e.g., 45, 68, 72.) 





Superior functioning in a wide range of activities, life’s problems never seem to get out of hand, 





Absent or minimal symptoms (e.g., mild anxiety before an exam), good functioning in all areas, 
interested and involved in a wide range of activities, socially effective, generally satisfied with 






If symptoms are present, they are transient and expectable reactions to psychosocial stressors 
(e.g., difficulty concentrating after family argument), no more than slight impairment in social, 





Some mild symptoms (e.g., depressed mood and mild insomnia) OR some difficulty in social, 
occupational, or school functioning (e.g., occasional truancy, or absences from work), but 





Moderate symptoms (e.g., flat affect and circumstantial speech, occasional panic attacks) OR 






Serious symptoms (e.g., suicidal ideation, severe obsessional rituals, frequent shoplifting) OR 
any serious impairment in social, occupational, or school functioning (e.g., no friends, unable to 






Some impairment in reality testing or communication (e.g., speech is at times illogical, obscure, 
or irrelevant) OR major impairment in several areas, such as work or school, family relations, 
judgment, thinking, or mood (e.g., depressed man avoids friends, neglects family, and is unable 






Behaviour is considerably influenced by delusions or hallucinations OR serious impairment in 
communication or judgment (e.g., sometimes incoherent, acts grossly  inappropriately, suicidal 
preoccupation) OR inability to function in almost all areas (e.g., stays in bed all day; no job, 





Some danger of hurting self or others (e.g., suicide attempts without clear expectation of death, 
frequently violent, manic excitement) OR occasionally fails to maintain minimal personal 






Persistent danger of severely hurting self or others (e.g., recurrent violence) OR persistent 




highest past year:  
Consider psychological, social, and occupational functioning on a 
hypothetical continuum of mental health-illness. Do not include 






Clinical global impression (CGI)                                                                                                        
Severity of illness 
 
Considering your total clinical experience with this particular population, how 
mentally ill is the patient at this time? 
 
1 Not assessed  
2 Normal, not at all ill  
3 Borderline mentally ill  
4 Mildly ill  
5 Moderately ill  
6 Markedly ill  
7 Severely ill  
































Beck depression inventory (BDI) 
 
Choose one statement from among the group of four statements in each question that 
best describes how you have been feeling during the past few days. Circle the 
number beside your choice.  
 
1. 0. I do not feel sad. 
    1. I feel sad.  
    2. I am sad all the time and I can’t snap out of it. 
    3.  I am so sad or unhappy that I can’t stand it. 
 
2.  0.  I am not particularly discouraged about the future. 
     1.  I feel discouraged about the future. 
     2.  I feel I have nothing to look forward to. 
     3.  I feel that the future is hopeless and that things cannot improve.  
 
3.  0.  I do not feel like a failure.  
     1.  I feel I have failed more than the average person. 
     2.  As I look back on my life, all I can see is a lot of failure.  
     3.  I feel I am a complete failure as a person. 
 
4.   0.  I get as much satisfaction out of things as I used to. 
      1.  I don’t enjoy things the way I used to.  
      2.  I don’t get any real satisfaction out of anything anymore. 
      3.  I am dissatisfied or bored with everything. 
 
5.   0.  I don’t feel particularly guilty. 
      1.  I feel guilty a good part of the time.  
      2.  I feel quite guilty most of the time. 
      3.  I feel guilty all of the time.  
 
6.   0.  I don’t feel I am being punished.  
      1.  I feel I may be punished.   
      2.  I expect to be punished.   
      3.  I feel I am being punished. 
 
7.   0.  I don’t feel disappointed in myself. 
      1.  I am disappointed in myself.  
      2.  I am disgusted with myself.  
 
8.  0.  I don’t feel I am any worse than anybody else.          
     1.  I am critical of myself for my weaknesses or mistakes.  
     2.  I blame myself all the time for my faults. 
     3.  I blame myself for everything bad that happens. 
 






     1.  I have thoughts of killing myself, but I would not carry them out. 
     2.  I would like to kill myself. 
     3.  I would kill myself if I had the chance. 
 
10.  0.  I don’t cry any more than usual.  
       1.  I cry more than I used to.   
       2.  I cry all the time now.   
       3.  I used to be able to cry, but now I can’t cry even though I want to. 
 
11.  0.  I am no more irritated by things than I ever am.        
       1.  I am slightly more irritated now than usual. 
       2.  I am quite annoyed or irritated a good deal of the time. 
       3.  I feel irritated all the time now. 
 
12.  0.  I have not lost interest in other people.     
       1.  I am less interested in other people than I used to be. 
       2.  I have lost most of my interest in other people.               
       3.  I have lost all of my interest in other people. 
 
13.  0.  I make decisions about as well as I ever could. 
       1.  I put off making decisions more than I used to. 
       2.  I have greater difficulty in making decisions than before. 
       3.  I can’t make decisions at all anymore 
 
14.  0.  I don’t feel that I look any worse than I used to. 
       1.  I am worried that I am looking old or unattractive.    
       2.  I feel that there are permanent changes in my appearance that make me look  
            unattractive. 
       3.  I believe that I look ugly.  
 
15.  0.  I can work about as well as before.  
       1.  It takes an extra effort to get started at doing something.  
       2.  I have to push myself very hard to do anything. 
       3.  I can’t do any work at all. 
 
16.  0.  I can sleep as well as usual. 
       1.  I don’t sleep as well as I used to. 
       2.  I wake up 1-2 hours earlier than usual and find it hard to get back to sleep.  
       3.  I wake up several hours earlier than I used to and cannot get back to sleep.  
 
17.  0.  I don’t get more tired than usual.   
       1.  I get tired more easily than I used to. 
       2.  I get tired from doing almost anything. 
       3.  I am too tired to do anything. 
 






       1.  My appetite is not as good as it used to be. 
       2.  My appetite is much worse now.  




19.  0.  I haven’t lost much weight, if any, lately. 
       1.  I have lost more than five pounds. 
       2.  I have lost more than ten pounds. 
       3.  I have lost more than fifteen pounds. 
 
20.  0.  I am no more worried about my health than usual. 
       1.  I am worried about physical problems such as aches and pains, or upset   
            stomach, or constipation. 
       2.  I am very worried about physical problems, and it’s hard to think of much   
            else. 
       3.  I am so worried about my physical problems that I cannot think about    
            anything else. 
 
21.  0.  I have not noticed any recent change in my interest in sex.   
       1.  I am less interested in sex than I used to be. 
       2.  I am much less interested in sex now. 







Perceived stress scale (PSS) 
 
The questions in this scale ask you about your feelings and thoughts during the last 
month. In each case, please indicate with a tick how often you felt or thought a 
certain way. 
 
Please write here the time of day at which this questionnaire was completed 
 
In the last month, how often have you been upset because of something that 
happened unexpectedly?  
 Never  □  Fairly often □ 
 Almost never □  Very often □ 
 Sometimes □ 
 
In the last month, how often have you felt that you were unable to control the 
important things in your life? 
 Never  □  Fairly often □ 
 Almost never □  Very often □ 
 Sometimes □ 
 
In the last month, how often have you felt nervous and "stressed"? 
 Never  □  Fairly often □ 
 Almost never □  Very often □ 
 Sometimes □ 
 
In the last month, how often have you felt confident about your ability to handle your 
personal problems? 
 Never  □  Fairly often □ 
 Almost never □  Very often □ 
 Sometimes □ 
 
In the last month, how often have you felt that things were going your way? 
 Never  □  Fairly often □ 
 Almost never □  Very often □ 
 Sometimes □ 
 
In the last month, how often have you found that you could not cope with all the 
things that you had to do? 
 Never  □  Fairly often □ 
 Almost never □  Very often □ 
 Sometimes □ 
 
In the last month, how often have you been able to control irritations in your life? 
 Never  □  Fairly often □ 
 Almost never □  Very often □ 







In the last month, how often have you felt that you were on top of things? 
 Never  □  Fairly often □ 
 Almost never □  Very often □ 
 Sometimes □ 
 
In the last month, how often have you been angered because of things that were 
outside of your control? 
 Never  □  Fairly often □ 
 Almost never □  Very often □ 
 Sometimes □ 
  
In the last month, how often have you felt difficulties were piling up so high that you 
could not overcome them? 
 Never  □  Fairly often □ 
 Almost never □  Very often □ 








Self- evaluation questionnaire (STAI; state) 
A number of statements which people have used to describe themselves are given 
below. Read each statement and then tick in the appropriate box on the right to 
indicate how you feel right now, that is, at this moment. There are no right or wrong 
answers. Do not spend too much time on any one statement but give the answer 
which seems to describe your present feelings best. 
 




I feel calm 1 2 3 4 
I feel secure 1 2 3 4 
I feel tense 1 2 3 4 
I feel strained 1 2 3 4 
I feel at ease 1 2 3 4 
I feel upset 1 2 3 4 
I am presently worrying over 
possible misfortunes 
1 2 3 4 
I feel satisfied  1 2 3 4 
I feel frightened 1 2 3 4 
I feel comfortable 1 2 3 4 
I feel self-confident 1 2 3 4 
I feel nervous 1 2 3 4 
I am  jittery 1 2 3 4 
I feel indecisive 1 2 3 4 
I am relaxed 1 2 3 4 
I feel content 1 2 3 4 
I am worried 1 2 3 4 
I feel confused 1 2 3 4 
I feel steady 1 2 3 4 






















Self- evaluation questionnaire (STAI; trait) 
A number of statements which people have used to describe themselves are given 
below. Read each statement and then tick in the appropriate box on the right to 
indicate how you generally feel. There are no right or wrong answers. Do not spend 
too much time on any one statement but give the answer which seems to describe 




Sometimes Often Almost 
always 
I feel pleasant 1 2 3 4 
I feel nervous and restless 1 2 3 4 
I feel satisfied with myself 1 2 3 4 
I wish I could be as happy as 
others seem to be 
1 2 3 4 
I feel like a failure 1 2 3 4 
I feel rested 1 2 3 4 
I am “calm, cool, and 
collected” 
1 2 3 4 
I feel that difficulties are 
piling up so that I cannot 
overcome them 
1 2 3 4 
I worry too much over 
something that really does not 
matter 
1 2 3 4 
I am happy 1 2 3 4 
I have disturbing thoughts 1 2 3 4 
I lack self-confidence 1 2 3 4 
I feel secure 1 2 3 4 
I make decisions easily 1 2 3 4 
I feel inadequate 1 2 3 4 
I am content 1 2 3 4 
Some unimportant thought 
runs through my mind and 
bothers me 
1 2 3 4 
I take disappointments so 
keenly that I cannot put them 
out of my mind 
1 2 3 4 
I am a steady person 1 2 3 4 
I get in a state of tension or 
turmoil as I think over my 
recent concerns and interests 










Athens insomnia scale (AIS) 
This scale is intended to record your own assessment of any sleep difficulty you 
might have experienced. Please check (by circling the appropriate number) the items 
below to indicate your estimate of any difficulty, provided that it occurred at least 
three times per week during the last 2 weeks.  
 
Sleep induction (time it takes you to fall asleep after turning-off the lights) 
0 No problem  
1  Slightly delayed  
2   Markedly delayed  
3   Very delayed or did not sleep at all 
 
Awakenings during the night 
0 No problem  
1 Minor problem 
2 Considerable problem  
3 Serious problem or did not sleep at all 
 
Final awakening earlier than desired 
0 Not earlier  
1 A little earlier  
2 Markedly earlier  
3 Much earlier or did not sleep at all 
 
Total sleep duration 
0 Sufficient  
1 Slightly insufficient  
2 Markedly insufficient 
3 Very insufficient or did not sleep at all 
 
Overall quality of sleep (no matter how long you slept) 
0 Satisfactory 
1 Slightly unsatisfactory  
2 Markedly unsatisfactory  
3 Very unsatisfactory or did not sleep at all 
 
Sense of well-being during the day 
0 Normal 
1 Slightly decreased  
2 Markedly decreased  











Functioning (physical and mental) during the day 
0 Normal  
1 Slightly decreased  
2 Markedly decreased  




Sleepiness during the day 
0 None  
1 Mild  











Prescribed medication at the time of the MRI scan in the “at risk group”. 
 
Table 1 CGA 
Medication Dose mg/day Exposure in days CPZ equivalent mg/day
Antipsychotics + additional (N=14)   
Olanzapine 3 682 60 
Olanzapine 5 47 100 
Olanzapine, Lithium 5, 1000 515, 18 100, NA 
Olanzapine 10 8 200 
Olanzapine, Citalopram 10, 30 59 200, NA 
Olanzapine, Valproate semisodium 10, 500 784 200, NA 
Olanzapine 15 85 300  
Quetiapine 13 24 17 
Quetiapine 400 398 533 
Quetiapine 400 520 533 
Quetiapine 600 26 800 
Risperidone, Promethazine 12, 25 68 600, NA 
Olanzapine unknown 233 NA 
Haloperidol unknown unknown NA 
Antidepressants (N=3)   
Citalopram unknown unknown NA 
Fluoxetine 60 202 NA 
Sertraline unknown unknown NA 
Benzodiazepines + additional (N=1)   
Clonazepam, Zopiclone unknown, 8 41 NA 
Table 1 shows the prescribed medication for the “at risk” group at the time of the MRI scan. The dose 
is displayed in milligram per day. The length of exposure is displayed in days. Chlorpromazine (CPZ)




















Prescribed medication at the time of the MRI scan in the NPE and PE groups. 
 
Table 2 SGA 
Medication Dose mg/day Exposure in days CPZ equivalent mg/day 
NPE group (N=7) 
Antipsychotics + additional  
Olanzapine 5 47 100 
Olanzapine, Valproate semisodium 10, 500 784 200, NA 
Quetiapine 400 398 533 
Quetiapine 400 520 533 
Haloperidol unknown unknown NA 
Antidepressants  
Fluoxetine 60 202 NA 
Sertraline unknown unknown NA 
PE group (N=11)   
Antipsychotics + additional 
Olanzapine 3 682 60 
Olanzapine, Lithium 5, 1000 515, 18 100, NA 
Olanzapine 10 8 200 
Olanzapine, Citalopram 10, 30 59 200, NA 
Olanzapine 15 85 300 
Quetiapine 13 24 17 
Quetiapine 600 26 800 
Risperidone, Promethazine 12, 25 68 600, NA 
Olanzapine unknown 233 NA 
Antidepressants  
Citalopram unknown unknown NA 
Benzodiazepines + additional 
Clonazepam, Zopiclone unknown, 8 41 NA 
Table 2 shows the prescribed medication for the “at risk” group at the time of the MRI scan. The dose 
is displayed in milligram per day. The length of exposure is displayed in days. Chlorpromazine (CPZ) 









First-degree relatives with a psychiatric illness in the “at risk” group. 
 
Table 3  (CGA) 
Relative Psychiatric illness 
At risk group (N=15) 
Mother / Sister PP / PD & anxiety 
Mother BD 
Brother BD 
Father Psychotic episode 
Brother / Father, Mother & Brother BD / MDD 
Father & Mother MDD 
Father MDD 







Brother / Mother MDD / Anorexia & agoraphobia 




Table 3 PP=postpartum psychosis. PD=postpartum depression. BD=bipolar disorder. 
MDD=major depressive disorder. PTSD=post-traumatic stress disorder. Each row 











First-degree relatives with a psychiatric illness in the NPE and PE groups. 
 
Table 4 First-degree relatives with a psychiatric illness (SGA) 
Relative Psychiatric illness 
NPE group (N=10)  
Mother BD 
Father Psychotic episode 
Brother / Father, Mother & Brother BD / MDD 
Father & Mother MDD 





Brother / Mother MDD / Anorexia & agoraphobia 









Table 4 PP=postpartum psychosis. PD=postpartum depression. BD=bipolar disorder. 
MDD=major depressive disorder. PTD=post-traumatic stress disorder. Each row 













INFORMATION SHEET (I) 
 
STUDY TITLE 
Risk factors of perinatal mental disorders: 
Stress, Electrophysiological, and Neuroimaging markers. 
(Research ethics Committee number: 10/H0807/14) 
 
A study conducted at the Institute of Psychiatry and funded by the National Alliance 
for Research on Schizophrenia and Depression (NARSAD). 
 
Principal Contact for general queries:  
Astrid Pauls Astrid.Pauls@kcl.ac.uk  
Chief Investigator: Dr. Paola Dazzan, Institute of Psychiatry, London SE5 8AF  
 
We would like to invite you to take part in a research study at the Institute of 
Psychiatry. Before you decide you need to understand why the research is being done 
and what it would involve for you. Please take time to read the following information 
carefully. Talk to others about the study if you wish. The information is separated 
into two parts. Part 1 tells you the purpose of this study and what will happen to you 
if you take part. Part 2 gives you more detailed information about the conduct of the 
study. Ask us if there is anything that is not clear or if you would like more 
information. Take time to decide whether or not you wish to take part. If you do 









Purpose of the research 
It is commonly believed that pregnancy is a time of good mental health. However, 
severe mental health problems occur around pregnancy (e.g. depression (feeling sad, 
withdrawn, not motivated) or postpartum psychosis (hearing voices, having bizarre 
and unshakable beliefs)). These problems can have huge consequences for mother 
and child. Yet, little research has been done in this area. In this study we want to 
examine whether there are changes, in response to stress, hormones, or in brain 
functioning, that can help us identify which women are most likely to develop these 
problems. Furthermore, we want to investigate how these problems affect the 
development of the baby. To achieve this, we aim to evaluate women who are at high 
risk or suffer from mental health problems around pregnancy and women who are at 
low risk of mental health problems around pregnancy, and their babies. We will look 
at the way mothers respond to stress, or whether there are changes in parts of the 
brain, or in the way these areas function, that makes them more likely to become 
unwell with the hormonal changes that happen around pregnancy. We will also look 
at whether these problems are associated with changes in the way the baby responds 
to stress and in the way he/she develops.  
 
Why have I been invited? 
We invited you to participate in our study as a healthy control because you are 
pregnant, and routine screening at your initial meeting with your midwife has not 
identified you as someone at risk for mental health problems. In total, we will 
include 150 pregnant women of which 100 will be at high and 50 at low risk for 
mental health problems. We will also include you baby after he/she is born. 
 
Do I have to take part? 
It is entirely up to you to decide whether or not to take part. We will describe the 
study and go through this information sheet, which we will then give to you. We will 






free to withdraw at any time, without giving a reason; this would not affect the 
standard of care you receive. 
  
What will happen to me and my baby if I take part?  
There will be up to 6 study visits, lasting 2-4 hours, over up to 18 months. The study 
itself will go on for four years in total.  
 
Visit 1  
Occurs when you are about 25 weeks pregnant. You will be seen by a clinical 
researcher who will ask you some background questions such as age, number of 
children, employment and ethnic origin. You will also complete clinical 
questionnaires and be asked about any problems you might experience concerning 
your mental health. You will have a blood test (20mls blood - about 1 tablespoon) to 
look at hormone levels and to assess your DNA. The researcher may also obtain 
background information from your medical notes. We are looking at cortisol (“stress 
hormone”) levels in saliva samples and you will be asked to provide saliva samples, 
which you can collect yourself on one of the following days after the visit. We will 
show you how to do this during your first visit.  
 
Visit 2 
Occurs shortly after the first visit. We will ask you again to complete some clinical 
questionnaires. In order to have a look at potential volume or function changes in 
brain areas, we will invite you to have a Magnetic Resonance Imaging (MRI) scan in 
our Centre for Neuroimaging Science shortly after your delivery. Therefore, during 
the current visit we will give you the opportunity to become familiar with our MRI 
scanner. You will be given the opportunity to lie in a mock-up scanner before lying 
in the real scanner. We will take a picture of your brain structure in the real scanner. 
We will also do a neurocognitive assessment, during which you will do some short 
tasks measuring domains such as attention or memory. Depending on how you feel, 
we will record the electrical activity of your brain with electroencephalography 






perform some simple cognitive tasks on a computer screen lasting approximately 20 
minutes.  
 
After this visit you will receive some short questionnaires by post and we will ask 
you to complete those and send them back to us, together with another set of saliva 
samples collected in the same way as during your first study visit.  
 
Visit 3 
This visit will take place shortly after your baby is born. We will ask you to fill in 
some questionnaires and answer questions concerning your mental health. Again, 
you will have a blood test to look at hormone levels (20mls blood - about 1 
tablespoon) and you will be asked to provide specimens of your saliva. 
During this scanning session (which will take about 90 minutes), we will collect 
pictures (scans) of your head while you are performing some simple cognitive tasks 
or while doing nothing (at rest). We use a very modern method of scanning known as 
Magnetic Resonance Imaging (MRI). This technique is commonly used to diagnose a 
number of diseases, but in this case it has been adapted to take images of which parts 
of your brain are active when you perform a task.  When a part of your brain is more 
active, more blood flows to that region. We will make a map of which parts of your 
brain has more blood flow than others. In order for us to take pictures of your brain, 
you will have to lie as still as possible in the MRI scanner. The scanner consists of a 
powerful magnet, but you will not feel any force or special sensation inside a 
magnetic field because your body is insensitive to it. Because of the magnetic field, 
you must not have a scan if you have received metal injuries to your eyes, had 
metallic objects (including clips) inserted into your body during an operation, or if 
you have received a gun shot injury or have a heart pace maker. The radiographer 
will go through a list of possible risks with you before you go into the scanner. 
Please note that MRI scans do not involve any form of ionising radiation (X-rays), 
but the scanner itself can be a bit claustrophobic; therefore please inform us if you 
have a fear of enclosed spaces. All the time you are in the scanner there will be a 






explain what will happen next. Some people find the machine noisy, but the 
headphones we provide allow adequate acoustic protection for most people.   
Important: 
During the scan your baby can stay at the ward under the care of midwives. If you 
have already left the ward, a developmental psychologist who has been working in 
perinatal psychiatry for over 30 years will be available to assist with the care of your 
baby.  
 
Again, depending on how you feel, we will record the electrical activity of your brain 
with electroencephalography (EEG). For this, you would have to sit still for 5-10 
minutes and consequently perform some simple cognitive tasks on a computer screen 
lasting approximately 20 minutes. 
 
Following the delivery of your baby, the midwives will take a small section of the 
umbilical cord or some blood from the umbilical cord after it has been removed from 
your baby. We will use this to look at the baby’s DNA for genetic studies. A study 




At 6 days postpartum we would like to assess the behaviour and development of your 
baby using the Neonatal Behavioural Assessment Scale (NBAS). This assessment 
looks at the full range of neonatal behaviour, including competencies and strengths, 
in autonomic stability, motor organization; state organization, and self-quieting 
capacities. This assessment will last about 20-30 minutes. The researcher will collect 
a specimen of your baby’s saliva shortly before and after the assessment, to look at 
levels of the stress hormone, cortisol, cotinine (a marker of exposure to tobacco) and 










This visit will take place 8 weeks after delivery. Similar to visit 1, you will be seen 
by a clinical researcher who will ask you some background questions such as 
employment. You will also complete clinical questionnaires and be asked about any 
problems you might experience concerning your mental health. The researcher may 
also obtain background information from your medical notes. Again, you will be 
asked to provide saliva samples, which you can collect yourself on one of the 
following days after the visit.  
We would also like to look at the interactions between you and your baby. In order to 
do this we will make a 3-5 minute video recording, for which you will be asked to 
play and talk to your baby as you normally would. We will also obtain saliva 
samples from your baby, to look at “stress hormone” levels, cotinine and DNA. The 
clinical researcher will meet with you & your baby when you attend for the baby’s 
routine vaccinations, & show you how to obtain the sample. 
 
Visit 6 
This visit will take part 1 year after delivery. Similar to visit 3, we will ask you to fill 
in questionnaires and ask questions concerning your mental health; you will have a 
blood test and you will be asked to provide specimens of your saliva. In order to have 
a look at potential volume or function changes in brain areas we might invite you 
again to be scanned in our Centre for Neuroimaging Science record or also record the 
electrical activity of your brain with electroencephalography (EEG).  
 
We will also assess the behaviour and development of your baby again, and look at 
the interactions between you and your baby by making a new 3-5 minute video 
recording as in visit 5. We will also ask questions about baby’s feeding and 
medication, and maternal medications and collect saliva samples of your baby.  
 
The study assessments are over and above those involved in standard care; normal 






All video recordings are treated as confidential, will not be used for commercial 
purposes and will be destroyed when the study is completed. 
 
Expenses and payments.  
You will be reimbursed for travel expenses you incur in attending for study visits and 
receive £40 for the scanning visits.  
 
What will I have to do? 
If you wish to take part in the study, you will be asked to sign the consent form at the 
end of this document; you will be given a copy to keep. You should be prepared to 
undertake the 6 study visits, as detailed above. Please also consider that in agreeing 
to participate, you are also providing consent on behalf of the baby you are 
expecting. 
 
What are the possible disadvantages and risks of taking part? 
You may find the study visits/procedures inconvenient, particularly after your baby 
is born, as this is often a busy period for new mothers. It is also possible that you 
may experience some minor discomfort and/or bruising from the blood test. 
Although it is not painful, your baby may experience some distress on collection of 
saliva samples.  
During the study, it is possible that other conditions are discovered of which you 
were unaware, which may have implications for your future health, or otherwise 
impact on your interests. If anything is identified, your GP or hospital consultant will 
be informed, with your agreement. 
 
What are the possible benefits of taking part? 
There are no direct benefits to you of taking part in the study; however the 









What do I do if I want to withdraw from the study? 
You are free to withdraw from the study at any time you like. You will not be 
required to give us any reasons for withdrawal from the study but please inform us as 
soon as possible if you wish to do so. This would not affect the standard of care you 
receive. 
 
Will my participation be kept confidential? 
Yes. We will follow ethical and legal practice and all information about you will be 
handled in confidence. More information on confidentiality is given in Part II of this 
information sheet. 
 
If you have any questions about matters related to the study please contact Astrid 
Pauls (Astrid.Pauls@kcl.ac.uk) or Dr. Paola Dazzan (Paola.Dazzan@kcl.ac.uk or on 
0207 848 0070).   
 
If the information in Part 1 has interested you and you are considering participation, 









What if there is a problem?  
If you have a concern about any aspect of this study, you should ask to speak to the 
researchers who will do their best to answer your questions (tel. 0207 848 0070). If 
you remain unhappy and wish to complain formally, you can do this through the 
NHS Complaints Procedure; details can be obtained from the hospital. 
 
In the event that something does go wrong and you are harmed during the research 
and this is due to someone’s negligence, then you may have grounds for a legal 
action for compensation against King’s College Hospital Foundation NHS Trust or 
the study sponsor, King’s College London, but you may have to pay your legal costs. 
The normal National Health Service complaints mechanisms will still be available to 
you.  
 
What will happen if I don’t want to carry on with the study?  
If you withdraw from the study we will destroy all identifiable information about 
you. We will retain and continue to use any data collected before such withdrawal of 
consent unless you request that you do not want us to use any data collected from 
you. 
 
Will my taking part in this study be kept confidential? 
Yes, your confidentiality will be safeguarded during and after the study, which is 
conducted in accordance with the Data Protection Act 1998. An identification code 
will be allocated to you and later to your baby. The information we collect will be 
recorded and put into electronic databases using this code rather than your name. 
Paper and electronic records are stored securely at the Institute of Psychiatry; the 
custodian of all study materials is Dr Paola Dazzan (Chief Investigator).  
The researchers will have access to your clinical notes and those of your baby. By 
signing the consent, you will be giving consent for the researchers to examine your 






Study data will be analysed and results will be submitted for publication; your 
identity will not be revealed. Study data will be retained and may be used in future 
studies, if this happens, further Research Ethics Committee approval will be sought. 
Authorized persons such as researchers, sponsors, regulatory authorities and 
Research and Development audit will have access to view identifiable data, for 
monitoring of the quality of the research. Study data will be retained for 10 years 
after completion of the study; and will be disposed of securely. You have the right to 
check the accuracy of data held about you and correct any errors according to local 
law and procedures. 
 
What will happen to any samples I give? 
All samples from you and your baby will be processed and then stored prior to 
analysis using the identification code described. The researchers and laboratory 
scientists will have access to the samples; the researcher will be able to link your 
other study data to data from the analysis of your sample by the identification code. 
All samples will be disposed in accordance with the Human Tissue Authority’s Code 
of Practice once the study is completed. 
 
What will happen to the results of the research study? 
The data and results from this study may be published in medical journals or used in 
scientific reports and may be communicated to the regulatory authorities. You will 
not be identified by name. Once the study has been completed, a report of the 
findings will prepared for participants; you can request a copy using the contact 
details below. 
 
Who is organising and funding the research?  
The Chief Investigator, Dr. Paola Dazzan is organizing the research, which is 
sponsored by the Institute of Psychiatry, King’s College London, and funded by the 
National Alliance for Research on Schizophrenia and Depression (NARSAD), the 






involved in conducting this study do not receive any financial incentives for 
including you in this study and do not benefit financially from this study. 
 
Who has reviewed the study?  
This research has been looked at by an independent group of people, called a 
Research Ethics Committee to protect your safety, rights, wellbeing and dignity. This 
study has been reviewed by Joint SLAM/IOP Research ethics Committee Ref 
number: 10/H0807/14. 
 
If you have any questions about matters related to the study please contact Astrid 
Pauls (Astrid.Pauls@kcl.ac.uk) or Dr. Paola Dazzan (Paola.Dazzan@kcl.ac.uk or on 
0207 848 0070).   
 
You will receive a copy of the information leaflet and signed consent form to keep. 
 












INFORMATION SHEET (II) 
 
STUDY TITLE 
Risk factors of perinatal mental disorders: 
Stress, Electrophysiological, and Neuroimaging markers. 
(Research ethics Committee number: 10/H0807/14) 
 
A study conducted at the Institute of Psychiatry and funded by the National Alliance 
for Research on Schizophrenia and Depression (NARSAD). 
 
Principal Contact for general queries:  
Astrid Pauls Astrid.Pauls@kcl.ac.uk  
Chief Investigator: Dr. Paola Dazzan, Institute of Psychiatry, London SE5 8AF  
 
 
  We would like to invite you to take part in a research study at the Institute of 
Psychiatry. Before you decide you need to understand why the research is being 
done and what it would involve for you. Please take time to read the following 
information carefully. Talk to others about the study if you wish. The information 
is separated into two parts. Part 1 tells you the purpose of this study and what will 
happen to you if you take part. Part 2 gives you more detailed information about 
the conduct of the study. Ask us if there is anything that is not clear or if you would 
like more information. Take time to decide whether or not you wish to take part. If 
you do decide to participate, you will be given a copy of this document to take 








Purpose of the research 
It is commonly believed that pregnancy is a time of good mental health. However, 
severe mental health problems occur around pregnancy (e.g. depression (feeling sad, 
withdrawn, not motivated) or postpartum psychosis (hearing voices, having bizarre 
and unshakable beliefs)). These problems can have huge consequences for mother 
and child. Yet, little research has been done in this area. In this study we want to 
examine whether there are changes, in response to stress, hormones, or in brain 
functioning, that can help us identify which women are most likely to develop these 
problems. Furthermore, we want to investigate how these problems affect the 
development of the baby. To achieve this, we aim to evaluate women who are at high 
risk or suffer from mental health problems around pregnancy and women who are at 
low risk of mental health problems around pregnancy, and their babies. We will look 
at the way mothers respond to stress, or whether there are changes in parts of the 
brain, or in the way these areas function, that makes them more likely to become 
unwell with the hormonal changes that happen around pregnancy. We will also look 
at whether these problems are associated with changes in the way the baby responds 
to stress and in the way he/she develops.  
 
Why have I been invited? 
We invited you to participate in our study because you are pregnant and your 
midwife or another healthcare professional have identified you as someone who may 
be at risk of developing, or actually suffering from, mental health problems. In total, 
we will include 150 pregnant women of which 100 will be at high and 50 at low risk 
for mental health problems. We would also like to include your baby after he/she is 
born. 
 
Do I have to take part? 
It is entirely up to you to decide whether or not to take part. We will describe the 






then ask you to sign a consent form to show you have agreed to take part. You are 
free to withdraw at any time, without giving a reason; this would not affect the 
standard of care you receive. 
 
What will happen to me and my baby if I take part?  
There will be up to 6 study visits, lasting 2-4 hours, over up to 18 months. The study 
itself will go on for four years in total.  
 
Visit 1  
Occurs when you are about 25 weeks pregnant. You will be seen by a clinical 
researcher who will ask you some background questions such as age, number of 
children, employment and ethnic origin. You will also complete clinical 
questionnaires and be asked about any problems you might experience concerning 
your mental health. You will have a blood test (20mls blood - about 1 tablespoon) to 
look at hormone levels and to assess your DNA. The researcher may also obtain 
background information from your medical notes. We are looking at cortisol (“stress 
hormone”) levels in saliva samples and you will be asked to provide saliva samples, 
which you can collect yourself on one of the following days after the visit. We will 
show you how to do this during your first visit.  
 
Visit 2 
Occurs shortly after the first visit. We will ask you again to complete some clinical 
questionnaires. In order to have a look at potential volume or function changes in 
brain areas, we will invite you to have a Magnetic Resonance Imaging (MRI) scan in 
our Centre for Neuroimaging Science shortly after your delivery. Therefore, during 
the current visit we will give you the opportunity to become familiar with our MRI 
scanner. You will be given the opportunity to lie in a mock-up scanner before lying 
in the real scanner. We will take a picture of your brain structure in the real scanner. 
We will also do a neurocognitive assessment, during which you will do some short 
tasks measuring domains such as attention or memory. Depending on how you feel, 






(EEG). For this, you would have to sit still for 5-10 minutes and consequently 
perform some simple cognitive tasks on a computer screen lasting approximately 20 
minutes.  
 
After this visit you will receive some short questionnaires by post and we will ask 
you to complete those and send them back to us, together with another set of saliva 
samples collected in the same way as during your first study visit.  
 
Visit 3 
This visit will take place shortly after your baby is born. We will ask you to fill in 
some questionnaires and answer questions concerning your mental health. Again, 
you will have a blood test to look at hormone levels (20mls blood - about 1 
tablespoon) and you will be asked to provide specimens of your saliva. 
During this scanning session (which will take about 90 minutes), we will collect 
pictures (scans) of your head while you are performing some simple cognitive tasks 
or while doing nothing (at rest). We use a very modern method of scanning known as 
Magnetic Resonance Imaging (MRI). This technique is commonly used to diagnose a 
number of diseases, but in this case it has been adapted to take images of which parts 
of your brain are active when you perform a task.  When a part of your brain is more 
active, more blood flows to that region. We will make a map of which parts of your 
brain has more blood flow than others. In order for us to take pictures of your brain, 
you will have to lie as still as possible in the MRI scanner. The scanner consists of a 
powerful magnet, but you will not feel any force or special sensation inside a 
magnetic field because your body is insensitive to it. Because of the magnetic field, 
you must not have a scan if you have received metal injuries to your eyes, had 
metallic objects (including clips) inserted into your body during an operation, or if 
you have received a gun shot injury or have a heart pace maker. The radiographer 
will go through a list of possible risks with you before you go into the scanner. 
Please note that MRI scans do not involve any form of ionising radiation (X-rays), 
but the scanner itself can be a bit claustrophobic; therefore please inform us if you 






microphone switched on so you can talk to us. We will talk to you regularly to 
explain what will happen next. Some people find the machine noisy, but the 
headphones we provide allow adequate acoustic protection for most people.   
Important: 
During the scan your baby can stay at the ward under the care of midwives. If you 
have already left the ward, a developmental psychologist who has been working in 
perinatal psychiatry for over 30 years will be available to assist with the care of your 
baby.  
 
Again, depending on how you feel, we will record the electrical activity of your brain 
with electroencephalography (EEG). For this, you would have to sit still for 5-10 
minutes and consequently perform some simple cognitive tasks on a computer screen 
lasting approximately 20 minutes. 
 
Following the delivery of your baby, the midwives will take a small section of the 
umbilical cord or some blood from the umbilical cord after it has been removed from 
your baby. We will use this to look at the baby’s DNA for genetic studies. A study 




At 6 days postpartum we would like to assess the behaviour and development of your 
baby using the Neonatal Behavioural Assessment Scale (NBAS). This assessment 
looks at the full range of neonatal behaviour, including competencies and strengths, 
in autonomic stability, motor organization; state organization, and self-quieting 
capacities. This assessment will last about 20-30 minutes. The researcher will collect 
a specimen of your baby’s saliva shortly before and after the assessment, to look at 
levels of the stress hormone, cortisol, cotinine (a marker of exposure to tobacco) and 









This visit will take place 8 weeks after delivery. Similar to visit 1, you will be seen 
by a clinical researcher who will ask you some background questions such as 
employment. You will also complete clinical questionnaires and be asked about any 
problems you might experience concerning your mental health. The researcher may 
also obtain background information from your medical notes. Again, you will be 
asked to provide saliva samples, which you can collect yourself on one of the 
following days after the visit.  
We would also like to look at the interactions between you and your baby. In order to 
do this we will make a 3-5 minute video recording, for which you will be asked to 
play and talk to your baby as you normally would. We will also obtain saliva 
samples from your baby, to look at “stress hormone” levels, cotinine and DNA. The 
clinical researcher will meet with you & your baby when you attend for the baby’s 
routine vaccinations, & show you how to obtain the sample. 
 
Visit 6 
This visit will take part 1 year after delivery. Similar to visit 3, we will ask you to fill 
in questionnaires and ask questions concerning your mental health; you will have a 
blood test and you will be asked to provide specimens of your saliva. In order to have 
a look at potential volume or function changes in brain areas we might invite you 
again to be scanned in our Centre for Neuroimaging Science record or also record the 
electrical activity of your brain with electroencephalography (EEG).  
 
We will also assess the behaviour and development of your baby again, and look at 
the interactions between you and your baby by making a new 3-5 minute video 
recording as in visit 5. We will also ask questions about baby’s feeding and 
medication, and maternal medications and collect saliva samples of your baby.  
 
The study assessments are over and above those involved in standard care; normal 






All video recordings are treated as confidential, will not be used for commercial 
purposes and will be destroyed when the study is completed. 
 
Expenses and payments.  
You will be reimbursed for travel expenses you incur in attending for study visits and 
receive £40 for the scanning visits.  
 
What will I have to do? 
If you wish to take part in the study, you will be asked to sign the consent form at the 
end of this document; you will be given a copy to keep. You should be prepared to 
undertake the 6 study visits, as detailed above. Please also consider that in agreeing 
to participate, you are also providing consent on behalf of the baby you are 
expecting. 
 
What are the possible disadvantages and risks of taking part? 
You may find the study visits/procedures inconvenient, particularly after your baby 
is born, as this is often a busy period for new mothers. It is also possible that you 
may experience some minor discomfort and/or bruising from the blood test. 
Although it is not painful, your baby may experience some distress on collection of 
saliva samples.  
During the study, it is possible that other conditions are discovered of which you 
were unaware, which may have implications for your future health, or otherwise 
impact on your interests. If anything is identified, your GP or hospital consultant will 
be informed, with your agreement. 
 
What are the possible benefits of taking part? 
There are no direct benefits to you of taking part in the study; however the 









What do I do if I want to withdraw from the study? 
You are free to withdraw from the study at any time you like. You will not be 
required to give us any reasons for withdrawal from the study but please inform us as 
soon as possible if you wish to do so. This would not affect the standard of care you 
receive. 
 
Will my participation be kept confidential? 
Yes. We will follow ethical and legal practice and all information about you will be 
handled in confidence. More information on confidentiality is given in Part II of this 
information sheet. 
 
If you have any questions about matters related to the study please contact Astrid 
Pauls (Astrid.Pauls@kcl.ac.uk) or Dr. Paola Dazzan (Paola.Dazzan@kcl.ac.uk or on 
0207 848 0070).   
 
If the information in Part 1 has interested you and you are considering participation, 









What if there is a problem?  
If you have a concern about any aspect of this study, you should ask to speak to the 
researchers who will do their best to answer your questions (tel. 0207 848 0070). If 
you remain unhappy and wish to complain formally, you can do this through the 
NHS Complaints Procedure; details can be obtained from the hospital. 
 
In the event that something does go wrong and you are harmed during the research 
and this is due to someone’s negligence, then you may have grounds for a legal 
action for compensation against King’s College Hospital Foundation NHS Trust or 
the study sponsor, King’s College London, but you may have to pay your legal costs. 
The normal National Health Service complaints mechanisms will still be available to 
you.  
 
What will happen if I don’t want to carry on with the study?  
If you withdraw from the study we will destroy all identifiable information about 
you. We will retain and continue to use any data collected before such withdrawal of 
consent unless you request that you do not want us to use any data collected from 
you. 
 
Will my taking part in this study be kept confidential? 
Yes, your confidentiality will be safeguarded during and after the study, which is 
conducted in accordance with the Data Protection Act 1998. An identification code 
will be allocated to you and later to your baby. The information we collect will be 
recorded and put into electronic databases using this code rather than your name. 
Paper and electronic records are stored securely at the Institute of Psychiatry; the 
custodian of all study materials is Dr Paola Dazzan (Chief Investigator).  
The researchers will have access to your clinical notes and those of your baby. By 
signing the consent, you will be giving consent for the researchers to examine your 






Study data will be analysed and results will be submitted for publication; your 
identity will not be revealed. Study data will be retained and may be used in future 
studies, if this happens, further Research Ethics Committee approval will be sought. 
Authorized persons such as researchers, sponsors, regulatory authorities and 
Research and Development audit will have access to view identifiable data, for 
monitoring of the quality of the research. Study data will be retained for 10 years 
after completion of the study; and will be disposed of securely. You have the right to 
check the accuracy of data held about you and correct any errors according to local 
law and procedures. 
 
What will happen to any samples I give? 
All samples from you and your baby will be processed and then stored prior to 
analysis using the identification code described. The researchers and laboratory 
scientists will have access to the samples; the researcher will be able to link your 
other study data to data from the analysis of your sample by the identification code. 
All samples will be disposed in accordance with the Human Tissue Authority’s Code 
of Practice once the study is completed. 
 
What will happen to the results of the research study? 
The data and results from this study may be published in medical journals or used in 
scientific reports and may be communicated to the regulatory authorities. You will 
not be identified by name. Once the study has been completed, a report of the 
findings will prepared for participants; you can request a copy using the contact 
details below. 
 
Who is organising and funding the research?  
The Chief Investigator, Dr. Paola Dazzan is organizing the research, which is 
sponsored by the Institute of Psychiatry, King’s College London, and funded by the 
National Alliance for Research on Schizophrenia and Depression (NARSAD), the 






involved in conducting this study do not receive any financial incentives for 
including you in this study and do not benefit financially from this study. 
 
Who has reviewed the study?  
This research has been looked at by an independent group of people, called a 
Research Ethics Committee to protect your safety, rights, wellbeing and dignity. This 
study has been reviewed by Joint SLAM/IOP Research ethics Committee Ref 
number: 10/H0807/14. 
 
If you have any questions about matters related to the study please contact Astrid 
Pauls (Astrid.Pauls@kcl.ac.uk) or Dr. Paola Dazzan (Paola.Dazzan@kcl.ac.uk or on 
0207 848 0070).   
 
You will receive a copy of the information leaflet and signed consent form to keep. 
 












Principal Contact for general queries:  
Astrid Pauls, Institute of Psychiatry, London SE5 8AF, Email: Astrid.Pauls@kcl.ac.uk 
 
 
Chief Investigator: Dr. Paola Dazzan, Institute of Psychiatry, London SE5 8AF  
Telephone: 0207 848 0070 
 
 
AGREEMENT TO PARTICIPATE 
Participant ID:   
Your Consent Please initial each box 
1. I confirm that I have read and understood the information sheet dated 
02.06.10 (Version 2) for the above study. I have had the opportunity to 
consider the information, ask questions and have had these answered. 
 
2. I understand that my participation is voluntary and that I am free to withdraw 
anytime without giving any reason and without my medical care or legal 
rights being affected. 
 
3. I give permission to members of the research team (Institute of Psychiatry) to 
access the sections of my clinical medical notes that are relevant to the study.    
 
4. I understand that members of research team at the Institute of Psychiatry will 
have access to the data from this study and agree not to restrict the use of any 
data or results, which arise from this study. 
 
5. I agree that my GP or hospital consultant will be informed if, during the 
study, other conditions are discovered of which I was unaware. 
 




Study Title: Risk factors of perinatal mental disorders: Stress, Electrophysiological, 
and Neuroimaging markers. (Research ethics Committee number: 10/H0807/14) 
Printed name of participant 
 
 Printed name of person explaining consent 
 
I have explained the study to the participant and 
answered all questions with regard to the study 
honestly and fully. 
   
 






































Frequency distributions of the performance and activation data of verbal memory, 










































































Facial emotion processing 
 
 
 
 
